1	Clinical	JJ	O	clinical	amod	2	SENT_1	[p1l594t81r727b111],
2	Therapeutics/Volume	NN	O	therapeutics/volume	_	0	SENT_1	[p1l742t81r1142b121],
3	32	CD	NUMBER	32	dep	2	SENT_1	[p1l1158t83r1215b118],
4	,	,	O	,	_	0	SENT_1	[p1l1158t83r1215b118],
5	Number	NNP	O	Number	appos	3	SENT_1	[p1l1234t81r1384b111],
6	12	CD	NUMBER	12	num	5	SENT_1	[p1l1400t83r1455b117],
7	,	,	O	,	_	0	SENT_1	[p1l1400t83r1455b117],
8	2010	CD	DATE	2010	num	5	SENT_1	[p1l1474t83r1566b111],

1	Efficacy	NN	O	efficacy	_	0	SENT_2	[p1l69t196r329b271],
2	and	CC	O	and	_	0	SENT_2	[p1l356t196r473b255],
3	Tolerability	NN	O	tolerability	conj_and	1	SENT_2	[p1l498t196r871b271],
4	of	IN	O	of	_	0	SENT_2	[p1l897t196r962b255],
5	First-Line	NNP	O	First-Line	nn	7	SENT_2	[p1l984t199r1291b255],
6	Triple	JJ	O	triple	amod	7	SENT_2	[p1l1316t196r1508b271],
7	Therapy	NN	O	therapy	prep_of	1	SENT_2	[p1l1533t196r1805b271],
8	With	IN	O	with	_	0	SENT_2	[p1l68t280r229b339],
9	Levofloxacin	NN	O	levofloxacin	prep_with	7	SENT_2	[p1l255t280r672b339],
10	and	CC	O	and	_	0	SENT_2	[p1l699t280r816b339],
11	Amoxicillin	NNP	O	Amoxicillin	nn	13	SENT_2	[p1l841t280r1222b339],
12	Plus	NNP	O	Plus	nn	13	SENT_2	[p1l1248t280r1375b339],
13	Esomeprazole	NNP	O	Esomeprazole	conj_and	9	SENT_2	[p1l1402t280r1846b355],
14	or	CC	O	or	_	0	SENT_2	[p1l1873t302r1940b339],
15	Rabeprazole	NNP	MISC	Rabeprazole	conj_or	7	SENT_2	[p1l70t363r469b438],
16	for	IN	O	for	_	0	SENT_2	[p1l496t363r587b422],
17	the	DT	O	the	det	18	SENT_2	[p1l612t363r709b422],
18	Eradication	NN	O	eradication	prep_for	15	SENT_2	[p1l735t363r1106b422],
19	of	IN	O	of	_	0	SENT_2	[p1l1133t363r1198b422],
20	Helicobacter	NNP	O	Helicobacter	nn	22	SENT_2	[p1l1218t363r1640b422],
21	pylori	NNP	O	pylori	nn	22	SENT_2	[p1l1657t363r1856b439],
22	Infection	NN	O	infection	prep_of	18	SENT_2	[p1l69t446r356b505],
23	and	CC	O	and	_	0	SENT_2	[p1l384t446r500b505],
24	the	DT	O	the	det	25	SENT_2	[p1l526t446r623b505],
25	Effect	NN	MISC	effect	conj_and	18	SENT_2	[p1l649t446r835b505],
26	of	IN	MISC	of	_	0	SENT_2	[p1l862t446r927b505],
27	CYPZCI9	NNP	MISC	CYPZCI9	nn	28	SENT_2	[p1l953t450r1274b505],
28	Genotype	NNP	MISC	Genotype	prep_of	25	SENT_2	[p1l1301t450r1629b521],
29	:	:	O	:	_	0	SENT_2	[p1l1301t450r1629b521],
30	A	NNP	O	A	nn	36	SENT_2	[p1l1657t449r1709b504],
31	1-Week	NNP	DURATION	1-Week	nn	36	SENT_2	[p1l1739t446r1987b517],
32	,	,	O	,	_	0	SENT_2	[p1l1739t446r1987b517],
33	Randomized	NNP	O	Randomized	appos	36	SENT_2	[p1l70t530r496b601],
34	,	,	O	,	_	0	SENT_2	[p1l70t530r496b601],
35	Open-Label	NNP	O	Open-Label	appos	36	SENT_2	[p1l525t530r905b605],
36	Study	NNP	O	Study	dep	1	SENT_2	[p1l933t530r1111b605],
37	in	IN	O	in	_	0	SENT_2	[p1l1136t533r1197b588],
38	Chinese	NNP	O	Chinese	nn	39	SENT_2	[p1l1224t530r1475b589],
39	Adults	NNS	O	adult	prep_in	36	SENT_2	[p1l1500t530r1707b589],

1	Xiaolin	NNP	PERSON	Xiaolin	nn	2	SENT_3	[p1l67t680r220b719],
2	Pan	NNP	PERSON	Pan	_	0	SENT_3	[p1l243t683r336b728],
3	,	,	O	,	_	0	SENT_3	[p1l243t683r336b728],
4	MD	NN	O	md	nsubj	21	SENT_3	[p1l358t683r453b728],
5	;	:	O	;	_	0	SENT_3	[p1l358t683r453b728],
6	Yuqing	NNP	PERSON	Yuqing	nn	7	SENT_3	[p1l469t681r622b733],
7	Li	NNP	PERSON	Li	dep	4	SENT_3	[p1l642t681r688b728],
8	,	,	O	,	_	0	SENT_3	[p1l642t681r688b728],
9	MD	NN	O	md	appos	7	SENT_3	[p1l710t683r805b728],
10	;	:	O	;	_	0	SENT_3	[p1l710t683r805b728],
11	Yuping	NNP	PERSON	Yuping	nn	12	SENT_3	[p1l822t681r974b733],
12	Qiu	NNP	PERSON	Qiu	dep	7	SENT_3	[p1l992t681r1085b728],
13	,	,	O	,	_	0	SENT_3	[p1l992t681r1085b728],
14	MD	NN	O	md	appos	12	SENT_3	[p1l1106t683r1202b728],
15	;	:	O	;	_	0	SENT_3	[p1l1106t683r1202b728],
16	Qiyun	NNP	PERSON	Qiyun	nn	17	SENT_3	[p1l1222t681r1353b732],
17	Tang	NNP	PERSON	Tang	dep	7	SENT_3	[p1l1370t683r1493b733],
18	,	,	O	,	_	0	SENT_3	[p1l1370t683r1493b733],
19	PhD	NN	O	phd	appos	17	SENT_3	[p1l1516t680r1621b728],
20	;	:	O	;	_	0	SENT_3	[p1l1516t680r1621b728],
21	Bingbing	VBG	O	bingb	dep	2	SENT_3	[p1l73t742r267b795],
22	Qian	NNP	O	Qian	dobj	21	SENT_3	[p1l284t743r405b790],
23	,	,	O	,	_	0	SENT_3	[p1l284t743r405b790],
24	MD	NN	O	md	appos	2	SENT_3	[p1l427t745r521b790],
25	;	:	O	;	_	0	SENT_3	[p1l427t745r521b790],
26	Linhua	NNP	PERSON	Linhua	nn	27	SENT_3	[p1l544t742r692b781],
27	Yao	NNP	PERSON	Yao	dep	2	SENT_3	[p1l706t745r799b790],
28	,	,	O	,	_	0	SENT_3	[p1l706t745r799b790],
29	MD	NN	O	md	appos	27	SENT_3	[p1l821t745r916b790],
30	;	:	O	;	_	0	SENT_3	[p1l821t745r916b790],
31	Ruihua	NNP	PERSON	Ruihua	nn	32	SENT_3	[p1l938t742r1094b781],
32	Shi	NNP	PERSON	Shi	conj_and	27	SENT_3	[p1l1110t742r1189b790],
33	,	,	O	,	_	0	SENT_3	[p1l1110t742r1189b790],
34	PhD	NN	O	phd	appos	32	SENT_3	[p1l1211t742r1316b790],
35	;	:	O	;	_	0	SENT_3	[p1l1211t742r1316b790],
36	and	CC	O	and	_	0	SENT_3	[p1l1337t742r1417b781],
37	Guoxin	NNP	PERSON	Guoxin	nn	38	SENT_3	[p1l1438t743r1594b781],
38	Zhang	NNP	PERSON	Zhang	dep	2	SENT_3	[p1l1613t742r1767b795],
39	,	,	O	,	_	0	SENT_3	[p1l1613t742r1767b795],
40	PhD	NNP	O	PhD	nn	41	SENT_3	[p1l1790t742r1881b780],
41	Department	NNP	O	Department	appos	2	SENT_3	[p1l70t811r299b858],
42	of	IN	O	of	_	0	SENT_3	[p1l312t808r356b855],
43	Gastroenterology	NNP	O	Gastroenterology	prep_of	41	SENT_3	[p1l362t808r686b858],
44	,	,	O	,	_	0	SENT_3	[p1l362t808r686b858],
45	First	NNP	ORGANIZATION	First	nn	47	SENT_3	[p1l706t810r790b845],
46	Affiliated	NNP	ORGANIZATION	Affiliated	nn	47	SENT_3	[p1l800t808r981b855],
47	Hospital	NNP	ORGANIZATION	Hospital	appos	2	SENT_3	[p1l995t808r1152b858],
48	of	IN	ORGANIZATION	of	_	0	SENT_3	[p1l1165t808r1209b855],
49	Nanjing	NNP	ORGANIZATION	Nanjing	nn	51	SENT_3	[p1l1213t810r1360b858],
50	Medical	NNP	ORGANIZATION	Medical	nn	51	SENT_3	[p1l1371t808r1521b845],
51	University	NNP	ORGANIZATION	University	prep_of	47	SENT_3	[p1l1536t810r1724b858],
52	,	,	O	,	_	0	SENT_3	[p1l1536t810r1724b858],
53	Nanjing	NNP	LOCATION	Nanjing	appos	2	SENT_3	[p1l1743t810r1898b858],
54	,	,	O	,	_	0	SENT_3	[p1l1743t810r1898b858],
55	China	NNP	LOCATION	China	appos	2	SENT_3	[p1l1920t808r2035b845],
56	.	.	O	.	_	0	SENT_3	[p1l1920t808r2035b845],

1	ABSTRACT	NN	O	abstract	_	0	SENT_4	[p1l6t970r521b1038],

1	Background	NN	O	background	_	0	SENT_5	[p1l118t1084r619b1176],
2	:	:	O	:	_	0	SENT_5	[p1l118t1084r619b1176],
3	First-line	JJ	O	first-line	amod	5	SENT_5	[p1l646t1085r990b1157],
4	triple	JJ	O	triple	amod	5	SENT_5	[p1l1014t1085r1217b1176],
5	therapy	NN	O	therapy	nsubjpass	23	SENT_5	[p1l1241t1084r1538b1176],
6	with	IN	O	with	_	0	SENT_5	[p1l1560t1084r1735b1157],
7	levofloXacin	NN	O	levofloxacin	prep_with	5	SENT_5	[p1l1759t1084r2148b1157, p1l8t1206r122b1274],
8	and	CC	O	and	_	0	SENT_5	[p1l157t1202r300b1274],
9	amoxicillin	NNP	O	amoxicillin	conj_and	5	SENT_5	[p1l336t1202r777b1274],
10	plus	CC	O	plus	_	0	SENT_5	[p1l810t1202r969b1294],
11	a	DT	O	a	det	14	SENT_5	[p1l1006t1230r1045b1274],
12	proton	NN	O	proton	nn	14	SENT_5	[p1l1079t1222r1348b1294],
13	pump	NN	O	pump	nn	14	SENT_5	[p1l1381t1229r1607b1294],
14	inhibitor	NN	O	inhibitor	conj_plus	9	SENT_5	[p1l1642t1202r1988b1274],
15	has	VBZ	O	have	aux	17	SENT_5	[p1l2021t1202r2149b1274],
16	been	VBN	O	be	auxpass	17	SENT_5	[p1l10t1320r189b1392],
17	reported	VBN	O	report	dep	1	SENT_5	[p1l221t1320r556b1412],
18	to	TO	O	to	aux	20	SENT_5	[p1l588t1340r664b1392],
19	be	VB	O	be	cop	20	SENT_5	[p1l700t1320r785b1392],
20	effective	JJ	O	effective	xcomp	17	SENT_5	[p1l819t1320r1142b1392],
21	and	CC	O	and	_	0	SENT_5	[p1l1176t1320r1319b1392],
22	well	RB	O	well	advmod	23	SENT_5	[p1l1350t1320r1511b1392],
23	tolerated	VBD	O	tolerate	dep	1	SENT_5	[p1l1543t1320r1894b1392],
24	in	IN	O	in	_	0	SENT_5	[p1l1926t1325r1999b1391],
25	the	DT	O	the	det	26	SENT_5	[p1l2030t1320r2149b1392],
26	eradication	NN	O	eradication	prep_in	23	SENT_5	[p1l9t1438r456b1510],
27	of	IN	O	of	_	0	SENT_5	[p1l501t1438r583b1510],
28	Helicobacter	NNP	O	Helicobacter	nn	30	SENT_5	[p1l622t1438r1135b1510],
29	pylori	NN	O	pylorus	nn	30	SENT_5	[p1l1174t1438r1410b1530],
30	infection	NN	O	infection	prep_of	26	SENT_5	[p1l1453t1438r1823b1510],
31	.	.	O	.	_	0	SENT_5	[p1l1453t1438r1823b1510],

1	Studies	NNS	O	study	nsubj	3	SENT_6	[p1l1870t1438r2148b1510],
2	have	VBP	O	have	aux	3	SENT_6	[p1l8t1556r185b1628],
3	reported	VBN	O	report	_	0	SENT_6	[p1l210t1556r539b1648],
4	that	IN	O	that	complm	13	SENT_6	[p1l562t1556r716b1628],
5	cytochrome	NN	O	cytochrome	nn	6	SENT_6	[p1l739t1556r1194b1647],
6	P450	NN	O	p450	nsubj	13	SENT_6	[p1l1218t1561r1415b1628],
7	(	CD	NUMBER	(	num	8	SENT_6	[p1l1446t1560r1672b1644],
8	CYP	NN	O	cyp	dep	6	SENT_6	[p1l1446t1560r1672b1644],
9	)	CD	NUMBER	)	num	11	SENT_6	[p1l1446t1560r1672b1644],
10	2C19	NN	O	2c19	nn	11	SENT_6	[p1l1699t1560r1912b1628],
11	genotypes	NNS	O	genotype	dep	6	SENT_6	[p1l1937t1584r2149b1648, p1l7t1694r207b1766],
12	may	MD	O	may	aux	13	SENT_6	[p1l232t1702r398b1766],
13	affect	VB	O	affect	ccomp	3	SENT_6	[p1l423t1674r637b1746],
14	the	DT	O	the	det	16	SENT_6	[p1l660t1674r778b1746],
15	clinical	JJ	O	clinical	amod	16	SENT_6	[p1l803t1674r1079b1746],
16	efficacy	NN	O	efficacy	dobj	13	SENT_6	[p1l1105t1674r1402b1766],
17	of	IN	O	of	_	0	SENT_6	[p1l1427t1674r1507b1746],
18	clarithromycin	NN	O	clarithromycin	nn	19	SENT_6	[p1l1527t1674r2153b1766],
19	—	NN	O	—	prep_of	16	SENT_6	[p1l1527t1674r2153b1766],
20	based	VBN	O	base	prep	13	SENT_6	[p1l10t1792r228b1864],
21	triple	JJ	O	triple	amod	22	SENT_6	[p1l252t1792r457b1884],
22	therapies	NNS	O	therapy	dep	20	SENT_6	[p1l481t1792r858b1884],
23	,	,	O	,	_	0	SENT_6	[p1l481t1792r858b1884],
24	although	IN	O	although	mark	26	SENT_6	[p1l883t1792r1229b1884],
25	there	EX	O	there	expl	26	SENT_6	[p1l1253t1792r1447b1864],
26	is	VBZ	O	be	dep	22	SENT_6	[p1l1473t1797r1528b1864],
27	only	RB	O	only	advmod	29	SENT_6	[p1l1556t1792r1725b1884],
28	one	CD	NUMBER	one	num	29	SENT_6	[p1l1750t1821r1886b1864],
29	report	NN	O	report	nsubj	26	SENT_6	[p1l1911t1813r2153b1884],
30	of	IN	O	of	_	0	SENT_6	[p1l10t1910r95b1982],
31	such	PDT	O	such	predet	33	SENT_6	[p1l148t1910r331b1982],
32	an	DT	O	a	det	33	SENT_6	[p1l389t1938r485b1982],
33	effect	NN	O	effect	prep_of	29	SENT_6	[p1l542t1910r768b1982],
34	with	IN	O	with	_	0	SENT_6	[p1l822t1910r1008b1982],
35	levofloXacin	NN	O	levofloxacin	prep_with	33	SENT_6	[p1l1065t1910r1872b1982],
36	—	CD	NUMBER	—	num	35	SENT_6	[p1l1065t1910r1872b1982],
37	based	VBN	O	base	partmod	35	SENT_6	[p1l1065t1910r1872b1982],
38	triple	JJ	O	triple	amod	39	SENT_6	[p1l1927t1910r2148b2002],
39	therapies	NNS	O	therapy	dobj	37	SENT_6	[p1l7t2028r385b2120],
40	.	.	O	.	_	0	SENT_6	[p1l7t2028r385b2120],

1	Objectives	NNS	O	objective	_	0	SENT_7	[p1l120t2146r550b2238],
2	:	:	O	:	_	0	SENT_7	[p1l120t2146r550b2238],
3	This	DT	O	this	det	4	SENT_7	[p1l573t2146r743b2218],
4	study	NN	O	study	nsubj	5	SENT_7	[p1l771t2146r982b2238],
5	evaluated	VBD	O	evaluate	dep	1	SENT_7	[p1l1006t2146r1381b2218],
6	the	DT	O	the	det	8	SENT_7	[p1l1406t2146r1524b2218],
7	clinical	JJ	O	clinical	amod	8	SENT_7	[p1l1550t2146r1828b2218],
8	efficacy	NN	O	efficacy	dobj	5	SENT_7	[p1l1854t2146r2153b2238],
9	and	CC	O	and	_	0	SENT_7	[p1l9t2264r153b2336],
10	tolerability	NN	O	tolerability	dobj	5	SENT_7	[p1l193t2264r627b2356],
11	of	IN	O	of	_	0	SENT_7	[p1l669t2264r750b2336],
12	a	DT	O	a	det	14	SENT_7	[p1l787t2292r826b2336],
13	1-week	JJ	DURATION	1-week	amod	14	SENT_7	[p1l875t2264r1152b2336],
14	course	NN	O	course	prep_of	8	SENT_7	[p1l1192t2292r1444b2336],
15	of	IN	O	of	_	0	SENT_7	[p1l1487t2264r1568b2336],
16	triple	JJ	O	triple	amod	17	SENT_7	[p1l1603t2264r1810b2356],
17	therapy	NN	O	therapy	prep_of	14	SENT_7	[p1l1851t2264r2151b2356],
18	with	IN	O	with	_	0	SENT_7	[p1l7t2382r184b2454],
19	levofloxacin	NN	O	levofloxacin	prep_with	17	SENT_7	[p1l224t2382r708b2454],
20	and	CC	O	and	_	0	SENT_7	[p1l749t2382r892b2454],
21	amoxicillin	NNP	O	amoxicillin	prep_of	14	SENT_7	[p1l934t2382r1375b2454],
22	plus	CC	O	plus	prep	21	SENT_7	[p1l1414t2382r1574b2474],
23	esomeprazole	NN	O	esomeprazole	dep	22	SENT_7	[p1l1616t2382r2150b2474],
24	or	CC	O	or	_	0	SENT_7	[p1l9t2529r91b2572],
25	rabeprazole	NN	O	rabeprazole	dep	22	SENT_7	[p1l115t2500r572b2592],
26	as	IN	O	as	_	0	SENT_7	[p1l599t2529r673b2572],
27	first-line	JJ	O	first-line	amod	28	SENT_7	[p1l700t2500r1024b2572],
28	treatment	NN	O	treatment	prep_as	5	SENT_7	[p1l1049t2521r1427b2572],
29	for	IN	O	for	_	0	SENT_7	[p1l1451t2500r1564b2572],
30	H	NN	O	h	nn	32	SENT_7	[p1l1587t2506r1665b2571],
31	pylori	NN	O	pylorus	nn	32	SENT_7	[p1l1682t2500r1913b2592],
32	infection	NN	O	infection	prep_for	28	SENT_7	[p1l1936t2500r2149b2572, p1l7t2622r166b2690],
33	in	IN	O	in	_	0	SENT_7	[p1l211t2622r285b2689],
34	Chinese	JJ	MISC	chinese	amod	35	SENT_7	[p1l332t2618r643b2690],
35	adults	NNS	O	adult	prep_in	32	SENT_7	[p1l690t2618r952b2690],
36	.	.	O	.	_	0	SENT_7	[p1l690t2618r952b2690],

1	It	PRP	O	it	nsubj	3	SENT_8	[p1l998t2623r1056b2690],
2	also	RB	O	also	advmod	3	SENT_8	[p1l1102t2618r1257b2690],
3	investigated	VBD	O	investigate	_	0	SENT_8	[p1l1303t2618r1781b2710],
4	whether	IN	O	whether	complm	9	SENT_8	[p1l1824t2618r2151b2690],
5	CYP2	NN	O	cyp2	nn	6	SENT_8	[p1l14t2740r254b2808],
6	C19	NN	O	c19	nsubj	9	SENT_8	[p1l273t2740r443b2808],
7	genotype	NN	O	genotype	nn	8	SENT_8	[p1l529t2756r922b2828],
8	status	NN	O	status	dep	6	SENT_8	[p1l1008t2756r1258b2808],
9	affected	VBD	O	affect	ccomp	3	SENT_8	[p1l1346t2736r1690b2808],
10	rates	NNS	O	rate	dobj	9	SENT_8	[p1l1774t2756r1980b2808],
11	of	IN	O	of	_	0	SENT_8	[p1l2067t2736r2154b2808],
12	H	NN	O	h	nn	14	SENT_8	[p1l7t2860r86b2925],
13	pylori	NN	O	pylorus	nn	14	SENT_8	[p1l108t2854r342b2946],
14	eradication	NN	O	eradication	prep_of	10	SENT_8	[p1l371t2854r813b2926],
15	with	IN	O	with	_	0	SENT_8	[p1l842t2854r1019b2926],
16	these	DT	O	these	det	17	SENT_8	[p1l1048t2854r1244b2926],
17	regimens	NNS	O	regimen	prep_with	9	SENT_8	[p1l1275t2859r1647b2946],
18	.	.	O	.	_	0	SENT_8	[p1l1275t2859r1647b2946],

1	Methods	NNS	O	method	nsubjpass	24	SENT_9	[p1l118t2972r496b3044],
2	:	:	O	:	_	0	SENT_9	[p1l118t2972r496b3044],
3	Consecutive	JJ	O	consecutive	amod	4	SENT_9	[p1l545t2976r1025b3044],
4	patients	NNS	O	patient	dep	1	SENT_9	[p1l1069t2976r1380b3064],
5	undergoing	VBG	O	undergo	partmod	4	SENT_9	[p1l1426t2972r1878b3064],
6	upper	JJ	O	upper	amod	7	SENT_9	[p1l1922t2999r2151b3064],
7	endoscopy	NN	O	endoscopy	dobj	5	SENT_9	[p1l9t3090r427b3182],
8	at	IN	O	at	_	0	SENT_9	[p1l463t3110r535b3162],
9	the	DT	O	the	det	12	SENT_9	[p1l570t3090r689b3162],
10	First	NNP	ORGANIZATION	First	nn	12	SENT_9	[p1l726t3095r902b3162],
11	Affiliated	NNP	ORGANIZATION	Affiliated	nn	12	SENT_9	[p1l933t3090r1304b3162],
12	Hospital	NNP	ORGANIZATION	Hospital	prep_at	5	SENT_9	[p1l1340t3090r1680b3182],
13	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l1718t3090r1799b3162],
14	Nanjing	NNP	ORGANIZATION	Nanjing	nn	16	SENT_9	[p1l1830t3095r2151b3182],
15	Medical	NNP	ORGANIZATION	Medical	nn	16	SENT_9	[p1l8t3209r328b3281],
16	University	NNP	ORGANIZATION	University	prep_of	12	SENT_9	[p1l369t3213r773b3300],
17	between	IN	O	between	_	0	SENT_9	[p1l817t3209r1140b3281],
18	May	NNP	DATE	May	prep_between	16	SENT_9	[p1l1183t3214r1365b3300],
19	2008	CD	DATE	2008	num	18	SENT_9	[p1l1407t3214r1603b3281],
20	and	CC	O	and	_	0	SENT_9	[p1l1653t3208r1796b3281],
21	January	NNP	DATE	January	conj_and	18	SENT_9	[p1l1834t3214r2150b3300],
22	2009	CD	DATE	2009	num	21	SENT_9	[p1l8t3331r208b3398],
23	were	VBD	O	be	auxpass	24	SENT_9	[p1l254t3354r442b3398],
24	evaluated	VBN	O	evaluate	_	0	SENT_9	[p1l487t3326r866b3398],
25	for	IN	O	for	_	0	SENT_9	[p1l911t3326r1025b3398],
26	inclusion	NN	O	inclusion	prep_for	24	SENT_9	[p1l1069t3326r1450b3398],
27	.	.	O	.	_	0	SENT_9	[p1l1069t3326r1450b3398],

1	Eligible	JJ	O	eligible	amod	2	SENT_10	[p1l1495t3326r1791b3418],
2	patients	NNS	O	patient	nsubj	4	SENT_10	[p1l1835t3330r2146b3418],
3	were	VBD	O	be	cop	4	SENT_10	[p1l7t3472r193b3516],
4	those	DT	O	those	_	0	SENT_10	[p1l229t3444r436b3516],
5	who	WP	O	who	nsubj	6	SENT_10	[p1l471t3444r641b3516],
6	tested	VBD	O	test	rcmod	4	SENT_10	[p1l678t3444r905b3516],
7	positive	JJ	O	positive	acomp	6	SENT_10	[p1l941t3449r1245b3536],
8	for	IN	O	for	_	0	SENT_10	[p1l1282t3444r1395b3516],
9	H	NN	O	h	nn	11	SENT_10	[p1l1430t3450r1508b3515],
10	pylori	NN	O	pylorus	nn	11	SENT_10	[p1l1537t3444r1771b3536],
11	infection	NN	O	infection	prep_for	7	SENT_10	[p1l1805t3444r2150b3516],
12	on	IN	O	on	_	0	SENT_10	[p1l9t3591r107b3634],
13	biopsy-based	JJ	O	biopsy-based	amod	16	SENT_10	[p1l140t3562r653b3654],
14	testing	NN	O	testing	nn	16	SENT_10	[p1l684t3567r943b3654],
15	(	CD	NUMBER	(	num	16	SENT_10	[p1l979t3567r1091b3651],
16	ie	NN	O	ie	prep_on	11	SENT_10	[p1l979t3567r1091b3651],
17	,	,	O	,	_	0	SENT_10	[p1l979t3567r1091b3651],
18	histology	NN	O	histology	conj_and	11	SENT_10	[p1l1121t3562r1483b3654],
19	and	CC	O	and	_	0	SENT_10	[p1l1515t3562r1659b3634],
20	an	DT	O	a	det	24	SENT_10	[p1l1692t3591r1784b3634],
21	in-house	JJ	O	in-house	amod	24	SENT_10	[p1l1815t3562r2149b3634],
22	rapid	JJ	O	rapid	amod	24	SENT_10	[p1l8t3679r215b3771],
23	urease	NN	O	urease	nn	24	SENT_10	[p1l251t3707r497b3751],
24	test	NN	O	test	prep_for	7	SENT_10	[p1l533t3684r694b3767],
25	)	CD	NUMBER	)	tmod	6	SENT_10	[p1l533t3684r694b3767],
26	or	CC	O	or	_	0	SENT_10	[p1l737t3707r819b3751],
27	a	DT	O	a	conj_or	25	SENT_10	[p1l856t3707r895b3751],
28	validated	VBN	O	validate	partmod	25	SENT_10	[p1l932t3679r1293b3751],
29	13C-urea	NN	O	13c-urea	nn	31	SENT_10	[p1l1333t3676r1668b3751],
30	breath	NN	O	breath	nn	31	SENT_10	[p1l1707t3679r1958b3751],
31	test	NN	O	test	dep	25	SENT_10	[p1l1993t3699r2149b3751],
32	.	.	O	.	_	0	SENT_10	[p1l1993t3699r2149b3751],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_11	[p2l8t25r316b92],
2	were	VBD	O	be	auxpass	3	SENT_11	[p2l349t48r536b92],
3	randomized	VBN	O	randomize	_	0	SENT_11	[p2l570t20r1038b92],
4	in	IN	O	in	_	0	SENT_11	[p2l1072t25r1145b91],
5	an	DT	O	a	det	7	SENT_11	[p2l1179t48r1272b92],
6	open-label	JJ	O	open-label	amod	7	SENT_11	[p2l1306t20r1717b112],
7	fashion	NN	O	fashion	prep_in	3	SENT_11	[p2l1751t20r2039b92],
8	to	TO	O	to	aux	9	SENT_11	[p2l2072t40r2149b92],
9	receive	VB	O	receive	xcomp	3	SENT_11	[p2l8t143r270b211],
10	levofloxacin	NN	O	levofloxacin	nn	12	SENT_11	[p2l296t138r771b211],
11	500	CD	NUMBER	500	num	12	SENT_11	[p2l797t144r941b211],
12	mg/d	NN	O	mg/d	dobj	9	SENT_11	[p2l966t139r1160b230],
13	and	CC	O	and	_	0	SENT_11	[p2l1186t139r1327b211],
14	amoxicillin	NNP	O	amoxicillin	conj_and	12	SENT_11	[p2l1352t138r1786b211],
15	1000	CD	DATE	1000	num	17	SENT_11	[p2l1816t144r2006b211],
16	mg	NN	O	mg	nn	17	SENT_11	[p2l2032t167r2150b230],
17	BID	NNP	O	BID	dep	14	SENT_11	[p2l9t261r160b327],
18	plus	CC	O	plus	_	0	SENT_11	[p2l203t256r362b348],
19	either	CC	O	either	advmod	12	SENT_11	[p2l405t256r626b328],
20	esomeprazole	NN	O	esomeprazole	nn	22	SENT_11	[p2l667t256r1200b348],
21	20	CD	NUMBER	20	num	22	SENT_11	[p2l1241t261r1338b328],
22	mg	NN	O	mg	dobj	9	SENT_11	[p2l1380t284r1500b348],
23	BID	NNP	O	BID	nn	25	SENT_11	[p2l1540t261r1691b327],
24	(	CD	NUMBER	(	num	25	SENT_11	[p2l1740t260r1996b348],
25	group	NN	O	group	dep	22	SENT_11	[p2l1740t260r1996b348],
26	A	DT	O	a	det	27	SENT_11	[p2l2034t259r2151b344],
27	)	NN	O	)	dep	22	SENT_11	[p2l2034t259r2151b344],
28	,	,	O	,	_	0	SENT_11	[p2l2034t259r2151b344],
29	esomeprazole	NN	O	esomeprazole	dobj	9	SENT_11	[p2l9t374r517b466],
30	40	CD	NUMBER	40	num	32	SENT_11	[p2l538t379r632b446],
31	mg	NN	O	mg	nn	32	SENT_11	[p2l654t402r771b466],
32	BID	NNP	O	BID	dep	29	SENT_11	[p2l792t380r938b445],
33	(	CD	NUMBER	(	num	36	SENT_11	[p2l967t379r1212b466],
34	group	NN	O	group	nn	36	SENT_11	[p2l967t379r1212b466],
35	B	NN	O	b	nn	36	SENT_11	[p2l1235t379r1335b463],
36	)	NN	O	)	dep	29	SENT_11	[p2l1235t379r1335b463],
37	,	,	O	,	_	0	SENT_11	[p2l1235t379r1335b463],
38	or	CC	O	or	_	0	SENT_11	[p2l1356t402r1435b446],
39	rabeprazole	NN	O	rabeprazole	dobj	9	SENT_11	[p2l1456t374r1895b466],
40	10	CD	NUMBER	10	num	42	SENT_11	[p2l1923t379r2010b446],
41	mg	NN	O	mg	nn	42	SENT_11	[p2l2033t402r2151b466],
42	BID	NNP	O	BID	dep	39	SENT_11	[p2l9t498r158b563],
43	(	CD	NUMBER	(	num	46	SENT_11	[p2l189t497r441b584],
44	group	NN	O	group	nn	46	SENT_11	[p2l189t497r441b584],
45	C	NN	O	c	nn	46	SENT_11	[p2l469t497r553b581],
46	)	NN	O	)	dep	39	SENT_11	[p2l469t497r553b581],
47	for	IN	O	for	_	0	SENT_11	[p2l582t492r693b565],
48	1	CD	DURATION	1	num	49	SENT_11	[p2l723t498r756b563],
49	week	NN	NUMBER	week	prep_for	9	SENT_11	[p2l785t493r1005b565],
50	.	.	O	.	_	0	SENT_11	[p2l785t493r1005b565],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_12	[p2l1029t497r1331b565],
2	were	VBD	O	be	auxpass	3	SENT_12	[p2l1355t521r1537b565],
3	asked	VBN	O	ask	_	0	SENT_12	[p2l1563t493r1779b565],
4	to	TO	O	to	aux	5	SENT_12	[p2l1802t513r1878b565],
5	record	VB	O	record	xcomp	3	SENT_12	[p2l1903t492r2151b565],
6	adverse	JJ	O	adverse	amod	7	SENT_12	[p2l9t610r301b682],
7	events	NNS	O	event	dobj	5	SENT_12	[p2l331t630r571b682],
8	in	IN	O	in	_	0	SENT_12	[p2l601t614r673b681],
9	a	DT	O	a	det	10	SENT_12	[p2l702t638r742b682],
10	diary	NN	O	diary	prep_in	5	SENT_12	[p2l772t610r985b701],
11	.	.	O	.	_	0	SENT_12	[p2l772t610r985b701],

1	Trained	VBN	O	train	amod	3	SENT_13	[p2l1009t610r1313b682],
2	study	NN	O	study	nn	3	SENT_13	[p2l1343t610r1554b702],
3	assistants	NNS	O	assistant	_	0	SENT_13	[p2l1582t614r1950b682],
4	contacted	VBN	O	contact	partmod	3	SENT_13	[p2l1979t638r2149b682, p2l7t728r245b800],
5	patients	NNS	O	patient	dobj	4	SENT_13	[p2l271t733r580b820],
6	by	IN	O	by	_	0	SENT_13	[p2l610t728r702b820],
7	telephone	NN	O	telephone	agent	4	SENT_13	[p2l727t728r1108b820],
8	within	IN	O	within	_	0	SENT_13	[p2l1134t728r1388b800],
9	the	DT	DURATION	the	det	11	SENT_13	[p2l1414t728r1533b800],
10	first	JJ	DURATION	first	amod	11	SENT_13	[p2l1561t728r1716b800],
11	week	NN	DURATION	week	prep_within	4	SENT_13	[p2l1740t728r1942b800],
12	after	IN	O	after	_	0	SENT_13	[p2l1971t728r2150b800],
13	completion	NN	O	completion	prep_after	3	SENT_13	[p2l8t847r451b938],
14	of	IN	O	of	_	0	SENT_13	[p2l483t846r564b919],
15	therapy	NN	O	therapy	prep_of	3	SENT_13	[p2l589t847r890b938],
16	to	TO	O	to	aux	17	SENT_13	[p2l918t867r995b919],
17	collect	VB	O	collect	infmod	15	SENT_13	[p2l1027t847r1281b919],
18	data	NNS	O	datum	dobj	17	SENT_13	[p2l1312t847r1479b919],
19	on	IN	O	on	_	0	SENT_13	[p2l1513t875r1610b919],
20	drug	NN	O	drug	nn	21	SENT_13	[p2l1642t847r1821b938],
21	compliance	NN	O	compliance	prep_on	17	SENT_13	[p2l1851t846r2149b938, p2l9t992r179b1036],
22	and	CC	O	and	_	0	SENT_13	[p2l205t964r345b1036],
23	adverse	JJ	O	adverse	amod	24	SENT_13	[p2l370t964r655b1036],
24	events	NNS	O	event	prep_on	17	SENT_13	[p2l680t984r936b1036],
25	.	.	O	.	_	0	SENT_13	[p2l680t984r936b1036],

1	H	NN	O	h	nn	3	SENT_14	[p2l960t969r1037b1035],
2	pylori	NN	O	pylorus	nn	3	SENT_14	[p2l1053t964r1282b1056],
3	status	NN	O	status	nsubjpass	5	SENT_14	[p2l1304t984r1523b1036],
4	was	VBD	O	be	auxpass	5	SENT_14	[p2l1547t992r1693b1036],
5	determined	VBN	O	determine	_	0	SENT_14	[p2l1719t964r2150b1036],
6	4	CD	DURATION	4	num	7	SENT_14	[p2l8t1087r53b1152],
7	weeks	NNS	NUMBER	week	tmod	5	SENT_14	[p2l78t1081r312b1153],
8	after	IN	O	after	_	0	SENT_14	[p2l339t1081r515b1153],
9	the	DT	O	the	det	10	SENT_14	[p2l539t1081r656b1153],
10	end	NN	O	end	prep_after	5	SENT_14	[p2l681t1081r819b1153],
11	of	IN	O	of	_	0	SENT_14	[p2l844t1081r924b1153],
12	therapy	NN	O	therapy	prep_of	10	SENT_14	[p2l943t1081r1239b1173],
13	using	VBG	O	use	xcomp	5	SENT_14	[p2l1263t1087r1466b1173],
14	a	DT	O	a	det	19	SENT_14	[p2l1491t1110r1530b1153],
15	13C	NN	O	13c	nn	19	SENT_14	[p2l1558t1079r1882b1153],
16	—	CD	NUMBER	—	num	19	SENT_14	[p2l1558t1079r1882b1153],
17	urea	NN	O	urea	nn	19	SENT_14	[p2l1558t1079r1882b1153],
18	breath	NN	O	breath	nn	19	SENT_14	[p2l1908t1081r2150b1153],
19	test	NN	O	test	dobj	13	SENT_14	[p2l7t1220r160b1272],
20	.	.	O	.	_	0	SENT_14	[p2l7t1220r160b1272],

1	Rates	NNS	O	rate	nsubjpass	7	SENT_15	[p2l185t1205r396b1272],
2	of	IN	O	of	_	0	SENT_15	[p2l421t1199r501b1272],
3	H	NN	O	h	nn	5	SENT_15	[p2l519t1205r597b1270],
4	pylori	NN	O	pylorus	nn	5	SENT_15	[p2l613t1199r842b1291],
5	eradication	NN	O	eradication	prep_of	1	SENT_15	[p2l864t1199r1297b1272],
6	were	VBD	O	be	auxpass	7	SENT_15	[p2l1319t1228r1501b1272],
7	calculated	VBN	O	calculate	_	0	SENT_15	[p2l1526t1199r1913b1272],
8	in	IN	O	in	_	0	SENT_15	[p2l1937t1204r2009b1270],
9	the	DT	O	the	prep_in	7	SENT_15	[p2l2031t1200r2150b1272],

1	November	NNP	DATE	November	_	0	SENT_16	[p2l68t1458r476b1523],
2	2010	CD	DATE	2010	dep	1	SENT_16	[p2l505t1461r696b1523],

1	intent	NN	O	intent	_	0	SENT_17	[p2l14t1572r559b1639],
2	—	CD	NUMBER	—	number	4	SENT_17	[p2l14t1572r559b1639],
3	to	TO	O	to	dep	4	SENT_17	[p2l14t1572r559b1639],
4	—	CD	NUMBER	—	dep	1	SENT_17	[p2l14t1572r559b1639],
5	treat	NN	O	treat	dep	4	SENT_17	[p2l14t1572r559b1639],
6	(	CD	NUMBER	(	num	7	SENT_17	[p2l588t1570r786b1656],
7	ITT	NNP	O	ITT	dep	1	SENT_17	[p2l588t1570r786b1656],
8	)	CD	NUMBER	)	num	7	SENT_17	[p2l588t1570r786b1656],
9	and	CC	O	and	_	0	SENT_17	[p2l816t1567r957b1639],
10	per-protocol	JJ	O	per-protocol	amod	14	SENT_17	[p2l981t1567r1461b1659],
11	(	NN	O	(	nn	14	SENT_17	[p2l1491t1572r1639b1656],
12	PP	NN	O	pp	nn	14	SENT_17	[p2l1491t1572r1639b1656],
13	)	NN	O	)	nn	14	SENT_17	[p2l1491t1572r1639b1656],
14	populations	NNS	O	population	conj_and	7	SENT_17	[p2l1667t1567r2149b1659],
15	.	.	O	.	_	0	SENT_17	[p2l1667t1567r2149b1659],

1	C	NN	O	c	nn	3	SENT_18	[p2l19t1688r78b1756],
2	YP2	NN	O	yp2	nn	3	SENT_18	[p2l86t1689r239b1754],
3	C1	NN	O	c1	nsubjpass	7	SENT_18	[p2l253t1688r349b1756],
4	9	CD	NUMBER	9	num	5	SENT_18	[p2l366t1689r410b1754],
5	genotype	NN	O	genotype	dep	3	SENT_18	[p2l435t1704r786b1775],
6	was	VBD	O	be	auxpass	7	SENT_18	[p2l811t1712r959b1756],
7	determined	VBN	O	determine	_	0	SENT_18	[p2l986t1683r1423b1756],
8	by	IN	O	by	_	0	SENT_18	[p2l1449t1684r1541b1775],
9	the	DT	O	the	det	17	SENT_18	[p2l1564t1684r1681b1756],
10	polymerase	NN	O	polymerase	nn	17	SENT_18	[p2l1706t1684r2149b1775],
11	chain	NN	O	chain	nn	17	SENT_18	[p2l13t1799r227b1871],
12	reaction	NN	O	reaction	nn	17	SENT_18	[p2l271t1803r1055b1871],
13	—	NN	O	—	nn	17	SENT_18	[p2l271t1803r1055b1871],
14	restriction	NN	O	restriction	nn	17	SENT_18	[p2l271t1803r1055b1871],
15	fragment-length	JJ	O	fragment-length	amod	17	SENT_18	[p2l1099t1799r1740b1891],
16	polymorphism	NN	O	polymorphism	nn	17	SENT_18	[p2l1784t1799r2147b1891, p2l12t1915r250b2007],
17	method	NN	O	method	agent	7	SENT_18	[p2l279t1915r599b1987],
18	.	.	O	.	_	0	SENT_18	[p2l279t1915r599b1987],

1	Results	NNS	O	result	dep	19	SENT_19	[p2l124t2031r429b2103],
2	:	:	O	:	_	0	SENT_19	[p2l124t2031r429b2103],
3	Of	IN	O	of	_	0	SENT_19	[p2l478t2031r583b2103],
4	199	CD	NUMBER	199	num	6	SENT_19	[p2l627t2036r768b2103],
5	consecutive	JJ	O	consecutive	amod	6	SENT_19	[p2l813t2036r1264b2103],
6	patients	NNS	O	patient	prep_of	19	SENT_19	[p2l1307t2036r1614b2123],
7	screened	VBN	O	screen	partmod	6	SENT_19	[p2l1660t2031r1993b2103],
8	for	IN	O	for	_	0	SENT_19	[p2l2036t2031r2149b2103],
9	eligibility	NN	O	eligibility	prep_for	7	SENT_19	[p2l14t2147r391b2239],
10	,	,	O	,	_	0	SENT_19	[p2l14t2147r391b2239],
11	1	CD	NUMBER	1	number	12	SENT_19	[p2l421t2152r454b2218],
12	84	CD	NUMBER	84	num	14	SENT_19	[p2l471t2152r562b2219],
13	H	NN	O	h	nn	14	SENT_19	[p2l588t2152r666b2218],
14	pylori	NN	O	pylorus	appos	9	SENT_19	[p2l683t2147r1265b2239],
15	—	CD	NUMBER	—	num	17	SENT_19	[p2l683t2147r1265b2239],
16	positive	JJ	O	positive	amod	17	SENT_19	[p2l683t2147r1265b2239],
17	patients	NNS	O	patient	nsubjpass	19	SENT_19	[p2l1290t2151r1596b2239],
18	were	VBD	O	be	auxpass	19	SENT_19	[p2l1621t2175r1806b2219],
19	enrolled	VBN	O	enrol	_	0	SENT_19	[p2l1832t2147r2149b2219],
20	in	IN	O	in	_	0	SENT_19	[p2l14t2268r86b2334],
21	the	DT	O	the	det	22	SENT_19	[p2l118t2263r236b2335],
22	study	NN	O	study	prep_in	19	SENT_19	[p2l272t2263r482b2355],
23	(	CD	NUMBER	(	number	24	SENT_19	[p2l519t2268r636b2352],
24	61	CD	NUMBER	61	num	22	SENT_19	[p2l519t2268r636b2352],
25	in	IN	O	in	_	0	SENT_19	[p2l677t2268r749b2334],
26	group	NN	O	group	nn	27	SENT_19	[p2l782t2291r1012b2355],
27	A	NN	O	a	prep_in	22	SENT_19	[p2l1042t2266r1128b2351],
28	,	,	O	,	_	0	SENT_19	[p2l1042t2266r1128b2351],
29	62	CD	NUMBER	62	conj_and	22	SENT_19	[p2l1163t2268r1256b2335],
30	in	IN	O	in	_	0	SENT_19	[p2l1292t2268r1364b2334],
31	group	NN	O	group	nn	32	SENT_19	[p2l1396t2291r1626b2355],
32	B	NN	O	b	prep_in	29	SENT_19	[p2l1662t2269r1736b2352],
33	,	,	O	,	_	0	SENT_19	[p2l1662t2269r1736b2352],
34	and	CC	O	and	_	0	SENT_19	[p2l1770t2263r1913b2335],
35	61	CD	NUMBER	61	prep_in	19	SENT_19	[p2l1948t2268r2036b2335],
36	in	IN	O	in	_	0	SENT_19	[p2l2077t2268r2149b2334],
37	group	NN	O	group	nn	39	SENT_19	[p2l13t2407r244b2471],
38	C	NN	O	c	nn	39	SENT_19	[p2l274t2384r386b2468],
39	)	NN	O	)	prep_in	35	SENT_19	[p2l274t2384r386b2468],
40	.	.	O	.	_	0	SENT_19	[p2l274t2384r386b2468],

1	The	DT	O	the	det	3	SENT_20	[p2l409t2379r558b2451],
2	overall	JJ	O	overall	amod	3	SENT_20	[p2l587t2379r852b2451],
3	sample	NN	O	sample	nsubjpass	5	SENT_20	[p2l880t2379r1150b2471],
4	was	VBD	O	be	auxpass	5	SENT_20	[p2l1177t2408r1326b2451],
5	balanced	VBN	O	balance	_	0	SENT_20	[p2l1356t2379r1703b2451],
6	in	IN	O	in	_	0	SENT_20	[p2l1730t2384r1802b2450],
7	terms	NNS	O	term	prep_in	5	SENT_20	[p2l1828t2400r2043b2451],
8	of	IN	O	of	_	0	SENT_20	[p2l2072t2379r2153b2451],
9	age	NN	O	age	prep_of	7	SENT_20	[p2l15t2523r165b2587],
10	,	,	O	,	_	0	SENT_20	[p2l15t2523r165b2587],
11	sex	NN	O	sex	prep_of	7	SENT_20	[p2l190t2523r335b2583],
12	,	,	O	,	_	0	SENT_20	[p2l190t2523r335b2583],
13	endoscopic	JJ	O	endoscopic	amod	14	SENT_20	[p2l359t2495r793b2587],
14	diagnosis	NN	O	diagnosis	conj_and	9	SENT_20	[p2l819t2495r1205b2587],
15	,	,	O	,	_	0	SENT_20	[p2l819t2495r1205b2587],
16	and	CC	O	and	_	0	SENT_20	[p2l1230t2495r1372b2567],
17	history	NN	O	history	conj_and	9	SENT_20	[p2l1397t2495r1669b2587],
18	of	IN	O	of	_	0	SENT_20	[p2l1694t2495r1775b2567],
19	smoking	NN	O	smoking	prep_of	17	SENT_20	[p2l1796t2495r2148b2587],
20	.	.	O	.	_	0	SENT_20	[p2l1796t2495r2148b2587],

1	Rates	NNS	O	rate	nsubj	12	SENT_21	[p2l14t2617r225b2683],
2	of	IN	O	of	_	0	SENT_21	[p2l252t2611r332b2683],
3	H	NN	O	h	nn	5	SENT_21	[p2l350t2617r428b2682],
4	pylori	NN	O	pylorus	nn	5	SENT_21	[p2l444t2611r674b2703],
5	eradication	NN	O	eradication	prep_of	1	SENT_21	[p2l696t2611r1131b2683],
6	in	IN	O	in	_	0	SENT_21	[p2l1155t2616r1227b2682],
7	the	DT	O	the	det	11	SENT_21	[p2l1250t2611r1367b2683],
8	ITT	NNP	ORGANIZATION	ITT	nn	11	SENT_21	[p2l1391t2614r1540b2682],
9	and	CC	O	and	_	0	SENT_21	[p2l1564t2611r1706b2683],
10	PP	NNP	O	PP	nn	11	SENT_21	[p2l1730t2617r1827b2682],
11	populations	NNS	O	population	prep_in	5	SENT_21	[p2l1850t2611r2149b2703, p2l13t2732r202b2799],
12	were	VBD	O	be	_	0	SENT_21	[p2l243t2756r429b2799],
13	as	IN	O	as	dep	14	SENT_21	[p2l471t2756r546b2799],
14	follows	VBZ	O	follow	advcl	12	SENT_21	[p2l588t2727r897b2799],
15	:	:	O	:	_	0	SENT_21	[p2l588t2727r897b2799],
16	group	NN	O	group	dep	22	SENT_21	[p2l941t2755r1171b2819],
17	A	DT	O	a	det	18	SENT_21	[p2l1209t2730r1629b2800],
18	—	NN	O	—	dep	16	SENT_21	[p2l1209t2730r1629b2800],
19	85.2	CD	PERCENT	85.2	num	20	SENT_21	[p2l1209t2730r1629b2800],
20	%	NN	PERCENT	%	dep	22	SENT_21	[p2l1209t2730r1629b2800],
21	(	CD	NUMBER	(	number	22	SENT_21	[p2l1681t2732r1959b2816],
22	52/61	CD	NUMBER	52/61	dep	40	SENT_21	[p2l1681t2732r1959b2816],
23	)	NN	O	)	dep	22	SENT_21	[p2l1681t2732r1959b2816],
24	and	CC	O	and	_	0	SENT_21	[p2l2006t2727r2149b2799],
25	86.7	CD	PERCENT	86.7	num	26	SENT_21	[p2l19t2847r274b2916],
26	%	NN	PERCENT	%	dep	40	SENT_21	[p2l19t2847r274b2916],
27	(	CD	NUMBER	(	number	28	SENT_21	[p2l314t2847r620b2931],
28	52/60	CD	NUMBER	52/60	num	29	SENT_21	[p2l314t2847r620b2931],
29	)	NN	O	)	rcmod	26	SENT_21	[p2l314t2847r620b2931],
30	,	,	O	,	_	0	SENT_21	[p2l314t2847r620b2931],
31	respectively	RB	O	respectively	advmod	29	SENT_21	[p2l647t2843r1127b2935],
32	;	:	O	;	_	0	SENT_21	[p2l647t2843r1127b2935],
33	group	NN	O	group	nn	34	SENT_21	[p2l1157t2870r1387b2935],
34	B	NN	O	b	dep	26	SENT_21	[p2l1418t2847r1826b2916],
35	—	CD	PERCENT	—	number	36	SENT_21	[p2l1418t2847r1826b2916],
36	87.1	CD	PERCENT	87.1	num	37	SENT_21	[p2l1418t2847r1826b2916],
37	%	NN	PERCENT	%	dep	34	SENT_21	[p2l1418t2847r1826b2916],
38	(	CD	NUMBER	(	number	39	SENT_21	[p2l1866t2847r2143b2931],
39	54/62	CD	NUMBER	54/62	num	40	SENT_21	[p2l1866t2847r2143b2931],
40	)	NN	O	)	dep	46	SENT_21	[p2l1866t2847r2143b2931],
41	and	CC	O	and	_	0	SENT_21	[p2l15t2959r158b3031],
42	90.0	CD	PERCENT	90.0	num	43	SENT_21	[p2l185t2963r443b3032],
43	%	NN	PERCENT	%	dep	46	SENT_21	[p2l185t2963r443b3032],
44	(	CD	NUMBER	(	number	45	SENT_21	[p2l480t2963r786b3048],
45	54/60	CD	NUMBER	54/60	num	43	SENT_21	[p2l480t2963r786b3048],
46	)	NN	O	)	dep	14	SENT_21	[p2l480t2963r786b3048],
47	;	:	O	;	_	0	SENT_21	[p2l480t2963r786b3048],
48	and	CC	O	and	dep	50	SENT_21	[p2l816t2959r958b3031],
49	group	NN	O	group	nn	50	SENT_21	[p2l983t2987r1214b3051],
50	C	NN	O	c	dep	46	SENT_21	[p2l1243t2963r1660b3032],
51	—	CD	PERCENT	—	number	52	SENT_21	[p2l1243t2963r1660b3032],
52	75.4	CD	PERCENT	75.4	dep	53	SENT_21	[p2l1243t2963r1660b3032],
53	%	NN	PERCENT	%	dep	50	SENT_21	[p2l1243t2963r1660b3032],
54	(	CD	NUMBER	(	number	55	SENT_21	[p2l1697t2963r1975b3048],
55	46/61	CD	NUMBER	46/61	num	56	SENT_21	[p2l1697t2963r1975b3048],
56	)	NN	O	)	nsubj	14	SENT_21	[p2l1697t2963r1975b3048],
57	and	CC	O	and	_	0	SENT_21	[p2l2006t2959r2149b3031],
58	75.4	CD	PERCENT	75.4	num	59	SENT_21	[p2l17t3080r274b3148],
59	%	NN	PERCENT	%	conj_and	56	SENT_21	[p2l17t3080r274b3148],
60	(	CD	NUMBER	(	number	61	SENT_21	[p2l323t3080r627b3164],
61	46/61	CD	NUMBER	46/61	num	62	SENT_21	[p2l323t3080r627b3164],
62	)	NN	O	)	dep	59	SENT_21	[p2l323t3080r627b3164],
63	.	.	O	.	_	0	SENT_21	[p2l323t3080r627b3164],

1	There	EX	O	there	expl	5	SENT_22	[p2l661t3075r888b3147],
2	were	VBD	O	be	cop	5	SENT_22	[p2l925t3104r1111b3147],
3	no	DT	O	no	det	5	SENT_22	[p2l1149t3104r1246b3147],
4	significant	JJ	O	significant	amod	5	SENT_22	[p2l1286t3075r1691b3167],
5	differences	NNS	O	difference	_	0	SENT_22	[p2l1729t3075r2147b3147],
6	in	IN	O	in	_	0	SENT_22	[p2l14t3200r86b3267],
7	eradication	NN	O	eradication	nn	8	SENT_22	[p2l115t3196r555b3268],
8	rates	NNS	O	rate	prep_in	5	SENT_22	[p2l583t3216r767b3268],
9	among	IN	O	among	_	0	SENT_22	[p2l798t3224r1064b3288],
10	groups	NNS	O	group	prep_among	5	SENT_22	[p2l1092t3223r1383b3288],
11	,	,	O	,	_	0	SENT_22	[p2l1092t3223r1383b3288],
12	nor	CC	O	nor	_	0	SENT_22	[p2l1410t3224r1544b3268],
13	were	VBD	O	be	cop	14	SENT_22	[p2l1571t3224r1757b3268],
14	there	EX	O	there	conj_nor	5	SENT_22	[p2l1785t3196r1980b3268],
15	any	DT	O	any	det	16	SENT_22	[p2l2010t3224r2149b3287],
16	differences	NNS	O	difference	dep	23	SENT_22	[p2l15t3312r433b3384],
17	in	IN	O	in	_	0	SENT_22	[p2l460t3317r532b3383],
18	rates	NNS	O	rate	prep_in	16	SENT_22	[p2l557t3332r741b3384],
19	of	IN	O	of	_	0	SENT_22	[p2l770t3312r850b3384],
20	compliance	NN	O	compliance	prep_of	18	SENT_22	[p2l871t3312r1317b3404],
21	(	CD	PERCENT	(	dep	23	SENT_22	[p2l1348t3316r1665b3401],
22	98.4	CD	PERCENT	98.4	num	23	SENT_22	[p2l1348t3316r1665b3401],
23	%	NN	PERCENT	%	dep	14	SENT_22	[p2l1348t3316r1665b3401],
24	,	,	O	,	_	0	SENT_22	[p2l1348t3316r1665b3401],
25	96.8	CD	PERCENT	96.8	num	26	SENT_22	[p2l1691t3316r1980b3401],
26	%	NN	PERCENT	%	conj_and	23	SENT_22	[p2l1691t3316r1980b3401],
27	,	,	O	,	_	0	SENT_22	[p2l1691t3316r1980b3401],
28	and	CC	O	and	_	0	SENT_22	[p2l2006t3312r2149b3384],
29	100	CD	PERCENT	100	num	30	SENT_22	[p2l19t3433r248b3501],
30	%	NN	PERCENT	%	conj_and	23	SENT_22	[p2l19t3433r248b3501],
31	in	IN	O	in	_	0	SENT_22	[p2l286t3433r358b3499],
32	groups	NNS	O	group	prep_in	14	SENT_22	[p2l389t3456r655b3520],
33	A	DT	O	a	amod	32	SENT_22	[p2l683t3432r769b3517],
34	,	,	O	,	_	0	SENT_22	[p2l683t3432r769b3517],
35	B	NN	O	b	dep	33	SENT_22	[p2l799t3434r874b3517],
36	,	,	O	,	_	0	SENT_22	[p2l799t3434r874b3517],
37	and	CC	O	and	_	0	SENT_22	[p2l905t3428r1048b3500],
38	C	NN	O	c	conj_and	32	SENT_22	[p2l1081t3433r1164b3517],
39	,	,	O	,	_	0	SENT_22	[p2l1081t3433r1164b3517],
40	respectively	RB	O	respectively	advmod	32	SENT_22	[p2l1193t3428r1676b3520],
41	)	CD	NUMBER	)	dep	32	SENT_22	[p2l1193t3428r1676b3520],
42	or	CC	O	or	_	0	SENT_22	[p2l1713t3457r1795b3500],
43	adverseevent	JJ	O	adverseevent	amod	44	SENT_22	[p2l1826t3428r2147b3500, p2l14t3564r218b3616],
44	profiles	NNS	O	profile	conj_or	41	SENT_22	[p2l241t3544r554b3636],
45	.	.	O	.	_	0	SENT_22	[p2l241t3544r554b3636],

1	Fifteen	CD	NUMBER	fifteen	num	2	SENT_23	[p2l580t3544r845b3616],
2	patients	NNS	O	patient	advmod	7	SENT_23	[p2l869t3548r1174b3636],
3	(	IN	O	(	_	0	SENT_23	[p2l1205t3548r1471b3632],
4	7.6	CD	PERCENT	7.6	num	5	SENT_23	[p2l1205t3548r1471b3632],
5	%	NN	PERCENT	%	prep_(	2	SENT_23	[p2l1205t3548r1471b3632],
6	)	CD	NUMBER	)	dep	2	SENT_23	[p2l1205t3548r1471b3632],
7	reported	VBD	O	report	_	0	SENT_23	[p2l1500t3544r1832b3636],
8	adverse	JJ	O	adverse	amod	9	SENT_23	[p2l1858t3544r2146b3616],
9	events	NNS	O	event	dobj	7	SENT_23	[p2l14t3680r249b3732],
10	during	IN	O	during	_	0	SENT_23	[p2l279t3660r531b3752],
11	the	DT	O	the	det	13	SENT_23	[p2l557t3660r673b3732],
12	study	NN	O	study	nn	13	SENT_23	[p2l703t3660r909b3752],
13	(	NN	O	(	prep_during	7	SENT_23	[p2l941t3665r1009b3749],
14	5	CD	PERCENT	5	number	15	SENT_23	[p2l941t3665r1009b3749],
15	[	CD	PERCENT	[	amod	13	SENT_23	[p2l1047t3664r1306b3749],
16	8.2	CD	PERCENT	8.2	num	17	SENT_23	[p2l1047t3664r1306b3749],
17	%	NN	PERCENT	%	dep	15	SENT_23	[p2l1047t3664r1306b3749],
18	]	CD	NUMBER	]	nsubj	7	SENT_23	[p2l1047t3664r1306b3749],
19	in	IN	O	in	_	0	SENT_23	[p2l1341t3665r1412b3731],
20	group	NN	O	group	nn	21	SENT_23	[p2l1439t3688r1666b3752],
21	A	NN	O	a	prep_in	18	SENT_23	[p2l1690t3663r1776b3749],
22	,	,	O	,	_	0	SENT_23	[p2l1690t3663r1776b3749],
23	6	CD	PERCENT	6	num	24	SENT_23	[p2l1804t3665r1847b3732],
24	[	NN	PERCENT	[	appos	18	SENT_23	[p2l1883t3664r2142b3749],
25	9.7	CD	PERCENT	9.7	num	26	SENT_23	[p2l1883t3664r2142b3749],
26	%	NN	PERCENT	%	dep	24	SENT_23	[p2l1883t3664r2142b3749],
27	]	CD	NUMBER	]	dep	24	SENT_23	[p2l1883t3664r2142b3749],

1	in	IN	O	in	dep	7	SENT_24	[p3l14t23r84b89],
2	group	NN	O	group	nn	3	SENT_24	[p3l106t46r330b110],
3	B	NN	O	b	pobj	1	SENT_24	[p3l354t24r427b107],
4	,	,	O	,	_	0	SENT_24	[p3l354t24r427b107],
5	and	CC	O	and	_	0	SENT_24	[p3l450t19r589b91],
6	4	CD	PERCENT	4	conj_and	1	SENT_24	[p3l611t24r656b89],
7	[	NN	PERCENT	[	_	0	SENT_24	[p3l686t23r754b107],
8	6	CD	PERCENT	6	number	9	SENT_24	[p3l686t23r754b107],
9	.6	CD	PERCENT	.6	dep	10	SENT_24	[p3l763t23r943b107],
10	%	NN	PERCENT	%	dep	7	SENT_24	[p3l763t23r943b107],
11	]	CD	NUMBER	]	dep	7	SENT_24	[p3l763t23r943b107],
12	in	IN	O	in	_	0	SENT_24	[p3l972t23r1042b89],
13	group	NN	O	group	nn	15	SENT_24	[p3l1064t46r1288b110],
14	C	NN	O	c	nn	15	SENT_24	[p3l1314t23r1423b107],
15	)	NN	O	)	prep_in	11	SENT_24	[p3l1314t23r1423b107],
16	.	.	O	.	_	0	SENT_24	[p3l1314t23r1423b107],

1	The	DT	O	the	det	3	SENT_25	[p3l1441t19r1587b91],
2	adverse	JJ	O	adverse	amod	3	SENT_25	[p3l1612t19r1892b91],
3	events	NNS	O	event	nsubj	4	SENT_25	[p3l1916t39r2148b91],
4	included	VBD	O	include	_	0	SENT_25	[p3l14t134r340b206],
5	diarrhea	NN	O	diarrhea	nn	6	SENT_25	[p3l372t134r692b206],
6	(	NN	O	(	dobj	4	SENT_25	[p3l727t138r797b222],
7	6	CD	NUMBER	6	num	8	SENT_25	[p3l727t138r797b222],
8	patients	NNS	O	patient	tmod	6	SENT_25	[p3l828t138r1183b226],
9	)	RB	O	)	advmod	8	SENT_25	[p3l828t138r1183b226],
10	,	,	O	,	_	0	SENT_25	[p3l828t138r1183b226],
11	dizziness	NN	O	dizziness	nn	12	SENT_25	[p3l1212t134r1547b206],
12	(	NN	O	(	dobj	4	SENT_25	[p3l1583t138r1706b222],
13	5	CD	NUMBER	5	num	14	SENT_25	[p3l1583t138r1706b222],
14	)	NN	O	)	dep	12	SENT_25	[p3l1583t138r1706b222],
15	,	,	O	,	_	0	SENT_25	[p3l1583t138r1706b222],
16	abdominal	JJ	O	abdominal	amod	18	SENT_25	[p3l1737t134r2148b206],
17	pain	NN	O	pain	nn	18	SENT_25	[p3l13t255r181b342],
18	(	NN	O	(	conj_and	6	SENT_25	[p3l223t255r347b339],
19	2	CD	NUMBER	2	num	20	SENT_25	[p3l223t255r347b339],
20	)	NN	O	)	dep	18	SENT_25	[p3l223t255r347b339],
21	,	,	O	,	_	0	SENT_25	[p3l223t255r347b339],
22	nausea	NN	O	nausea	nn	23	SENT_25	[p3l384t278r645b322],
23	(	NN	O	(	conj_and	6	SENT_25	[p3l689t255r813b339],
24	1	CD	NUMBER	1	num	25	SENT_25	[p3l689t255r813b339],
25	)	NN	O	)	dep	23	SENT_25	[p3l689t255r813b339],
26	,	,	O	,	_	0	SENT_25	[p3l689t255r813b339],
27	and	CC	O	and	_	0	SENT_25	[p3l851t250r992b322],
28	skin	NN	O	skin	nn	30	SENT_25	[p3l1032t250r1187b322],
29	rash	NN	O	rash	nn	30	SENT_25	[p3l1224t250r1386b322],
30	(	NN	O	(	conj_and	6	SENT_25	[p3l1429t255r1551b339],
31	1	CD	NUMBER	1	num	32	SENT_25	[p3l1429t255r1551b339],
32	)	NN	O	)	dep	30	SENT_25	[p3l1429t255r1551b339],
33	.	.	O	.	_	0	SENT_25	[p3l1429t255r1551b339],

1	Three	CD	NUMBER	three	num	2	SENT_26	[p3l1586t250r1808b322],
2	patients	NNS	O	patient	nsubj	9	SENT_26	[p3l1846t255r2147b342],
3	discontinued	VBN	O	discontinue	amod	4	SENT_26	[p3l15t368r505b440],
4	treatment	NN	O	treatment	dep	2	SENT_26	[p3l528t388r901b440],
5	because	IN	O	because	_	0	SENT_26	[p3l925t368r1220b440],
6	of	IN	O	of	prepc_because_of	2	SENT_26	[p3l1245t367r1325b440],
7	adverse	JJ	O	adverse	amod	8	SENT_26	[p3l1345t368r1629b440],
8	events	NNS	O	event	pobj	2	SENT_26	[p3l1654t388r1888b440],
9	(	VBP	O	(	_	0	SENT_26	[p3l1917t372r1982b456],
10	1	CD	NUMBER	1	num	17	SENT_26	[p3l1917t372r1982b456],
11	due	JJ	O	due	amod	17	SENT_26	[p3l2014t368r2148b440],
12	to	TO	O	to	_	0	SENT_26	[p3l13t503r89b555],
13	skin	NN	O	skin	nn	14	SENT_26	[p3l120t483r275b555],
14	rash	NN	O	rash	prep_to	11	SENT_26	[p3l304t483r466b555],
15	in	IN	O	in	_	0	SENT_26	[p3l495t487r566b554],
16	group	NN	O	group	prep_in	14	SENT_26	[p3l594t511r821b575],
17	A	NN	O	a	dobj	9	SENT_26	[p3l847t486r910b554],
18	and	CC	O	and	_	0	SENT_26	[p3l940t483r1081b555],
19	2	CD	NUMBER	2	num	26	SENT_26	[p3l1109t488r1154b554],
20	due	JJ	O	due	_	0	SENT_26	[p3l1186t483r1321b555],
21	to	TO	O	to	_	0	SENT_26	[p3l1350t503r1426b555],
22	dizziness	NN	O	dizziness	prep_due_to	26	SENT_26	[p3l1457t483r1791b555],
23	in	IN	O	in	_	0	SENT_26	[p3l1821t487r1893b554],
24	group	NN	O	group	nn	25	SENT_26	[p3l1921t510r2148b575],
25	B	NN	O	b	prep_in	22	SENT_26	[p3l14t604r116b688],
26	)	NN	O	)	dobj	9	SENT_26	[p3l14t604r116b688],
27	.	.	O	.	_	0	SENT_26	[p3l14t604r116b688],

1	In	IN	O	in	mark	5	SENT_27	[p3l142t605r219b670],
2	the	DT	O	the	det	4	SENT_27	[p3l244t599r360b671],
3	147	CD	NUMBER	147	num	4	SENT_27	[p3l393t604r535b671],
4	patients	NNS	O	patient	nsubj	5	SENT_27	[p3l559t604r860b691],
5	included	VBD	O	include	advcl	21	SENT_27	[p3l888t599r1214b671],
6	in	IN	O	in	_	0	SENT_27	[p3l1241t604r1312b670],
7	the	DT	O	the	det	9	SENT_27	[p3l1337t599r1453b671],
8	PP	NN	O	pp	nn	9	SENT_27	[p3l1480t605r1576b670],
9	analysis	NN	O	analysis	prep_in	5	SENT_27	[p3l1604t599r1903b691],
10	of	IN	O	of	_	0	SENT_27	[p3l1931t599r2011b671],
11	the	DT	O	the	det	12	SENT_27	[p3l2031t599r2148b671],
12	effect	NN	O	effect	prep_of	9	SENT_27	[p3l14t715r225b788],
13	of	IN	O	of	_	0	SENT_27	[p3l268t715r349b788],
14	CYP2C19	NN	O	cyp2c19	nn	15	SENT_27	[p3l392t720r787b788],
15	genotype	NN	O	genotype	prep_of	12	SENT_27	[p3l831t736r1209b807],
16	,	,	O	,	_	0	SENT_27	[p3l831t736r1209b807],
17	eradication	NN	O	eradication	nn	18	SENT_27	[p3l1251t716r1693b788],
18	rates	NNS	O	rate	nsubj	21	SENT_27	[p3l1734t736r1919b788],
19	were	VBD	O	be	cop	21	SENT_27	[p3l1961t744r2147b788],
20	88.9	CD	PERCENT	88.9	num	21	SENT_27	[p3l19t835r270b904],
21	%	NN	PERCENT	%	_	0	SENT_27	[p3l19t835r270b904],
22	(	CD	NUMBER	(	number	23	SENT_27	[p3l312t835r584b919],
23	32/36	CD	NUMBER	32/36	num	24	SENT_27	[p3l312t835r584b919],
24	)	NN	O	)	attr	21	SENT_27	[p3l312t835r584b919],
25	in	IN	O	in	_	0	SENT_27	[p3l619t835r690b902],
26	poor	JJ	O	poor	amod	27	SENT_27	[p3l720t858r903b923],
27	metabolizers	NNS	O	metabolizer	prep_in	24	SENT_27	[p3l933t831r1443b919],
28	,	,	O	,	_	0	SENT_27	[p3l933t831r1443b919],
29	82.0	CD	PERCENT	82.0	num	30	SENT_27	[p3l1477t835r1728b904],
30	%	NN	PERCENT	%	attr	21	SENT_27	[p3l1477t835r1728b904],
31	(	CD	NUMBER	(	number	32	SENT_27	[p3l1770t835r2042b919],
32	50/61	CD	NUMBER	50/61	num	33	SENT_27	[p3l1770t835r2042b919],
33	)	NN	O	)	dep	30	SENT_27	[p3l1770t835r2042b919],
34	in	IN	O	in	_	0	SENT_27	[p3l2078t835r2149b902],
35	heterozygous	JJ	O	heterozygous	amod	37	SENT_27	[p3l13t947r512b1039],
36	extensive	JJ	O	extensive	amod	37	SENT_27	[p3l536t952r880b1019],
37	metabolizers	NNS	O	metabolizer	prep_in	33	SENT_27	[p3l903t947r1404b1036],
38	,	,	O	,	_	0	SENT_27	[p3l903t947r1404b1036],
39	and	CC	O	and	_	0	SENT_27	[p3l1426t947r1565b1019],
40	82.0	CD	PERCENT	82.0	num	41	SENT_27	[p3l1593t951r1841b1020],
41	%	NN	PERCENT	%	conj_and	24	SENT_27	[p3l1593t951r1841b1020],
42	(	CD	NUMBER	(	number	43	SENT_27	[p3l1874t951r2142b1036],
43	41/50	CD	NUMBER	41/50	num	44	SENT_27	[p3l1874t951r2142b1036],
44	)	NN	O	)	dep	41	SENT_27	[p3l1874t951r2142b1036],
45	in	IN	O	in	_	0	SENT_27	[p3l14t1068r84b1134],
46	homozygous	JJ	O	homozygous	amod	48	SENT_27	[p3l106t1063r588b1155],
47	extensive	JJ	O	extensive	amod	48	SENT_27	[p3l613t1068r958b1136],
48	metabolizers	NNS	O	metabolizer	prep_in	44	SENT_27	[p3l981t1063r1482b1136],
49	.	.	O	.	_	0	SENT_27	[p3l981t1063r1482b1136],

1	Eradication	NN	O	eradication	nn	2	SENT_28	[p3l1505t1064r1946b1136],
2	rates	NNS	O	rate	nsubj	5	SENT_28	[p3l1968t1084r2146b1136],
3	did	VBD	O	do	aux	5	SENT_28	[p3l15t1179r135b1251],
4	not	RB	O	not	neg	5	SENT_28	[p3l163t1199r291b1251],
5	differ	VB	O	differ	_	0	SENT_28	[p3l320t1179r525b1251],
6	significantly	RB	O	significantly	advmod	5	SENT_28	[p3l555t1179r1020b1271],
7	among	IN	O	among	_	0	SENT_28	[p3l1049t1207r1311b1271],
8	genotype	NN	O	genotype	nn	9	SENT_28	[p3l1339t1199r1693b1271],
9	groups	NNS	O	group	prep_among	5	SENT_28	[p3l1723t1206r2012b1271],
10	.	.	O	.	_	0	SENT_28	[p3l1723t1206r2012b1271],

1	Accepted	JJ	O	accepted	_	0	SENT_29	[p3l7t1496r257b1567],
2	for	IN	O	for	_	0	SENT_29	[p3l273t1496r354b1563],
3	publication	NN	O	publication	prep_for	1	SENT_29	[p3l367t1496r665b1567],
4	September	NNP	DATE	September	tmod	3	SENT_29	[p3l687t1496r980b1567],
5	21	CD	DATE	21	num	4	SENT_29	[p3l994t1500r1077b1561],
6	,	,	DATE	,	_	0	SENT_29	[p3l994t1500r1077b1561],
7	2070	CD	DATE	2070	num	4	SENT_29	[p3l1102t1500r1261b1549],
8	.	.	O	.	_	0	SENT_29	[p3l1102t1500r1261b1549],

1	doi	FW	O	doi	nsubj	20	SENT_30	[p3l13t1584r1115b1656],
2	:10.1016	CD	NUMBER	:10.1016	nsubj	13	SENT_30	[p3l13t1584r1115b1656],
3	/	:	O	/	punct	6	SENT_30	[p3l13t1584r1115b1656],
4	j.	NN	O	j.	nn	6	SENT_30	[p3l13t1584r1115b1656],
5	c	NN	O	c	nn	6	SENT_30	[p3l13t1584r1115b1656],
6	|	NN	O	|	dep	2	SENT_30	[p3l13t1584r1115b1656],
7	inthera	NN	O	inthera	prep	6	SENT_30	[p3l13t1584r1115b1656],
8	.2010.11.005	CD	NUMBER	.2010.11.005	num	9	SENT_30	[p3l13t1584r1115b1656],
9	0149-2918	CD	DURATION	0149-2918	dep	7	SENT_30	[p3l13t1671r402b1736],
10	/	:	O	/	punct	6	SENT_30	[p3l13t1671r402b1736],
11	$	$	MONEY	$	amod	2	SENT_30	[p3l13t1671r402b1736],
12	-	:	O	-	_	0	SENT_30	[p3l430t1702r448b1708],
13	see	VB	O	see	rcmod	1	SENT_30	[p3l474t1690r565b1724],
14	front	JJ	O	front	amod	15	SENT_30	[p3l591t1671r746b1724],
15	matter	NN	O	matter	dobj	13	SENT_30	[p3l773t1685r981b1724],
16	©	CD	NUMBER	©	num	19	SENT_30	[p3l12t1763r63b1812],
17	2010	CD	DATE	2010	num	19	SENT_30	[p3l91t1763r237b1812],
18	Elsevier	NNP	O	Elsevier	nn	19	SENT_30	[p3l269t1760r498b1812],
19	HSjourna	NNP	O	HSjourna	dep	15	SENT_30	[p3l524t1760r904b1825],
20	|	VBD	O	|	_	0	SENT_30	[p3l524t1760r904b1825],
21	s	NNS	O	s	dobj	20	SENT_30	[p3l524t1760r904b1825],
22	,	,	O	,	_	0	SENT_30	[p3l524t1760r904b1825],
23	Inc.	NNP	ORGANIZATION	Inc.	appos	21	SENT_30	[p3l935t1764r1039b1812],
24	.	.	O	.	_	0	SENT_30	[p3l935t1764r1039b1812],

1	All	DT	O	all	det	2	SENT_31	[p3l1066t1760r1143b1811],
2	rights	NNS	O	rights	nsubj	3	SENT_31	[p3l1173t1760r1345b1831],
3	reserved	VBN	O	reserve	_	0	SENT_31	[p3l1372t1760r1645b1812],
4	.	.	O	.	_	0	SENT_31	[p3l1372t1760r1645b1812],

1	Clinical	JJ	O	clinical	amod	2	SENT_32	[p3l69t2105r345b2171],
2	Therapeutics	NNS	O	therapeutics	_	0	SENT_32	[p3l375t2105r879b2194],

1	Conclusions	NNS	O	conclusion	_	0	SENT_33	[p3l124t2361r628b2433],
2	:	:	O	:	_	0	SENT_33	[p3l124t2361r628b2433],
3	One	CD	DURATION	one	num	4	SENT_33	[p3l674t2365r835b2433],
4	week	NN	NUMBER	week	dep	1	SENT_33	[p3l875t2360r1077b2433],
5	of	IN	O	of	_	0	SENT_33	[p3l1119t2360r1200b2433],
6	first-line	JJ	O	first-line	amod	8	SENT_33	[p3l1235t2360r1563b2433],
7	triple	JJ	O	triple	amod	8	SENT_33	[p3l1603t2361r1808b2452],
8	therapy	NN	O	therapy	prep_of	4	SENT_33	[p3l1849t2360r2149b2452],
9	with	IN	O	with	_	0	SENT_33	[p3l11t2479r188b2551],
10	levofloxacin	NN	O	levofloxacin	prep_with	8	SENT_33	[p3l228t2479r710b2551],
11	and	CC	O	and	_	0	SENT_33	[p3l751t2479r894b2551],
12	amoxicillin	NNP	O	amoxicillin	prep_of	4	SENT_33	[p3l935t2479r1375b2551],
13	plus	CC	O	plus	prep	12	SENT_33	[p3l1414t2479r1573b2571],
14	esomeprazole	JJ	O	esomeprazole	amod	23	SENT_33	[p3l1615t2479r2147b2571],
15	20	CD	NUMBER	20	tmod	14	SENT_33	[p3l12t2603r108b2670],
16	or	CC	O	or	_	0	SENT_33	[p3l136t2626r217b2670],
17	40	CD	NUMBER	40	tmod	14	SENT_33	[p3l241t2603r337b2670],
18	mg	NN	O	mg	nn	23	SENT_33	[p3l363t2626r482b2690],
19	BID	NNP	O	BID	nn	23	SENT_33	[p3l507t2604r657b2669],
20	or	CC	O	or	_	0	SENT_33	[p3l685t2626r766b2670],
21	rabeprazole	JJ	O	rabeprazole	conj_or	19	SENT_33	[p3l790t2598r1248b2690],
22	10	CD	NUMBER	10	tmod	21	SENT_33	[p3l1280t2603r1369b2670],
23	mg	NN	O	mg	dep	13	SENT_33	[p3l1395t2626r1514b2690],
24	BID	NNP	O	BID	nsubjpass	26	SENT_33	[p3l1539t2604r1688b2669],
25	was	VBD	O	be	auxpass	26	SENT_33	[p3l1715t2626r1863b2670],
26	associated	VBN	O	associate	rcmod	4	SENT_33	[p3l1890t2603r2148b2670, p3l14t2717r177b2790],
27	with	IN	O	with	_	0	SENT_33	[p3l203t2718r379b2790],
28	H	NN	O	h	nn	31	SENT_33	[p3l404t2723r482b2788],
29	pylori	NN	O	pylorus	nn	31	SENT_33	[p3l501t2718r735b2809],
30	eradication	NN	O	eradication	nn	31	SENT_33	[p3l760t2717r1200b2790],
31	rates	NNS	O	rate	prep_with	26	SENT_33	[p3l1226t2738r1411b2790],
32	of	IN	O	of	_	0	SENT_33	[p3l1440t2717r1521b2790],
33	85.2	CD	PERCENT	85.2	num	34	SENT_33	[p3l1548t2722r1833b2806],
34	%	NN	PERCENT	%	prep_of	31	SENT_33	[p3l1548t2722r1833b2806],
35	,	,	O	,	_	0	SENT_33	[p3l1548t2722r1833b2806],
36	87.1	CD	PERCENT	87.1	num	37	SENT_33	[p3l1864t2723r2026b2790],
37	%	NN	PERCENT	%	prep_of	31	SENT_33	[p3l2045t2722r2149b2806],
38	,	,	O	,	_	0	SENT_33	[p3l2045t2722r2149b2806],
39	and	CC	O	and	_	0	SENT_33	[p3l14t2836r156b2908],
40	75.4	CD	PERCENT	75.4	num	41	SENT_33	[p3l184t2840r469b2924],
41	%	NN	PERCENT	%	prep_of	31	SENT_33	[p3l184t2840r469b2924],
42	,	,	O	,	_	0	SENT_33	[p3l184t2840r469b2924],
43	respectively	RB	O	respectively	advmod	26	SENT_33	[p3l493t2836r960b2928],
44	,	,	O	,	_	0	SENT_33	[p3l493t2836r960b2928],
45	with	IN	O	with	_	0	SENT_33	[p3l982t2836r1157b2908],
46	no	DT	O	no	det	48	SENT_33	[p3l1182t2864r1278b2908],
47	significant	JJ	O	significant	amod	48	SENT_33	[p3l1306t2836r1707b2928],
48	differences	NNS	O	difference	prep_with	26	SENT_33	[p3l1732t2836r2147b2908],
49	between	IN	O	between	_	0	SENT_33	[p3l15t2955r336b3027],
50	treatment	NN	O	treatment	nn	51	SENT_33	[p3l374t2975r755b3027],
51	groups	NNS	O	group	prep_between	48	SENT_33	[p3l793t2983r1082b3047],
52	.	.	O	.	_	0	SENT_33	[p3l793t2983r1082b3047],

1	There	EX	O	there	expl	2	SENT_34	[p3l1117t2955r1343b3027],
2	were	VBD	O	be	_	0	SENT_34	[p3l1380t2983r1566b3027],
3	no	DT	O	no	det	5	SENT_34	[p3l1606t2983r1703b3027],
4	significant	JJ	O	significant	amod	5	SENT_34	[p3l1744t2955r2149b3047],
5	differences	NNS	O	difference	nsubj	2	SENT_34	[p3l14t3074r438b3147],
6	in	IN	O	in	_	0	SENT_34	[p3l484t3079r557b3145],
7	eradication	NN	O	eradication	prep_in	5	SENT_34	[p3l601t3075r1048b3147],
8	of	IN	O	of	_	0	SENT_34	[p3l1093t3074r1175b3147],
9	H	NN	O	h	nn	10	SENT_34	[p3l1213t3080r1291b3145],
10	pylori	NN	O	pylorus	prep_of	7	SENT_34	[p3l1327t3074r1564b3166],
11	by	IN	O	by	_	0	SENT_34	[p3l1607t3075r1700b3166],
12	CYP2C19	NN	O	cyp2c19	nn	13	SENT_34	[p3l1749t3079r2146b3147],
13	genotype	NN	O	genotype	prep_by	2	SENT_34	[p3l12t3213r366b3285],
14	in	IN	O	in	_	0	SENT_34	[p3l409t3197r481b3264],
15	this	DT	O	this	det	17	SENT_34	[p3l521t3193r659b3265],
16	small	JJ	O	small	amod	17	SENT_34	[p3l703t3193r907b3265],
17	population	NN	O	population	prep_in	13	SENT_34	[p3l948t3193r1380b3285],
18	of	IN	O	of	_	0	SENT_34	[p3l1422t3193r1503b3265],
19	Chinese	JJ	MISC	chinese	amod	20	SENT_34	[p3l1543t3193r1847b3265],
20	adults	NNS	O	adult	prep_of	17	SENT_34	[p3l1891t3193r2147b3265],
21	.	.	O	.	_	0	SENT_34	[p3l1891t3193r2147b3265],

1	(	NN	O	(	_	0	SENT_35	[p3l18t3312r208b3401],
2	Clin	NNP	O	Clin	nn	3	SENT_35	[p3l18t3312r208b3401],
3	Ther	NNP	O	Ther	dep	1	SENT_35	[p3l242t3312r445b3385],
4	.	.	O	.	_	0	SENT_35	[p3l242t3312r445b3385],

1	2010	CD	DATE	2010	num	3	SENT_36	[p3l479t3317r1316b3401],
2	;	:	O	;	_	0	SENT_36	[p3l479t3317r1316b3401],
3	32:2003	CD	NUMBER	32:2003	_	0	SENT_36	[p3l479t3317r1316b3401],
4	—	CD	NUMBER	—	num	5	SENT_36	[p3l479t3317r1316b3401],
5	2011	CD	DATE	2011	dep	3	SENT_36	[p3l479t3317r1316b3401],
6	)	CD	NUMBER	)	number	7	SENT_36	[p3l479t3317r1316b3401],
7	©	CD	NUMBER	©	dep	5	SENT_36	[p3l1356t3316r1424b3385],
8	2010	CD	DATE	2010	num	10	SENT_36	[p3l1458t3317r1656b3385],
9	Elsevier	NNP	ORGANIZATION	Elsevier	nn	10	SENT_36	[p3l1693t3312r1996b3385],
10	HS	NN	ORGANIZATION	h	dep	3	SENT_36	[p3l2029t3316r2146b3385],
11	Journals	NNPS	ORGANIZATION	Journals	dep	10	SENT_36	[p3l7t3431r365b3522],
12	,	,	ORGANIZATION	,	_	0	SENT_36	[p3l7t3431r365b3522],
13	Inc.	NNP	ORGANIZATION	Inc.	appos	3	SENT_36	[p3l393t3437r533b3504],
14	.	.	O	.	_	0	SENT_36	[p3l393t3437r533b3504],

1	Key	NN	O	key	nn	2	SENT_37	[p3l122t3555r272b3641],
2	words	NNS	O	word	_	0	SENT_37	[p3l314t3550r582b3622],
3	:	:	O	:	_	0	SENT_37	[p3l314t3550r582b3622],
4	proton	NN	O	proton	nn	6	SENT_37	[p3l629t3570r903b3642],
5	pump	NN	O	pump	nn	6	SENT_37	[p3l947t3577r1176b3642],
6	inhibitor	NN	O	inhibitor	dep	2	SENT_37	[p3l1222t3550r1588b3638],
7	,	,	O	,	_	0	SENT_37	[p3l1222t3550r1588b3638],
8	levofloxacin	NN	O	levofloxacin	appos	6	SENT_37	[p3l1632t3550r2150b3638],
9	,	,	O	,	_	0	SENT_37	[p3l1632t3550r2150b3638],

1	CYPZC19	NN	O	cypzc19	_	0	SENT_38	[p3l16t3673r433b3758],
2	,	,	O	,	_	0	SENT_38	[p3l16t3673r433b3758],
3	Helicobacter	NNP	PERSON	Helicobacter	nn	4	SENT_38	[p3l462t3669r968b3741],
4	pylori	NNP	PERSON	pylori	appos	1	SENT_38	[p3l993t3669r1247b3761],
5	,	,	O	,	_	0	SENT_38	[p3l993t3669r1247b3761],
6	eradication	NN	O	eradication	appos	4	SENT_38	[p3l1277t3669r1739b3741],
7	.	.	O	.	_	0	SENT_38	[p3l1277t3669r1739b3741],

1	INTRODUCTION	NN	O	introduction	_	0	SENT_39	[p4l18t136r782b204],

1	Helicobacter	NNP	PERSON	Helicobacter	nn	2	SENT_40	[p4l12t250r516b323],
2	pylori	NNP	PERSON	pylori	nsubjpass	12	SENT_40	[p4l536t250r769b342],
3	is	VBZ	O	be	_	0	SENT_40	[p4l792t255r847b323],
4	among	IN	O	among	_	0	SENT_40	[p4l875t279r1140b342],
5	the	DT	O	the	det	9	SENT_40	[p4l1164t250r1282b323],
6	most	RBS	O	most	advmod	7	SENT_40	[p4l1307t271r1498b323],
7	prevalent	JJ	O	prevalent	amod	9	SENT_40	[p4l1521t251r1886b342],
8	bacterial	JJ	O	bacterial	amod	9	SENT_40	[p4l1912t251r2144b323, p4l12t368r141b440],
9	pathogens	NNS	O	pathogen	prep_among	3	SENT_40	[p4l175t368r575b460],
10	and	CC	O	and	_	0	SENT_40	[p4l612t368r754b440],
11	is	VBZ	O	be	auxpass	12	SENT_40	[p4l789t372r845b440],
12	associated	VBN	O	associate	conj_and	3	SENT_40	[p4l881t368r1281b440],
13	with	IN	O	with	_	0	SENT_40	[p4l1313t368r1490b440],
14	such	JJ	O	such	amod	17	SENT_40	[p4l1525t368r1699b440],
15	upper	JJ	O	upper	amod	17	SENT_40	[p4l1733t395r1959b460],
16	gastrointestinal	JJ	O	gastrointestinal	amod	17	SENT_40	[p4l1993t396r2146b460, p4l12t486r490b558],
17	disorders	NNS	O	disorder	prep_with	12	SENT_40	[p4l519t486r876b558],
18	as	IN	O	as	_	0	SENT_40	[p4l908t514r982b558],
19	gastritis	NN	O	gastritis	prep_as	17	SENT_40	[p4l1012t491r1343b578],
20	,	,	O	,	_	0	SENT_40	[p4l1012t491r1343b578],
21	peptic	JJ	O	peptic	amod	23	SENT_40	[p4l1369t491r1607b578],
22	ulcer	NN	O	ulcer	nn	23	SENT_40	[p4l1635t486r1825b558],
23	disease	NN	O	disease	appos	19	SENT_40	[p4l1855t486r2149b575],
24	,	,	O	,	_	0	SENT_40	[p4l1855t486r2149b575],
25	gastric	JJ	O	gastric	amod	27	SENT_40	[p4l12t609r269b696],
26	mucosa	NN	O	mucosa	nn	27	SENT_40	[p4l293t604r1041b676],
27	—	NN	O	—	appos	19	SENT_40	[p4l293t604r1041b676],
28	associated	VBN	O	associate	partmod	27	SENT_40	[p4l293t604r1041b676],
29	lymphoid	JJ	O	lymphoid	amod	31	SENT_40	[p4l1066t604r1439b696],
30	tissue	NN	O	tissue	nn	31	SENT_40	[p4l1464t609r1679b676],
31	lymphoma	NN	O	lymphoma	dobj	28	SENT_40	[p4l1705t604r2148b696],
32	,	,	O	,	_	0	SENT_40	[p4l1705t604r2148b696],
33	and	CC	O	and	_	0	SENT_40	[p4l14t721r157b793],
34	gastric	JJ	O	gastric	amod	36	SENT_40	[p4l185t726r442b813],
35	cancer	NN	O	cancer	nn	36	SENT_40	[p4l470t718r826b793],
36	.1	NN	NUMBER	.1	conj_and	19	SENT_40	[p4l470t718r826b793],
37	=	JJ	O	=	amod	39	SENT_40	[p4l470t718r826b793],
38	2	CD	NUMBER	2	tmod	37	SENT_40	[p4l470t718r826b793],
39	Eradication	NN	O	eradication	nsubjpass	46	SENT_40	[p4l856t721r1312b793],
40	of	IN	O	of	_	0	SENT_40	[p4l1342t721r1423b793],
41	H	NN	O	h	nn	43	SENT_40	[p4l1446t727r1524b792],
42	pylori	NN	O	pylorus	nn	43	SENT_40	[p4l1544t721r1778b812],
43	infection	NN	O	infection	prep_of	39	SENT_40	[p4l1804t721r2148b793],
44	has	VBZ	O	have	aux	46	SENT_40	[p4l12t839r140b911],
45	been	VBN	O	be	auxpass	46	SENT_40	[p4l168t839r345b911],
46	reported	VBN	O	report	rcmod	36	SENT_40	[p4l370t839r703b931],
47	to	TO	O	to	aux	51	SENT_40	[p4l727t859r803b911],
48	be	VB	O	be	cop	51	SENT_40	[p4l831t839r916b911],
49	an	DT	O	a	det	51	SENT_40	[p4l943t867r1034b911],
50	effective	JJ	O	effective	amod	51	SENT_40	[p4l1060t839r1381b911],
51	approach	NN	O	approach	xcomp	46	SENT_40	[p4l1407t839r1775b931],
52	to	TO	O	to	_	0	SENT_40	[p4l1799t859r1875b911],
53	curing	VBG	O	cure	prepc_to	51	SENT_40	[p4l1901t844r2148b931],
54	or	CC	O	or	_	0	SENT_40	[p4l14t985r96b1028],
55	preventing	VBG	O	prevent	prepc_to	51	SENT_40	[p4l124t962r542b1048],
56	these	DT	O	these	det	59	SENT_40	[p4l570t956r766b1028],
57	H	NN	O	h	nn	59	SENT_40	[p4l796t963r874b1027],
58	pylori	NN	O	pylorus	nn	59	SENT_40	[p4l897t956r1579b1048],
59	—	NN	O	—	dobj	53	SENT_40	[p4l897t956r1579b1048],
60	associated	VBN	O	associate	partmod	59	SENT_40	[p4l897t956r1579b1048],
61	diseases	NNS	O	disease	nn	62	SENT_40	[p4l1610t954r2031b1028],
62	.3	NN	NUMBER	.3	dobj	60	SENT_40	[p4l1610t954r2031b1028],
63	=	JJ	O	=	amod	62	SENT_40	[p4l1610t954r2031b1028],
64	4	CD	NUMBER	4	tmod	63	SENT_40	[p4l1610t954r2031b1028],

1	The	DT	O	the	det	5	SENT_41	[p4l122t1074r272b1146],
2	Maastricht	NNP	MISC	Maastricht	nn	5	SENT_41	[p4l307t1074r739b1146],
3	III	NNP	MISC	III	nn	5	SENT_41	[p4l772t1079r859b1145],
4	Consensus	NNP	MISC	Consensus	nn	5	SENT_41	[p4l897t1078r1308b1146],
5	Report	NNP	MISC	Report	nsubj	6	SENT_41	[p4l1345t1079r1617b1166],
6	recommends	VBZ	O	recommend	_	0	SENT_41	[p4l1650t1074r2146b1146],
7	1	CD	DURATION	1	num	8	SENT_41	[p4l19t1197r51b1263],
8	week	NN	NUMBER	week	dobj	6	SENT_41	[p4l77t1192r270b1264],
9	of	IN	O	of	_	0	SENT_41	[p4l291t1192r369b1264],
10	triple	JJ	O	triple	amod	11	SENT_41	[p4l383t1192r574b1284],
11	therapy	NN	O	therapy	prep_of	8	SENT_41	[p4l594t1192r876b1284],
12	with	IN	O	with	_	0	SENT_41	[p4l893t1192r1060b1264],
13	clarithromycin	NN	O	clarithromycin	prep_with	11	SENT_41	[p4l1080t1192r1642b1284],
14	,	,	O	,	_	0	SENT_41	[p4l1080t1192r1642b1284],
15	either	CC	O	either	preconj	16	SENT_41	[p4l1661t1192r1867b1264],
16	amoxicillin	NNP	O	amoxicillin	dobj	6	SENT_41	[p4l1888t1197r2148b1264, p4l12t1310r198b1382],
17	or	CC	O	or	_	0	SENT_41	[p4l240t1339r321b1382],
18	metronidazole	NN	O	metronidazole	conj_or	16	SENT_41	[p4l361t1310r937b1399],
19	,	,	O	,	_	0	SENT_41	[p4l361t1310r937b1399],
20	and	CC	O	and	_	0	SENT_41	[p4l978t1310r1119b1382],
21	a	DT	O	a	det	25	SENT_41	[p4l1162t1339r1201b1382],
22	proton	NN	O	proton	nn	25	SENT_41	[p4l1242t1331r1506b1402],
23	pump	NN	O	pump	nn	25	SENT_41	[p4l1546t1338r1769b1402],
24	inhibitor	NN	O	inhibitor	nn	25	SENT_41	[p4l1812t1310r2148b1382],
25	(	NN	O	(	conj_and	8	SENT_41	[p4l17t1432r186b1515],
26	PPI	NNP	O	PPI	dep	25	SENT_41	[p4l17t1432r186b1515],
27	)	CD	NUMBER	)	num	26	SENT_41	[p4l17t1432r186b1515],
28	as	IN	O	as	_	0	SENT_41	[p4l212t1455r284b1499],
29	first-line	JJ	O	first-line	amod	30	SENT_41	[p4l305t1427r607b1499],
30	treatment	NN	O	treatment	prep_as	6	SENT_41	[p4l627t1447r984b1499],
31	for	IN	O	for	_	0	SENT_41	[p4l1003t1427r1111b1499],
32	the	DT	O	the	det	33	SENT_41	[p4l1129t1427r1241b1499],
33	eradication	NN	O	eradication	prep_for	30	SENT_41	[p4l1263t1427r1674b1499],
34	of	IN	O	of	_	0	SENT_41	[p4l1695t1427r1773b1499],
35	H	NN	O	h	nn	36	SENT_41	[p4l1786t1433r1863b1498],
36	pylori	NN	O	pylorus	prep_of	33	SENT_41	[p4l1876t1424r2147b1519],
37	?	.	O	?	_	0	SENT_41	[p4l1876t1424r2147b1519],

1	Such	JJ	O	such	amod	2	SENT_42	[p4l15t1545r192b1617],
2	regimens	NNS	O	regimen	nsubjpass	4	SENT_42	[p4l231t1550r566b1637],
3	are	VBP	O	be	auxpass	4	SENT_42	[p4l608t1573r721b1617],
4	associated	VBN	O	associate	_	0	SENT_42	[p4l763t1545r1145b1617],
5	with	IN	O	with	_	0	SENT_42	[p4l1182t1545r1353b1617],
6	eradication	NN	O	eradication	nn	7	SENT_42	[p4l1393t1545r1816b1617],
7	rates	NNS	O	rate	prep_with	4	SENT_42	[p4l1854t1565r2031b1617],
8	of	IN	O	of	_	0	SENT_42	[p4l2073t1545r2152b1617],
9	~	NN	O	~	prep_of	7	SENT_42	[p4l15t1667r242b1735],
10	70	CD	PERCENT	70	number	14	SENT_42	[p4l15t1667r242b1735],
11	%	NN	PERCENT	%	dep	14	SENT_42	[p4l15t1667r242b1735],
12	to	TO	O	to	dep	14	SENT_42	[p4l282t1683r357b1734],
13	85	CD	PERCENT	85	number	14	SENT_42	[p4l397t1660r687b1735],
14	%	NN	PERCENT	%	num	15	SENT_42	[p4l397t1660r687b1735],
15	.5	CD	NUMBER	.5	dobj	16	SENT_42	[p4l397t1660r687b1735],
16	>	JJR	O	>	dep	9	SENT_42	[p4l397t1660r687b1735],
17	6	CD	NUMBER	6	num	19	SENT_42	[p4l397t1660r687b1735],
18	Eradication	NN	O	eradication	nn	19	SENT_42	[p4l722t1663r1160b1734],
19	failure	NN	O	failure	nsubjpass	22	SENT_42	[p4l1194t1662r1434b1734],
20	may	MD	O	may	aux	22	SENT_42	[p4l1468t1691r1630b1754],
21	be	VB	O	be	auxpass	22	SENT_42	[p4l1665t1662r1748b1734],
22	related	VBN	O	relate	ccomp	16	SENT_42	[p4l1782t1662r2038b1734],
23	to	TO	O	to	_	0	SENT_42	[p4l2071t1683r2146b1734],
24	poor	JJ	O	poor	amod	25	SENT_42	[p4l12t1807r192b1871],
25	compliance	NN	O	compliance	prep_to	22	SENT_42	[p4l212t1779r638b1871],
26	and/or	JJ	O	and/or	amod	29	SENT_42	[p4l661t1779r906b1851],
27	antibiotic	JJ	O	antibiotic	amod	29	SENT_42	[p4l928t1779r1282b1851],
28	resistance	NN	O	resistance	nn	29	SENT_42	[p4l1303t1776r1768b1851],
29	.7	NN	NUMBER	.7	dobj	22	SENT_42	[p4l1303t1776r1768b1851],
30	=	JJ	O	=	amod	29	SENT_42	[p4l1303t1776r1768b1851],
31	8	CD	NUMBER	8	tmod	30	SENT_42	[p4l1303t1776r1768b1851],
32	However	RB	O	however	advmod	45	SENT_42	[p4l1792t1785r2149b1867],
33	,	,	O	,	_	0	SENT_42	[p4l1792t1785r2149b1867],
34	the	DT	O	the	det	35	SENT_42	[p4l12t1897r132b1969],
35	prevalence	NN	O	prevalence	nsubj	45	SENT_42	[p4l177t1897r597b1989],
36	of	IN	O	of	_	0	SENT_42	[p4l644t1897r727b1969],
37	clarithromycin	NN	O	clarithromycin	npadvmod	39	SENT_42	[p4l766t1897r1721b1989],
38	—	CD	NUMBER	—	num	37	SENT_42	[p4l766t1897r1721b1989],
39	resistant	JJ	O	resistant	amod	40	SENT_42	[p4l766t1897r1721b1989],
40	strains	NNS	O	strain	prep_of	35	SENT_42	[p4l1767t1902r2024b1969],
41	of	IN	O	of	_	0	SENT_42	[p4l2071t1897r2153b1969],
42	H	NN	O	h	nn	43	SENT_42	[p4l12t2021r90b2085],
43	pylori	NN	O	pylorus	prep_of	40	SENT_42	[p4l108t2014r332b2106],
44	is	VBZ	O	be	aux	45	SENT_42	[p4l355t2020r409b2086],
45	increasing	VBG	O	increase	rcmod	29	SENT_42	[p4l436t2020r815b2106],
46	worldwide	JJ	O	worldwide	amod	47	SENT_42	[p4l839t2012r1440b2086],
47	.6	NN	NUMBER	.6	nsubj	48	SENT_42	[p4l839t2012r1440b2086],
48	=	JJ	O	=	ccomp	45	SENT_42	[p4l839t2012r1440b2086],
49	9	CD	NUMBER	9	num	51	SENT_42	[p4l839t2012r1440b2086],
50	=	JJ	O	=	amod	51	SENT_42	[p4l839t2012r1440b2086],
51	10	CD	NUMBER	10	dobj	48	SENT_42	[p4l839t2012r1440b2086],
52	Therefore	RB	O	therefore	advmod	45	SENT_42	[p4l1462t2014r1855b2103],
53	,	,	O	,	_	0	SENT_42	[p4l1462t2014r1855b2103],
54	there	EX	O	there	expl	55	SENT_42	[p4l1879t2014r2067b2086],
55	is	VBZ	O	be	dep	45	SENT_42	[p4l2093t2020r2146b2086],
56	a	DT	O	a	det	57	SENT_42	[p4l14t2160r54b2204],
57	need	NN	O	need	nsubj	55	SENT_42	[p4l81t2132r255b2204],
58	for	IN	O	for	_	0	SENT_42	[p4l282t2132r391b2204],
59	effective	JJ	O	effective	amod	60	SENT_42	[p4l419t2132r725b2204],
60	alternatives	NNS	O	alternative	prep_for	57	SENT_42	[p4l754t2132r1183b2204],
61	to	TO	O	to	_	0	SENT_42	[p4l1210t2152r1285b2204],
62	clarithromycin	NN	O	clarithromycin	prep_to	16	SENT_42	[p4l1312t2132r1887b2223],
63	.	.	O	.	_	0	SENT_42	[p4l1312t2132r1887b2223],

1	One	CD	NUMBER	one	dep	127	SENT_43	[p4l126t2254r287b2322],
2	potential	JJ	O	potential	dep	127	SENT_43	[p4l330t2250r679b2342],
3	candidate	NN	O	candidate	dep	127	SENT_43	[p4l722t2250r1101b2322],
4	is	VBZ	O	be	dep	127	SENT_43	[p4l1145t2255r1200b2322],
5	levofloxacin	NN	O	levofloxacin	dep	127	SENT_43	[p4l1244t2250r1750b2339],
6	,	,	O	,	_	0	SENT_43	[p4l1244t2250r1750b2339],
7	a	DT	O	a	dep	127	SENT_43	[p4l1793t2278r1832b2322],
8	fluoroquinolone	JJ	O	fluoroquinolone	dep	127	SENT_43	[p4l1876t2250r2147b2322, p4l14t2369r418b2460],
9	antibiotic	JJ	O	antibiotic	dep	127	SENT_43	[p4l465t2369r849b2441],
10	that	IN	O	that	dep	127	SENT_43	[p4l893t2369r1053b2441],
11	exerts	VBZ	O	exert	dep	127	SENT_43	[p4l1098t2389r1333b2441],
12	bactericidal	JJ	O	bactericidal	dep	127	SENT_43	[p4l1381t2368r1849b2441],
13	effects	NNS	O	effect	dep	127	SENT_43	[p4l1895t2368r2147b2441],
14	through	IN	O	through	dep	127	SENT_43	[p4l12t2486r326b2578],
15	inhibition	NN	O	inhibition	dep	127	SENT_43	[p4l354t2486r739b2558],
16	of	IN	O	of	dep	127	SENT_43	[p4l768t2486r849b2558],
17	the	DT	O	the	dep	127	SENT_43	[p4l872t2486r990b2558],
18	DNA	NN	O	dna	dep	127	SENT_43	[p4l1019t2489r1230b2557],
19	gyrase	NN	O	gyrase	dep	127	SENT_43	[p4l1257t2514r1503b2578],
20	and	CC	O	and	dep	127	SENT_43	[p4l1533t2486r1676b2558],
21	has	VBZ	O	have	dep	127	SENT_43	[p4l1704t2486r1831b2558],
22	activity	NN	O	activity	dep	127	SENT_43	[p4l1862t2490r2149b2577],
23	against	IN	O	against	dep	127	SENT_43	[p4l14t2609r291b2696],
24	gram-positive	JJ	O	gram-positive	dep	127	SENT_43	[p4l321t2609r859b2696],
25	and	CC	O	and	dep	127	SENT_43	[p4l893t2604r1036b2676],
26	gram	NN	O	gram	dep	127	SENT_43	[p4l1068t2609r1626b2696],
27	—	CD	NUMBER	—	dep	127	SENT_43	[p4l1068t2609r1626b2696],
28	negative	JJ	O	negative	dep	127	SENT_43	[p4l1068t2609r1626b2696],
29	bacteria	NNS	O	bacterium	dep	127	SENT_43	[p4l1661t2604r1971b2676],
30	and	CC	O	and	dep	127	SENT_43	[p4l2005t2604r2148b2676],
31	atypical	JJ	O	atypical	dep	127	SENT_43	[p4l14t2722r314b2813],
32	respiratory	JJ	O	respiratory	dep	127	SENT_43	[p4l338t2727r761b2813],
33	pathogens	NNS	O	pathogen	dep	127	SENT_43	[p4l783t2719r1357b2813],
34	.11	NN	NUMBER	.11	dep	127	SENT_43	[p4l783t2719r1357b2813],
35	=	JJ	O	=	dep	127	SENT_43	[p4l783t2719r1357b2813],
36	12	CD	NUMBER	12	dep	127	SENT_43	[p4l783t2719r1357b2813],
37	In	IN	O	in	dep	127	SENT_43	[p4l1381t2728r1458b2792],
38	Vitro	NNP	O	Vitro	dep	127	SENT_43	[p4l1481t2727r1662b2794],
39	studies	NNS	O	study	dep	127	SENT_43	[p4l1688t2722r1946b2794],
40	have	VBP	O	have	dep	127	SENT_43	[p4l1971t2722r2148b2794],
41	found	VBN	O	find	dep	127	SENT_43	[p4l13t2839r244b2911],
42	that	IN	O	that	dep	127	SENT_43	[p4l279t2839r435b2911],
43	levofloxacin	NN	O	levofloxacin	dep	127	SENT_43	[p4l470t2839r952b2911],
44	has	VBZ	O	have	dep	127	SENT_43	[p4l988t2839r1115b2911],
45	activity	NN	O	activity	dep	127	SENT_43	[p4l1154t2843r1441b2931],
46	against	IN	O	against	dep	127	SENT_43	[p4l1477t2843r1754b2931],
47	H	NN	O	h	dep	127	SENT_43	[p4l1788t2844r1866b2910],
48	pylori	NN	O	pylorus	dep	127	SENT_43	[p4l1894t2839r2149b2931],
49	,	,	O	,	_	0	SENT_43	[p4l1894t2839r2149b2931],
50	with	IN	O	with	dep	127	SENT_43	[p4l11t2957r188b3029],
51	an	DT	O	a	dep	127	SENT_43	[p4l230t2986r322b3029],
52	MIC50	NN	O	mic50	dep	127	SENT_43	[p4l363t2962r619b3057],
53	of	IN	O	of	dep	127	SENT_43	[p4l663t2957r744b3029],
54	1	CD	NUMBER	1	dep	127	SENT_43	[p4l787t2963r821b3028],
55	mg/L	NN	O	mg/l	dep	127	SENT_43	[p4l869t2954r1256b3049],
56	,13	NN	O	,13	dep	127	SENT_43	[p4l869t2954r1256b3049],
57	=	JJ	O	=	dep	127	SENT_43	[p4l869t2954r1256b3049],
58	14	CD	NUMBER	14	dep	127	SENT_43	[p4l869t2954r1256b3049],
59	and	CC	O	and	dep	127	SENT_43	[p4l1300t2957r1443b3030],
60	has	VBZ	O	have	dep	127	SENT_43	[p4l1484t2957r1611b3029],
61	a	DT	O	a	dep	127	SENT_43	[p4l1656t2986r1695b3030],
62	synergistic	JJ	O	synergistic	dep	127	SENT_43	[p4l1739t2963r2148b3049],
63	effect	NN	O	effect	dep	127	SENT_43	[p4l13t3074r224b3146],
64	with	IN	O	with	dep	127	SENT_43	[p4l259t3074r435b3146],
65	PPIs	NNS	O	ppi	dep	127	SENT_43	[p4l472t3072r732b3146],
66	.15	CD	NUMBER	.15	dep	127	SENT_43	[p4l472t3072r732b3146],
67	In	IN	O	in	dep	127	SENT_43	[p4l770t3081r848b3145],
68	clinical	JJ	O	clinical	dep	127	SENT_43	[p4l885t3074r1162b3147],
69	studies	NNS	O	study	dep	127	SENT_43	[p4l1201t3075r1490b3163],
70	,	,	O	,	_	0	SENT_43	[p4l1201t3075r1490b3163],
71	7	CD	DURATION	7	dep	127	SENT_43	[p4l1529t3081r1573b3147],
72	to	TO	DURATION	to	dep	127	SENT_43	[p4l1608t3095r1685b3147],
73	10	CD	DURATION	10	dep	127	SENT_43	[p4l1729t3080r1819b3147],
74	days	NNS	NUMBER	day	dep	127	SENT_43	[p4l1860t3075r2032b3166],
75	of	IN	O	of	dep	127	SENT_43	[p4l2072t3074r2152b3147],
76	second-line	JJ	O	second-line	dep	127	SENT_43	[p4l14t3192r453b3264],
77	triple	JJ	O	triple	dep	127	SENT_43	[p4l481t3192r687b3284],
78	therapy	NN	O	therapy	dep	127	SENT_43	[p4l714t3192r1014b3284],
79	with	IN	O	with	dep	127	SENT_43	[p4l1039t3192r1216b3264],
80	levofloxacin	NN	O	levofloxacin	dep	127	SENT_43	[p4l1244t3192r1726b3264],
81	500	CD	NUMBER	500	dep	127	SENT_43	[p4l1755t3197r1901b3264],
82	mg/d	NN	O	mg/d	dep	127	SENT_43	[p4l1930t3192r2149b3284],
83	,	,	O	,	_	0	SENT_43	[p4l1930t3192r2149b3284],
84	another	DT	O	another	dep	127	SENT_43	[p4l14t3310r312b3382],
85	antibiotic	JJ	O	antibiotic	dep	127	SENT_43	[p4l338t3310r728b3399],
86	,	,	O	,	_	0	SENT_43	[p4l338t3310r728b3399],
87	and	CC	O	and	dep	127	SENT_43	[p4l753t3310r894b3382],
88	a	DT	O	a	dep	127	SENT_43	[p4l919t3338r958b3382],
89	PPI	NNP	O	PPI	dep	127	SENT_43	[p4l983t3316r1111b3381],
90	achieved	VBD	O	achieve	dep	127	SENT_43	[p4l1136t3310r1469b3382],
91	H	NN	O	h	dep	127	SENT_43	[p4l1493t3316r1570b3381],
92	pylori	NN	O	pylorus	dep	127	SENT_43	[p4l1587t3310r1817b3402],
93	eradication	NN	O	eradication	dep	127	SENT_43	[p4l1840t3310r2146b3382, p4l12t3433r167b3501],
94	rates	NNS	O	rate	dep	127	SENT_43	[p4l199t3449r383b3501],
95	of	IN	O	of	dep	127	SENT_43	[p4l418t3428r499b3501],
96	63	CD	PERCENT	63	dep	127	SENT_43	[p4l529t3433r710b3502],
97	%	NN	PERCENT	%	dep	127	SENT_43	[p4l529t3433r710b3502],
98	to	TO	O	to	dep	127	SENT_43	[p4l748t3449r825b3501],
99	94	CD	PERCENT	94	dep	127	SENT_43	[p4l860t3433r1073b3517],
100	%	NN	PERCENT	%	dep	127	SENT_43	[p4l860t3433r1073b3517],
101	,	,	O	,	_	0	SENT_43	[p4l860t3433r1073b3517],
102	as	IN	O	as	dep	127	SENT_43	[p4l1105t3457r1179b3501],
103	Well	NNP	O	Well	dep	127	SENT_43	[p4l1212t3429r1372b3501],
104	as	IN	O	as	dep	127	SENT_43	[p4l1406t3457r1481b3501],
105	overcoming	VBG	O	overcome	dep	127	SENT_43	[p4l1516t3433r1977b3520],
106	clarithromycin	NN	O	clarithromycin	dep	127	SENT_43	[p4l2009t3429r2146b3501, p4l12t3545r488b3636],
107	resistance	NN	O	resistance	dep	127	SENT_43	[p4l531t3542r1121b3617],
108	.16	CD	NUMBER	.16	dep	127	SENT_43	[p4l531t3542r1121b3617],
109	‘	CD	NUMBER	‘	dep	127	SENT_43	[p4l531t3542r1121b3617],
110	18	CD	NUMBER	18	dep	127	SENT_43	[p4l531t3542r1121b3617],
111	For	IN	O	for	dep	127	SENT_43	[p4l1168t3551r1304b3617],
112	example	NN	O	example	dep	127	SENT_43	[p4l1348t3545r1705b3637],
113	,	,	O	,	_	0	SENT_43	[p4l1348t3545r1705b3637],
114	one	CD	NUMBER	one	dep	127	SENT_43	[p4l1750t3573r1888b3617],
115	study	NN	O	study	dep	127	SENT_43	[p4l1935t3545r2149b3637],
116	reported	VBD	O	report	dep	127	SENT_43	[p4l12t3663r347b3755],
117	an	DT	O	a	dep	127	SENT_43	[p4l383t3691r474b3735],
118	88	CD	PERCENT	88	dep	127	SENT_43	[p4l515t3667r693b3736],
119	%	NN	PERCENT	%	dep	127	SENT_43	[p4l515t3667r693b3736],
120	rate	NN	O	rate	dep	127	SENT_43	[p4l735t3683r884b3735],
121	of	IN	O	of	dep	127	SENT_43	[p4l921t3663r1002b3735],
122	H	NN	O	h	dep	127	SENT_43	[p4l1032t3669r1110b3734],
123	pylori	NN	O	pylorus	dep	127	SENT_43	[p4l1138t3663r1371b3755],
124	eradication	NN	O	eradication	dep	127	SENT_43	[p4l1405t3663r1845b3735],
125	in	IN	O	in	dep	127	SENT_43	[p4l1881t3668r1953b3734],
126	7	CD	NUMBER	7	dep	127	SENT_43	[p4l1991t3670r2036b3735],
127	of	IN	O	of	_	0	SENT_43	[p4l2072t3663r2153b3735],

1	8	CD	NUMBER	8	dep	111	SENT_44	[p5l18t26r54b93],
2	patients	NNS	O	patient	dep	111	SENT_44	[p5l78t25r365b112],
3	with	IN	O	with	dep	111	SENT_44	[p5l385t21r553b93],
4	clarithromycin	NN	O	clarithromycin	dep	111	SENT_44	[p5l572t21r1114b112],
5	resistance	NN	O	resistance	dep	111	SENT_44	[p5l1134t25r1487b93],
6	treated	VBN	O	treat	dep	111	SENT_44	[p5l1507t21r1762b93],
7	for	IN	O	for	dep	111	SENT_44	[p5l1782t20r1890b93],
8	7	CD	DURATION	7	dep	111	SENT_44	[p5l1912t27r1956b93],
9	days	NNS	NUMBER	day	dep	111	SENT_44	[p5l1977t21r2145b112],
10	with	IN	O	with	dep	111	SENT_44	[p5l11t138r190b210],
11	levofloxacin-based	JJ	O	levofloxacin-based	dep	111	SENT_44	[p5l234t138r983b210],
12	triple	JJ	O	triple	dep	111	SENT_44	[p5l1026t138r1235b230],
13	therapy	NN	O	therapy	dep	111	SENT_44	[p5l1279t138r1582b230],
14	(	NN	O	(	dep	111	SENT_44	[p5l1630t138r2146b226],
15	levofloxacin	NN	O	levofloxacin	dep	111	SENT_44	[p5l1630t138r2146b226],
16	500	CD	NUMBER	500	dep	111	SENT_44	[p5l15t261r160b328],
17	mg/d	NN	O	mg/d	dep	111	SENT_44	[p5l191t256r410b348],
18	,	,	O	,	_	0	SENT_44	[p5l191t256r410b348],
19	rifabutin	NN	O	rifabutin	dep	111	SENT_44	[p5l438t256r782b328],
20	300	CD	NUMBER	300	dep	111	SENT_44	[p5l814t261r959b328],
21	mg/d	NN	O	mg/d	dep	111	SENT_44	[p5l990t256r1209b348],
22	,	,	O	,	_	0	SENT_44	[p5l990t256r1209b348],
23	and	CC	O	and	dep	111	SENT_44	[p5l1239t256r1382b328],
24	rabeprazole	NN	O	rabeprazole	dep	111	SENT_44	[p5l1411t256r1872b348],
25	20	CD	NUMBER	20	dep	111	SENT_44	[p5l1902t261r1998b328],
26	mg	NN	O	mg	dep	111	SENT_44	[p5l2029t284r2148b348],
27	BID	NNP	O	BID	dep	111	SENT_44	[p5l13t371r296b462],
28	)	CD	NUMBER	)	dep	111	SENT_44	[p5l13t371r296b462],
29	.17	CD	NUMBER	.17	dep	111	SENT_44	[p5l13t371r296b462],
30	In	IN	O	in	dep	111	SENT_44	[p5l326t380r403b444],
31	another	DT	O	another	dep	111	SENT_44	[p5l436t374r738b446],
32	study	NN	O	study	dep	111	SENT_44	[p5l770t374r994b465],
33	,	,	O	,	_	0	SENT_44	[p5l770t374r994b465],
34	H	NN	O	h	dep	111	SENT_44	[p5l1023t380r1102b444],
35	pylori	NN	O	pylorus	dep	111	SENT_44	[p5l1125t374r1358b465],
36	eradication	NN	O	eradication	dep	111	SENT_44	[p5l1388t374r1829b446],
37	rates	NNS	O	rate	dep	111	SENT_44	[p5l1859t394r2043b446],
38	in	IN	O	in	dep	111	SENT_44	[p5l2076t379r2148b444],
39	patients	NNS	O	patient	dep	111	SENT_44	[p5l6t744r315b831],
40	who	WP	O	who	dep	111	SENT_44	[p5l349t739r520b811],
41	had	VBD	O	have	dep	111	SENT_44	[p5l556t739r701b811],
42	failed	VBN	O	fail	dep	111	SENT_44	[p5l736t739r952b811],
43	to	TO	O	to	dep	111	SENT_44	[p5l987t760r1064b811],
44	respond	VB	O	respond	dep	111	SENT_44	[p5l1100t739r1415b831],
45	to	TO	O	to	dep	111	SENT_44	[p5l1449t760r1526b811],
46	standard	JJ	O	standard	dep	111	SENT_44	[p5l1564t739r1908b811],
47	triple	JJ	O	triple	dep	111	SENT_44	[p5l1942t739r2148b831],
48	therapy	NN	O	therapy	dep	111	SENT_44	[p5l6t857r307b949],
49	were	VBD	O	be	dep	111	SENT_44	[p5l332t885r519b929],
50	94	CD	PERCENT	94	dep	111	SENT_44	[p5l550t861r732b930],
51	%	NN	PERCENT	%	dep	111	SENT_44	[p5l550t861r732b930],
52	after	IN	O	after	dep	111	SENT_44	[p5l768t857r948b929],
53	10	CD	DURATION	10	dep	111	SENT_44	[p5l982t862r1072b929],
54	days	NNS	NUMBER	day	dep	111	SENT_44	[p5l1104t857r1276b948],
55	of	IN	O	of	dep	111	SENT_44	[p5l1307t857r1388b929],
56	triple	JJ	O	triple	dep	111	SENT_44	[p5l1411t857r1617b949],
57	therapy	NN	O	therapy	dep	111	SENT_44	[p5l1646t857r1946b949],
58	with	IN	O	with	dep	111	SENT_44	[p5l1972t857r2149b929],
59	levofloxacin	NN	O	levofloxacin	dep	111	SENT_44	[p5l7t975r491b1047],
60	500	CD	NUMBER	500	dep	111	SENT_44	[p5l523t980r668b1047],
61	mg/d	NN	O	mg/d	dep	111	SENT_44	[p5l701t975r920b1067],
62	,	,	O	,	_	0	SENT_44	[p5l701t975r920b1067],
63	amoxicillin	NNP	O	amoxicillin	dep	111	SENT_44	[p5l951t975r1392b1047],
64	1000	CD	DATE	1000	dep	111	SENT_44	[p5l1428t980r1621b1047],
65	mg	NN	O	mg	dep	111	SENT_44	[p5l1653t1003r1772b1067],
66	BID	NNP	O	BID	dep	111	SENT_44	[p5l1803t981r1975b1064],
67	,	,	O	,	_	0	SENT_44	[p5l1803t981r1975b1064],
68	and	CC	O	and	dep	111	SENT_44	[p5l2006t975r2149b1047],
69	rabeprazole	NN	O	rabeprazole	dep	111	SENT_44	[p5l7t1094r462b1185],
70	20	CD	NUMBER	20	dep	111	SENT_44	[p5l488t1099r583b1166],
71	mg	NN	O	mg	dep	111	SENT_44	[p5l609t1122r727b1185],
72	BID	NNP	O	BID	dep	111	SENT_44	[p5l752t1099r922b1182],
73	,	,	O	,	_	0	SENT_44	[p5l752t1099r922b1182],
74	and	CC	O	and	dep	111	SENT_44	[p5l946t1094r1088b1166],
75	90	CD	PERCENT	90	dep	111	SENT_44	[p5l1114t1098r1295b1167],
76	%	NN	PERCENT	%	dep	111	SENT_44	[p5l1114t1098r1295b1167],
77	after	IN	O	after	dep	111	SENT_44	[p5l1327t1093r1504b1166],
78	10	CD	DURATION	10	dep	111	SENT_44	[p5l1533t1099r1622b1166],
79	days	NNS	NUMBER	day	dep	111	SENT_44	[p5l1650t1093r1821b1185],
80	of	IN	O	of	dep	111	SENT_44	[p5l1848t1093r1928b1166],
81	triple	JJ	O	triple	dep	111	SENT_44	[p5l1947t1093r2150b1185],
82	therapy	NN	O	therapy	dep	111	SENT_44	[p5l6t1211r305b1303],
83	with	IN	O	with	dep	111	SENT_44	[p5l327t1211r503b1283],
84	levofloxacin	NN	O	levofloxacin	dep	111	SENT_44	[p5l528t1211r1008b1283],
85	500	CD	NUMBER	500	dep	111	SENT_44	[p5l1034t1216r1179b1283],
86	mg/d	NN	O	mg/d	dep	111	SENT_44	[p5l1206t1211r1424b1303],
87	,	,	O	,	_	0	SENT_44	[p5l1206t1211r1424b1303],
88	tinidazole	NN	O	tinidazole	dep	111	SENT_44	[p5l1447t1211r1830b1283],
89	500	CD	NUMBER	500	dep	111	SENT_44	[p5l1858t1216r2002b1283],
90	mg	NN	O	mg	dep	111	SENT_44	[p5l2029t1239r2148b1303],
91	BID	NNP	O	BID	dep	111	SENT_44	[p5l8t1335r180b1417],
92	,	,	O	,	_	0	SENT_44	[p5l8t1335r180b1417],
93	and	CC	O	and	dep	111	SENT_44	[p5l206t1329r349b1401],
94	rabeprazole	NN	O	rabeprazole	dep	111	SENT_44	[p5l374t1329r837b1421],
95	20	CD	NUMBER	20	dep	111	SENT_44	[p5l863t1334r960b1401],
96	mg	NN	O	mg	dep	111	SENT_44	[p5l987t1357r1106b1421],
97	BID	NNP	O	BID	dep	111	SENT_44	[p5l1133t1335r1305b1417],
98	,	,	O	,	_	0	SENT_44	[p5l1133t1335r1305b1417],
99	both	DT	O	both	dep	111	SENT_44	[p5l1331t1329r1510b1401],
100	in	IN	O	in	dep	111	SENT_44	[p5l1536t1334r1608b1400],
101	the	DT	O	the	dep	111	SENT_44	[p5l1633t1329r1751b1401],
102	intenttotreat	NN	O	intenttotreat	dep	111	SENT_44	[p5l1779t1334r2147b1401, p5l6t1467r192b1519],
103	(	CD	NUMBER	(	dep	111	SENT_44	[p5l240t1450r446b1535],
104	ITT	NNP	O	ITT	dep	111	SENT_44	[p5l240t1450r446b1535],
105	)	CD	NUMBER	)	dep	111	SENT_44	[p5l240t1450r446b1535],
106	and	CC	O	and	dep	111	SENT_44	[p5l497t1447r642b1519],
107	per-protocol	JJ	O	per-protocol	dep	111	SENT_44	[p5l686t1447r1185b1538],
108	(	NN	O	(	dep	111	SENT_44	[p5l1235t1452r1388b1535],
109	PP	NN	O	pp	dep	111	SENT_44	[p5l1235t1452r1388b1535],
110	)	NN	O	)	dep	111	SENT_44	[p5l1235t1452r1388b1535],
111	analyses	NNS	O	analysis	_	0	SENT_44	[p5l1439t1444r1866b1538],
112	.	.	O	.	_	0	SENT_44	[p5l1439t1444r1866b1538],

1	”	NN	O	”	nn	3	SENT_45	[p5l1439t1444r1866b1538],
2	Other	JJ	O	other	amod	3	SENT_45	[p5l1915t1447r2149b1519],
3	studies	NNS	O	study	nsubj	31	SENT_45	[p5l8t1564r280b1636],
4	evaluating	VBG	O	evaluate	partmod	3	SENT_45	[p5l327t1564r743b1656],
5	7	CD	NUMBER	7	dobj	4	SENT_45	[p5l790t1570r865b1636],
6	-	:	O	-	_	0	SENT_45	[p5l790t1570r865b1636],
7	or	CC	O	or	_	0	SENT_45	[p5l913t1592r996b1636],
8	10-day	JJ	DURATION	10-day	amod	10	SENT_45	[p5l1046t1564r1320b1656],
9	triple	JJ	O	triple	amod	10	SENT_45	[p5l1363t1564r1574b1656],
10	therapy	NN	O	therapy	nsubj	31	SENT_45	[p5l1619t1564r1927b1656],
11	with	IN	O	with	_	0	SENT_45	[p5l1969t1564r2150b1636],
12	levofloxacin	NN	O	levofloxacin	nn	14	SENT_45	[p5l7t1682r491b1754],
13	500	CD	NUMBER	500	num	14	SENT_45	[p5l527t1687r673b1754],
14	mg/d	NN	O	mg/d	prep_with	10	SENT_45	[p5l709t1682r905b1774],
15	or	CC	O	or	_	0	SENT_45	[p5l942t1710r1023b1754],
16	BID	NNP	O	BID	conj_or	14	SENT_45	[p5l1058t1688r1231b1771],
17	,	,	O	,	_	0	SENT_45	[p5l1058t1688r1231b1771],
18	amoxicillin	NNP	O	amoxicillin	nsubj	31	SENT_45	[p5l1266t1682r1730b1771],
19	,	,	O	,	_	0	SENT_45	[p5l1266t1682r1730b1771],
20	and	CC	O	and	_	0	SENT_45	[p5l1765t1682r1908b1754],
21	a	DT	O	a	det	22	SENT_45	[p5l1944t1710r1983b1754],
22	PPI	NNP	O	PPI	nsubj	31	SENT_45	[p5l2019t1688r2148b1753],
23	as	IN	O	as	_	0	SENT_45	[p5l8t1829r83b1873],
24	first-line	JJ	O	first-line	amod	25	SENT_45	[p5l113t1800r441b1873],
25	therapy	NN	O	therapy	prep_as	22	SENT_45	[p5l470t1801r771b1892],
26	for	IN	O	for	_	0	SENT_45	[p5l798t1800r912b1873],
27	eradication	NN	O	eradication	prep_for	25	SENT_45	[p5l941t1800r1383b1873],
28	of	IN	O	of	_	0	SENT_45	[p5l1413t1800r1494b1873],
29	H	NN	O	h	nn	30	SENT_45	[p5l1517t1806r1595b1871],
30	pylori	NN	O	pylorus	prep_of	27	SENT_45	[p5l1615t1801r1850b1892],
31	reported	VBD	O	report	_	0	SENT_45	[p5l1875t1821r2147b1892, p5l8t1918r96b1990],
32	eradication	NN	O	eradication	nn	33	SENT_45	[p5l140t1918r587b1990],
33	rates	NNS	O	rate	dobj	31	SENT_45	[p5l631t1938r817b1990],
34	of	IN	O	of	_	0	SENT_45	[p5l864t1918r945b1990],
35	87	CD	PERCENT	87	number	39	SENT_45	[p5l990t1922r1170b1991],
36	%	NN	PERCENT	%	dep	39	SENT_45	[p5l990t1922r1170b1991],
37	to	TO	O	to	dep	39	SENT_45	[p5l1220t1938r1297b1990],
38	96	CD	PERCENT	96	number	39	SENT_45	[p5l1345t1922r1528b1991],
39	%	NN	PERCENT	%	prep_of	33	SENT_45	[p5l1345t1922r1528b1991],
40	and	CC	O	and	_	0	SENT_45	[p5l1580t1918r1725b1990],
41	comparable	JJ	O	comparable	amod	42	SENT_45	[p5l1769t1945r2147b2010, p5l9t2036r120b2108],
42	tolerability	NN	O	tolerability	conj_and	33	SENT_45	[p5l163t2036r597b2128],
43	to	TO	O	to	_	0	SENT_45	[p5l639t2056r716b2108],
44	the	DT	O	the	det	47	SENT_45	[p5l759t2036r878b2108],
45	standard	JJ	O	standard	amod	47	SENT_45	[p5l923t2036r1267b2108],
46	clarithromycin	NN	O	clarithromycin	nn	47	SENT_45	[p5l1310t2036r2149b2128],
47	—	NN	O	—	prep_to	42	SENT_45	[p5l1310t2036r2149b2128],
48	based	VBN	O	base	partmod	47	SENT_45	[p5l1310t2036r2149b2128],
49	regimen	NNS	O	regimen	dobj	48	SENT_45	[p5l7t2151r520b2245],
50	.19	CD	NUMBER	.19	number	51	SENT_45	[p5l7t2151r520b2245],
51	‘	CD	NUMBER	‘	dep	49	SENT_45	[p5l7t2151r520b2245],
52	23	CD	NUMBER	23	dep	51	SENT_45	[p5l7t2151r520b2245],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_46	[p5l121t2271r591b2362],
2	P450	NN	O	p450	nsubj	13	SENT_46	[p5l614t2276r808b2343],
3	(	CD	NUMBER	(	num	6	SENT_46	[p5l838t2275r1060b2359],
4	CYP	NN	O	cyp	nn	6	SENT_46	[p5l838t2275r1060b2359],
5	)	NN	O	)	nn	6	SENT_46	[p5l838t2275r1060b2359],
6	isozymes	NNS	O	isozyme	dep	2	SENT_46	[p5l1088t2275r1425b2363],
7	(	CD	NUMBER	(	num	9	SENT_46	[p5l1454t2271r1739b2363],
8	mainly	RB	O	mainly	advmod	9	SENT_46	[p5l1454t2271r1739b2363],
9	CYPZC19	NN	O	cypzc19	dep	2	SENT_46	[p5l1764t2275r2146b2343],
10	and	CC	O	and	_	0	SENT_46	[p5l8t2389r150b2461],
11	CYP3A4	NN	O	cyp3a4	dep	2	SENT_46	[p5l177t2392r542b2478],
12	)	CD	NUMBER	)	num	11	SENT_46	[p5l177t2392r542b2478],
13	play	VBP	O	play	_	0	SENT_46	[p5l570t2389r734b2481],
14	an	DT	O	a	det	16	SENT_46	[p5l759t2417r850b2461],
15	important	JJ	O	important	amod	16	SENT_46	[p5l874t2394r1265b2481],
16	role	NN	O	role	dobj	13	SENT_46	[p5l1288t2389r1435b2461],
17	in	IN	O	in	_	0	SENT_46	[p5l1460t2394r1531b2460],
18	the	DT	O	the	det	19	SENT_46	[p5l1555t2389r1672b2461],
19	metabolism	NN	O	metabolism	prep_in	16	SENT_46	[p5l1696t2389r2148b2461],
20	of	IN	O	of	_	0	SENT_46	[p5l8t2507r88b2580],
21	PPIs	NNS	O	ppi	prep_of	19	SENT_46	[p5l108t2513r270b2580],
22	in	IN	O	in	_	0	SENT_46	[p5l297t2512r368b2578],
23	humans	NNS	O	human	prep_in	21	SENT_46	[p5l393t2508r720b2580],
24	.	.	O	.	_	0	SENT_46	[p5l393t2508r720b2580],

1	Minor	JJ	O	minor	amod	2	SENT_47	[p5l745t2512r996b2580],
2	mutations	NNS	O	mutation	nsubjpass	10	SENT_47	[p5l1019t2512r1411b2580],
3	or	CC	O	or	_	0	SENT_47	[p5l1438t2536r1519b2580],
4	polymorphisms	NNS	O	polymorphism	conj_or	2	SENT_47	[p5l1543t2508r2148b2599],
5	in	IN	O	in	_	0	SENT_47	[p5l7t2629r80b2696],
6	CYP2	NN	O	cyp2	nn	7	SENT_47	[p5l110t2629r332b2697],
7	C19	NN	O	c19	prep_in	2	SENT_47	[p5l347t2629r505b2697],
8	have	VBP	O	have	aux	10	SENT_47	[p5l532t2625r712b2697],
9	been	VBN	O	be	auxpass	10	SENT_47	[p5l740t2625r919b2697],
10	reported	VBN	O	report	_	0	SENT_47	[p5l944t2625r1278b2717],
11	to	TO	O	to	aux	12	SENT_47	[p5l1303t2645r1380b2697],
12	affect	VB	O	affect	xcomp	10	SENT_47	[p5l1409t2625r1624b2697],
13	its	PRP$	O	its	poss	14	SENT_47	[p5l1649t2629r1736b2697],
14	activity	NN	O	activity	dobj	12	SENT_47	[p5l1764t2629r2052b2716],
15	in	IN	O	in	_	0	SENT_47	[p5l2076t2629r2149b2696],
16	the	DT	O	the	det	17	SENT_47	[p5l6t2743r125b2815],
17	liver	NN	O	liver	prep_in	12	SENT_47	[p5l152t2743r323b2815],
18	and	CC	O	and	dep	26	SENT_47	[p5l350t2743r517b2832],
19	,	,	O	,	_	0	SENT_47	[p5l350t2743r517b2832],
20	thus	RB	O	thus	dep	26	SENT_47	[p5l541t2743r731b2831],
21	,	,	O	,	_	0	SENT_47	[p5l541t2743r731b2831],
22	the	DT	O	the	det	26	SENT_47	[p5l755t2743r874b2815],
23	metabolic	JJ	O	metabolic	amod	26	SENT_47	[p5l901t2743r1287b2815],
24	and	CC	O	and	_	0	SENT_47	[p5l1315t2743r1458b2815],
25	pharmacokinetic	JJ	O	pharmacokinetic	conj_and	23	SENT_47	[p5l1484t2743r2148b2835],
26	profiles	NNS	O	profile	dep	12	SENT_47	[p5l6t2860r299b2952],
27	of	IN	O	of	_	0	SENT_47	[p5l337t2860r419b2932],
28	PPIs	NNS	O	ppi	prep_of	26	SENT_47	[p5l449t2858r800b2932],
29	.24	CD	NUMBER	.24	num	32	SENT_47	[p5l449t2858r800b2932],
30	=	JJ	O	=	amod	32	SENT_47	[p5l449t2858r800b2932],
31	25	CD	NUMBER	25	num	32	SENT_47	[p5l449t2858r800b2932],
32	Polymorphisms	NNS	O	polymorphism	nsubjpass	37	SENT_47	[p5l837t2860r1448b2952],
33	in	IN	O	in	_	0	SENT_47	[p5l1485t2866r1558b2931],
34	CYP2	NN	O	cyp2	nn	35	SENT_47	[p5l1599t2865r1820b2932],
35	C19	NN	O	c19	prep_in	32	SENT_47	[p5l1835t2865r1992b2932],
36	are	VBP	O	be	auxpass	37	SENT_47	[p5l2031t2889r2148b2932],
37	associated	VBN	O	associate	ccomp	10	SENT_47	[p5l8t2978r413b3050],
38	With	IN	O	with	_	0	SENT_47	[p5l455t2978r634b3050],
39	3	CD	NUMBER	3	num	40	SENT_47	[p5l680t2983r720b3050],
40	genotypes	NNS	O	genotype	prep_with	37	SENT_47	[p5l768t2998r1186b3070],
41	:	:	O	:	_	0	SENT_47	[p5l768t2998r1186b3070],
42	homozygous	JJ	O	homozygous	amod	47	SENT_47	[p5l1234t2978r1737b3070],
43	extensive	JJ	O	extensive	amod	47	SENT_47	[p5l1783t2982r2146b3050],
44	metabolizer	NN	O	metabolizer	nn	47	SENT_47	[p5l7t3096r458b3168],
45	(	NN	O	(	nn	47	SENT_47	[p5l485t3101r906b3185],
46	HomEM	NNP	O	HomEM	nn	47	SENT_47	[p5l485t3101r906b3185],
47	)	NNP	O	)	prep_with	37	SENT_47	[p5l485t3101r906b3185],
48	,	,	O	,	_	0	SENT_47	[p5l485t3101r906b3185],
49	heterozygous	JJ	O	heterozygous	amod	51	SENT_47	[p5l928t3096r1433b3188],
50	extensive	JJ	O	extensive	amod	51	SENT_47	[p5l1458t3101r1807b3168],
51	metabolizer	NN	O	metabolizer	prep_with	37	SENT_47	[p5l1831t3096r2146b3168, p5l7t3214r172b3286],
52	(	NN	O	(	nn	54	SENT_47	[p5l216t3219r589b3303],
53	HetEM	NN	O	hetem	nn	54	SENT_47	[p5l216t3219r589b3303],
54	)	NN	O	)	dep	51	SENT_47	[p5l216t3219r589b3303],
55	,	,	O	,	_	0	SENT_47	[p5l216t3219r589b3303],
56	and	CC	O	and	_	0	SENT_47	[p5l628t3214r771b3286],
57	poor	JJ	O	poor	amod	61	SENT_47	[p5l809t3242r996b3306],
58	metabolizer	NN	O	metabolizer	nn	61	SENT_47	[p5l1034t3214r1498b3286],
59	(	NN	O	(	nn	61	SENT_47	[p5l1541t3219r1759b3303],
60	PM	NN	O	pm	nn	61	SENT_47	[p5l1541t3219r1759b3303],
61	)	NN	O	)	conj_and	40	SENT_47	[p5l1541t3219r1759b3303],
62	.	.	O	.	_	0	SENT_47	[p5l1541t3219r1759b3303],

1	HomEM	NNP	O	HomEM	nn	2	SENT_48	[p5l1799t3220r2149b3286],
2	status	NN	O	status	nsubj	3	SENT_48	[p5l8t3352r231b3404],
3	involves	VBZ	O	involve	_	0	SENT_48	[p5l257t3332r573b3404],
4	2	CD	NUMBER	2	num	6	SENT_48	[p5l599t3337r643b3403],
5	wild-type	JJ	O	wild-type	amod	6	SENT_48	[p5l669t3332r1038b3424],
6	alleles	NNS	O	allele	dobj	3	SENT_48	[p5l1065t3332r1322b3420],
7	;	:	O	;	_	0	SENT_48	[p5l1065t3332r1322b3420],
8	it	PRP	O	it	nsubj	9	SENT_48	[p5l1350t3336r1402b3404],
9	produces	VBZ	O	produce	parataxis	3	SENT_48	[p5l1425t3332r1778b3424],
10	an	DT	O	a	det	11	SENT_48	[p5l1805t3360r1897b3404],
11	abundance	NN	O	abundance	dobj	9	SENT_48	[p5l1923t3332r2145b3404, p5l8t3450r233b3522],
12	of	IN	O	of	_	0	SENT_48	[p5l269t3450r350b3522],
13	CYP2C19	NN	O	cyp2c19	prep_of	11	SENT_48	[p5l382t3454r801b3539],
14	,	,	O	,	_	0	SENT_48	[p5l382t3454r801b3539],
15	metabolizing	VBG	O	metabolize	dep	9	SENT_48	[p5l833t3450r1344b3542],
16	PPIs	NNS	O	ppi	dobj	15	SENT_48	[p5l1377t3456r1540b3522],
17	at	IN	O	at	_	0	SENT_48	[p5l1577t3470r1649b3522],
18	higher	JJR	O	higher	amod	19	SENT_48	[p5l1682t3450r1930b3542],
19	rates	NNS	O	rate	prep_at	15	SENT_48	[p5l1963t3470r2147b3522],
20	than	IN	O	than	_	0	SENT_48	[p5l6t3568r184b3640],
21	the	DT	O	the	det	24	SENT_48	[p5l226t3568r345b3640],
22	other	JJ	O	other	amod	24	SENT_48	[p5l390t3568r596b3640],
23	2	CD	NUMBER	2	num	24	SENT_48	[p5l639t3573r684b3639],
24	genotypes	NNS	O	genotype	prep_than	19	SENT_48	[p5l729t3589r1121b3660],
25	and	CC	O	and	_	0	SENT_48	[p5l1166t3568r1311b3640],
26	thus	RB	O	thus	advmod	27	SENT_48	[p5l1353t3568r1518b3640],
27	decreasing	VBG	O	decrease	conj_and	15	SENT_48	[p5l1564t3568r1977b3660],
28	PPI	NNP	O	PPI	nn	29	SENT_48	[p5l2019t3574r2149b3639],
29	concentrations	NNS	O	concentration	dobj	27	SENT_48	[p5l7t3690r576b3758],
30	.	.	O	.	_	0	SENT_48	[p5l7t3690r576b3758],

1	HetEM	NN	MISC	hetem	nn	2	SENT_49	[p5l598t3691r881b3758],
2	status	NN	O	status	_	0	SENT_49	[p5l903t3706r1137b3774],
3	,	,	O	,	_	0	SENT_49	[p5l903t3706r1137b3774],
4	which	WDT	O	which	nsubj	19	SENT_49	[p5l1156t3686r1384b3758],
5	involves	VBZ	O	involve	dep	2	SENT_49	[p5l1405t3686r1706b3758],
6	1	CD	NUMBER	1	num	8	SENT_49	[p5l1734t3691r1767b3757],
7	wild-type	JJ	O	wild-type	amod	8	SENT_49	[p5l1794t3686r2146b3778],
8	allele	NN	O	allele	dobj	5	SENT_49	[p6l8t20r206b92],
9	and	CC	O	and	_	0	SENT_49	[p6l232t20r375b92],
10	1	CD	NUMBER	1	num	12	SENT_49	[p6l406t25r439b91],
11	mutation-type	JJ	O	mutation-type	amod	12	SENT_49	[p6l471t25r1027b112],
12	allele	NN	O	allele	dobj	5	SENT_49	[p6l1054t20r1276b108],
13	,	,	O	,	_	0	SENT_49	[p6l1054t20r1276b108],
14	compromises	NNS	O	compromise	nn	15	SENT_49	[p6l1299t25r1814b112],
15	production	NN	O	production	appos	8	SENT_49	[p6l1840t20r2146b112, p6l6t143r160b210],
16	of	IN	O	of	_	0	SENT_49	[p6l185t138r266b210],
17	CYPZC19	NN	O	cypzc19	prep_of	15	SENT_49	[p6l288t143r677b210],
18	and	CC	O	and	_	0	SENT_49	[p6l705t138r847b210],
19	slows	VBZ	O	slow	conj_and	5	SENT_49	[p6l872t138r1083b210],
20	the	DT	O	the	det	21	SENT_49	[p6l1108t138r1225b210],
21	rate	NN	O	rate	dobj	19	SENT_49	[p6l1250t159r1397b210],
22	of	IN	O	of	_	0	SENT_49	[p6l1423t138r1504b210],
23	PPI	NNP	O	PPI	nn	24	SENT_49	[p6l1523t144r1651b209],
24	metabolism	NN	O	metabolism	prep_of	21	SENT_49	[p6l1674t138r2148b210],
25	.	.	O	.	_	0	SENT_49	[p6l1674t138r2148b210],

1	PM	NN	O	pm	nn	2	SENT_50	[p6l7t261r147b327],
2	status	NN	O	status	nsubj	9	SENT_50	[p6l175t276r424b344],
3	,	,	O	,	_	0	SENT_50	[p6l175t276r424b344],
4	involving	VBG	O	involve	partmod	2	SENT_50	[p6l451t256r817b348],
5	2	CD	NUMBER	2	num	7	SENT_50	[p6l843t261r889b327],
6	mutation-type	JJ	O	mutation-type	amod	7	SENT_50	[p6l918t260r1478b348],
7	alleles	NNS	O	allele	dobj	4	SENT_50	[p6l1508t256r1767b344],
8	,	,	O	,	_	0	SENT_50	[p6l1508t256r1767b344],
9	produces	VBZ	O	produce	_	0	SENT_50	[p6l1792t256r2147b348],
10	hardly	RB	O	hardly	advmod	9	SENT_50	[p6l7t374r258b466],
11	any	DT	O	any	det	12	SENT_50	[p6l283t402r421b466],
12	CYP2C19	NN	O	cyp2c19	dobj	9	SENT_50	[p6l447t378r862b463],
13	;	:	O	;	_	0	SENT_50	[p6l447t378r862b463],
14	lower	JJR	O	lower	amod	15	SENT_50	[p6l889t374r1109b446],
15	metabolism	NN	O	metabolism	nsubj	18	SENT_50	[p6l1133t374r1587b446],
16	of	IN	O	of	_	0	SENT_50	[p6l1612t374r1692b446],
17	PPIS	NNP	O	PPIS	prep_of	15	SENT_50	[p6l1712t380r1874b446],
18	results	VBZ	O	result	parataxis	9	SENT_50	[p6l1900t374r2149b446],
19	in	IN	O	in	_	0	SENT_50	[p6l7t497r80b562],
20	higher	JJR	O	higher	amod	22	SENT_50	[p6l109t491r358b583],
21	drug	NN	O	drug	nn	22	SENT_50	[p6l389t491r568b583],
22	concentrations.-7-649	NN	O	concentrations.-7-649	prep_in	18	SENT_50	[p6l598t489r1380b563],

1	The	DT	O	the	det	2	SENT_51	[p6l117t609r267b681],
2	effect	NN	O	effect	nsubjpass	26	SENT_51	[p6l298t609r510b681],
3	of	IN	O	of	_	0	SENT_51	[p6l541t609r622b681],
4	CYP2	NN	O	cyp2	nn	6	SENT_51	[p6l653t613r874b681],
5	C19	NN	O	c19	nn	6	SENT_51	[p6l889t613r1047b681],
6	genotype	NN	O	genotype	prep_of	2	SENT_51	[p6l1078t629r1434b701],
7	on	IN	O	on	_	0	SENT_51	[p6l1466t637r1563b681],
8	the	DT	O	the	det	10	SENT_51	[p6l1592t609r1711b681],
9	clinical	JJ	O	clinical	amod	10	SENT_51	[p6l1742t609r2020b681],
10	efficacy	NN	O	efficacy	prep_on	6	SENT_51	[p6l2051t609r2147b681, p6l7t727r234b819],
11	of	IN	O	of	_	0	SENT_51	[p6l259t727r340b799],
12	PPI	NNP	O	PPI	prep_of	10	SENT_51	[p6l360t727r745b799],
13	—	CD	NUMBER	—	num	12	SENT_51	[p6l360t727r745b799],
14	based	VBN	O	base	partmod	2	SENT_51	[p6l360t727r745b799],
15	triple	JJ	O	triple	amod	16	SENT_51	[p6l769t727r974b819],
16	therapy	NN	O	therapy	dobj	14	SENT_51	[p6l999t727r1299b819],
17	for	IN	O	for	_	0	SENT_51	[p6l1323t727r1436b799],
18	the	DT	O	the	det	19	SENT_51	[p6l1460t727r1578b799],
19	eradication	NN	O	eradication	prep_for	14	SENT_51	[p6l1605t727r2045b799],
20	of	IN	O	of	_	0	SENT_51	[p6l2072t727r2152b799],
21	H	NN	O	h	nn	22	SENT_51	[p6l6t851r83b916],
22	pylori	NN	O	pylorus	prep_of	19	SENT_51	[p6l97t845r321b937],
23	has	VBZ	O	have	aux	26	SENT_51	[p6l341t846r464b918],
24	been	VBN	O	be	auxpass	26	SENT_51	[p6l489t845r661b918],
25	extensively	RB	O	extensively	advmod	26	SENT_51	[p6l683t845r1095b937],
26	evaluated	VBN	O	evaluate	_	0	SENT_51	[p6l1117t845r1495b918],
27	.	.	O	.	_	0	SENT_51	[p6l1117t845r1495b918],

1	However	RB	O	however	dep	148	SENT_52	[p6l1518t851r1876b934],
2	,	,	O	,	_	0	SENT_52	[p6l1518t851r1876b934],
3	almost	RB	O	almost	dep	148	SENT_52	[p6l1898t846r2149b918],
4	all	DT	O	all	dep	148	SENT_52	[p6l8t963r100b1035],
5	previous	JJ	O	previous	dep	148	SENT_52	[p6l136t967r470b1055],
6	studies	NNS	O	study	dep	148	SENT_52	[p6l510t963r775b1035],
7	have	VBP	O	have	dep	148	SENT_52	[p6l814t963r993b1035],
8	investigated	VBN	O	investigate	dep	148	SENT_52	[p6l1032t963r1499b1055],
9	clarithromycinbased	JJ	O	clarithromycinbased	dep	148	SENT_52	[p6l1536t963r2147b1054, p6l9t1081r228b1153],
10	triple	JJ	O	triple	dep	148	SENT_52	[p6l262t1081r469b1173],
11	therapy	NN	O	therapy	dep	148	SENT_52	[p6l503t1081r804b1173],
12	that	WDT	O	that	dep	148	SENT_52	[p6l837t1081r993b1153],
13	included	VBD	O	include	dep	148	SENT_52	[p6l1027t1081r1362b1153],
14	omeprazole	NN	O	omeprazole	dep	148	SENT_52	[p6l1398t1081r1878b1173],
15	,	,	O	,	_	0	SENT_52	[p6l1398t1081r1878b1173],
16	lanso	NN	O	lanso	dep	148	SENT_52	[p6l1912t1081r2147b1153],
17	—	NN	O	—	dep	148	SENT_52	[p6l1912t1081r2147b1153],
18	prazole	NN	O	prazole	dep	148	SENT_52	[p6l6t1199r318b1290],
19	,	,	O	,	_	0	SENT_52	[p6l6t1199r318b1290],
20	or	CC	O	or	dep	148	SENT_52	[p6l343t1227r425b1271],
21	rabeprazole	NN	O	rabeprazole	dep	148	SENT_52	[p6l449t1199r910b1290],
22	as	IN	O	as	dep	148	SENT_52	[p6l937t1227r1012b1271],
23	the	DT	O	the	dep	148	SENT_52	[p6l1037t1199r1155b1271],
24	PPI	NNP	O	PPI	dep	148	SENT_52	[p6l1181t1205r1310b1269],
25	component	NN	O	component	dep	148	SENT_52	[p6l1335t1196r1976b1290],
26	.30	CD	NUMBER	.30	dep	148	SENT_52	[p6l1335t1196r1976b1290],
27	‘	CD	NUMBER	‘	dep	148	SENT_52	[p6l1335t1196r1976b1290],
28	35	CD	NUMBER	35	dep	148	SENT_52	[p6l1335t1196r1976b1290],
29	The	DT	O	the	dep	148	SENT_52	[p6l1998t1199r2148b1271],
30	clinical	JJ	O	clinical	dep	148	SENT_52	[p6l7t1316r273b1388],
31	efficacy	NN	O	efficacy	dep	148	SENT_52	[p6l296t1316r582b1408],
32	of	IN	O	of	dep	148	SENT_52	[p6l605t1316r684b1388],
33	triple	JJ	O	triple	dep	148	SENT_52	[p6l701t1316r898b1408],
34	therapies	NNS	O	therapy	dep	148	SENT_52	[p6l921t1316r1261b1408],
35	containing	VBG	O	contain	dep	148	SENT_52	[p6l1284t1320r1685b1408],
36	omeprazole	NN	O	omeprazole	dep	148	SENT_52	[p6l1709t1316r2147b1408],
37	or	CC	O	or	dep	148	SENT_52	[p6l8t1462r90b1506],
38	lansoprazole	NN	O	lansoprazole	dep	148	SENT_52	[p6l133t1434r632b1526],
39	has	VBZ	O	have	dep	148	SENT_52	[p6l675t1434r803b1506],
40	been	VBN	O	be	dep	148	SENT_52	[p6l850t1434r1029b1506],
41	reported	VBN	O	report	dep	148	SENT_52	[p6l1072t1434r1407b1526],
42	to	TO	O	to	dep	148	SENT_52	[p6l1449t1454r1526b1506],
43	be	VB	O	be	dep	148	SENT_52	[p6l1572t1434r1658b1506],
44	affected	VBN	O	affect	dep	148	SENT_52	[p6l1703t1434r2011b1506],
45	by	IN	O	by	dep	148	SENT_52	[p6l2055t1434r2148b1526],
46	CYP2C19	NN	O	cyp2c19	dep	148	SENT_52	[p6l13t1557r410b1625],
47	genotype	NN	O	genotype	dep	148	SENT_52	[p6l455t1573r839b1644],
48	;	:	O	;	_	0	SENT_52	[p6l455t1573r839b1644],
49	PM	NNP	O	PM	dep	148	SENT_52	[p6l884t1558r1025b1624],
50	status	NN	O	status	dep	148	SENT_52	[p6l1070t1573r1296b1625],
51	has	VBZ	O	have	dep	148	SENT_52	[p6l1341t1553r1470b1625],
52	been	VBN	O	be	dep	148	SENT_52	[p6l1518t1552r1698b1625],
53	associated	VBN	O	associate	dep	148	SENT_52	[p6l1743t1553r2148b1625],
54	with	IN	O	with	dep	148	SENT_52	[p6l6t1670r182b1742],
55	an	DT	O	a	dep	148	SENT_52	[p6l208t1698r300b1742],
56	increased	VBN	O	increase	dep	148	SENT_52	[p6l325t1670r689b1742],
57	rate	NN	O	rate	dep	148	SENT_52	[p6l713t1690r862b1742],
58	of	IN	O	of	dep	148	SENT_52	[p6l889t1670r970b1742],
59	H	NN	O	h	dep	148	SENT_52	[p6l990t1675r1068b1741],
60	pylori	NN	O	pylorus	dep	148	SENT_52	[p6l1085t1670r1319b1761],
61	eradication	NN	O	eradication	dep	148	SENT_52	[p6l1342t1670r1806b1758],
62	,	,	O	,	_	0	SENT_52	[p6l1342t1670r1806b1758],
63	whereas	IN	O	whereas	dep	148	SENT_52	[p6l1829t1670r2147b1742],
64	HomEM	NNP	O	HomEM	dep	148	SENT_52	[p6l7t1794r362b1860],
65	status	NN	O	status	dep	148	SENT_52	[p6l408t1808r635b1860],
66	has	VBZ	O	have	dep	148	SENT_52	[p6l681t1788r811b1860],
67	been	VBN	O	be	dep	148	SENT_52	[p6l858t1788r1040b1860],
68	associated	VBN	O	associate	dep	148	SENT_52	[p6l1085t1788r1493b1860],
69	with	IN	O	with	dep	148	SENT_52	[p6l1536t1788r1715b1860],
70	treatment	NN	O	treatment	dep	148	SENT_52	[p6l1759t1808r2148b1860],
71	failure	NN	O	failure	dep	148	SENT_52	[p6l7t1903r443b1978],
72	.30	CD	NUMBER	.30	dep	148	SENT_52	[p6l7t1903r443b1978],
73	=	JJ	O	=	dep	148	SENT_52	[p6l7t1903r443b1978],
74	31	CD	NUMBER	31	dep	148	SENT_52	[p6l7t1903r443b1978],
75	For	IN	O	for	dep	148	SENT_52	[p6l474t1912r608b1978],
76	example	NN	O	example	dep	148	SENT_52	[p6l635t1906r987b1997],
77	,	,	O	,	_	0	SENT_52	[p6l635t1906r987b1997],
78	a	DT	O	a	dep	148	SENT_52	[p6l1014t1934r1054b1978],
79	meta-analysis	NN	O	meta-analysis	dep	148	SENT_52	[p6l1081t1906r1615b1997],
80	found	VBD	O	find	dep	148	SENT_52	[p6l1643t1905r1875b1978],
81	higher	JJR	O	higher	dep	148	SENT_52	[p6l1901t1906r2149b1997],
82	rates	NNS	O	rate	dep	148	SENT_52	[p6l7t2043r185b2095],
83	of	IN	O	of	dep	148	SENT_52	[p6l210t2023r289b2095],
84	H	NN	O	h	dep	148	SENT_52	[p6l307t2028r384b2094],
85	pylori	NN	O	pylorus	dep	148	SENT_52	[p6l400t2023r626b2115],
86	eradication	NN	O	eradication	dep	148	SENT_52	[p6l647t2023r1074b2095],
87	with	IN	O	with	dep	148	SENT_52	[p6l1096t2023r1267b2095],
88	triple	JJ	O	triple	dep	148	SENT_52	[p6l1289t2023r1488b2115],
89	omeprazole	NN	O	omeprazole	dep	148	SENT_52	[p6l1513t2023r1983b2115],
90	-	:	O	-	_	0	SENT_52	[p6l1513t2023r1983b2115],
91	and	CC	O	and	dep	148	SENT_52	[p6l2009t2023r2148b2095],
92	lansoprazole	JJ	O	lansoprazole	dep	148	SENT_52	[p6l7t2141r729b2233],
93	—	NN	O	—	dep	148	SENT_52	[p6l7t2141r729b2233],
94	based	VBN	O	base	dep	148	SENT_52	[p6l7t2141r729b2233],
95	therapies	NNS	O	therapy	dep	148	SENT_52	[p6l751t2141r1089b2233],
96	in	IN	O	in	dep	148	SENT_52	[p6l1113t2146r1183b2212],
97	those	DT	O	those	dep	148	SENT_52	[p6l1204t2141r1402b2213],
98	with	IN	O	with	dep	148	SENT_52	[p6l1423t2141r1594b2213],
99	PM	NN	O	pm	dep	148	SENT_52	[p6l1615t2147r1751b2213],
100	compared	VBN	O	compare	dep	148	SENT_52	[p6l1773t2141r2149b2233],
101	with	IN	O	with	dep	148	SENT_52	[p6l6t2260r178b2332],
102	HomEM	NNP	O	HomEM	dep	148	SENT_52	[p6l200t2265r543b2332],
103	status	NN	O	status	dep	148	SENT_52	[p6l567t2280r784b2332],
104	(	CD	NUMBER	(	dep	148	SENT_52	[p6l813t2260r1017b2348],
105	odds	NNS	O	odds	dep	148	SENT_52	[p6l813t2260r1017b2348],
106	ratio	NN	O	ratio	dep	148	SENT_52	[p6l1041t2264r1220b2332],
107	[	CD	NUMBER	[	dep	148	SENT_52	[p6l1251t2264r1434b2348],
108	OR	NN	O	or	dep	148	SENT_52	[p6l1251t2264r1434b2348],
109	]	NN	O	]	dep	148	SENT_52	[p6l1251t2264r1434b2348],
110	=	JJ	O	=	dep	148	SENT_52	[p6l1466t2297r1507b2323],
111	4.28	CD	NUMBER	4.28	dep	148	SENT_52	[p6l1532t2265r1698b2332],
112	[	CD	NUMBER	[	dep	148	SENT_52	[p6l1733t2264r1808b2348],
113	P	NN	O	p	dep	148	SENT_52	[p6l1733t2264r1808b2348],
114	=	JJ	O	=	dep	148	SENT_52	[p6l1832t2297r1873b2323],
115	0.001	CD	NUMBER	0.001	dep	148	SENT_52	[p6l1901t2264r2142b2348],
116	]	NN	O	]	dep	148	SENT_52	[p6l1901t2264r2142b2348],
117	for	IN	O	for	dep	148	SENT_52	[p6l7t2377r121b2449],
118	omeprazole-based	JJ	O	omeprazole-based	dep	148	SENT_52	[p6l152t2377r865b2469],
119	therapy	NN	O	therapy	dep	148	SENT_52	[p6l895t2377r1217b2469],
120	;	:	O	;	_	0	SENT_52	[p6l895t2377r1217b2469],
121	OR	NN	O	or	dep	148	SENT_52	[p6l1253t2381r1390b2449],
122	=	JJ	O	=	dep	148	SENT_52	[p6l1422t2414r1464b2439],
123	3.06	CD	NUMBER	3.06	dep	148	SENT_52	[p6l1498t2382r1669b2449],
124	[	CD	NUMBER	[	dep	148	SENT_52	[p6l1708t2381r1785b2466],
125	P	NN	O	p	dep	148	SENT_52	[p6l1708t2381r1785b2466],
126	=	JJ	O	=	dep	148	SENT_52	[p6l1817t2414r1858b2439],
127	0.001	CD	NUMBER	0.001	dep	148	SENT_52	[p6l1893t2381r2142b2465],
128	]	NN	O	]	dep	148	SENT_52	[p6l1893t2381r2142b2465],
129	for	IN	O	for	dep	148	SENT_52	[p6l7t2495r124b2567],
130	lansoprazole	JJ	O	lansoprazole	dep	148	SENT_52	[p6l169t2495r947b2587],
131	—	NN	O	—	dep	148	SENT_52	[p6l169t2495r947b2587],
132	based	VBN	O	base	dep	148	SENT_52	[p6l169t2495r947b2587],
133	therapy	NN	O	therapy	dep	148	SENT_52	[p6l991t2495r1355b2587],
134	)	NN	O	)	dep	148	SENT_52	[p6l991t2495r1355b2587],
135	,	,	O	,	_	0	SENT_52	[p6l991t2495r1355b2587],
136	and	CC	O	and	dep	148	SENT_52	[p6l1400t2495r1547b2567],
137	in	IN	O	in	dep	148	SENT_52	[p6l1592t2500r1666b2566],
138	those	DT	O	those	dep	148	SENT_52	[p6l1710t2495r1922b2567],
139	with	IN	O	with	dep	148	SENT_52	[p6l1966t2495r2148b2567],
140	HetEM	NN	O	hetem	dep	148	SENT_52	[p6l7t2619r308b2686],
141	compared	VBN	O	compare	dep	148	SENT_52	[p6l345t2614r749b2705],
142	with	IN	O	with	dep	148	SENT_52	[p6l785t2613r967b2686],
143	HomEM	NNP	O	HomEM	dep	148	SENT_52	[p6l1004t2619r1363b2686],
144	status	NN	O	status	dep	148	SENT_52	[p6l1400t2634r1634b2686],
145	(	CD	NUMBER	(	dep	148	SENT_52	[p6l1677t2618r1847b2702],
146	OR	NN	O	or	dep	148	SENT_52	[p6l1677t2618r1847b2702],
147	=	JJ	O	=	dep	148	SENT_52	[p6l1886t2651r1928b2676],
148	3.22	CD	NUMBER	3.22	_	0	SENT_52	[p6l1970t2619r2146b2686],

1	Volume	NN	O	volume	_	0	SENT_53	[p6l1184t2872r1479b2937],
2	32	CD	NUMBER	32	dep	1	SENT_53	[p6l1512t2875r1603b2937],
3	Number	NNP	O	Number	dep	1	SENT_53	[p6l1642t2872r1964b2937],
4	12	CD	NUMBER	12	num	3	SENT_53	[p6l1996t2875r2081b2936],

1	[	NN	O	[	nn	2	SENT_54	[p6l15t2988r94b3072],
2	P	NN	O	p	_	0	SENT_54	[p6l15t2988r94b3072],
3	<	JJR	O	<	dep	2	SENT_54	[p6l131t3013r173b3054],
4	0.001	CD	NUMBER	0.001	dep	3	SENT_54	[p6l210t2988r459b3072],
5	]	NN	O	]	dep	2	SENT_54	[p6l210t2988r459b3072],
6	and	CC	O	and	_	0	SENT_54	[p6l499t2984r642b3056],
7	OR	NN	O	or	dep	2	SENT_54	[p6l677t2988r815b3056],
8	=	JJ	O	=	amod	5	SENT_54	[p6l849t3021r890b3046],
9	1.95	CD	NUMBER	1.95	tmod	8	SENT_54	[p6l931t2988r1097b3056],
10	[	CD	NUMBER	[	num	11	SENT_54	[p6l1139t2988r1216b3072],
11	P	NN	O	p	dep	2	SENT_54	[p6l1139t2988r1216b3072],
12	=	JJ	O	=	amod	14	SENT_54	[p6l1250t3021r1292b3046],
13	0.040	CD	NUMBER	0.040	tmod	12	SENT_54	[p6l1329t2988r1608b3072],
14	]	NN	O	]	dep	11	SENT_54	[p6l1329t2988r1608b3072],
15	,	,	O	,	_	0	SENT_54	[p6l1329t2988r1608b3072],
16	respectively	RB	O	respectively	advmod	17	SENT_54	[p6l1639t2984r2149b3075],
17	)	CD	NUMBER	)	appos	2	SENT_54	[p6l1639t2984r2149b3075],
18	.	.	O	.	_	0	SENT_54	[p6l1639t2984r2149b3075],

1	Eradication	NN	O	eradication	nn	2	SENT_55	[p6l9t3101r467b3173],
2	rates	NNS	O	rate	nsubj	40	SENT_55	[p6l501t3121r685b3173],
3	were	VBD	O	be	cop	40	SENT_55	[p6l721t3129r907b3173],
4	significantly	RB	O	significantly	advmod	5	SENT_55	[p6l944t3101r1422b3193],
5	different	JJ	O	different	amod	40	SENT_55	[p6l1458t3101r1791b3173],
6	between	IN	O	between	_	0	SENT_55	[p6l1828t3101r2150b3173],
7	those	DT	O	those	prep_between	5	SENT_55	[p6l7t3219r214b3292],
8	with	IN	O	with	_	0	SENT_55	[p6l251t3219r428b3291],
9	PM	NN	O	pm	prep_with	7	SENT_55	[p6l465t3225r605b3291],
10	and	CC	O	and	_	0	SENT_55	[p6l644t3219r787b3291],
11	HomEM	NNP	O	HomEM	nn	12	SENT_55	[p6l825t3225r1175b3291],
12	status	NN	O	status	conj_and	9	SENT_55	[p6l1214t3239r1438b3292],
13	(	CD	NUMBER	(	num	14	SENT_55	[p6l1482t3223r1648b3308],
14	OR	NN	O	or	npadvmod	15	SENT_55	[p6l1482t3223r1648b3308],
15	=	JJ	O	=	amod	12	SENT_55	[p6l1688t3257r1729b3282],
16	2.79	CD	NUMBER	2.79	number	17	SENT_55	[p6l1770t3224r1942b3292],
17	[	CD	NUMBER	[	num	18	SENT_55	[p6l1990t3223r2066b3308],
18	P	NN	O	p	npadvmod	19	SENT_55	[p6l1990t3223r2066b3308],
19	<	JJR	O	<	amod	12	SENT_55	[p6l2106t3249r2147b3290],
20	0.001	CD	NUMBER	0.001	num	22	SENT_55	[p6l10t3342r292b3426],
21	]	NN	O	]	nn	22	SENT_55	[p6l10t3342r292b3426],
22	)	NN	O	)	dep	12	SENT_55	[p6l10t3342r292b3426],
23	and	CC	O	and	_	0	SENT_55	[p6l323t3337r467b3410],
24	between	IN	O	between	_	0	SENT_55	[p6l493t3338r816b3410],
25	those	DT	O	those	prep_between	7	SENT_55	[p6l840t3337r1046b3410],
26	with	IN	O	with	_	0	SENT_55	[p6l1070t3338r1247b3410],
27	PM	NN	O	pm	nn	30	SENT_55	[p6l1272t3343r1412b3409],
28	and	CC	O	and	_	0	SENT_55	[p6l1438t3338r1581b3410],
29	HetEM	NN	O	hetem	nn	30	SENT_55	[p6l1606t3343r1900b3410],
30	status	NN	O	status	prep_with	25	SENT_55	[p6l1926t3358r2150b3410],
31	(	CD	NUMBER	(	num	32	SENT_55	[p6l13t3459r178b3543],
32	OR	NN	O	or	dep	7	SENT_55	[p6l13t3459r178b3543],
33	=	JJ	O	=	amod	40	SENT_55	[p6l205t3493r246b3518],
34	1.73	CD	NUMBER	1.73	number	35	SENT_55	[p6l280t3460r442b3527],
35	[	CD	NUMBER	[	num	40	SENT_55	[p6l479t3459r555b3544],
36	P	NN	O	p	nn	40	SENT_55	[p6l479t3459r555b3544],
37	=	JJ	O	=	amod	40	SENT_55	[p6l582t3493r623b3518],
38	0.002	CD	NUMBER	0.002	number	39	SENT_55	[p6l653t3459r958b3544],
39	]	CD	NUMBER	]	dep	37	SENT_55	[p6l653t3459r958b3544],
40	)	NN	O	)	_	0	SENT_55	[p6l653t3459r958b3544],
41	.	.	O	.	_	0	SENT_55	[p6l653t3459r958b3544],

1	Eradication	NN	O	eradication	nn	2	SENT_56	[p6l984t3455r1438b3527],
2	rates	NNS	O	rate	nsubj	4	SENT_56	[p6l1462t3475r1646b3527],
3	also	RB	O	also	advmod	4	SENT_56	[p6l1673t3455r1824b3527],
4	differed	VBD	O	differ	_	0	SENT_56	[p6l1851t3455r2152b3527],
5	significantly	RB	O	significantly	amod	14	SENT_56	[p6l9t3573r488b3665],
6	between	IN	O	between	_	0	SENT_56	[p6l517t3573r840b3645],
7	those	DT	O	those	prep_between	5	SENT_56	[p6l867t3573r1073b3645],
8	with	IN	O	with	_	0	SENT_56	[p6l1100t3573r1277b3645],
9	HetEM	NN	O	hetem	prep_with	7	SENT_56	[p6l1306t3579r1599b3645],
10	and	CC	O	and	_	0	SENT_56	[p6l1629t3573r1772b3645],
11	HomEM	NNP	O	HomEM	nn	12	SENT_56	[p6l1800t3579r2151b3645],
12	status	NN	O	status	conj_and	9	SENT_56	[p6l9t3712r236b3764],
13	(	CD	NUMBER	(	num	12	SENT_56	[p6l275t3696r442b3780],
14	OR	NN	O	or	nsubj	19	SENT_56	[p6l275t3696r442b3780],
15	=	JJ	O	=	amod	14	SENT_56	[p6l476t3730r518b3755],
16	2.00	CD	NUMBER	2.00	tmod	15	SENT_56	[p6l552t3697r727b3764],
17	[	CD	NUMBER	[	num	18	SENT_56	[p6l769t3696r846b3780],
18	P	NN	O	p	npadvmod	19	SENT_56	[p6l769t3696r846b3780],
19	<	JJR	O	<	xcomp	4	SENT_56	[p6l881t3721r922b3763],
20	0.002	CD	NUMBER	0.002	num	21	SENT_56	[p6l960t3689r1347b3780],
21	]	NN	O	]	dep	19	SENT_56	[p6l960t3689r1347b3780],
22	)	CD	NUMBER	)	num	23	SENT_56	[p6l960t3689r1347b3780],
23	.30	CD	NUMBER	.30	npadvmod	24	SENT_56	[p6l960t3689r1347b3780],
24	On	IN	O	on	dep	19	SENT_56	[p6l1383t3696r1505b3764],
25	the	DT	O	the	det	27	SENT_56	[p6l1537t3692r1656b3764],
26	other	JJ	O	other	amod	27	SENT_56	[p6l1691t3692r1898b3764],
27	hand	NN	O	hand	pobj	24	SENT_56	[p6l1930t3692r2151b3780],
28	,	,	O	,	_	0	SENT_56	[p6l1930t3692r2151b3780],

1	studies	NNS	O	study	nsubj	3	SENT_57	[p7l9t21r277b93],
2	have	VBP	O	have	aux	3	SENT_57	[p7l305t21r486b93],
3	reported	VBN	O	report	_	0	SENT_57	[p7l512t21r850b113],
4	that	IN	O	that	complm	15	SENT_57	[p7l875t21r1033b93],
5	the	DT	O	the	det	7	SENT_57	[p7l1058t21r1177b93],
6	clinical	JJ	O	clinical	amod	7	SENT_57	[p7l1204t21r1485b93],
7	efficacy	NN	O	efficacy	nsubjpass	15	SENT_57	[p7l1512t21r1814b113],
8	of	IN	O	of	_	0	SENT_57	[p7l1841t21r1922b93],
9	triple	JJ	O	triple	amod	10	SENT_57	[p7l1942t21r2151b113],
10	therapies	NNS	O	therapy	prep_of	7	SENT_57	[p7l7t139r366b231],
11	containing	VBG	O	contain	partmod	10	SENT_57	[p7l402t144r823b231],
12	rabeprazole	NN	O	rabeprazole	dobj	11	SENT_57	[p7l857t139r1325b231],
13	was	VBD	O	be	auxpass	15	SENT_57	[p7l1359t167r1509b211],
14	not	RB	O	not	neg	15	SENT_57	[p7l1545t159r1677b211],
15	affected	VBN	O	affect	ccomp	3	SENT_57	[p7l1711t139r2022b211],
16	by	IN	O	by	_	0	SENT_57	[p7l2059t139r2151b231],
17	CYPZCI9	NN	O	cypzci9	agent	15	SENT_57	[p7l14t261r418b329],
18	genetic	JJ	O	genetic	amod	20	SENT_57	[p7l465t262r747b348],
19	polymorphism	NN	O	polymorphism	nn	20	SENT_57	[p7l792t254r1766b348],
20	.30	NN	NUMBER	.30	npadvmod	23	SENT_57	[p7l792t254r1766b348],
21	=	JJ	O	=	amod	20	SENT_57	[p7l792t254r1766b348],
22	31	CD	NUMBER	31	tmod	21	SENT_57	[p7l792t254r1766b348],
23	=	JJ	O	=	amod	17	SENT_57	[p7l792t254r1766b348],
24	34	CD	NUMBER	34	num	26	SENT_57	[p7l792t254r1766b348],
25	=	JJ	O	=	amod	26	SENT_57	[p7l792t254r1766b348],
26	35	CD	NUMBER	35	dobj	15	SENT_57	[p7l792t254r1766b348],
27	To	TO	O	to	_	0	SENT_57	[p7l1809t260r1910b329],
28	date	NN	O	date	prep_to	15	SENT_57	[p7l1958t257r2151b345],
29	,	,	O	,	_	0	SENT_57	[p7l1958t257r2151b345],
30	there	EX	O	there	expl	35	SENT_57	[p7l7t374r205b446],
31	has	VBZ	O	have	aux	35	SENT_57	[p7l234t374r363b446],
32	been	VBN	O	be	auxpass	35	SENT_57	[p7l395t374r575b446],
33	only	RB	O	only	advmod	35	SENT_57	[p7l605t374r777b466],
34	one	CD	NUMBER	one	pobj	33	SENT_57	[p7l806t402r944b446],
35	published	VBN	O	publish	dep	15	SENT_57	[p7l973t374r1358b466],
36	report	NN	O	report	dobj	35	SENT_57	[p7l1387t394r1633b466],
37	on	IN	O	on	_	0	SENT_57	[p7l1662t402r1759b446],
38	the	DT	O	the	det	39	SENT_57	[p7l1787t374r1907b446],
39	effect	NN	O	effect	prep_on	35	SENT_57	[p7l1937t374r2151b446],
40	of	IN	O	of	_	0	SENT_57	[p7l9t492r91b564],
41	CYP2	NN	O	cyp2	nn	43	SENT_57	[p7l122t496r345b564],
42	C19	NN	O	c19	nn	43	SENT_57	[p7l360t496r519b564],
43	genotype	NN	O	genotype	prep_of	39	SENT_57	[p7l550t512r908b584],
44	on	IN	O	on	_	0	SENT_57	[p7l939t520r1037b564],
45	levofloxacin	NN	O	levofloxacin	prep_on	43	SENT_57	[p7l1067t492r1556b564],
46	and	CC	O	and	_	0	SENT_57	[p7l1586t492r1730b564],
47	PPI-based	JJ	O	ppi-based	amod	48	SENT_57	[p7l1760t492r2150b564],
48	therapies	NNS	O	therapy	prep_of	39	SENT_57	[p7l7t607r466b701],
49	.36	CD	NUMBER	.36	dep	48	SENT_57	[p7l7t607r466b701],

1	The	DT	O	the	det	2	SENT_58	[p7l118t727r268b799],
2	objective	NN	O	objective	nsubj	6	SENT_58	[p7l301t727r649b818],
3	of	IN	O	of	_	0	SENT_58	[p7l682t727r763b799],
4	this	DT	O	this	det	5	SENT_58	[p7l788t727r927b799],
5	study	NN	O	study	prep_of	2	SENT_58	[p7l961t727r1172b819],
6	was	VBD	O	be	_	0	SENT_58	[p7l1200t755r1350b799],
7	to	TO	O	to	aux	8	SENT_58	[p7l1381t747r1458b799],
8	evaluate	VB	O	evaluate	xcomp	6	SENT_58	[p7l1491t727r1814b799],
9	the	DT	O	the	det	10	SENT_58	[p7l1845t727r1963b799],
10	efficacy	NN	O	efficacy	dobj	8	SENT_58	[p7l1996t727r2149b799, p7l8t873r179b937],
11	and	CC	O	and	_	0	SENT_58	[p7l210t845r354b917],
12	tolerability	NN	O	tolerability	conj_and	10	SENT_58	[p7l383t845r818b937],
13	of	IN	O	of	_	0	SENT_58	[p7l848t845r930b917],
14	a	DT	O	a	det	16	SENT_58	[p7l956t873r996b917],
15	1-week	JJ	DURATION	1-week	amod	16	SENT_58	[p7l1034t845r1311b917],
16	course	NN	O	course	prep_of	10	SENT_58	[p7l1341t873r1593b917],
17	of	IN	O	of	_	0	SENT_58	[p7l1626t845r1707b917],
18	triple	JJ	O	triple	amod	19	SENT_58	[p7l1732t845r1938b937],
19	therapy	NN	O	therapy	prep_of	16	SENT_58	[p7l1969t845r2149b917, p7l9t991r148b1055],
20	with	IN	O	with	_	0	SENT_58	[p7l178t963r355b1036],
21	levofloxacin	NN	O	levofloxacin	prep_with	19	SENT_58	[p7l387t963r870b1036],
22	and	CC	O	and	_	0	SENT_58	[p7l903t964r1046b1036],
23	amoxicillin	NNP	O	amoxicillin	prep_of	16	SENT_58	[p7l1079t964r1520b1036],
24	plus	CC	O	plus	prep	23	SENT_58	[p7l1551t964r1710b1055],
25	esomeprazole	NN	O	esomeprazole	dep	24	SENT_58	[p7l1744t991r2149b1055, p7l8t1081r162b1153],
26	or	CC	O	or	_	0	SENT_58	[p7l194t1109r276b1153],
27	rabeprazole	NN	O	rabeprazole	dep	24	SENT_58	[p7l305t1081r768b1173],
28	as	IN	O	as	_	0	SENT_58	[p7l800t1109r874b1153],
29	first-line	JJ	O	first-line	amod	30	SENT_58	[p7l906t1081r1234b1153],
30	treatment	NN	O	treatment	prep_as	8	SENT_58	[p7l1264t1101r1646b1153],
31	for	IN	O	for	_	0	SENT_58	[p7l1676t1081r1789b1153],
32	H	NN	O	h	nn	34	SENT_58	[p7l1818t1086r1896b1152],
33	pylori	NN	O	pylorus	nn	34	SENT_58	[p7l1918t1081r2152b1173],
34	infection	NN	O	infection	prep_for	30	SENT_58	[p7l9t1199r355b1271],
35	in	IN	O	in	_	0	SENT_58	[p7l398t1204r470b1270],
36	an	DT	O	a	det	39	SENT_58	[p7l515t1227r608b1271],
37	adult	JJ	O	adult	amod	39	SENT_58	[p7l652t1199r853b1271],
38	Chinese	JJ	LOCATION	chinese	amod	39	SENT_58	[p7l898t1199r1205b1271],
39	population	NN	O	population	prep_in	34	SENT_58	[p7l1248t1199r1704b1291],
40	.	.	O	.	_	0	SENT_58	[p7l1248t1199r1704b1291],

1	It	PRP	O	it	nsubj	3	SENT_59	[p7l1749t1205r1807b1271],
2	also	RB	O	also	advmod	3	SENT_59	[p7l1851t1199r2003b1271],
3	investigated	VBD	O	investigate	_	0	SENT_59	[p7l2048t1204r2150b1270, p7l7t1317r399b1409],
4	whether	IN	O	whether	complm	9	SENT_59	[p7l426t1317r747b1389],
5	CYPZ	NNP	O	CYPZ	nn	8	SENT_59	[p7l780t1322r1002b1389],
6	C19	NN	O	c19	nn	8	SENT_59	[p7l1016t1322r1174b1389],
7	genotype	NN	O	genotype	nn	8	SENT_59	[p7l1203t1337r1558b1409],
8	status	NN	O	status	nsubj	9	SENT_59	[p7l1588t1338r1812b1389],
9	affected	VBD	O	affect	ccomp	3	SENT_59	[p7l1842t1317r2150b1389],
10	rates	NNS	O	rate	dobj	9	SENT_59	[p7l8t1455r198b1507],
11	of	IN	O	of	_	0	SENT_59	[p7l246t1435r328b1507],
12	H	NN	O	h	nn	14	SENT_59	[p7l368t1440r447b1506],
13	pylori	NN	O	pylorus	nn	14	SENT_59	[p7l484t1435r724b1527],
14	eradication	NN	O	eradication	prep_of	10	SENT_59	[p7l767t1435r1222b1507],
15	associated	VBN	O	associate	partmod	14	SENT_59	[p7l1268t1435r1680b1507],
16	with	IN	O	with	_	0	SENT_59	[p7l1723t1435r1904b1507],
17	these	DT	O	these	det	18	SENT_59	[p7l1949t1435r2150b1507],
18	regimens	NNS	O	regimen	prep_with	15	SENT_59	[p7l8t1558r380b1645],
19	.	.	O	.	_	0	SENT_59	[p7l8t1558r380b1645],

1	PATIENTS	NNS	O	patient	_	0	SENT_60	[p7l13t1798r459b1866],
2	AND	CC	O	and	_	0	SENT_60	[p7l494t1798r712b1866],
3	METHODS	NNS	O	method	conj_and	1	SENT_60	[p7l751t1798r1241b1866],
4	Patients	NNS	O	patient	dep	1	SENT_60	[p7l12t1910r359b1982],

1	Study	NN	O	study	nn	2	SENT_61	[p7l121t2026r342b2118],
2	participants	NNS	O	participant	nsubjpass	4	SENT_61	[p7l372t2031r840b2118],
3	were	VBD	O	be	auxpass	4	SENT_61	[p7l873t2055r1059b2098],
4	recruited	VBN	O	recruit	_	0	SENT_61	[p7l1091t2026r1442b2098],
5	from	IN	O	from	_	0	SENT_61	[p7l1475t2026r1665b2098],
6	consecutive	JJ	O	consecutive	amod	7	SENT_61	[p7l1697t2031r2149b2098],
7	patients	NNS	O	patient	prep_from	4	SENT_61	[p7l7t2146r316b2234],
8	undergoing	VBG	O	undergo	xcomp	4	SENT_61	[p7l354t2142r802b2234],
9	upper	JJ	O	upper	amod	10	SENT_61	[p7l838t2169r1065b2234],
10	endoscopy	NN	O	endoscopy	dobj	8	SENT_61	[p7l1101t2142r1519b2234],
11	at	IN	O	at	_	0	SENT_61	[p7l1556t2162r1628b2214],
12	the	DT	O	the	det	15	SENT_61	[p7l1662t2142r1781b2214],
13	First	NNP	ORGANIZATION	First	nn	15	SENT_61	[p7l1819t2146r1994b2214],
14	Affiliated	NNP	ORGANIZATION	Affiliated	nn	15	SENT_61	[p7l2025t2142r2149b2213, p7l8t2258r273b2330],
15	Hospital	NNP	ORGANIZATION	Hospital	prep_at	8	SENT_61	[p7l296t2258r627b2350],
16	of	IN	ORGANIZATION	of	_	0	SENT_61	[p7l652t2258r732b2330],
17	Nanjing	NNP	ORGANIZATION	Nanjing	nn	19	SENT_61	[p7l749t2263r1062b2350],
18	Medical	NNP	ORGANIZATION	Medical	nn	19	SENT_61	[p7l1085t2258r1396b2330],
19	University	NNP	ORGANIZATION	University	prep_of	15	SENT_61	[p7l1418t2263r1811b2350],
20	between	IN	O	between	_	0	SENT_61	[p7l1835t2258r2150b2330],
21	May	NNP	DATE	May	prep_between	19	SENT_61	[p7l8t2380r189b2466],
22	2008	CD	DATE	2008	num	21	SENT_61	[p7l230t2379r427b2446],
23	and	CC	O	and	_	0	SENT_61	[p7l475t2374r619b2446],
24	January	NNP	DATE	January	prep_between	19	SENT_61	[p7l655t2380r971b2466],
25	2009	CD	DATE	2009	num	24	SENT_61	[p7l1012t2379r1235b2446],
26	.	.	O	.	_	0	SENT_61	[p7l1012t2379r1235b2446],

1	Eligible	JJ	O	eligible	amod	2	SENT_62	[p7l1278t2374r1570b2466],
2	patients	NNS	O	patient	nsubj	8	SENT_62	[p7l1612t2379r1921b2466],
3	were	VBD	O	be	cop	8	SENT_62	[p7l1963t2403r2149b2446],
4	those	DT	O	those	det	8	SENT_62	[p7l7t2490r214b2562],
5	aged	JJ	O	aged	amod	8	SENT_62	[p7l248t2490r427b2582],
6	>	JJR	O	>	amod	8	SENT_62	[p7l462t2495r604b2562],
7	18	CD	DURATION	18	num	8	SENT_62	[p7l462t2495r604b2562],
8	years	NNS	NUMBER	year	_	0	SENT_62	[p7l640t2518r841b2581],
9	who	WP	O	who	nsubj	10	SENT_62	[p7l873t2490r1043b2562],
10	tested	VBD	O	test	dep	8	SENT_62	[p7l1075t2490r1303b2562],
11	positive	JJ	O	positive	amod	15	SENT_62	[p7l1334t2494r1638b2582],
12	for	IN	O	for	_	0	SENT_62	[p7l1671t2490r1785b2562],
13	H	NN	O	h	nn	14	SENT_62	[p7l1815t2495r1893b2561],
14	pylori	NN	O	pylorus	prep_for	11	SENT_62	[p7l1918t2490r2152b2582],
15	infection	NN	O	infection	dobj	10	SENT_62	[p7l9t2606r353b2678],
16	on	IN	O	on	_	0	SENT_62	[p7l385t2634r482b2678],
17	biopsy	NN	O	biopsy	nn	18	SENT_62	[p7l514t2606r1027b2698],
18	—	NN	O	—	prep_on	10	SENT_62	[p7l514t2606r1027b2698],
19	based	VBN	O	base	partmod	18	SENT_62	[p7l514t2606r1027b2698],
20	testing	NN	O	testing	nn	22	SENT_62	[p7l1056t2611r1315b2698],
21	(	CD	NUMBER	(	num	22	SENT_62	[p7l1350t2611r1462b2695],
22	ie	NN	O	ie	nsubj	31	SENT_62	[p7l1350t2611r1462b2695],
23	,	,	O	,	_	0	SENT_62	[p7l1350t2611r1462b2695],
24	histology	NN	O	histology	conj_and	22	SENT_62	[p7l1491t2606r1852b2698],
25	and	CC	O	and	_	0	SENT_62	[p7l1883t2606r2027b2678],
26	an	DT	O	a	det	30	SENT_62	[p7l2058t2634r2150b2678],
27	in-house	JJ	O	in-house	amod	30	SENT_62	[p7l8t2722r330b2794],
28	rapid	JJ	O	rapid	amod	30	SENT_62	[p7l353t2722r553b2814],
29	urease	NN	O	urease	nn	30	SENT_62	[p7l576t2751r813b2794],
30	test	NN	O	test	conj_and	22	SENT_62	[p7l836t2727r991b2811],
31	)	CD	NUMBER	)	xcomp	19	SENT_62	[p7l836t2727r991b2811],
32	or	CC	O	or	_	0	SENT_62	[p7l1019t2751r1099b2794],
33	a	DT	O	a	xcomp	19	SENT_62	[p7l1123t2751r1161b2794],
34	validated	VBN	O	validate	partmod	31	SENT_62	[p7l1184t2722r1532b2795],
35	13C-urea	NN	O	13c-urea	nn	37	SENT_62	[p7l1559t2720r1882b2794],
36	breath	NN	O	breath	nn	37	SENT_62	[p7l1908t2722r2150b2794],
37	test	NN	O	test	dobj	34	SENT_62	[p7l7t2858r164b2910],
38	.	.	O	.	_	0	SENT_62	[p7l7t2858r164b2910],

1	The	DT	O	the	det	3	SENT_63	[p7l192t2838r341b2910],
2	exclusion	NN	O	exclusion	nn	3	SENT_63	[p7l375t2838r745b2910],
3	criteria	NNS	O	criterion	nsubj	15	SENT_63	[p7l776t2842r1054b2910],
4	were	VBD	O	be	cop	8	SENT_63	[p7l1085t2866r1271b2910],
5	acute	JJ	O	acute	amod	8	SENT_63	[p7l1305t2858r1509b2910],
6	upper	JJ	O	upper	amod	8	SENT_63	[p7l1542t2865r1768b2930],
7	gastrointestinal	JJ	O	gastrointestinal	amod	8	SENT_63	[p7l1800t2842r2149b2930, p7l7t2954r288b3026],
8	bleeding	NN	O	bleeding	_	0	SENT_63	[p7l315t2954r662b3046],
9	;	:	O	;	_	0	SENT_63	[p7l315t2954r662b3046],
10	previous	JJ	O	previous	amod	12	SENT_63	[p7l688t2959r1020b3046],
11	gastric	JJ	O	gastric	amod	12	SENT_63	[p7l1045t2959r1300b3046],
12	surgery	NN	O	surgery	conj_and	8	SENT_63	[p7l1326t2982r1634b3046],
13	;	:	O	;	_	0	SENT_63	[p7l1326t2982r1634b3046],
14	concomitant	JJ	O	concomitant	amod	15	SENT_63	[p7l1660t2959r2150b3026],
15	renal	JJ	O	renal	conj_and	8	SENT_63	[p7l8t3075r204b3147],
16	or	CC	O	or	_	0	SENT_63	[p7l245t3103r327b3147],
17	hepatic	JJ	O	hepatic	amod	18	SENT_63	[p7l365t3074r649b3166],
18	impairment	NN	O	impairment	conj_or	15	SENT_63	[p7l689t3079r1170b3166],
19	;	:	O	;	_	0	SENT_63	[p7l689t3079r1170b3166],
20	pregnancy	NN	O	pregnancy	conj_and	8	SENT_63	[p7l1210t3102r1619b3166],
21	or	CC	O	or	_	0	SENT_63	[p7l1659t3103r1740b3147],
22	lactation	NN	O	lactation	conj_and	8	SENT_63	[p7l1780t3075r2148b3163],
23	;	:	O	;	_	0	SENT_63	[p7l1780t3075r2148b3163],
24	previous	JJ	O	previous	amod	28	SENT_63	[p7l7t3194r342b3282],
25	H	NN	O	h	nn	28	SENT_63	[p7l378t3195r456b3261],
26	pylori	NN	O	pylorus	nn	28	SENT_63	[p7l484t3190r718b3281],
27	eradication	NN	O	eradication	nn	28	SENT_63	[p7l752t3190r1194b3262],
28	therapy	NN	O	therapy	conj_and	8	SENT_63	[p7l1228t3190r1551b3282],
29	;	:	O	;	_	0	SENT_63	[p7l1228t3190r1551b3282],
30	and	CC	O	and	_	0	SENT_63	[p7l1590t3190r1734b3262],
31	treatment	NN	O	treatment	conj_and	8	SENT_63	[p7l1768t3210r2151b3262],
32	with	IN	O	with	prep	31	SENT_63	[p7l7t3306r184b3378],
33	an	DT	O	a	det	34	SENT_63	[p7l227t3334r318b3378],
34	NSAID	NN	O	nsaid	dep	41	SENT_63	[p7l359t3309r663b3395],
35	,	,	O	,	_	0	SENT_63	[p7l359t3309r663b3395],
36	anticoagulant	NN	O	anticoagulant	appos	34	SENT_63	[p7l705t3306r1267b3398],
37	,	,	O	,	_	0	SENT_63	[p7l705t3306r1267b3398],
38	acid	NN	O	acid	appos	34	SENT_63	[p7l1309t3306r1468b3378],
39	suppressant	NN	O	suppressant	dep	41	SENT_63	[p7l1511t3326r1973b3398],
40	(	CD	NUMBER	(	num	39	SENT_63	[p7l2019t3311r2151b3398],
41	eg	FW	O	eg	dep	32	SENT_63	[p7l2019t3311r2151b3398],
42	,	,	O	,	_	0	SENT_63	[p7l2019t3311r2151b3398],
43	PPI	NNP	O	PPI	conj_or	41	SENT_63	[p7l8t3429r161b3512],
44	,	,	O	,	_	0	SENT_63	[p7l8t3429r161b3512],
45	histamine-2	JJ	O	histamine-2	amod	47	SENT_63	[p7l186t3423r647b3496],
46	blocker	NN	O	blocker	nn	47	SENT_63	[p7l677t3423r1024b3512],
47	)	NN	O	)	conj_or	41	SENT_63	[p7l677t3423r1024b3512],
48	,	,	O	,	_	0	SENT_63	[p7l677t3423r1024b3512],
49	or	CC	O	or	_	0	SENT_63	[p7l1050t3452r1132b3496],
50	antibiotic	JJ	O	antibiotic	conj_or	41	SENT_63	[p7l1160t3423r1534b3496],
51	within	IN	O	within	_	0	SENT_63	[p7l1559t3423r1813b3496],
52	4	CD	DURATION	4	num	53	SENT_63	[p7l1839t3428r1884b3494],
53	weeks	NNS	NUMBER	week	prep_within	8	SENT_63	[p7l1912t3423r2149b3496],
54	before	IN	O	before	_	0	SENT_63	[p7l10t3539r255b3611],
55	study	NN	O	study	nn	56	SENT_63	[p7l287t3539r498b3630],
56	entry	NN	O	entry	prep_before	53	SENT_63	[p7l528t3559r741b3630],
57	.	.	O	.	_	0	SENT_63	[p7l528t3559r741b3630],

1	Study	NNP	O	Study	nn	2	SENT_64	[p8l8t81r254b179],
2	Design	NNP	O	Design	_	0	SENT_64	[p8l290t80r577b179],

1	Random	JJ	O	random	amod	2	SENT_65	[p8l120t198r469b270],
2	numbers	NNS	O	number	nsubjpass	4	SENT_65	[p8l514t198r863b270],
3	were	VBD	O	be	auxpass	4	SENT_65	[p8l909t226r1101b270],
4	used	VBN	O	use	_	0	SENT_65	[p8l1148t198r1328b270],
5	to	TO	O	to	aux	6	SENT_65	[p8l1373t218r1452b270],
6	allocate	VB	O	allocate	xcomp	4	SENT_65	[p8l1500t198r1813b270],
7	eligible	JJ	O	eligible	amod	8	SENT_65	[p8l1860t198r2148b290],
8	patients	NNS	O	patient	dobj	6	SENT_65	[p8l7t321r312b408],
9	to	TO	O	to	_	0	SENT_65	[p8l337t336r414b388],
10	one	CD	NUMBER	one	prep_to	8	SENT_65	[p8l441t344r577b388],
11	of	IN	O	of	_	0	SENT_65	[p8l603t316r683b388],
12	the	DT	O	the	det	14	SENT_65	[p8l702t316r820b388],
13	following	VBG	O	follow	amod	14	SENT_65	[p8l845t316r1217b408],
14	groups	NNS	O	group	prep_of	10	SENT_65	[p8l1241t344r1505b408],
15	in	IN	O	in	_	0	SENT_65	[p8l1531t321r1603b387],
16	an	DT	O	a	det	18	SENT_65	[p8l1628t344r1719b388],
17	open-label	JJ	O	open-label	amod	18	SENT_65	[p8l1745t316r2150b408],
18	fashion	NN	O	fashion	prep_in	14	SENT_65	[p8l8t434r309b507],
19	:	:	O	:	_	0	SENT_65	[p8l8t434r309b507],
20	group	NN	O	group	nn	21	SENT_65	[p8l336t462r562b526],
21	A	NN	O	a	conj_and	8	SENT_65	[p8l582t438r667b523],
22	,	,	O	,	_	0	SENT_65	[p8l582t438r667b523],
23	which	WDT	O	which	nsubj	24	SENT_65	[p8l687t435r921b507],
24	received	VBD	O	receive	rcmod	21	SENT_65	[p8l943t434r1254b507],
25	levoﬂoxacin	NN	O	levoﬂoxacin	dobj	24	SENT_65	[p8l1277t434r1747b507],
26	500	CD	NUMBER	500	num	27	SENT_65	[p8l1771t440r1914b507],
27	mg/d	NN	O	mg/d	dep	25	SENT_65	[p8l1939t434r2153b526],
28	,	,	O	,	_	0	SENT_65	[p8l1939t434r2153b526],
29	amoxicillin	NNP	O	amoxicillin	dobj	24	SENT_65	[p8l9t552r437b624],
30	1000	CD	DATE	1000	num	32	SENT_65	[p8l466t557r654b624],
31	mg	NN	O	mg	nn	32	SENT_65	[p8l679t580r796b644],
32	BID	NNP	O	BID	dep	29	SENT_65	[p8l819t557r987b640],
33	,	,	O	,	_	0	SENT_65	[p8l819t557r987b640],
34	and	CC	O	and	_	0	SENT_65	[p8l1010t552r1150b624],
35	esomeprazole	NN	O	esomeprazole	dobj	24	SENT_65	[p8l1174t552r1692b644],
36	20	CD	NUMBER	20	num	38	SENT_65	[p8l1714t557r1809b624],
37	mg	NN	O	mg	nn	38	SENT_65	[p8l1834t580r1952b644],
38	BID	NNP	O	BID	dep	35	SENT_65	[p8l1974t557r2148b640],
39	;	:	O	;	_	0	SENT_65	[p8l1974t557r2148b640],
40	group	NN	O	group	nn	41	SENT_65	[p8l8t698r229b762],
41	B	NN	O	b	dobj	6	SENT_65	[p8l253t676r325b759],
42	,	,	O	,	_	0	SENT_65	[p8l253t676r325b759],
43	which	WDT	O	which	nsubj	44	SENT_65	[p8l344t670r573b742],
44	received	VBD	O	receive	rcmod	41	SENT_65	[p8l594t670r899b742],
45	levofloxacin	NN	O	levofloxacin	nn	48	SENT_65	[p8l921t670r1380b742],
46	5	CD	NUMBER	5	num	48	SENT_65	[p8l1403t677r1444b742],
47	oo	NN	O	oo	nn	48	SENT_65	[p8l1453t675r1544b742],
48	mg/d	NN	O	mg/d	dobj	44	SENT_65	[p8l1567t670r1778b762],
49	,	,	O	,	_	0	SENT_65	[p8l1567t670r1778b762],
50	amoXicillin	NNP	O	amoXicillin	dobj	44	SENT_65	[p8l1799t670r2150b742, p8l8t789r105b859],
51	1000	CD	DATE	1000	num	53	SENT_65	[p8l151t794r340b861],
52	mg	NN	O	mg	nn	53	SENT_65	[p8l382t817r501b880],
53	BID	NNP	O	BID	dep	50	SENT_65	[p8l541t794r710b877],
54	,	,	O	,	_	0	SENT_65	[p8l541t794r710b877],
55	and	CC	O	and	_	0	SENT_65	[p8l750t789r892b861],
56	esomeprazole	NN	O	esomeprazole	dobj	44	SENT_65	[p8l932t789r1455b880],
57	40	CD	NUMBER	40	num	59	SENT_65	[p8l1495t793r1591b861],
58	mg	NN	O	mg	nn	59	SENT_65	[p8l1632t817r1751b880],
59	BID	NNP	O	BID	dep	56	SENT_65	[p8l1791t794r1965b877],
60	;	:	O	;	_	0	SENT_65	[p8l1791t794r1965b877],
61	and	CC	O	and	_	0	SENT_65	[p8l2009t789r2150b861],
62	group	NN	O	group	nn	63	SENT_65	[p8l8t933r235b998],
63	C	NN	O	c	dobj	6	SENT_65	[p8l264t910r346b994],
64	,	,	O	,	_	0	SENT_65	[p8l264t910r346b994],
65	which	WDT	O	which	nsubj	66	SENT_65	[p8l369t906r603b978],
66	received	VBD	O	receive	rcmod	63	SENT_65	[p8l628t906r941b978],
67	levofloxacin	NN	O	levofloxacin	nn	70	SENT_65	[p8l966t906r1439b978],
68	5	CD	NUMBER	5	num	70	SENT_65	[p8l1467t912r1508b978],
69	oo	NN	O	oo	nn	70	SENT_65	[p8l1517t911r1610b978],
70	mg/d	NN	O	mg/d	dobj	66	SENT_65	[p8l1637t906r1853b998],
71	,	,	O	,	_	0	SENT_65	[p8l1637t906r1853b998],
72	amoXicillin	NNP	O	amoXicillin	dobj	66	SENT_65	[p8l1878t910r2149b978, p8l8t1024r195b1096],
73	1000	CD	DATE	1000	num	75	SENT_65	[p8l239t1029r429b1096],
74	mg	NN	O	mg	nn	75	SENT_65	[p8l469t1052r588b1116],
75	BID	NNP	O	BID	dep	72	SENT_65	[p8l626t1030r796b1112],
76	,	,	O	,	_	0	SENT_65	[p8l626t1030r796b1112],
77	and	CC	O	and	_	0	SENT_65	[p8l834t1024r976b1096],
78	rabeprazole	NN	O	rabeprazole	dobj	66	SENT_65	[p8l1014t1024r1467b1116],
79	10	CD	NUMBER	10	num	81	SENT_65	[p8l1512t1029r1601b1096],
80	mg	NN	O	mg	nn	81	SENT_65	[p8l1642t1052r1760b1116],
81	BID	NNP	O	BID	dep	78	SENT_65	[p8l1799t1030r1966b1096],
82	.	.	O	.	_	0	SENT_65	[p8l1799t1030r1966b1096],

1	The	DT	O	the	det	2	SENT_66	[p8l2001t1024r2149b1096],
2	duration	NN	O	duration	nsubj	6	SENT_66	[p8l9t1143r342b1215],
3	of	IN	O	of	_	0	SENT_66	[p8l374t1142r454b1215],
4	all	DT	O	all	det	5	SENT_66	[p8l482t1142r571b1215],
5	regimens	NNS	O	regimen	prep_of	2	SENT_66	[p8l602t1147r945b1234],
6	was	VBD	O	be	_	0	SENT_66	[p8l976t1171r1124b1215],
7	1	CD	DURATION	1	num	8	SENT_66	[p8l1162t1148r1196b1213],
8	week	NN	NUMBER	week	tmod	6	SENT_66	[p8l1233t1142r1453b1215],
9	.	.	O	.	_	0	SENT_66	[p8l1233t1142r1453b1215],

1	One	CD	DURATION	one	num	2	SENT_67	[p8l1488t1147r1647b1215],
2	month	NN	DURATION	month	_	0	SENT_67	[p8l1679t1143r1937b1215],
3	after	IN	O	after	dep	2	SENT_67	[p8l1971t1142r2150b1215],

1	November	NNP	DATE	November	_	0	SENT_68	[p8l68t1401r476b1467],
2	2010	CD	DATE	2010	dep	1	SENT_68	[p8l505t1404r696b1467],

1	X.	NNP	O	X.	nn	2	SENT_69	[p8l1609t1517r1687b1578],
2	Pan	NNP	O	Pan	_	0	SENT_69	[p8l1726t1517r1865b1578],
3	et	FW	O	et	nn	4	SENT_69	[p8l1900t1527r1975b1578],
4	al.	FW	O	al.	dep	2	SENT_69	[p8l2003t1512r2090b1578],
5	.	.	O	.	_	0	SENT_69	[p8l2003t1512r2090b1578],

1	the	DT	O	the	det	2	SENT_70	[p8l9t1748r127b1820],
2	completion	NN	O	completion	nsubj	7	SENT_70	[p8l151t1748r588b1839],
3	of	IN	O	of	_	0	SENT_70	[p8l613t1747r693b1820],
4	therapy	NN	O	therapy	prep_of	2	SENT_70	[p8l712t1748r1021b1839],
5	,	,	O	,	_	0	SENT_70	[p8l712t1748r1021b1839],
6	patients	NNS	O	patient	appos	4	SENT_70	[p8l1044t1753r1347b1839],
7	underwent	VBD	O	undergo	_	0	SENT_70	[p8l1374t1748r1790b1820],
8	13C-urea	JJ	O	13c-urea	amod	10	SENT_70	[p8l1817t1745r2148b1820],
9	breath	NN	O	breath	nn	10	SENT_70	[p8l12t1865r262b1937],
10	testing	NN	O	testing	dobj	7	SENT_70	[p8l292t1869r550b1957],
11	to	TO	O	to	aux	12	SENT_70	[p8l579t1885r656b1937],
12	evaluate	VB	O	evaluate	xcomp	7	SENT_70	[p8l689t1865r1011b1937],
13	H	NN	O	h	nn	15	SENT_70	[p8l1041t1870r1119b1936],
14	pylori	NN	O	pylorus	nn	15	SENT_70	[p8l1142t1865r1375b1956],
15	eradication	NN	O	eradication	dobj	12	SENT_70	[p8l1404t1865r1867b1937],
16	.	.	O	.	_	0	SENT_70	[p8l1404t1865r1867b1937],

1	The	DT	O	the	det	2	SENT_71	[p8l120t1983r270b2055],
2	study	NN	O	study	nsubjpass	4	SENT_71	[p8l301t1983r511b2075],
3	was	VBD	O	be	auxpass	4	SENT_71	[p8l537t2011r687b2055],
4	approved	VBN	O	approve	_	0	SENT_71	[p8l718t1983r1087b2075],
5	by	IN	O	by	_	0	SENT_71	[p8l1117t1983r1210b2075],
6	the	DT	O	the	det	9	SENT_71	[p8l1236t1983r1355b2055],
7	institutional	JJ	O	institutional	amod	9	SENT_71	[p8l1385t1983r1862b2055],
8	review	NN	O	review	nn	9	SENT_71	[p8l1891t1988r2150b2055],
9	board	NN	O	board	agent	4	SENT_71	[p8l12t2102r241b2174],
10	of	IN	O	of	_	0	SENT_71	[p8l268t2101r349b2174],
11	the	DT	O	the	det	12	SENT_71	[p8l368t2101r486b2174],
12	hospital	NN	O	hospital	prep_of	9	SENT_71	[p8l512t2102r848b2193],
13	,	,	O	,	_	0	SENT_71	[p8l512t2102r848b2193],
14	and	CC	O	and	_	0	SENT_71	[p8l873t2101r1016b2174],
15	all	DT	O	all	det	16	SENT_71	[p8l1042t2102r1133b2174],
16	patients	NNS	O	patient	nsubj	17	SENT_71	[p8l1158t2106r1465b2193],
17	provided	VBD	O	provide	conj_and	4	SENT_71	[p8l1490t2102r1840b2193],
18	written	VBN	O	write	amod	20	SENT_71	[p8l1863t2106r2147b2174],
19	informed	VBN	O	inform	amod	20	SENT_71	[p8l11t2219r370b2291],
20	consent	NN	O	consent	dobj	17	SENT_71	[p8l400t2239r720b2291],
21	.	.	O	.	_	0	SENT_71	[p8l400t2239r720b2291],

1	Tolerability	NN	O	tolerability	_	0	SENT_72	[p8l6t2457r497b2556],
2	and	CC	O	and	_	0	SENT_72	[p8l528t2458r682b2530],
3	Compliance	NN	O	compliance	conj_and	1	SENT_72	[p8l721t2457r1224b2555],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_73	[p8l121t2579r415b2647],
2	were	VBD	O	be	auxpass	3	SENT_73	[p8l448t2603r628b2647],
3	asked	VBN	O	ask	_	0	SENT_73	[p8l663t2575r876b2647],
4	to	TO	O	to	aux	5	SENT_73	[p8l908t2595r984b2647],
5	record	VB	O	record	xcomp	3	SENT_73	[p8l1018t2575r1261b2647],
6	in	IN	O	in	_	0	SENT_73	[p8l1294t2579r1364b2646],
7	a	DT	O	a	det	8	SENT_73	[p8l1399t2603r1438b2647],
8	diary	NN	O	diary	prep_in	5	SENT_73	[p8l1473t2575r1667b2666],
9	any	DT	O	any	det	11	SENT_73	[p8l1700t2603r1835b2666],
10	adverse	JJ	O	adverse	amod	11	SENT_73	[p8l1868t2575r2148b2647],
11	events	NNS	O	event	dobj	5	SENT_73	[p8l11t2713r241b2765],
12	occurring	VBG	O	occur	partmod	11	SENT_73	[p8l269t2698r629b2785],
13	during	IN	O	during	_	0	SENT_73	[p8l655t2693r902b2785],
14	the	DT	O	the	det	15	SENT_73	[p8l926t2693r1041b2765],
15	course	NN	O	course	prep_during	12	SENT_73	[p8l1067t2721r1309b2765],
16	of	IN	O	of	_	0	SENT_73	[p8l1336t2693r1416b2765],
17	therapy	NN	O	therapy	prep_of	15	SENT_73	[p8l1436t2693r1734b2785],
18	.	.	O	.	_	0	SENT_73	[p8l1436t2693r1734b2785],

1	In	IN	O	in	_	0	SENT_74	[p8l1760t2699r1836b2764],
2	the	DT	DURATION	the	det	4	SENT_74	[p8l1860t2693r1976b2765],
3	first	JJ	DURATION	first	amod	4	SENT_74	[p8l2002t2693r2149b2765],
4	week	NN	DURATION	week	prep_in	13	SENT_74	[p8l9t2812r206b2884],
5	after	IN	O	after	_	0	SENT_74	[p8l241t2811r412b2884],
6	the	DT	O	the	det	7	SENT_74	[p8l445t2812r559b2884],
7	completion	NN	O	completion	prep_after	4	SENT_74	[p8l594t2812r1019b2903],
8	of	IN	O	of	_	0	SENT_74	[p8l1054t2811r1133b2884],
9	therapy	NN	O	therapy	prep_of	7	SENT_74	[p8l1161t2812r1462b2903],
10	,	,	O	,	_	0	SENT_74	[p8l1161t2812r1462b2903],
11	trained	JJ	O	trained	amod	12	SENT_74	[p8l1494t2811r1762b2884],
12	assistants	NNS	O	assistant	nsubj	18	SENT_74	[p8l1796t2816r2147b2884],
13	contacted	VBN	O	contact	_	0	SENT_74	[p8l10t2929r375b3001],
14	patients	NNS	O	patient	dobj	13	SENT_74	[p8l397t2933r692b3021],
15	by	IN	O	by	_	0	SENT_74	[p8l718t2929r808b3021],
16	telephone	NN	O	telephone	prep_by	13	SENT_74	[p8l829t2929r1194b3021],
17	and	CC	O	and	_	0	SENT_74	[p8l1219t2929r1358b3001],
18	used	VBD	O	use	conj_and	13	SENT_74	[p8l1381t2929r1550b3001],
19	a	DT	O	a	det	20	SENT_74	[p8l1574t2957r1613b3001],
20	questionnaire	NN	O	questionnaire	dobj	18	SENT_74	[p8l1638t2933r2148b3021],
21	to	TO	O	to	aux	22	SENT_74	[p8l9t3067r83b3119],
22	record	VB	O	record	xcomp	18	SENT_74	[p8l103t3047r340b3119],
23	drug	NN	O	drug	nn	24	SENT_74	[p8l362t3047r531b3139],
24	compliance	NN	O	compliance	dobj	22	SENT_74	[p8l550t3047r968b3139],
25	and	CC	O	and	_	0	SENT_74	[p8l990t3047r1126b3119],
26	adverse	JJ	O	adverse	amod	27	SENT_74	[p8l1147t3047r1419b3119],
27	events	NNS	O	event	dobj	22	SENT_74	[p8l1440t3067r1684b3119],
28	.	.	O	.	_	0	SENT_74	[p8l1440t3067r1684b3119],

1	Compliance	NN	O	compliance	nsubjpass	3	SENT_75	[p8l1708t3047r2149b3139],
2	was	VBD	O	be	auxpass	3	SENT_75	[p8l9t3194r151b3238],
3	categorized	VBN	O	categorize	_	0	SENT_75	[p8l171t3166r585b3257],
4	as	IN	O	as	_	0	SENT_75	[p8l605t3194r677b3238],
5	either	DT	O	either	det	7	SENT_75	[p8l698t3166r902b3238],
6	good	JJ	O	good	amod	7	SENT_75	[p8l917t3165r1108b3257],
7	(	NN	O	(	prep_as	3	SENT_75	[p8l1129t3170r1374b3254],
8	280	CD	PERCENT	280	num	9	SENT_75	[p8l1129t3170r1374b3254],
9	%	NN	PERCENT	%	dobj	3	SENT_75	[p8l1129t3170r1374b3254],
10	of	IN	O	of	_	0	SENT_75	[p8l1401t3165r1478b3238],
11	medication	NN	O	medication	prep_of	9	SENT_75	[p8l1492t3165r1899b3238],
12	taken	VBN	O	take	partmod	11	SENT_75	[p8l1918t3166r2143b3254],
13	)	CD	NUMBER	)	num	17	SENT_75	[p8l1918t3166r2143b3254],
14	or	CC	O	or	_	0	SENT_75	[p8l12t3311r91b3355],
15	poor	JJ	O	poor	amod	16	SENT_75	[p8l119t3301r304b3374],
16	(	NN	O	(	num	17	SENT_75	[p8l338t3287r592b3371],
17	<	JJR	O	<	dobj	12	SENT_75	[p8l338t3287r592b3371],
18	80	CD	PERCENT	80	number	19	SENT_75	[p8l338t3287r592b3371],
19	%	NN	PERCENT	%	amod	17	SENT_75	[p8l338t3287r592b3371],
20	of	IN	O	of	_	0	SENT_75	[p8l631t3283r710b3355],
21	medication	NN	O	medication	prep_of	12	SENT_75	[p8l736t3283r1157b3355],
22	taken	VBN	O	take	partmod	21	SENT_75	[p8l1187t3283r1421b3371],
23	)	CD	NUMBER	)	dobj	22	SENT_75	[p8l1187t3283r1421b3371],
24	based	VBN	O	base	_	0	SENT_75	[p8l1458t3283r1671b3355],
25	on	IN	O	on	prepc_based_on	22	SENT_75	[p8l1703t3311r1798b3355],
26	patients	NNS	O	patient	pobj	22	SENT_75	[p8l1828t3287r2145b3375],
27	’	CD	NUMBER	’	num	28	SENT_75	[p8l1828t3287r2145b3375],
28	counts	NNS	O	count	dep	26	SENT_75	[p8l10t3421r253b3473],
29	of	IN	O	of	_	0	SENT_75	[p8l277t3401r355b3473],
30	unused	JJ	O	unused	amod	31	SENT_75	[p8l371t3401r636b3473],
31	medication	NN	O	medication	prep_of	28	SENT_75	[p8l656t3401r1090b3473],
32	.	.	O	.	_	0	SENT_75	[p8l656t3401r1090b3473],

1	Adverse	JJ	O	adverse	amod	2	SENT_76	[p8l1109t3401r1408b3473],
2	events	NNS	O	event	nsubjpass	4	SENT_76	[p8l1429t3419r1656b3473],
3	were	VBD	O	be	auxpass	4	SENT_76	[p8l1676t3429r1854b3473],
4	defined	VBN	O	define	_	0	SENT_76	[p8l1877t3401r2149b3473],
5	as	IN	O	as	_	0	SENT_76	[p8l11t3548r85b3592],
6	any	DT	O	any	det	8	SENT_76	[p8l116t3548r251b3611],
7	new	JJ	O	new	amod	8	SENT_76	[p8l278t3548r436b3592],
8	symptoms	NNS	O	symptom	prep_as	4	SENT_76	[p8l464t3540r849b3611],
9	and/or	NN	O	and/or	nn	10	SENT_76	[p8l880t3520r1127b3592],
10	signs	NNS	O	sign	dep	8	SENT_76	[p8l1156t3524r1337b3611],
11	or	CC	O	or	_	0	SENT_76	[p8l1368t3548r1448b3592],
12	worsening	VBG	O	worsen	prep_as	4	SENT_76	[p8l1474t3524r1867b3611],
13	of	IN	O	of	_	0	SENT_76	[p8l1897t3519r1976b3592],
14	preexisting	VBG	O	preexist	prepc_of	12	SENT_76	[p8l1999t3547r2147b3611, p8l11t3641r301b3729],
15	symptoms	NNS	O	symptom	nn	17	SENT_76	[p8l329t3657r713b3729],
16	and/or	NN	O	and/or	nn	17	SENT_76	[p8l743t3637r990b3709],
17	signs	NNS	O	sign	dobj	14	SENT_76	[p8l1018t3641r1198b3729],
18	during	IN	O	during	_	0	SENT_76	[p8l1227t3637r1474b3729],
19	the	DT	O	the	det	21	SENT_76	[p8l1500t3637r1615b3709],
20	treatment	NN	O	treatment	nn	21	SENT_76	[p8l1641t3657r2008b3709],
21	period	NN	O	period	prep_during	17	SENT_76	[p8l2033t3664r2147b3729, p9l10t20r186b109],
22	;	:	O	;	_	0	SENT_76	[p8l2033t3664r2147b3729, p9l10t20r186b109],

1	serious	JJ	O	serious	amod	3	SENT_77	[p9l225t27r487b93],
2	adverse	JJ	O	adverse	amod	3	SENT_77	[p9l526t20r807b93],
3	events	NNS	O	event	nsubjpass	5	SENT_77	[p9l846t38r1075b93],
4	were	VBD	O	be	auxpass	5	SENT_77	[p9l1113t49r1294b93],
5	defined	VBN	O	define	_	0	SENT_77	[p9l1334t20r1610b93],
6	as	IN	O	as	_	0	SENT_77	[p9l1650t49r1723b93],
7	those	DT	O	those	prep_as	5	SENT_77	[p9l1762t20r1960b93],
8	that	WDT	O	that	dobj	10	SENT_77	[p9l1999t20r2149b93],
9	patients	NNS	O	patient	nsubj	10	SENT_77	[p9l9t143r304b230],
10	considered	VBN	O	consider	rcmod	7	SENT_77	[p9l332t138r737b210],
11	as	IN	O	as	_	0	SENT_77	[p9l765t167r838b210],
12	disrupting	VBG	O	disrupt	prepc_as	10	SENT_77	[p9l867t138r1251b230],
13	their	PRP$	O	they	poss	15	SENT_77	[p9l1276t138r1450b210],
14	daily	JJ	SET	daily	amod	15	SENT_77	[p9l1478t138r1660b230],
15	life	NN	O	life	dobj	12	SENT_77	[p9l1686t138r1818b210],
16	.	.	O	.	_	0	SENT_77	[p9l1686t138r1818b210],

1	CYP2C	NN	O	cyp2c	_	0	SENT_78	[p9l13t383r310b450],
2	19	CD	NUMBER	19	num	3	SENT_78	[p9l319t383r408b452],
3	Genotyping	NN	O	genotyping	dep	1	SENT_78	[p9l443t378r945b477],

1	Blood	NN	O	blood	nn	2	SENT_79	[p9l122t496r362b568],
2	samples	NNS	O	sample	nsubj	3	SENT_79	[p9l409t496r727b588],
3	(	VBP	O	(	_	0	SENT_79	[p9l779t501r849b585],
4	3	CD	NUMBER	3	num	6	SENT_79	[p9l779t501r849b585],
5	mL	NN	O	ml	nn	6	SENT_79	[p9l899t501r1060b585],
6	)	NN	O	)	nsubjpass	14	SENT_79	[p9l899t501r1060b585],
7	for	IN	O	for	_	0	SENT_79	[p9l1111t496r1229b568],
8	the	DT	O	the	det	9	SENT_79	[p9l1274t496r1396b568],
9	determination	NN	O	determination	prep_for	6	SENT_79	[p9l1445t496r2021b568],
10	of	IN	O	of	_	0	SENT_79	[p9l2069t496r2152b568],
11	CYP2C19	NN	O	cyp2c19	nn	12	SENT_79	[p9l16t618r413b686],
12	genotype	NN	O	genotype	prep_of	9	SENT_79	[p9l459t634r817b706],
13	were	VBD	O	be	auxpass	14	SENT_79	[p9l860t642r1048b686],
14	collected	VBN	O	collect	ccomp	3	SENT_79	[p9l1092t614r1441b686],
15	into	IN	O	into	_	0	SENT_79	[p9l1485t618r1640b686],
16	heparinized	JJ	O	heparinized	amod	17	SENT_79	[p9l1685t614r2147b706],
17	tubes	NNS	O	tube	prep_into	14	SENT_79	[p9l9t732r237b804],
18	.	.	O	.	_	0	SENT_79	[p9l9t732r237b804],

1	Genotyping	VBG	O	genotype	nsubjpass	3	SENT_80	[p9l265t736r725b824],
2	was	VBD	O	be	auxpass	3	SENT_80	[p9l748t760r897b804],
3	performed	VBN	O	perform	_	0	SENT_80	[p9l923t732r1334b824],
4	after	IN	O	after	_	0	SENT_80	[p9l1360t732r1538b804],
5	the	DT	O	the	det	6	SENT_80	[p9l1562t732r1681b804],
6	completion	NN	O	completion	prep_after	3	SENT_80	[p9l1706t732r2148b824],
7	of	IN	O	of	_	0	SENT_80	[p9l11t850r92b922],
8	treatment	NN	O	treatment	prep_of	6	SENT_80	[p9l110t871r507b922],
9	.	.	O	.	_	0	SENT_80	[p9l110t871r507b922],

1	DNA	NN	O	dna	nsubjpass	3	SENT_81	[p9l532t853r742b922],
2	was	VBD	O	be	auxpass	3	SENT_81	[p9l764t879r912b922],
3	isolated	VBN	O	isolate	_	0	SENT_81	[p9l938t850r1237b922],
4	from	IN	O	from	_	0	SENT_81	[p9l1261t850r1449b922],
5	peripheral	JJ	O	peripheral	amod	7	SENT_81	[p9l1472t850r1868b942],
6	mononuclear	JJ	O	mononuclear	amod	7	SENT_81	[p9l1892t879r2146b922, p9l10t968r309b1040],
7	cells	NNS	O	cell	prep_from	3	SENT_81	[p9l353t968r523b1040],
8	using	VBG	O	use	partmod	7	SENT_81	[p9l570t972r783b1060],
9	the	DT	O	the	det	11	SENT_81	[p9l827t968r949b1040],
10	phenol-chloroform	NN	O	phenol-chloroform	nn	11	SENT_81	[p9l995t968r1772b1060],
11	method	NN	O	method	dobj	8	SENT_81	[p9l1817t968r2147b1040],
12	.	.	O	.	_	0	SENT_81	[p9l1817t968r2147b1040],

1	CYP2	NN	MISC	cyp2	nn	3	SENT_82	[p9l16t1090r237b1158],
2	C19	NN	MISC	c19	nn	3	SENT_82	[p9l252t1090r409b1158],
3	genotyping	NN	O	genotyping	_	0	SENT_82	[p9l447t1091r884b1178],
4	was	VBD	O	be	auxpass	5	SENT_82	[p9l918t1114r1068b1158],
5	performed	VBN	O	perform	rcmod	3	SENT_82	[p9l1104t1086r1516b1178],
6	using	VBG	O	use	dep	3	SENT_82	[p9l1552t1091r1758b1178],
7	the	DT	O	the	det	10	SENT_82	[p9l1793t1086r1911b1158],
8	polymerase	NN	O	polymerase	nn	10	SENT_82	[p9l1947t1086r2147b1178, p9l10t1233r274b1276],
9	chain	NN	O	chain	nn	10	SENT_82	[p9l298t1204r503b1276],
10	reaction	NN	O	reaction	dobj	6	SENT_82	[p9l526t1209r835b1276],
11	(	CD	NUMBER	(	num	12	SENT_82	[p9l863t1209r1515b1293],
12	PCR	NN	O	pcr	dep	10	SENT_82	[p9l863t1209r1515b1293],
13	)	SYM	O	)	dep	10	SENT_82	[p9l863t1209r1515b1293],
14	-	:	O	-	_	0	SENT_82	[p9l863t1209r1515b1293],
15	restriction	NN	O	restriction	nn	17	SENT_82	[p9l863t1209r1515b1293],
16	fragment-length	JJ	O	fragment-length	amod	17	SENT_82	[p9l1538t1204r2149b1296],
17	polymorphism	NN	O	polymorphism	dep	6	SENT_82	[p9l9t1322r583b1414],
18	method	NN	O	method	nsubj	51	SENT_82	[p9l607t1322r904b1394],
19	with	IN	O	with	_	0	SENT_82	[p9l927t1322r1102b1394],
20	primers	NNS	O	primer	prep_with	18	SENT_82	[p9l1126t1326r1422b1414],
21	as	IN	O	as	mark	40	SENT_82	[p9l1449t1350r1524b1394],
22	described	VBN	O	describe	csubj	40	SENT_82	[p9l1551t1322r1918b1394],
23	by	IN	O	by	_	0	SENT_82	[p9l1944t1322r2036b1413],
24	de	FW	PERSON	de	nn	27	SENT_82	[p9l2061t1322r2147b1394],
25	Morais	FW	PERSON	morais	nn	27	SENT_82	[p9l10t1445r294b1511],
26	et	FW	O	et	nn	27	SENT_82	[p9l340t1459r408b1511],
27	al.	FW	O	al.	prep_by	22	SENT_82	[p9l453t1437r619b1511],
28	37	CD	NUMBER	37	dep	27	SENT_82	[p9l453t1437r619b1511],
29	The	DT	O	the	det	30	SENT_82	[p9l657t1439r808b1511],
30	forward	JJ	O	forward	dep	27	SENT_82	[p9l853t1439r1174b1511],
31	and	CC	O	and	_	0	SENT_82	[p9l1219t1439r1363b1511],
32	reverse	JJ	O	reverse	amod	33	SENT_82	[p9l1406t1468r1681b1511],
33	primers	NNS	O	primer	prep_by	22	SENT_82	[p9l1725t1445r2025b1531],
34	of	IN	O	of	_	0	SENT_82	[p9l2072t1439r2153b1511],
35	mutation	NN	O	mutation	prep_of	33	SENT_82	[p9l10t1562r370b1629],
36	1	CD	NUMBER	1	number	37	SENT_82	[p9l415t1562r448b1628],
37	(	CD	NUMBER	(	num	39	SENT_82	[p9l500t1562r675b1645],
38	m1	NN	O	m1	nn	39	SENT_82	[p9l500t1562r675b1645],
39	)	NN	O	)	dobj	22	SENT_82	[p9l500t1562r675b1645],
40	were	VBD	O	be	dep	20	SENT_82	[p9l718t1585r903b1629],
41	5	CD	NUMBER	5	advmod	40	SENT_82	[p9l945t1563r986b1629],
42	’	SYM	O	’	dep	40	SENT_82	[p9l1001t1560r1241b1628],
43	-	:	O	-	_	0	SENT_82	[p9l1001t1560r1241b1628],
44	AAT	NN	O	aat	nn	51	SENT_82	[p9l1001t1560r1241b1628],
45	TAC	NN	O	tac	nn	51	SENT_82	[p9l1274t1560r1454b1629],
46	AAC	NN	O	aac	nn	51	SENT_82	[p9l1490t1560r1682b1629],
47	CAG	NN	O	cag	nn	51	SENT_82	[p9l1724t1560r1917b1629],
48	AGC	NN	O	agc	nn	51	SENT_82	[p9l1951t1560r2148b1629],
49	TTG	NN	O	ttg	nn	51	SENT_82	[p9l9t1680r201b1749],
50	GC-3	NN	O	gc-3	nn	51	SENT_82	[p9l246t1681r484b1749],
51	’	NN	O	’	rcmod	17	SENT_82	[p9l246t1681r484b1749],
52	and	CC	O	and	_	0	SENT_82	[p9l534t1677r677b1749],
53	5	CD	NUMBER	5	rcmod	17	SENT_82	[p9l721t1680r1005b1749],
54	’	SYM	O	’	dep	51	SENT_82	[p9l721t1680r1005b1749],
55	-	:	O	-	_	0	SENT_82	[p9l721t1680r1005b1749],
56	TAT	NN	O	tat	nn	58	SENT_82	[p9l721t1680r1005b1749],
57	CAC	NN	O	cac	nn	58	SENT_82	[p9l1049t1680r1234b1749],
58	TTT	NN	O	ttt	dep	17	SENT_82	[p9l1274t1680r1456b1748],
59	CCA	NNP	O	CCA	nn	64	SENT_82	[p9l1500t1680r1691b1749],
60	TAA	NNP	O	TAA	nn	64	SENT_82	[p9l1728t1680r1913b1748],
61	AAG	NNP	O	AAG	nn	64	SENT_82	[p9l1950t1680r2149b1749],
62	CAA	NNP	O	CAA	nn	64	SENT_82	[p9l13t1798r199b1867],
63	G-3	NN	O	g-3	nn	64	SENT_82	[p9l224t1799r417b1867],
64	’	NN	O	’	dep	58	SENT_82	[p9l224t1799r417b1867],
65	.	.	O	.	_	0	SENT_82	[p9l224t1799r417b1867],

1	The	DT	O	the	det	5	SENT_83	[p9l436t1795r582b1867],
2	forward	JJ	O	forward	amod	5	SENT_83	[p9l607t1795r916b1867],
3	and	CC	O	and	_	0	SENT_83	[p9l940t1795r1080b1867],
4	reverse	JJ	O	reverse	conj_and	2	SENT_83	[p9l1102t1823r1366b1867],
5	primers	NNS	O	primer	_	0	SENT_83	[p9l1389t1800r1678b1887],
6	of	IN	O	of	_	0	SENT_83	[p9l1703t1795r1782b1867],
7	mutation	NN	O	mutation	prep_of	5	SENT_83	[p9l1800t1800r2150b1867],
8	2	CD	NUMBER	2	num	7	SENT_83	[p9l10t1918r55b1984],
9	(	CD	NUMBER	(	num	11	SENT_83	[p9l84t1918r255b2001],
10	m2	NN	O	m2	nn	11	SENT_83	[p9l84t1918r255b2001],
11	)	NN	O	)	nsubj	12	SENT_83	[p9l84t1918r255b2001],
12	were	VBD	O	be	rcmod	5	SENT_83	[p9l281t1941r461b1985],
13	5	CD	NUMBER	5	advmod	12	SENT_83	[p9l486t1920r527b1985],
14	’	SYM	O	’	dep	12	SENT_83	[p9l541t1918r554b1945],
15	-	:	O	-	_	0	SENT_83	[p9l566t1916r763b1984],
16	TAT	NN	O	tat	nn	18	SENT_83	[p9l566t1916r763b1984],
17	TAT	NN	O	tat	nn	18	SENT_83	[p9l780t1916r950b1984],
18	TAT	NN	O	tat	dep	5	SENT_83	[p9l967t1916r1137b1984],
19	CTG	NNP	O	CTG	nn	24	SENT_83	[p9l1161t1916r1351b1985],
20	TTA	NNP	O	TTA	nn	24	SENT_83	[p9l1368t1916r1544b1984],
21	ACT	NNP	O	ACT	nn	24	SENT_83	[p9l1561t1916r1746b1985],
22	AAT	NNP	O	AAT	nn	24	SENT_83	[p9l1764t1917r1945b1984],
23	ATG	NN	O	atg	nn	24	SENT_83	[p9l1962t1917r2149b1985],
24	A-3	NN	O	a-3	rcmod	18	SENT_83	[p9l9t2036r176b2105],
25	'	''	O	'	_	0	SENT_83	[p9l9t2036r176b2105],
26	and	CC	O	and	_	0	SENT_83	[p9l218t2033r359b2105],
27	5	CD	NUMBER	5	rcmod	18	SENT_83	[p9l394t2036r690b2105],
28	’	SYM	O	’	dep	24	SENT_83	[p9l394t2036r690b2105],
29	-	:	O	-	_	0	SENT_83	[p9l394t2036r690b2105],
30	ACT	NN	O	act	nn	36	SENT_83	[p9l394t2036r690b2105],
31	TCA	NN	O	tca	nn	36	SENT_83	[p9l718t2036r905b2105],
32	GGG	NN	O	ggg	nn	36	SENT_83	[p9l940t2037r1148b2105],
33	CTT	NNP	O	CTT	nn	36	SENT_83	[p9l1183t2036r1364b2105],
34	GGT	NNP	O	GGT	nn	36	SENT_83	[p9l1400t2036r1597b2105],
35	CAA	NNP	O	CAA	nn	36	SENT_83	[p9l1632t2036r1821b2105],
36	TA-3	NN	O	ta-3	dep	5	SENT_83	[p9l1849t2036r2148b2105],
37	'	''	O	'	_	0	SENT_83	[p9l1849t2036r2148b2105],
38	5	CD	NUMBER	5	dep	36	SENT_83	[p9l1849t2036r2148b2105],
39	.	.	O	.	_	0	SENT_83	[p9l1849t2036r2148b2105],

1	The	DT	O	the	det	4	SENT_84	[p9l9t2151r157b2223],
2	amplified	VBN	O	amplify	amod	4	SENT_84	[p9l192t2151r553b2243],
3	PCR	NN	O	pcr	nn	4	SENT_84	[p9l586t2155r765b2223],
4	products	NNS	O	product	nsubj	6	SENT_84	[p9l796t2151r1134b2243],
5	were	VBD	O	be	cop	6	SENT_84	[p9l1167t2179r1350b2223],
6	169	CD	NUMBER	169	_	0	SENT_84	[p9l1390t2156r1579b2223],
7	-	:	O	-	_	0	SENT_84	[p9l1390t2156r1579b2223],
8	and	CC	O	and	_	0	SENT_84	[p9l1611t2151r1752b2223],
9	329	CD	NUMBER	329	number	10	SENT_84	[p9l1787t2151r2148b2223],
10	—	CD	NUMBER	—	num	14	SENT_84	[p9l1787t2151r2148b2223],
11	base	NN	O	base	nn	14	SENT_84	[p9l1787t2151r2148b2223],
12	pair	NN	O	pair	nn	14	SENT_84	[p9l9t2274r162b2361],
13	gene	NN	O	gene	nn	14	SENT_84	[p9l195t2298r367b2361],
14	fragments	NNS	O	fragment	conj_and	6	SENT_84	[p9l402t2269r807b2361],
15	,	,	O	,	_	0	SENT_84	[p9l402t2269r807b2361],
16	respectively	RB	O	respectively	advmod	6	SENT_84	[p9l839t2270r1304b2361],
17	.	.	O	.	_	0	SENT_84	[p9l839t2270r1304b2361],

1	The	DT	O	the	det	3	SENT_85	[p9l1336t2270r1485b2342],
2	PCR	NN	O	pcr	nn	3	SENT_85	[p9l1521t2274r1703b2342],
3	conditions	NNS	O	condition	nsubj	6	SENT_85	[p9l1737t2270r2147b2342],
4	were	VBD	O	be	cop	6	SENT_85	[p9l9t2415r195b2459],
5	1	CD	NUMBER	1	num	6	SENT_85	[p9l238t2392r271b2458],
6	uL	NN	O	ul	_	0	SENT_85	[p9l315t2392r419b2479],
7	forward	RB	O	forward	advmod	8	SENT_85	[p9l455t2387r773b2459],
8	primer	NN	O	primer	dep	6	SENT_85	[p9l809t2391r1085b2479],
9	,	,	O	,	_	0	SENT_85	[p9l809t2391r1085b2479],
10	1	CD	NUMBER	1	num	11	SENT_85	[p9l1126t2392r1160b2458],
11	uL	NN	O	ul	conj_and	6	SENT_85	[p9l1204t2392r1307b2478],
12	reverse	JJ	O	reverse	amod	13	SENT_85	[p9l1343t2415r1615b2459],
13	primer	NN	O	primer	dep	11	SENT_85	[p9l1651t2391r1927b2479],
14	,	,	O	,	_	0	SENT_85	[p9l1651t2391r1927b2479],
15	1	CD	NUMBER	1	num	16	SENT_85	[p9l1969t2392r2002b2458],
16	uL	NN	O	ul	conj_and	6	SENT_85	[p9l2046t2392r2149b2478],
17	genomic	JJ	O	genomic	amod	18	SENT_85	[p9l10t2510r339b2597],
18	DNA	NN	MISC	dna	dep	16	SENT_85	[p9l372t2508r606b2594],
19	,	,	O	,	_	0	SENT_85	[p9l372t2508r606b2594],
20	7	CD	NUMBER	7	num	21	SENT_85	[p9l640t2512r685b2577],
21	uL	NN	O	ul	conj_and	6	SENT_85	[p9l717t2511r820b2597],
22	deionized	JJ	O	deionized	amod	23	SENT_85	[p9l854t2505r1228b2577],
23	water	NN	O	water	dep	21	SENT_85	[p9l1258t2525r1494b2594],
24	,	,	O	,	_	0	SENT_85	[p9l1258t2525r1494b2594],
25	and	CC	O	and	_	0	SENT_85	[p9l1527t2505r1670b2577],
26	10	CD	NUMBER	10	num	27	SENT_85	[p9l1708t2510r1798b2577],
27	uL	NN	O	ul	conj_and	6	SENT_85	[p9l1833t2511r1937b2597],
28	PCR	NN	O	pcr	nn	30	SENT_85	[p9l1969t2509r2150b2577],
29	master	NN	O	master	nn	30	SENT_85	[p9l10t2644r273b2696],
30	mix	NN	O	mix	dep	27	SENT_85	[p9l308t2628r479b2696],
31	.	.	O	.	_	0	SENT_85	[p9l308t2628r479b2696],

1	The	DT	O	the	det	2	SENT_86	[p9l511t2624r661b2696],
2	procedure	NN	O	procedure	nsubj	3	SENT_86	[p9l697t2624r1092b2715],
3	consisted	VBD	O	consist	ccomp	37	SENT_86	[p9l1129t2624r1489b2696],
4	of	IN	O	of	_	0	SENT_86	[p9l1527t2623r1608b2696],
5	an	DT	O	a	det	8	SENT_86	[p9l1640t2652r1732b2696],
6	initial	JJ	O	initial	amod	8	SENT_86	[p9l1768t2624r1994b2696],
7	denaturation	NN	O	denaturation	nn	8	SENT_86	[p9l2032t2624r2147b2696, p9l10t2745r426b2813],
8	step	NN	O	step	prep_of	3	SENT_86	[p9l467t2761r619b2833],
9	at	IN	O	at	_	0	SENT_86	[p9l661t2761r733b2813],
10	95	CD	NUMBER	95	number	11	SENT_86	[p9l773t2745r972b2813],
11	°	CD	NUMBER	°	num	12	SENT_86	[p9l773t2745r972b2813],
12	C	NN	O	c	prep_at	3	SENT_86	[p9l773t2745r972b2813],
13	for	IN	O	for	_	0	SENT_86	[p9l1012t2741r1126b2813],
14	15	CD	DURATION	15	num	15	SENT_86	[p9l1171t2746r1259b2813],
15	minutes	NNS	NUMBER	minute	prep_for	12	SENT_86	[p9l1302t2745r1634b2829],
16	,	,	O	,	_	0	SENT_86	[p9l1302t2745r1634b2829],
17	followed	VBN	O	follow	_	0	SENT_86	[p9l1673t2741r2017b2813],
18	by	IN	O	by	prepc_followed_by	3	SENT_86	[p9l2057t2741r2150b2833],
19	35	CD	NUMBER	35	num	20	SENT_86	[p9l13t2864r103b2931],
20	cycles	NNS	O	cycle	pobj	3	SENT_86	[p9l128t2859r343b2951],
21	of	IN	O	of	_	0	SENT_86	[p9l367t2859r447b2931],
22	denaturation	NN	O	denaturation	prep_of	20	SENT_86	[p9l465t2859r952b2931],
23	at	IN	O	at	_	0	SENT_86	[p9l974t2879r1044b2931],
24	94	CD	NUMBER	94	number	25	SENT_86	[p9l1067t2863r1260b2931],
25	°	CD	NUMBER	°	num	26	SENT_86	[p9l1067t2863r1260b2931],
26	C	NN	O	c	prep_at	22	SENT_86	[p9l1067t2863r1260b2931],
27	for	IN	O	for	_	0	SENT_86	[p9l1283t2859r1393b2931],
28	60	CD	DURATION	60	num	29	SENT_86	[p9l1416t2864r1508b2931],
29	seconds	NNS	NUMBER	seconds	prep_for	26	SENT_86	[p9l1532t2859r1845b2948],
30	,	,	O	,	_	0	SENT_86	[p9l1532t2859r1845b2948],
31	annealing	NN	O	annealing	nsubj	37	SENT_86	[p9l1867t2859r2147b2931, p9l10t2982r126b3069],
32	at	IN	O	at	_	0	SENT_86	[p9l150t2998r220b3050],
33	55	CD	NUMBER	55	num	35	SENT_86	[p9l244t2982r438b3050],
34	°	NN	O	°	nn	35	SENT_86	[p9l244t2982r438b3050],
35	C	NN	O	c	prep_at	31	SENT_86	[p9l244t2982r438b3050],
36	(	CD	NUMBER	(	num	37	SENT_86	[p9l467t2982r638b3066],
37	m1	NN	O	m1	_	0	SENT_86	[p9l467t2982r638b3066],
38	)	CD	NUMBER	)	num	45	SENT_86	[p9l467t2982r638b3066],
39	or	CC	O	or	_	0	SENT_86	[p9l667t3006r747b3050],
40	53	CD	NUMBER	53	num	45	SENT_86	[p9l772t2982r966b3050],
41	°	NN	O	°	nn	45	SENT_86	[p9l772t2982r966b3050],
42	C	NN	O	c	nn	45	SENT_86	[p9l772t2982r966b3050],
43	(	CD	NUMBER	(	num	45	SENT_86	[p9l995t2982r1166b3066],
44	m2	NN	O	m2	nn	45	SENT_86	[p9l995t2982r1166b3066],
45	)	NN	O	)	dobj	37	SENT_86	[p9l995t2982r1166b3066],
46	for	IN	O	for	_	0	SENT_86	[p9l1194t2977r1304b3050],
47	60	CD	DURATION	60	num	48	SENT_86	[p9l1329t2983r1421b3050],
48	seconds	NNS	NUMBER	seconds	prep_for	45	SENT_86	[p9l1447t2978r1763b3066],
49	,	,	O	,	_	0	SENT_86	[p9l1447t2978r1763b3066],
50	extension	NN	O	extension	dobj	37	SENT_86	[p9l1785t2982r2149b3050],
51	at	IN	O	at	_	0	SENT_86	[p9l12t3115r84b3167],
52	72	CD	NUMBER	72	number	53	SENT_86	[p9l122t3099r320b3167],
53	°	CD	NUMBER	°	num	54	SENT_86	[p9l122t3099r320b3167],
54	C	NN	O	c	prep_at	50	SENT_86	[p9l122t3099r320b3167],
55	for	IN	O	for	_	0	SENT_86	[p9l357t3095r471b3167],
56	60	CD	DURATION	60	num	57	SENT_86	[p9l510t3100r603b3167],
57	seconds	NNS	NUMBER	seconds	prep_for	54	SENT_86	[p9l643t3095r968b3183],
58	,	,	O	,	_	0	SENT_86	[p9l643t3095r968b3183],
59	and	CC	O	and	_	0	SENT_86	[p9l1005t3095r1148b3167],
60	a	DT	O	a	det	63	SENT_86	[p9l1185t3123r1225b3167],
61	final	JJ	O	final	amod	63	SENT_86	[p9l1263t3095r1437b3167],
62	extension	NN	O	extension	nn	63	SENT_86	[p9l1474t3099r1849b3167],
63	step	NN	O	step	dobj	37	SENT_86	[p9l1887t3115r2038b3187],
64	at	IN	O	at	_	0	SENT_86	[p9l2077t3115r2149b3167],
65	72	CD	NUMBER	72	number	66	SENT_86	[p9l13t3217r211b3285],
66	°	CD	NUMBER	°	num	67	SENT_86	[p9l13t3217r211b3285],
67	C	NN	O	c	prep_at	63	SENT_86	[p9l13t3217r211b3285],
68	for	IN	O	for	_	0	SENT_86	[p9l246t3213r360b3285],
69	7	CD	DURATION	7	num	70	SENT_86	[p9l396t3220r441b3285],
70	minutes	NNS	NUMBER	minute	prep_for	37	SENT_86	[p9l474t3218r804b3285],
71	.	.	O	.	_	0	SENT_86	[p9l474t3218r804b3285],

1	The	DT	O	the	det	2	SENT_87	[p9l834t3213r984b3285],
2	PCR	NN	MISC	pcr	nsubj	9	SENT_87	[p9l1018t3217r1200b3285],
3	products	NNS	O	product	nsubjpass	5	SENT_87	[p9l1232t3213r1576b3305],
4	were	VBD	O	be	auxpass	5	SENT_87	[p9l1610t3241r1795b3285],
5	digested	VBN	O	digest	rcmod	2	SENT_87	[p9l1832t3213r2149b3305],
6	with	IN	O	with	_	0	SENT_87	[p9l9t3331r181b3404],
7	restriction	NN	O	restriction	nn	8	SENT_87	[p9l204t3336r594b3404],
8	endonucleases	NNS	O	endonuclease	prep_with	5	SENT_87	[p9l618t3332r1160b3404],
9	(	VBP	O	(	_	0	SENT_87	[p9l1190t3336r1406b3420],
10	Smal	JJ	O	smal	dobj	9	SENT_87	[p9l1190t3336r1406b3420],
11	for	IN	O	for	_	0	SENT_87	[p9l1429t3331r1540b3404],
12	m1	NN	O	m1	prep_for	10	SENT_87	[p9l1562t3337r1673b3403],
13	and	CC	O	and	_	0	SENT_87	[p9l1709t3332r1849b3404],
14	BamHI	NN	O	bamhus	conj_and	12	SENT_87	[p9l1873t3337r2149b3404],
15	for	IN	O	for	_	0	SENT_87	[p9l11t3449r124b3521],
16	m2	NN	O	m2	nn	17	SENT_87	[p9l152t3453r328b3537],
17	)	NN	O	)	prep_for	9	SENT_87	[p9l152t3453r328b3537],
18	.	.	O	.	_	0	SENT_87	[p9l152t3453r328b3537],

1	The	DT	O	the	det	4	SENT_88	[p9l354t3449r503b3521],
2	digested	VBN	O	digest	amod	4	SENT_88	[p9l534t3449r852b3541],
3	PCR	NN	O	pcr	nn	4	SENT_88	[p9l880t3453r1062b3521],
4	products	NNS	O	product	nsubjpass	6	SENT_88	[p9l1089t3449r1433b3541],
5	were	VBD	O	be	auxpass	6	SENT_88	[p9l1461t3477r1648b3521],
6	analyzed	VBN	O	analyze	_	0	SENT_88	[p9l1678t3449r2021b3540],
7	on	IN	O	on	_	0	SENT_88	[p9l2052t3477r2149b3521],
8	2	CD	PERCENT	2	number	9	SENT_88	[p9l10t3571r142b3640],
9	%	NN	PERCENT	%	amod	11	SENT_88	[p9l10t3571r142b3640],
10	agarose	NN	O	agarose	nn	11	SENT_88	[p9l188t3595r484b3659],
11	gels	NNS	O	gel	prep_on	6	SENT_88	[p9l521t3567r665b3659],
12	and	CC	O	and	_	0	SENT_88	[p9l704t3567r847b3639],
13	stained	VBN	O	stain	conj_and	6	SENT_88	[p9l886t3567r1162b3639],
14	with	IN	O	with	_	0	SENT_88	[p9l1197t3567r1374b3639],
15	ethidium	NN	O	ethidium	nn	16	SENT_88	[p9l1411t3567r1761b3639],
16	bromide	NN	O	bromide	prep_with	13	SENT_88	[p9l1799t3567r2148b3639],
17	.	.	O	.	_	0	SENT_88	[p9l1799t3567r2148b3639],

1	Because	IN	O	because	mark	5	SENT_89	[p9l11t3690r311b3757],
2	CYP2	NN	O	cyp2	nn	4	SENT_89	[p9l341t3689r558b3757],
3	C19	NN	O	c19	nn	4	SENT_89	[p9l572t3689r726b3757],
4	m1	NN	O	m1	nsubj	5	SENT_89	[p9l751t3690r863b3755],
5	lacks	VBZ	O	lack	_	0	SENT_89	[p9l897t3684r1087b3757],
6	an	DT	O	a	det	8	SENT_89	[p9l1113t3713r1203b3757],
7	Smal	JJ	MISC	smal	amod	8	SENT_89	[p9l1228t3689r1418b3757],
8	site	NN	O	site	dobj	5	SENT_89	[p9l1443t3689r1566b3757],
9	and	CC	O	and	_	0	SENT_89	[p9l1592t3685r1732b3757],
10	CYP2C19	NN	O	cyp2c19	dobj	5	SENT_89	[p9l1761t3689r2147b3757],

1	Clinical	JJ	O	clinical	amod	3	SENT_90	[p10l64t242r341b308],
2	Therapeutics	NNS	O	therapeutics	nn	3	SENT_90	[p10l372t242r878b331],
3	m2	NN	O	m2	nsubj	4	SENT_90	[p10l8t504r127b570],
4	lacks	VBZ	O	lack	ccomp	13	SENT_90	[p10l156t498r347b571],
5	a	DT	O	a	det	7	SENT_90	[p10l374t527r413b571],
6	BamHI	NN	O	bamhus	nn	7	SENT_90	[p10l439t504r719b571],
7	site	NN	O	site	dobj	4	SENT_90	[p10l744t503r893b587],
8	,	,	O	,	_	0	SENT_90	[p10l744t503r893b587],
9	the	DT	O	the	det	11	SENT_90	[p10l915t499r1032b571],
10	mutant	JJ	O	mutant	amod	11	SENT_90	[p10l1057t519r1338b571],
11	alleles	NNS	O	allele	nsubj	13	SENT_90	[p10l1363t499r1594b571],
12	were	VBD	O	be	cop	13	SENT_90	[p10l1618t527r1801b571],
13	resistant	JJ	O	resistant	_	0	SENT_90	[p10l1826t503r2152b571],
14	to	TO	O	to	_	0	SENT_90	[p10l7t634r85b686],
15	endonuclease	NN	O	endonuclease	nn	16	SENT_90	[p10l117t614r640b686],
16	digestion	NN	O	digestion	prep_to	13	SENT_90	[p10l673t614r1048b706],
17	.	.	O	.	_	0	SENT_90	[p10l673t614r1048b706],

1	Study	NN	O	study	nn	2	SENT_91	[p10l121t730r342b822],
2	patients	NNS	O	patient	nsubjpass	4	SENT_91	[p10l365t735r674b822],
3	were	VBD	O	be	auxpass	4	SENT_91	[p10l699t758r885b802],
4	categorized	VBN	O	categorize	_	0	SENT_91	[p10l911t730r1358b822],
5	into	IN	O	into	_	0	SENT_91	[p10l1384t735r1537b802],
6	3	CD	NUMBER	3	num	7	SENT_91	[p10l1566t735r1605b802],
7	groups	NNS	O	group	prep_into	4	SENT_91	[p10l1635t758r1902b822],
8	based	VBN	O	base	partmod	7	SENT_91	[p10l1930t730r2150b802],
9	on	IN	O	on	_	0	SENT_91	[p10l9t875r107b919],
10	the	DT	O	the	det	11	SENT_91	[p10l141t847r259b919],
11	existence	NN	O	existence	prep_on	8	SENT_91	[p10l296t851r650b919],
12	of	IN	O	of	_	0	SENT_91	[p10l687t846r768b919],
13	m1	NN	O	m1	prep_of	11	SENT_91	[p10l798t852r912b917],
14	or	CC	O	or	_	0	SENT_91	[p10l959t875r1041b919],
15	1442	CD	DATE	1442	prep_on	8	SENT_91	[p10l1076t852r1195b917],
16	on	IN	O	on	_	0	SENT_91	[p10l1236t875r1334b919],
17	CYPZCI9	NN	O	cypzci9	nn	18	SENT_91	[p10l1374t851r1768b919],
18	genotyping	NN	O	genotyping	prep_on	15	SENT_91	[p10l1805t867r2149b938, p10l9t966r149b1054],
19	:	:	O	:	_	0	SENT_91	[p10l1805t867r2149b938, p10l9t966r149b1054],
20	HomEM	NNP	O	HomEM	conj_or	11	SENT_91	[p10l184t967r535b1034],
21	(	CD	NUMBER	(	num	20	SENT_91	[p10l571t962r766b1050],
22	wild	JJ	O	wild	amod	23	SENT_91	[p10l571t962r766b1050],
23	type	NN	O	type	dep	20	SENT_91	[p10l797t982r962b1054],
24	[	CD	NUMBER	[	num	26	SENT_91	[p10l1001t966r1337b1051],
25	wt	JJ	O	wt	amod	26	SENT_91	[p10l1001t966r1337b1051],
26	]	NN	O	]	dep	23	SENT_91	[p10l1001t966r1337b1051],
27	/	:	O	/	punct	29	SENT_91	[p10l1001t966r1337b1051],
28	Wt	JJ	O	wt	amod	29	SENT_91	[p10l1001t966r1337b1051],
29	)	NN	O	)	dep	26	SENT_91	[p10l1001t966r1337b1051],
30	,	,	O	,	_	0	SENT_91	[p10l1001t966r1337b1051],
31	HetEM	NN	O	hetem	nn	33	SENT_91	[p10l1367t967r1660b1034],
32	(	CD	NUMBER	(	num	33	SENT_91	[p10l1696t966r1963b1050],
33	wt/m1	NN	O	wt/m1	dep	26	SENT_91	[p10l1696t966r1963b1050],
34	and	CC	O	and	_	0	SENT_91	[p10l2007t962r2151b1034],
35	wt/m2	NN	O	wt/m2	nn	36	SENT_91	[p10l7t1083r315b1168],
36	)	NN	O	)	dep	26	SENT_91	[p10l7t1083r315b1168],
37	,	,	O	,	_	0	SENT_91	[p10l7t1083r315b1168],
38	and	CC	O	and	_	0	SENT_91	[p10l345t1079r489b1152],
39	PM	NNP	O	PM	nn	41	SENT_91	[p10l519t1085r659b1151],
40	(	CD	NUMBER	(	num	41	SENT_91	[p10l694t1083r1021b1168],
41	m1/ml	NN	O	m1/ml	conj_and	11	SENT_91	[p10l694t1083r1021b1168],
42	,	,	O	,	_	0	SENT_91	[p10l694t1083r1021b1168],
43	m1/m2	NN	O	m1/m2	conj_and	11	SENT_91	[p10l1050t1083r1352b1168],
44	,	,	O	,	_	0	SENT_91	[p10l1050t1083r1352b1168],
45	and	CC	O	and	_	0	SENT_91	[p10l1382t1079r1526b1151],
46	m2/m2	NN	O	m2/m2	nn	47	SENT_91	[p10l1556t1083r1887b1168],
47	)	NN	O	)	conj_and	11	SENT_91	[p10l1556t1083r1887b1168],
48	.	.	O	.	_	0	SENT_91	[p10l1556t1083r1887b1168],

1	Statistical	JJ	O	statistical	amod	2	SENT_92	[p10l8t1318r427b1391],
2	Analysis	NN	O	analysis	_	0	SENT_92	[p10l463t1318r819b1417],

1	The	DT	O	the	det	4	SENT_93	[p10l118t1437r268b1509],
2	estimated	VBN	O	estimate	amod	4	SENT_93	[p10l309t1437r684b1509],
3	sample	NN	O	sample	nn	4	SENT_93	[p10l724t1437r995b1529],
4	size	NN	O	size	nsubjpass	8	SENT_93	[p10l1036t1442r1173b1509],
5	of	IN	O	of	_	0	SENT_93	[p10l1215t1437r1296b1509],
6	180	CD	NUMBER	180	prep_of	4	SENT_93	[p10l1336t1442r1478b1509],
7	was	VBD	O	be	auxpass	8	SENT_93	[p10l1518t1465r1667b1509],
8	determined	VBN	O	determine	_	0	SENT_93	[p10l1709t1437r2150b1509],
9	based	VBN	O	base	_	0	SENT_93	[p10l10t1556r225b1628],
10	on	IN	O	on	prepc_based_on	8	SENT_93	[p10l250t1584r346b1628],
11	data	NNS	O	datum	pobj	8	SENT_93	[p10l370t1555r535b1628],
12	on	IN	O	on	_	0	SENT_93	[p10l561t1584r656b1628],
13	estimated	VBN	O	estimate	amod	14	SENT_93	[p10l680t1556r1046b1628],
14	rates	NNS	O	rate	prep_on	11	SENT_93	[p10l1069t1576r1250b1628],
15	of	IN	O	of	_	0	SENT_93	[p10l1276t1555r1356b1628],
16	H	NN	O	h	nn	18	SENT_93	[p10l1374t1561r1452b1626],
17	pylori	NN	O	pylorus	nn	18	SENT_93	[p10l1468t1556r1697b1647],
18	eradication	NN	O	eradication	prep_of	14	SENT_93	[p10l1719t1556r2150b1628],
19	from	IN	O	from	_	0	SENT_93	[p10l9t1672r199b1744],
20	a	DT	O	a	det	22	SENT_93	[p10l230t1700r270b1744],
21	previous	JJ	O	previous	amod	22	SENT_93	[p10l300t1677r634b1764],
22	publication	NN	O	publication	prep_from	18	SENT_93	[p10l665t1669r1211b1764],
23	.	.	O	.	_	0	SENT_93	[p10l665t1669r1211b1764],

1	”	NN	O	”	_	0	SENT_94	[p10l665t1669r1211b1764],

1	Rates	NNS	O	rate	nsubjpass	9	SENT_95	[p10l120t1796r334b1862],
2	of	IN	O	of	_	0	SENT_95	[p10l368t1790r449b1862],
3	eradication	NN	O	eradication	prep_of	1	SENT_95	[p10l475t1790r917b1862],
4	of	IN	O	of	_	0	SENT_95	[p10l949t1790r1030b1862],
5	H	NN	O	h	nn	7	SENT_95	[p10l1055t1796r1134b1861],
6	pylori	NN	O	pylorus	nn	7	SENT_95	[p10l1157t1790r1391b1882],
7	infection	NN	O	infection	prep_of	3	SENT_95	[p10l1419t1790r1764b1862],
8	were	VBD	O	be	auxpass	9	SENT_95	[p10l1793t1818r1979b1862],
9	calculated	VBN	O	calculate	_	0	SENT_95	[p10l2011t1790r2149b1862, p10l8t1908r286b1981],
10	in	IN	O	in	_	0	SENT_95	[p10l310t1913r381b1979],
11	the	DT	O	the	det	15	SENT_95	[p10l404t1909r520b1981],
12	ITT	NNP	ORGANIZATION	ITT	nn	15	SENT_95	[p10l545t1912r693b1979],
13	and	CC	O	and	_	0	SENT_95	[p10l717t1908r859b1981],
14	PP	NNP	O	PP	nn	15	SENT_95	[p10l882t1914r979b1979],
15	populations	NNS	O	population	prep_in	9	SENT_95	[p10l1002t1909r1483b2000],
16	.	.	O	.	_	0	SENT_95	[p10l1002t1909r1483b2000],

1	The	DT	O	the	det	3	SENT_96	[p10l1503t1908r1650b1981],
2	ITT	NN	O	itt	nn	3	SENT_96	[p10l1675t1912r1823b1979],
3	analysis	NN	O	analysis	nsubj	4	SENT_96	[p10l1848t1909r2148b2000],
4	included	VBD	O	include	_	0	SENT_96	[p10l9t2026r342b2098],
5	all	DT	O	all	dobj	4	SENT_96	[p10l368t2026r459b2098],
6	randomized	VBN	O	randomize	partmod	5	SENT_96	[p10l484t2026r951b2098],
7	patients	NNS	O	patient	dobj	6	SENT_96	[p10l975t2030r1305b2118],
8	.	.	O	.	_	0	SENT_96	[p10l975t2030r1305b2118],

1	Patients	NNS	O	patient	nsubjpass	10	SENT_97	[p10l1331t2030r1637b2098],
2	whose	WP$	O	whose	dep	6	SENT_97	[p10l1662t2026r1909b2098],
3	infection	NN	O	infection	nn	4	SENT_97	[p10l1935t2026r2149b2098, p10l7t2149r156b2216],
4	status	NN	O	status	nsubj	6	SENT_97	[p10l180t2164r393b2216],
5	was	VBD	O	be	cop	6	SENT_97	[p10l415t2172r559b2216],
6	unknown	JJ	O	unknown	dep	1	SENT_97	[p10l583t2144r944b2216],
7	after	IN	O	after	_	0	SENT_97	[p10l967t2144r1138b2216],
8	treatment	NN	O	treatment	prep_after	6	SENT_97	[p10l1159t2164r1524b2216],
9	were	VBD	O	be	auxpass	10	SENT_97	[p10l1544t2172r1723b2216],
10	considered	VBN	O	consider	_	0	SENT_97	[p10l1745t2144r2149b2216],
11	treatment	NN	O	treatment	nn	12	SENT_97	[p10l7t2283r387b2335],
12	failures	NNS	O	failure	dobj	10	SENT_97	[p10l411t2262r696b2335],
13	for	IN	O	for	_	0	SENT_97	[p10l722t2262r835b2335],
14	the	DT	O	the	det	15	SENT_97	[p10l859t2262r977b2335],
15	purposes	NNS	O	purpose	prep_for	10	SENT_97	[p10l1002t2290r1349b2354],
16	of	IN	O	of	_	0	SENT_97	[p10l1377t2262r1457b2335],
17	ITT	NN	ORGANIZATION	itt	nn	18	SENT_97	[p10l1477t2266r1627b2333],
18	analysis	NN	O	analysis	prep_of	15	SENT_97	[p10l1652t2263r1979b2354],
19	.	.	O	.	_	0	SENT_97	[p10l1652t2263r1979b2354],

1	The	DT	O	the	det	3	SENT_98	[p10l2000t2263r2149b2335],
2	PP	NN	O	pp	nn	3	SENT_98	[p10l8t2385r106b2451],
3	analysis	NN	O	analysis	nsubj	4	SENT_98	[p10l151t2380r457b2472],
4	excluded	VBN	O	exclude	_	0	SENT_98	[p10l502t2380r851b2452],
5	patients	NNS	O	patient	dobj	4	SENT_98	[p10l893t2384r1202b2472],
6	whose	WP$	O	whose	poss	7	SENT_98	[p10l1245t2380r1493b2452],
7	H	NN	O	h	dobj	13	SENT_98	[p10l1536t2385r1613b2451],
8	pylori	NN	O	pylorus	nn	9	SENT_98	[p10l1649t2380r1883b2472],
9	status	NN	O	status	nsubj	13	SENT_98	[p10l1925t2400r2149b2452],
10	after	IN	O	after	_	0	SENT_98	[p10l9t2498r189b2570],
11	therapy	NN	O	therapy	prep_after	9	SENT_98	[p10l215t2498r515b2590],
12	was	VBD	O	be	cop	13	SENT_98	[p10l540t2526r689b2570],
13	unknown	JJ	O	unknown	rcmod	5	SENT_98	[p10l718t2498r1093b2570],
14	and	CC	O	and	_	0	SENT_98	[p10l1122t2498r1265b2570],
15	those	DT	O	those	conj_and	4	SENT_98	[p10l1291t2498r1497b2570],
16	with	IN	O	with	_	0	SENT_98	[p10l1523t2498r1700b2570],
17	major	JJ	O	major	amod	19	SENT_98	[p10l1726t2503r1959b2590],
18	protocol	NN	O	protocol	nn	19	SENT_98	[p10l1984t2526r2149b2590, p10l7t2616r204b2688],
19	Violations	NNS	O	violation	prep_with	15	SENT_98	[p10l237t2616r646b2688],
20	.	.	O	.	_	0	SENT_98	[p10l237t2616r646b2688],

1	Because	IN	O	because	mark	6	SENT_99	[p10l681t2622r989b2688],
2	CYP2	NN	O	cyp2	nn	4	SENT_99	[p10l1029t2621r1251b2688],
3	C19	NN	O	c19	nn	4	SENT_99	[p10l1266t2621r1423b2688],
4	genotype	NN	O	genotype	nsubjpass	6	SENT_99	[p10l1458t2637r1813b2708],
5	was	VBD	O	be	auxpass	6	SENT_99	[p10l1846t2645r1996b2688],
6	determined	VBN	O	determine	advcl	32	SENT_99	[p10l2033t2616r2149b2688, p10l7t2734r353b2806],
7	only	RB	O	only	advmod	6	SENT_99	[p10l378t2734r546b2826],
8	in	IN	O	in	_	0	SENT_99	[p10l569t2738r640b2805],
9	patients	NNS	O	patient	prep_in	6	SENT_99	[p10l663t2738r966b2826],
10	who	WP	O	who	nsubj	14	SENT_99	[p10l991t2734r1159b2806],
11	completed	VBD	O	complete	rcmod	9	SENT_99	[p10l1184t2734r1584b2826],
12	treatment	NN	O	treatment	dobj	11	SENT_99	[p10l1608t2754r1983b2806],
13	and	CC	O	and	_	0	SENT_99	[p10l2008t2734r2150b2806],
14	had	VBD	O	have	conj_and	11	SENT_99	[p10l8t2852r153b2924],
15	evaluable	JJ	O	evaluable	amod	17	SENT_99	[p10l190t2852r560b2924],
16	blood	NN	O	blood	nn	17	SENT_99	[p10l600t2852r824b2924],
17	samples	NNS	O	sample	dobj	14	SENT_99	[p10l863t2852r1194b2944],
18	,	,	O	,	_	0	SENT_99	[p10l863t2852r1194b2944],
19	the	DT	O	the	det	20	SENT_99	[p10l1229t2852r1348b2924],
20	effect	NN	O	effect	nsubjpass	32	SENT_99	[p10l1386t2852r1598b2924],
21	of	IN	O	of	_	0	SENT_99	[p10l1635t2852r1716b2924],
22	CYPZCI9	NN	O	cypzci9	nn	23	SENT_99	[p10l1754t2856r2148b2924],
23	genotype	NN	O	genotype	prep_of	20	SENT_99	[p10l8t2991r363b3062],
24	on	IN	O	on	_	0	SENT_99	[p10l396t2999r493b3042],
25	rates	NNS	O	rate	prep_on	23	SENT_99	[p10l524t2990r709b3042],
26	of	IN	O	of	_	0	SENT_99	[p10l743t2970r824b3042],
27	eradication	NN	O	eradication	prep_of	25	SENT_99	[p10l852t2970r1294b3042],
28	of	IN	O	of	_	0	SENT_99	[p10l1327t2970r1408b3042],
29	H	NN	O	h	nn	30	SENT_99	[p10l1433t2976r1511b3041],
30	pylori	NN	O	pylorus	prep_of	27	SENT_99	[p10l1535t2970r1770b3062],
31	was	VBD	O	be	auxpass	32	SENT_99	[p10l1798t2999r1947b3042],
32	analyzed	VBN	O	analyze	_	0	SENT_99	[p10l1981t2999r2149b3042, p10l9t3088r209b3179],
33	in	IN	O	in	_	0	SENT_99	[p10l240t3092r312b3159],
34	the	DT	O	the	det	36	SENT_99	[p10l341t3088r460b3160],
35	PP	NN	O	pp	nn	36	SENT_99	[p10l491t3093r590b3159],
36	population	NN	O	population	prep_in	32	SENT_99	[p10l619t3088r1074b3180],
37	.	.	O	.	_	0	SENT_99	[p10l619t3088r1074b3180],

1	The	DT	O	the	det	4	SENT_100	[p10l118t3206r266b3278],
2	Fisher	NNP	O	Fisher	nn	4	SENT_100	[p10l308t3206r541b3278],
3	direct-probability	NN	O	direct-probability	nn	4	SENT_100	[p10l583t3206r1261b3298],
4	method	NN	O	method	nsubjpass	6	SENT_100	[p10l1301t3206r1595b3278],
5	was	VBD	O	be	auxpass	6	SENT_100	[p10l1635t3234r1782b3278],
6	used	VBN	O	use	_	0	SENT_100	[p10l1825t3206r1998b3278],
7	for	IN	O	for	_	0	SENT_100	[p10l2039t3206r2151b3278],
8	categorical	JJ	O	categorical	amod	9	SENT_100	[p10l8t3324r429b3416],
9	data	NNS	O	datum	prep_for	6	SENT_100	[p10l472t3324r662b3413],
10	,	,	O	,	_	0	SENT_100	[p10l472t3324r662b3413],
11	and	CC	O	and	_	0	SENT_100	[p10l704t3324r846b3396],
12	one-way	JJ	O	one-way	amod	13	SENT_100	[p10l890t3353r1221b3416],
13	ANOVA	NNP	O	ANOVA	nsubjpass	15	SENT_100	[p10l1257t3327r1590b3396],
14	was	VBD	O	be	auxpass	15	SENT_100	[p10l1630t3353r1778b3396],
15	used	VBN	O	use	conj_and	6	SENT_100	[p10l1822t3324r1995b3396],
16	for	IN	O	for	_	0	SENT_100	[p10l2037t3324r2150b3396],
17	numeric	JJ	O	numeric	amod	18	SENT_100	[p10l8t3446r321b3514],
18	data	NNS	O	datum	prep_for	15	SENT_100	[p10l352t3438r610b3514],
19	.33	CD	NUMBER	.33	tmod	15	SENT_100	[p10l352t3438r610b3514],
20	An	DT	O	a	det	24	SENT_100	[p10l638t3444r751b3513],
21	exact	JJ	O	exact	amod	24	SENT_100	[p10l780t3461r983b3514],
22	95	CD	PERCENT	95	number	23	SENT_100	[p10l1012t3446r1193b3515],
23	%	NN	PERCENT	%	amod	24	SENT_100	[p10l1012t3446r1193b3515],
24	CI	NN	O	ci	nsubjpass	26	SENT_100	[p10l1231t3446r1320b3514],
25	was	VBD	O	be	auxpass	26	SENT_100	[p10l1347t3469r1495b3514],
26	calculated	VBN	O	calculate	rcmod	19	SENT_100	[p10l1525t3441r1913b3514],
27	when	WRB	O	when	advmod	28	SENT_100	[p10l1940t3441r2150b3514],
28	appropriate	JJ	O	appropriate	advcl	26	SENT_100	[p10l9t3565r473b3652],
29	.	.	O	.	_	0	SENT_100	[p10l9t3565r473b3652],

1	All	DT	O	all	det	3	SENT_101	[p10l491t3560r601b3631],
2	statistical	JJ	O	statistical	amod	3	SENT_101	[p10l625t3560r976b3632],
3	analyses	NNS	O	analysis	nsubjpass	5	SENT_101	[p10l1000t3560r1308b3652],
4	were	VBD	O	be	auxpass	5	SENT_101	[p10l1330t3588r1510b3632],
5	performed	VBN	O	perform	_	0	SENT_101	[p10l1532t3560r1930b3652],
6	using	VBG	O	use	xcomp	5	SENT_101	[p10l1952t3565r2151b3652],
7	SPSS	NNP	ORGANIZATION	SPSS	nn	8	SENT_101	[p10l10t3683r187b3750],
8	Version	NNP	O	Version	nsubj	12	SENT_101	[p10l210t3683r484b3750],
9	13.0	CD	NUMBER	13.0	num	12	SENT_101	[p10l512t3683r674b3750],
10	(	CD	NUMBER	(	num	12	SENT_101	[p10l703t3683r906b3767],
11	SPSS	NNP	ORGANIZATION	SPSS	nn	12	SENT_101	[p10l703t3683r906b3767],
12	Inc.	NNP	ORGANIZATION	Inc.	xcomp	6	SENT_101	[p10l929t3684r1091b3767],
13	,	,	O	,	_	0	SENT_101	[p10l929t3684r1091b3767],
14	Chicago	NNP	LOCATION	Chicago	appos	12	SENT_101	[p10l1115t3678r1447b3770],
15	,	,	O	,	_	0	SENT_101	[p10l1115t3678r1447b3770],
16	Illinois	NNP	LOCATION	Illinois	nn	17	SENT_101	[p10l1468t3678r1774b3767],
17	)	NN	O	)	appos	14	SENT_101	[p10l1468t3678r1774b3767],
18	.	.	O	.	_	0	SENT_101	[p10l1468t3678r1774b3767],

1	A	DT	O	a	det	3	SENT_102	[p10l1793t3682r1856b3749],
2	P	NN	O	p	nn	3	SENT_102	[p10l1877t3684r1929b3749],
3	Value	NN	O	value	_	0	SENT_102	[p10l1950t3678r2149b3750],

1	<	JJR	O	<	nsubjpass	4	SENT_103	[p11l11t25r228b92],
2	0.05	CD	NUMBER	0.05	dep	1	SENT_103	[p11l11t25r228b92],
3	was	VBD	O	be	auxpass	4	SENT_103	[p11l259t48r407b92],
4	regarded	VBN	O	regard	_	0	SENT_103	[p11l436t20r774b112],
5	as	IN	O	as	_	0	SENT_103	[p11l804t48r879b92],
6	statistically	RB	O	statistically	advmod	7	SENT_103	[p11l910t20r1341b112],
7	significant	JJ	O	significant	prep_as	4	SENT_103	[p11l1369t20r1786b112],
8	.	.	O	.	_	0	SENT_103	[p11l1369t20r1786b112],

1	RESULTS	NNS	O	result	_	0	SENT_104	[p11l14t265r412b332],
2	Study	NNP	O	Study	dep	1	SENT_104	[p11l8t377r255b475],
3	Groups	NNS	O	group	dep	1	SENT_104	[p11l286t381r603b474],

1	Of	IN	O	of	_	0	SENT_105	[p11l122t493r226b565],
2	199	CD	NUMBER	199	num	4	SENT_105	[p11l256t498r395b565],
3	consecutive	JJ	O	consecutive	amod	4	SENT_105	[p11l425t498r868b565],
4	patients	NNS	O	patient	prep_of	12	SENT_105	[p11l896t498r1198b585],
5	screened	VBN	O	screen	partmod	4	SENT_105	[p11l1228t493r1578b582],
6	,	,	O	,	_	0	SENT_105	[p11l1228t493r1578b582],
7	184	CD	NUMBER	184	num	8	SENT_105	[p11l1610t498r1750b565],
8	H	NN	O	h	npadvmod	9	SENT_105	[p11l1779t499r1857b564],
9	pyloripositive	JJ	O	pyloripositive	amod	10	SENT_105	[p11l1878t493r2153b585, p11l7t614r305b701],
10	patients	NNS	O	patient	nsubjpass	12	SENT_105	[p11l330t614r631b701],
11	were	VBD	O	be	auxpass	12	SENT_105	[p11l656t638r840b682],
12	enrolled	VBN	O	enrol	_	0	SENT_105	[p11l866t609r1178b682],
13	in	IN	O	in	_	0	SENT_105	[p11l1203t614r1275b680],
14	the	DT	O	the	det	15	SENT_105	[p11l1298t610r1415b682],
15	study	NN	O	study	prep_in	12	SENT_105	[p11l1442t610r1649b701],
16	(	CD	NUMBER	(	number	17	SENT_105	[p11l1678t614r1793b698],
17	61	CD	NUMBER	61	num	15	SENT_105	[p11l1678t614r1793b698],
18	in	IN	O	in	_	0	SENT_105	[p11l1825t614r1897b680],
19	group	NN	O	group	nn	20	SENT_105	[p11l1921t637r2149b701],
20	A	NN	O	a	prep_in	15	SENT_105	[p11l7t728r93b813],
21	,	,	O	,	_	0	SENT_105	[p11l7t728r93b813],
22	62	CD	NUMBER	62	prep_in	12	SENT_105	[p11l132t730r225b797],
23	in	IN	O	in	_	0	SENT_105	[p11l265t729r336b796],
24	group	NN	O	group	nn	25	SENT_105	[p11l373t752r600b817],
25	B	NN	O	b	prep_in	22	SENT_105	[p11l640t730r713b813],
26	,	,	O	,	_	0	SENT_105	[p11l640t730r713b813],
27	and	CC	O	and	_	0	SENT_105	[p11l751t725r893b797],
28	61	CD	NUMBER	61	conj_and	15	SENT_105	[p11l933t730r1020b797],
29	in	IN	O	in	_	0	SENT_105	[p11l1065t729r1136b796],
30	group	NN	O	group	nn	32	SENT_105	[p11l1174t752r1401b817],
31	C	NN	O	c	nn	32	SENT_105	[p11l1442t729r1552b813],
32	)	NN	O	)	prep_in	28	SENT_105	[p11l1442t729r1552b813],
33	.	.	O	.	_	0	SENT_105	[p11l1442t729r1552b813],

1	Three	CD	NUMBER	three	num	2	SENT_106	[p11l1586t725r1809b797],
2	patients	NNS	O	patient	nsubj	3	SENT_106	[p11l1847t729r2149b817],
3	discontinued	VBN	O	discontinue	_	0	SENT_106	[p11l9t841r499b913],
4	treatment	NN	O	treatment	nsubj	5	SENT_106	[p11l521t861r892b913],
5	due	JJ	O	due	xcomp	3	SENT_106	[p11l916t841r1050b913],
6	to	TO	O	to	_	0	SENT_106	[p11l1073t861r1148b913],
7	adverse	JJ	O	adverse	amod	8	SENT_106	[p11l1174t841r1458b913],
8	events	NNS	O	event	prep_to	5	SENT_106	[p11l1482t861r1739b930],
9	,	,	O	,	_	0	SENT_106	[p11l1482t861r1739b930],
10	1	CD	NUMBER	1	dep	17	SENT_106	[p11l1767t846r1800b912],
11	in	IN	O	in	_	0	SENT_106	[p11l1831t846r1901b912],
12	group	NN	O	group	nn	13	SENT_106	[p11l1924t869r2150b933],
13	A	NN	O	a	prep_in	10	SENT_106	[p11l7t961r71b1028],
14	(	CD	NUMBER	(	num	17	SENT_106	[p11l99t958r281b1046],
15	skin	NN	O	skin	nn	17	SENT_106	[p11l99t958r281b1046],
16	rash	NN	O	rash	nn	17	SENT_106	[p11l305t958r493b1046],
17	)	NN	O	)	conj_and	3	SENT_106	[p11l305t958r493b1046],
18	and	CC	O	and	_	0	SENT_106	[p11l523t958r665b1030],
19	2	CD	NUMBER	2	dep	25	SENT_106	[p11l688t963r734b1028],
20	in	IN	O	in	_	0	SENT_106	[p11l760t962r832b1028],
21	group	NN	O	group	nn	22	SENT_106	[p11l855t985r1082b1049],
22	B	NN	O	b	prep_in	19	SENT_106	[p11l1108t963r1159b1028],
23	(	CD	NUMBER	(	num	25	SENT_106	[p11l1189t958r1602b1046],
24	dizziness	NN	O	dizziness	nn	25	SENT_106	[p11l1189t958r1602b1046],
25	)	NN	O	)	conj_and	3	SENT_106	[p11l1189t958r1602b1046],
26	.	.	O	.	_	0	SENT_106	[p11l1189t958r1602b1046],

1	Thus	RB	O	thus	advmod	8	SENT_107	[p11l1622t958r1839b1046],
2	,	,	O	,	_	0	SENT_107	[p11l1622t958r1839b1046],
3	the	DT	O	the	det	4	SENT_107	[p11l1861t958r1978b1030],
4	ITT	NNP	ORGANIZATION	ITT	nsubj	8	SENT_107	[p11l2003t961r2151b1028],
5	and	CC	O	and	_	0	SENT_107	[p11l9t1073r151b1145],
6	PP	NN	O	pp	nn	7	SENT_107	[p11l179t1078r276b1144],
7	analyses	NNS	O	analysis	conj_and	4	SENT_107	[p11l306t1073r621b1165],
8	included	VBD	O	include	_	0	SENT_107	[p11l652t1073r980b1145],
9	184	CD	NUMBER	184	num	12	SENT_107	[p11l1014t1078r1154b1145],
10	and	CC	O	and	_	0	SENT_107	[p11l1185t1073r1326b1145],
11	181	CD	NUMBER	181	num	12	SENT_107	[p11l1361t1078r1496b1145],
12	patients	NNS	O	patient	dobj	8	SENT_107	[p11l1530t1077r1856b1165],
13	,	,	O	,	_	0	SENT_107	[p11l1530t1077r1856b1165],
14	respectively	RB	O	respectively	advmod	8	SENT_107	[p11l1883t1100r2149b1165, p11l7t1189r227b1281],
15	.	.	O	.	_	0	SENT_107	[p11l1883t1100r2149b1165, p11l7t1189r227b1281],

1	Overall	RB	O	overall	advmod	4	SENT_108	[p11l261t1189r569b1278],
2	,	,	O	,	_	0	SENT_108	[p11l261t1189r569b1278],
3	there	EX	O	there	expl	4	SENT_108	[p11l598t1189r790b1261],
4	were	VBD	O	be	_	0	SENT_108	[p11l820t1217r1003b1261],
5	no	DT	O	no	det	7	SENT_108	[p11l1034t1217r1130b1261],
6	significant	JJ	O	significant	amod	7	SENT_108	[p11l1164t1189r1560b1281],
7	differences	NNS	O	difference	nsubj	4	SENT_108	[p11l1591t1189r2001b1261],
8	between	IN	O	between	_	0	SENT_108	[p11l2035t1189r2149b1261, p11l7t1326r237b1378],
9	groups	NNS	O	group	prep_between	7	SENT_108	[p11l263t1333r526b1397],
10	in	IN	O	in	_	0	SENT_108	[p11l554t1310r626b1376],
11	such	JJ	O	such	amod	13	SENT_108	[p11l654t1306r826b1378],
12	clinical	JJ	O	clinical	amod	13	SENT_108	[p11l853t1306r1124b1378],
13	characteristics	NNS	O	characteristic	prep_in	9	SENT_108	[p11l1152t1306r1698b1378],
14	as	IN	O	as	_	0	SENT_108	[p11l1728t1334r1802b1378],
15	age	NN	O	age	prep_as	13	SENT_108	[p11l1832t1334r1981b1397],
16	,	,	O	,	_	0	SENT_108	[p11l1832t1334r1981b1397],
17	sex	NN	O	sex	conj_and	15	SENT_108	[p11l2008t1334r2151b1394],
18	,	,	O	,	_	0	SENT_108	[p11l2008t1334r2151b1394],
19	endoscopic	JJ	O	endoscopic	amod	20	SENT_108	[p11l9t1421r437b1513],
20	diagnosis	NN	O	diagnosis	conj_and	15	SENT_108	[p11l468t1421r848b1513],
21	,	,	O	,	_	0	SENT_108	[p11l468t1421r848b1513],
22	and	CC	O	and	_	0	SENT_108	[p11l877t1421r1019b1493],
23	history	NN	O	history	prep_as	13	SENT_108	[p11l1048t1421r1317b1512],
24	of	IN	O	of	_	0	SENT_108	[p11l1347t1421r1427b1493],
25	smoking	NN	O	smoking	nn	27	SENT_108	[p11l1453t1421r1781b1513],
26	(	CD	NUMBER	(	num	27	SENT_108	[p11l1815t1425r1923b1509],
27	ie	NN	O	ie	prep_of	23	SENT_108	[p11l1815t1425r1923b1509],
28	,	,	O	,	_	0	SENT_108	[p11l1815t1425r1923b1509],
29	more	JJR	O	more	mwe	30	SENT_108	[p11l1952t1449r2150b1493],
30	than	IN	O	than	quantmod	31	SENT_108	[p11l7t1537r181b1609],
31	one	CD	NUMBER	one	num	32	SENT_108	[p11l211t1566r346b1609],
32	pack	NN	O	pack	nsubj	39	SENT_108	[p11l374t1537r558b1629],
33	of	IN	O	of	_	0	SENT_108	[p11l588t1537r668b1609],
34	cigarettes	NNS	O	cigarette	prep_of	32	SENT_108	[p11l692t1542r1053b1629],
35	per	IN	O	per	_	0	SENT_108	[p11l1082t1565r1205b1629],
36	week36	NN	O	week36	prep_per	34	SENT_108	[p11l1231t1535r1527b1626],
37	)	CD	NUMBER	)	number	38	SENT_108	[p11l1231t1535r1527b1626],
38	(	CD	NUMBER	(	num	39	SENT_108	[p11l1565t1537r1805b1626],
39	Table	NNP	O	Table	xcomp	4	SENT_108	[p11l1565t1537r1805b1626],
40	I	PRP	O	I	nsubj	41	SENT_108	[p11l1832t1542r1910b1626],
41	)	VBP	O	)	rcmod	39	SENT_108	[p11l1832t1542r1910b1626],
42	.	.	O	.	_	0	SENT_108	[p11l1832t1542r1910b1626],

1	Eradication	NN	O	eradication	_	0	SENT_109	[p11l14t1776r500b1849],
2	of	IN	O	of	_	0	SENT_109	[p11l539t1777r635b1849],
3	H	NN	O	h	nn	5	SENT_109	[p11l659t1783r732b1848],
4	pylori	NN	O	pylorus	nn	5	SENT_109	[p11l756t1777r987b1875],
5	Infection	NN	O	infection	prep_of	1	SENT_109	[p11l1022t1776r1393b1849],

1	H	NN	O	h	nn	3	SENT_110	[p11l118t1899r197b1964],
2	pylori	NN	O	pylorus	nn	3	SENT_110	[p11l228t1893r462b1985],
3	infection	NN	O	infection	nsubjpass	5	SENT_110	[p11l500t1893r844b1965],
4	was	VBD	O	be	auxpass	5	SENT_110	[p11l882t1921r1032b1965],
5	eradicated	VBN	O	eradicate	_	0	SENT_110	[p11l1073t1893r1479b1965],
6	in	IN	O	in	_	0	SENT_110	[p11l1518t1898r1591b1964],
7	152	CD	NUMBER	152	num	8	SENT_110	[p11l1636t1898r1778b1965],
8	patients	NNS	O	patient	prep_in	5	SENT_110	[p11l1818t1898r2149b1985],
9	.	.	O	.	_	0	SENT_110	[p11l1818t1898r2149b1985],

1	Rates	NNS	O	rate	nsubj	12	SENT_111	[p11l9t2015r218b2082],
2	of	IN	O	of	_	0	SENT_111	[p11l245t2009r325b2082],
3	eradication	NN	O	eradication	prep_of	1	SENT_111	[p11l344t2009r775b2082],
4	in	IN	O	in	_	0	SENT_111	[p11l799t2014r870b2080],
5	the	DT	O	the	det	9	SENT_111	[p11l893t2010r1009b2082],
6	ITT	NNP	ORGANIZATION	ITT	nn	9	SENT_111	[p11l1033t2013r1181b2080],
7	and	CC	O	and	_	0	SENT_111	[p11l1205t2010r1345b2082],
8	PP	NNP	O	PP	nn	9	SENT_111	[p11l1368t2015r1465b2080],
9	populations	NNS	O	population	prep_in	3	SENT_111	[p11l1488t2010r1945b2101],
10	were	VBD	O	be	cop	12	SENT_111	[p11l1968t2038r2151b2082],
11	82.6	CD	PERCENT	82.6	num	12	SENT_111	[p11l13t2134r269b2203],
12	%	NN	PERCENT	%	_	0	SENT_111	[p11l13t2134r269b2203],
13	(	CD	PERCENT	(	num	16	SENT_111	[p11l311t2134r521b2218],
14	95	CD	PERCENT	95	number	15	SENT_111	[p11l311t2134r521b2218],
15	%	NN	PERCENT	%	amod	16	SENT_111	[p11l311t2134r521b2218],
16	CI	NN	O	ci	attr	12	SENT_111	[p11l561t2134r675b2218],
17	,	,	O	,	_	0	SENT_111	[p11l561t2134r675b2218],
18	76.18	CD	PERCENT	76.18	num	19	SENT_111	[p11l707t2134r1420b2218],
19	%	NN	PERCENT	%	appos	16	SENT_111	[p11l707t2134r1420b2218],
20	.	.	O	.	_	0	SENT_111	[p11l707t2134r1420b2218],

1	—	NN	O	—	_	0	SENT_112	[p11l707t2134r1420b2218],
2	.	.	O	.	_	0	SENT_112	[p11l707t2134r1420b2218],

1	87.64	CD	PERCENT	87.64	num	2	SENT_113	[p11l707t2134r1420b2218],
2	%	NN	PERCENT	%	_	0	SENT_113	[p11l707t2134r1420b2218],
3	)	CD	NUMBER	)	dep	2	SENT_113	[p11l707t2134r1420b2218],
4	and	CC	O	and	_	0	SENT_113	[p11l1457t2130r1600b2202],
5	84.0	CD	PERCENT	84.0	num	6	SENT_113	[p11l1635t2134r1891b2203],
6	%	NN	PERCENT	%	dep	2	SENT_113	[p11l1635t2134r1891b2203],
7	(	CD	PERCENT	(	num	10	SENT_113	[p11l1933t2134r2143b2218],
8	95	CD	PERCENT	95	number	9	SENT_113	[p11l1933t2134r2143b2218],
9	%	NN	PERCENT	%	amod	10	SENT_113	[p11l1933t2134r2143b2218],
10	CI	NN	O	ci	dep	2	SENT_113	[p11l11t2250r124b2335],
11	,	,	O	,	_	0	SENT_113	[p11l11t2250r124b2335],
12	77.63	CD	PERCENT	77.63	num	13	SENT_113	[p11l151t2251r369b2318],
13	%	NN	PERCENT	%	appos	10	SENT_113	[p11l385t2250r890b2335],
14	.	.	O	.	_	0	SENT_113	[p11l385t2250r890b2335],

1	—	NN	O	—	_	0	SENT_114	[p11l385t2250r890b2335],
2	.	.	O	.	_	0	SENT_114	[p11l385t2250r890b2335],

1	88.84	CD	PERCENT	88.84	num	2	SENT_115	[p11l385t2250r890b2335],
2	%	NN	PERCENT	%	_	0	SENT_115	[p11l385t2250r890b2335],
3	)	CD	NUMBER	)	dep	2	SENT_115	[p11l385t2250r890b2335],
4	,	,	O	,	_	0	SENT_115	[p11l385t2250r890b2335],
5	respectively	RB	O	respectively	advmod	3	SENT_115	[p11l913t2246r1382b2338],
6	.	.	O	.	_	0	SENT_115	[p11l913t2246r1382b2338],

1	In	IN	O	in	_	0	SENT_116	[p11l1408t2252r1485b2317],
2	groups	NNS	O	group	prep_in	17	SENT_116	[p11l1510t2274r1776b2338],
3	A	DT	O	a	amod	2	SENT_116	[p11l1798t2249r1884b2334],
4	,	,	O	,	_	0	SENT_116	[p11l1798t2249r1884b2334],
5	B	NN	O	b	dep	3	SENT_116	[p11l1909t2252r1983b2334],
6	,	,	O	,	_	0	SENT_116	[p11l1909t2252r1983b2334],
7	and	CC	O	and	_	0	SENT_116	[p11l2008t2246r2151b2318],
8	C	NN	O	c	conj_and	2	SENT_116	[p11l11t2367r94b2451],
9	,	,	O	,	_	0	SENT_116	[p11l11t2367r94b2451],
10	the	DT	O	the	det	12	SENT_116	[p11l122t2363r241b2435],
11	corresponding	JJ	O	corresponding	amod	12	SENT_116	[p11l272t2363r839b2454],
12	rates	NNS	O	rate	nsubj	17	SENT_116	[p11l868t2383r1053b2435],
13	of	IN	O	of	_	0	SENT_116	[p11l1086t2362r1167b2435],
14	eradication	NN	O	eradication	prep_of	12	SENT_116	[p11l1194t2363r1636b2435],
15	were	VBD	O	be	cop	17	SENT_116	[p11l1664t2391r1850b2435],
16	85.2	CD	PERCENT	85.2	num	17	SENT_116	[p11l1887t2367r2143b2435],
17	%	NN	PERCENT	%	_	0	SENT_116	[p11l1887t2367r2143b2435],

1	(	NN	O	(	_	0	SENT_117	[p11l14t2736r291b2820],
2	52/61	CD	NUMBER	52/61	num	3	SENT_117	[p11l14t2736r291b2820],
3	)	NN	O	)	dep	1	SENT_117	[p11l14t2736r291b2820],
4	and	CC	O	and	_	0	SENT_117	[p11l322t2732r464b2804],
5	86.7	CD	PERCENT	86.7	num	6	SENT_117	[p11l494t2736r749b2805],
6	%	NN	PERCENT	%	dep	1	SENT_117	[p11l494t2736r749b2805],
7	(	CD	NUMBER	(	number	8	SENT_117	[p11l785t2736r1090b2820],
8	52/60	CD	NUMBER	52/60	num	9	SENT_117	[p11l785t2736r1090b2820],
9	)	NN	O	)	dep	1	SENT_117	[p11l785t2736r1090b2820],
10	,	,	O	,	_	0	SENT_117	[p11l785t2736r1090b2820],
11	87.1	CD	PERCENT	87.1	num	12	SENT_117	[p11l1118t2736r1373b2805],
12	%	NN	PERCENT	%	appos	9	SENT_117	[p11l1118t2736r1373b2805],
13	(	CD	NUMBER	(	number	14	SENT_117	[p11l1409t2736r1686b2820],
14	54/62	CD	NUMBER	54/62	num	12	SENT_117	[p11l1409t2736r1686b2820],
15	)	NN	O	)	dep	1	SENT_117	[p11l1409t2736r1686b2820],
16	and	CC	O	and	_	0	SENT_117	[p11l1717t2732r1860b2804],
17	90.0	CD	PERCENT	90.0	num	18	SENT_117	[p11l1886t2736r2144b2805],
18	%	NN	PERCENT	%	dep	1	SENT_117	[p11l1886t2736r2144b2805],
19	(	CD	NUMBER	(	number	20	SENT_117	[p11l14t2855r301b2939],
20	54/60	CD	NUMBER	54/60	num	21	SENT_117	[p11l14t2855r301b2939],
21	)	NN	O	)	dep	1	SENT_117	[p11l14t2855r301b2939],
22	,	,	O	,	_	0	SENT_117	[p11l14t2855r301b2939],
23	and	CC	O	and	_	0	SENT_117	[p11l324t2851r462b2923],
24	75.4	CD	PERCENT	75.4	num	25	SENT_117	[p11l487t2855r734b2924],
25	%	NN	PERCENT	%	conj_and	21	SENT_117	[p11l487t2855r734b2924],
26	(	CD	NUMBER	(	number	27	SENT_117	[p11l768t2855r1030b2939],
27	46/61	CD	NUMBER	46/61	num	25	SENT_117	[p11l768t2855r1030b2939],
28	)	NN	O	)	dep	1	SENT_117	[p11l768t2855r1030b2939],
29	and	CC	O	and	_	0	SENT_117	[p11l1058t2851r1196b2923],
30	75.4	CD	PERCENT	75.4	num	31	SENT_117	[p11l1221t2855r1468b2924],
31	%	NN	PERCENT	%	dep	1	SENT_117	[p11l1221t2855r1468b2924],
32	(	CD	NUMBER	(	number	33	SENT_117	[p11l1502t2855r1765b2939],
33	46/61	CD	NUMBER	46/61	num	34	SENT_117	[p11l1502t2855r1765b2939],
34	)	NN	O	)	dep	1	SENT_117	[p11l1502t2855r1765b2939],
35	(	CD	NUMBER	(	num	38	SENT_117	[p11l1796t2851r2027b2939],
36	Table	NNP	O	Table	nn	38	SENT_117	[p11l1796t2851r2027b2939],
37	II	NNP	O	II	nn	38	SENT_117	[p11l2047t2855r2150b2939],
38	)	NN	O	)	dep	34	SENT_117	[p11l2047t2855r2150b2939],
39	.	.	O	.	_	0	SENT_117	[p11l2047t2855r2150b2939],

1	There	EX	O	there	expl	2	SENT_118	[p11l8t2971r235b3043],
2	was	VBD	O	be	_	0	SENT_118	[p11l259t2999r409b3043],
3	no	DT	O	no	det	5	SENT_118	[p11l435t2999r532b3043],
4	significant	JJ	O	significant	amod	5	SENT_118	[p11l560t2971r966b3063],
5	difference	NN	O	difference	nsubj	2	SENT_118	[p11l992t2971r1376b3043],
6	in	IN	O	in	_	0	SENT_118	[p11l1401t2976r1474b3042],
7	eradication	NN	O	eradication	nn	8	SENT_118	[p11l1499t2971r1941b3043],
8	rates	NNS	O	rate	prep_in	5	SENT_118	[p11l1966t2991r2151b3043],
9	among	IN	O	among	_	0	SENT_118	[p11l10t3120r277b3183],
10	the	DT	O	the	det	12	SENT_118	[p11l306t3091r425b3164],
11	3	CD	NUMBER	3	num	12	SENT_118	[p11l459t3097r498b3164],
12	groups	NNS	O	group	prep_among	8	SENT_118	[p11l533t3119r823b3183],
13	.	.	O	.	_	0	SENT_118	[p11l533t3119r823b3183],

1	Adverse	JJ	O	adverse	amod	2	SENT_119	[p11l7t3331r352b3404],
2	Events	NNS	O	event	_	0	SENT_119	[p11l392t3337r668b3404],
3	and	CC	O	and	_	0	SENT_119	[p11l705t3331r859b3403],
4	Compliance	NN	O	compliance	conj_and	2	SENT_119	[p11l898t3331r1401b3429],

1	Adverse	JJ	O	adverse	amod	2	SENT_120	[p11l119t3448r422b3520],
2	events	NNS	O	event	nsubjpass	4	SENT_120	[p11l447t3468r678b3520],
3	were	VBD	O	be	auxpass	4	SENT_120	[p11l701t3476r882b3520],
4	reported	VBN	O	report	_	0	SENT_120	[p11l906t3448r1228b3539],
5	in	IN	O	in	_	0	SENT_120	[p11l1252t3452r1323b3518],
6	15	CD	PERCENT	15	number	7	SENT_120	[p11l1352t3453r1438b3520],
7	(	CD	PERCENT	(	prep_in	4	SENT_120	[p11l1470t3452r1730b3536],
8	7.6	CD	PERCENT	7.6	number	9	SENT_120	[p11l1470t3452r1730b3536],
9	%	NN	PERCENT	%	amod	7	SENT_120	[p11l1470t3452r1730b3536],
10	)	CD	NUMBER	)	dobj	4	SENT_120	[p11l1470t3452r1730b3536],
11	of	IN	O	of	_	0	SENT_120	[p11l1760t3447r1839b3520],
12	184	CD	NUMBER	184	num	13	SENT_120	[p11l1863t3452r2001b3520],
13	patients	NNS	O	patient	prep_of	10	SENT_120	[p11l2026t3475r2150b3539, p11l8t3567r241b3635],
14	:	:	O	:	_	0	SENT_120	[p11l2026t3475r2150b3539, p11l8t3567r241b3635],
15	5	CD	PERCENT	5	number	16	SENT_120	[p11l272t3569r313b3635],
16	(	CD	PERCENT	(	dep	13	SENT_120	[p11l346t3567r614b3651],
17	8.2	CD	PERCENT	8.2	num	18	SENT_120	[p11l346t3567r614b3651],
18	%	NN	PERCENT	%	dep	32	SENT_120	[p11l346t3567r614b3651],
19	)	CD	NUMBER	)	dep	18	SENT_120	[p11l346t3567r614b3651],
20	of	IN	O	of	_	0	SENT_120	[p11l645t3563r726b3635],
21	the	DT	O	the	det	23	SENT_120	[p11l745t3563r863b3635],
22	61	CD	NUMBER	61	num	23	SENT_120	[p11l892t3568r980b3635],
23	patients	NNS	O	patient	prep_of	19	SENT_120	[p11l1011t3567r1318b3655],
24	in	IN	O	in	_	0	SENT_120	[p11l1345t3567r1417b3634],
25	group	NN	O	group	nn	26	SENT_120	[p11l1441t3590r1671b3655],
26	A	NN	O	a	prep_in	23	SENT_120	[p11l1693t3566r1780b3651],
27	,	,	O	,	_	0	SENT_120	[p11l1693t3566r1780b3651],
28	6	CD	PERCENT	6	num	29	SENT_120	[p11l1806t3568r1849b3635],
29	(	NN	PERCENT	(	appos	26	SENT_120	[p11l1880t3567r2148b3651],
30	9.7	CD	PERCENT	9.7	num	31	SENT_120	[p11l1880t3567r2148b3651],
31	%	NN	PERCENT	%	dep	32	SENT_120	[p11l1880t3567r2148b3651],
32	)	CD	NUMBER	)	dep	45	SENT_120	[p11l1880t3567r2148b3651],
33	of	IN	O	of	_	0	SENT_120	[p11l10t3679r92b3751],
34	the	DT	O	the	det	36	SENT_120	[p11l130t3679r249b3751],
35	62	CD	NUMBER	62	num	36	SENT_120	[p11l297t3684r391b3751],
36	patients	NNS	O	patient	prep_of	32	SENT_120	[p11l436t3684r747b3771],
37	in	IN	O	in	_	0	SENT_120	[p11l792t3684r865b3750],
38	group	NN	O	group	nn	39	SENT_120	[p11l908t3707r1141b3771],
39	B	NN	O	b	prep_in	36	SENT_120	[p11l1186t3685r1262b3768],
40	,	,	O	,	_	0	SENT_120	[p11l1186t3685r1262b3768],
41	and	CC	O	and	_	0	SENT_120	[p11l1306t3679r1449b3751],
42	4	CD	PERCENT	4	number	43	SENT_120	[p11l1493t3684r1538b3750],
43	(	CD	PERCENT	(	conj_and	36	SENT_120	[p11l1589t3683r1859b3768],
44	6.6	CD	PERCENT	6.6	num	45	SENT_120	[p11l1589t3683r1859b3768],
45	%	NN	PERCENT	%	dep	46	SENT_120	[p11l1589t3683r1859b3768],
46	)	CD	NUMBER	)	dep	13	SENT_120	[p11l1589t3683r1859b3768],
47	of	IN	O	of	_	0	SENT_120	[p11l1909t3679r1991b3751],
48	the	DT	O	the	prep_of	13	SENT_120	[p11l2029t3679r2148b3751],

1	61	CD	NUMBER	61	num	2	SENT_121	[p12l12t24r98b91],
2	patients	NNS	O	patient	_	0	SENT_121	[p12l129t23r430b110],
3	in	IN	O	in	_	0	SENT_121	[p12l455t23r527b89],
4	group	NN	O	group	prep_in	2	SENT_121	[p12l550t46r776b110],
5	C	NN	O	c	prep	2	SENT_121	[p12l804t23r862b91],
6	(	CD	NUMBER	(	num	9	SENT_121	[p12l892t19r1131b107],
7	Table	NNP	O	Table	nn	9	SENT_121	[p12l892t19r1131b107],
8	III	NNP	O	III	nn	9	SENT_121	[p12l1153t23r1291b107],
9	)	NN	O	)	dep	5	SENT_121	[p12l1153t23r1291b107],
10	.	.	O	.	_	0	SENT_121	[p12l1153t23r1291b107],

1	The	DT	O	the	det	4	SENT_122	[p12l1311t19r1458b91],
2	15	CD	NUMBER	15	num	4	SENT_122	[p12l1489t24r1576b91],
3	adverse	JJ	O	adverse	amod	4	SENT_122	[p12l1604t18r1889b91],
4	events	NNS	O	event	nsubj	7	SENT_122	[p12l1914t39r2150b91],
5	were	VBD	O	be	cop	7	SENT_122	[p12l8t162r190b206],
6	diarrhea	NN	O	diarrhea	nn	7	SENT_122	[p12l216t134r536b206],
7	(	NN	O	(	_	0	SENT_122	[p12l565t138r634b222],
8	6	CD	NUMBER	6	num	9	SENT_122	[p12l565t138r634b222],
9	patients	NNS	O	patient	tmod	7	SENT_122	[p12l659t138r1014b226],
10	)	RB	O	)	advmod	9	SENT_122	[p12l659t138r1014b226],
11	,	,	O	,	_	0	SENT_122	[p12l659t138r1014b226],
12	dizziness	NN	O	dizziness	nn	13	SENT_122	[p12l1037t134r1371b206],
13	(	NN	O	(	conj_and	7	SENT_122	[p12l1401t138r1525b222],
14	5	CD	NUMBER	5	num	15	SENT_122	[p12l1401t138r1525b222],
15	)	NN	O	)	dep	13	SENT_122	[p12l1401t138r1525b222],
16	,	,	O	,	_	0	SENT_122	[p12l1401t138r1525b222],
17	abdominal	JJ	O	abdominal	amod	19	SENT_122	[p12l1549t134r1960b206],
18	pain	NN	O	pain	nn	19	SENT_122	[p12l1983t138r2151b226],
19	(	NN	O	(	conj_and	7	SENT_122	[p12l14t255r136b339],
20	2	CD	NUMBER	2	num	21	SENT_122	[p12l14t255r136b339],
21	)	NN	O	)	dep	19	SENT_122	[p12l14t255r136b339],
22	,	,	O	,	_	0	SENT_122	[p12l14t255r136b339],
23	nausea	NN	O	nausea	nn	24	SENT_122	[p12l159t278r417b322],
24	(	NN	O	(	conj_and	7	SENT_122	[p12l448t255r569b339],
25	1	CD	NUMBER	1	num	26	SENT_122	[p12l448t255r569b339],
26	)	NN	O	)	dep	24	SENT_122	[p12l448t255r569b339],
27	,	,	O	,	_	0	SENT_122	[p12l448t255r569b339],
28	and	CC	O	and	_	0	SENT_122	[p12l594t250r734b322],
29	skin	NN	O	skin	nn	31	SENT_122	[p12l761t250r913b322],
30	rash	NN	O	rash	nn	31	SENT_122	[p12l938t250r1098b322],
31	(	NN	O	(	conj_and	7	SENT_122	[p12l1128t255r1247b339],
32	1	CD	NUMBER	1	num	33	SENT_122	[p12l1128t255r1247b339],
33	)	NN	O	)	dep	31	SENT_122	[p12l1128t255r1247b339],
34	.	.	O	.	_	0	SENT_122	[p12l1128t255r1247b339],

1	One	CD	NUMBER	one	num	2	SENT_123	[p12l1276t254r1434b322],
2	patient	NN	O	patient	nsubj	20	SENT_123	[p12l1459t255r1722b342],
3	in	IN	O	in	_	0	SENT_123	[p12l1747t255r1818b321],
4	group	NN	O	group	prep_in	2	SENT_123	[p12l1842t278r2065b342],
5	A	DT	O	a	det	7	SENT_123	[p12l2087t253r2152b321],
6	discontinued	JJ	O	discontinued	amod	7	SENT_123	[p12l10t366r498b439],
7	treatment	NN	O	treatment	dep	4	SENT_123	[p12l520t387r891b439],
8	due	JJ	O	due	amod	7	SENT_123	[p12l914t367r1048b439],
9	to	TO	O	to	_	0	SENT_123	[p12l1071t387r1147b439],
10	a	DT	O	a	det	12	SENT_123	[p12l1172t395r1211b439],
11	skin	NN	O	skin	nn	12	SENT_123	[p12l1236t367r1391b439],
12	rash	NN	O	rash	prep_to	8	SENT_123	[p12l1413t367r1596b455],
13	,	,	O	,	_	0	SENT_123	[p12l1413t367r1596b455],
14	and	CC	O	and	_	0	SENT_123	[p12l1619t367r1759b439],
15	2	CD	NUMBER	2	num	16	SENT_123	[p12l1781t372r1827b437],
16	patients	NNS	O	patient	conj_and	4	SENT_123	[p12l1850t371r2149b458],
17	in	IN	O	in	_	0	SENT_123	[p12l9t486r80b553],
18	group	NN	O	group	nn	19	SENT_123	[p12l104t509r335b574],
19	B	NN	O	b	prep_in	16	SENT_123	[p12l361t487r412b553],
20	discontinued	VBN	O	discontinue	_	0	SENT_123	[p12l439t482r940b554],
21	treatment	NN	O	treatment	nsubj	22	SENT_123	[p12l964t502r1345b554],
22	due	JJ	O	due	xcomp	20	SENT_123	[p12l1371t482r1508b554],
23	to	TO	O	to	_	0	SENT_123	[p12l1532t502r1609b554],
24	dizziness	NN	O	dizziness	prep_to	22	SENT_123	[p12l1637t482r2001b554],
25	.	.	O	.	_	0	SENT_123	[p12l1637t482r2001b554],

1	No	DT	O	no	det	4	SENT_124	[p12l2025t487r2149b554],
2	serious	JJ	O	serious	amod	4	SENT_124	[p12l10t603r281b670],
3	adverse	JJ	O	adverse	amod	4	SENT_124	[p12l323t598r614b670],
4	events	NNS	O	event	nsubj	7	SENT_124	[p12l655t618r895b670],
5	or	CC	O	or	_	0	SENT_124	[p12l937t626r1019b670],
6	deaths	NNS	O	death	nsubj	7	SENT_124	[p12l1060t598r1309b670],
7	occurred	VBD	O	occur	_	0	SENT_124	[p12l1351t598r1695b670],
8	during	IN	O	during	_	0	SENT_124	[p12l1736t598r1992b690],
9	the	DT	O	the	det	10	SENT_124	[p12l2031t598r2150b670],
10	study	NN	O	study	prep_during	7	SENT_124	[p12l10t715r233b806],
11	.	.	O	.	_	0	SENT_124	[p12l10t715r233b806],

1	Rates	NNS	O	rate	nsubj	14	SENT_125	[p12l121t836r336b903],
2	of	IN	O	of	_	0	SENT_125	[p12l382t831r464b903],
3	compliance	NN	O	compliance	prep_of	1	SENT_125	[p12l503t831r953b923],
4	in	IN	O	in	_	0	SENT_125	[p12l997t835r1070b902],
5	groups	NNS	O	group	prep_in	3	SENT_125	[p12l1113t858r1382b923],
6	A	DT	O	a	amod	5	SENT_125	[p12l1422t834r1509b919],
7	,	,	O	,	_	0	SENT_125	[p12l1422t834r1509b919],
8	B	NN	O	b	dep	6	SENT_125	[p12l1552t836r1627b919],
9	,	,	O	,	_	0	SENT_125	[p12l1552t836r1627b919],
10	and	CC	O	and	_	0	SENT_125	[p12l1671t831r1815b903],
11	C	NN	O	c	conj_and	3	SENT_125	[p12l1861t835r1920b903],
12	were	VBD	O	be	cop	14	SENT_125	[p12l1963t859r2150b903],
13	98.4	CD	PERCENT	98.4	num	14	SENT_125	[p12l11t952r273b1022],
14	%	NN	PERCENT	%	_	0	SENT_125	[p12l11t952r273b1022],
15	(	CD	NUMBER	(	number	16	SENT_125	[p12l329t952r640b1037],
16	60/61	CD	NUMBER	60/61	num	17	SENT_125	[p12l329t952r640b1037],
17	)	NN	O	)	dep	14	SENT_125	[p12l329t952r640b1037],
18	,	,	O	,	_	0	SENT_125	[p12l329t952r640b1037],
19	96.8	CD	PERCENT	96.8	num	20	SENT_125	[p12l685t952r947b1022],
20	%	NN	PERCENT	%	conj_and	14	SENT_125	[p12l685t952r947b1022],
21	(	CD	NUMBER	(	number	22	SENT_125	[p12l1003t952r1315b1037],
22	60/62	CD	NUMBER	60/62	num	23	SENT_125	[p12l1003t952r1315b1037],
23	)	NN	O	)	dep	20	SENT_125	[p12l1003t952r1315b1037],
24	,	,	O	,	_	0	SENT_125	[p12l1003t952r1315b1037],
25	and	CC	O	and	_	0	SENT_125	[p12l1359t948r1504b1021],
26	100	CD	PERCENT	100	num	27	SENT_125	[p12l1553t952r1786b1022],
27	%	NN	PERCENT	%	conj_and	14	SENT_125	[p12l1553t952r1786b1022],
28	(	CD	NUMBER	(	number	29	SENT_125	[p12l1841t952r2152b1037],
29	61/61	CD	NUMBER	61/61	num	30	SENT_125	[p12l1841t952r2152b1037],
30	)	NN	O	)	dep	27	SENT_125	[p12l1841t952r2152b1037],
31	,	,	O	,	_	0	SENT_125	[p12l1841t952r2152b1037],
32	respectively	RB	O	respectively	advmod	14	SENT_125	[p12l9t1064r480b1156],
33	.	.	O	.	_	0	SENT_125	[p12l9t1064r480b1156],

1	Effect	NN	O	effect	_	0	SENT_126	[p12l15t1304r266b1376],
2	of	IN	O	of	_	0	SENT_126	[p12l298t1304r395b1376],
3	CYPZC	NNP	O	CYPZC	prep_of	1	SENT_126	[p12l420t1309r717b1376],
4	19	CD	NUMBER	19	num	3	SENT_126	[p12l726t1309r815b1378],
5	Genotype	NN	O	genotype	dep	1	SENT_126	[p12l850t1309r1269b1402],
6	on	IN	O	on	_	0	SENT_126	[p12l1304t1331r1407b1376],
7	Efficacy	NN	O	efficacy	prep_on	5	SENT_126	[p12l1451t1304r1792b1402],

1	Blood	NN	O	blood	nn	2	SENT_127	[p12l121t1420r348b1492],
2	samples	NNS	O	sample	nsubj	10	SENT_127	[p12l376t1420r676b1512],
3	for	IN	O	for	_	0	SENT_127	[p12l704t1420r816b1492],
4	determination	NN	O	determination	prep_for	2	SENT_127	[p12l843t1420r1386b1492],
5	of	IN	O	of	_	0	SENT_127	[p12l1413t1420r1494b1492],
6	CYP2	NN	O	cyp2	nn	8	SENT_127	[p12l1520t1425r1739b1492],
7	C19	NN	O	c19	nn	8	SENT_127	[p12l1752t1425r1909b1492],
8	genotype	NN	O	genotype	prep_of	4	SENT_127	[p12l1936t1449r2150b1512, p12l8t1556r173b1628],
9	were	VBD	O	be	cop	10	SENT_127	[p12l212t1564r398b1608],
10	available	JJ	O	available	_	0	SENT_127	[p12l440t1536r788b1608],
11	for	IN	O	for	_	0	SENT_127	[p12l828t1536r942b1608],
12	147	CD	NUMBER	147	num	13	SENT_127	[p12l987t1541r1132b1608],
13	patients	NNS	O	patient	prep_for	10	SENT_127	[p12l1169t1540r1477b1628],
14	(	IN	O	(	tmod	10	SENT_127	[p12l1523t1540r1670b1624],
15	47	CD	NUMBER	47	dep	14	SENT_127	[p12l1523t1540r1670b1624],
16	,	,	O	,	_	0	SENT_127	[p12l1523t1540r1670b1624],
17	46	CD	NUMBER	46	num	15	SENT_127	[p12l1708t1541r1830b1624],
18	,	,	O	,	_	0	SENT_127	[p12l1708t1541r1830b1624],
19	and	CC	NUMBER	and	_	0	SENT_127	[p12l1870t1536r2013b1608],
20	54	CD	NUMBER	54	dep	14	SENT_127	[p12l2054t1541r2149b1608],
21	in	IN	O	in	_	0	SENT_127	[p12l9t1657r82b1723],
22	groups	NNS	O	group	prep_in	15	SENT_127	[p12l113t1680r380b1744],
23	A	DT	O	a	dep	14	SENT_127	[p12l409t1655r495b1741],
24	,	,	O	,	_	0	SENT_127	[p12l409t1655r495b1741],
25	B	NN	O	b	conj_and	14	SENT_127	[p12l526t1658r601b1740],
26	,	,	O	,	_	0	SENT_127	[p12l526t1658r601b1740],
27	and	CC	O	and	_	0	SENT_127	[p12l633t1652r776b1724],
28	C	NN	O	c	conj_and	14	SENT_127	[p12l810t1656r893b1740],
29	,	,	O	,	_	0	SENT_127	[p12l810t1656r893b1740],
30	respectively	RB	O	respectively	advmod	14	SENT_127	[p12l923t1652r1436b1744],
31	)	CD	NUMBER	)	dep	14	SENT_127	[p12l923t1652r1436b1744],
32	;	:	O	;	_	0	SENT_127	[p12l923t1652r1436b1744],
33	samples	NNS	O	sample	nsubjpass	40	SENT_127	[p12l1471t1652r1777b1744],
34	from	IN	O	from	_	0	SENT_127	[p12l1810t1652r2001b1724],
35	the	DT	O	the	det	38	SENT_127	[p12l2032t1652r2150b1724],
36	remaining	VBG	O	remain	amod	38	SENT_127	[p12l9t1773r406b1860],
37	37	CD	NUMBER	37	num	38	SENT_127	[p12l447t1773r544b1840],
38	patients	NNS	O	patient	prep_from	33	SENT_127	[p12l581t1773r889b1860],
39	were	VBD	O	be	auxpass	40	SENT_127	[p12l928t1797r1114b1840],
40	damaged	VBN	O	damage	parataxis	10	SENT_127	[p12l1156t1768r1509b1860],
41	during	IN	O	during	_	0	SENT_127	[p12l1550t1768r1807b1860],
42	storage	NN	O	storage	prep_during	40	SENT_127	[p12l1847t1789r2150b1860],
43	.	.	O	.	_	0	SENT_127	[p12l1847t1789r2150b1860],

1	Based	VBN	O	base	_	0	SENT_128	[p12l10t1884r236b1956],
2	on	IN	O	on	prepc_based_on	12	SENT_128	[p12l265t1912r362b1956],
3	genotyping	NN	O	genotyping	pobj	12	SENT_128	[p12l390t1888r852b1976],
4	,	,	O	,	_	0	SENT_128	[p12l390t1888r852b1976],
5	50	CD	NUMBER	50	num	6	SENT_128	[p12l881t1889r975b1956],
6	patients	NNS	O	patient	nsubjpass	12	SENT_128	[p12l1004t1888r1313b1976],
7	(	IN	O	(	_	0	SENT_128	[p12l1347t1888r1667b1972],
8	34.0	CD	PERCENT	34.0	num	9	SENT_128	[p12l1347t1888r1667b1972],
9	%	NN	PERCENT	%	prep_(	6	SENT_128	[p12l1347t1888r1667b1972],
10	)	CD	NUMBER	)	dep	9	SENT_128	[p12l1347t1888r1667b1972],
11	were	VBD	O	be	auxpass	12	SENT_128	[p12l1699t1912r1885b1956],
12	classified	VBN	O	classify	_	0	SENT_128	[p12l1914t1884r2150b1956, p12l9t2001r149b2073],
13	as	IN	O	as	_	0	SENT_128	[p12l173t2030r246b2074],
14	HomEM	NNP	O	HomEM	prep_as	12	SENT_128	[p12l270t2007r634b2090],
15	,	,	O	,	_	0	SENT_128	[p12l270t2007r634b2090],
16	61	CD	PERCENT	61	number	17	SENT_128	[p12l659t2006r745b2074],
17	(	CD	PERCENT	(	appos	14	SENT_128	[p12l780t2005r1090b2090],
18	41.5	CD	PERCENT	41.5	num	19	SENT_128	[p12l780t2005r1090b2090],
19	%	NN	PERCENT	%	dep	17	SENT_128	[p12l780t2005r1090b2090],
20	)	CD	NUMBER	)	dep	14	SENT_128	[p12l780t2005r1090b2090],
21	as	IN	O	as	_	0	SENT_128	[p12l1119t2030r1193b2074],
22	HetEM	NN	O	hetem	prep_as	20	SENT_128	[p12l1217t2007r1525b2090],
23	,	,	O	,	_	0	SENT_128	[p12l1217t2007r1525b2090],
24	and	CC	O	and	_	0	SENT_128	[p12l1548t2001r1688b2074],
25	36	CD	PERCENT	36	number	26	SENT_128	[p12l1713t2006r1805b2074],
26	(	CD	PERCENT	(	prep_as	12	SENT_128	[p12l1834t2005r2144b2090],
27	24.5	CD	PERCENT	24.5	number	28	SENT_128	[p12l1834t2005r2144b2090],
28	%	NN	PERCENT	%	amod	26	SENT_128	[p12l1834t2005r2144b2090],
29	)	CD	NUMBER	)	npadvmod	26	SENT_128	[p12l1834t2005r2144b2090],
30	as	IN	O	as	_	0	SENT_128	[p12l10t2146r84b2189],
31	PM	NN	O	pm	prep_as	26	SENT_128	[p12l119t2123r276b2189],
32	.	.	O	.	_	0	SENT_128	[p12l119t2123r276b2189],

1	There	EX	O	there	expl	2	SENT_129	[p12l306t2117r526b2189],
2	were	VBD	O	be	_	0	SENT_129	[p12l559t2146r739b2189],
3	no	DT	O	no	det	5	SENT_129	[p12l774t2146r869b2189],
4	significant	JJ	O	significant	amod	5	SENT_129	[p12l905t2117r1293b2209],
5	differences	NNS	O	difference	nsubj	2	SENT_129	[p12l1327t2117r1728b2189],
6	in	IN	O	in	_	0	SENT_129	[p12l1764t2122r1834b2188],
7	the	DT	O	the	det	8	SENT_129	[p12l1867t2117r1982b2189],
8	distribution	NN	O	distribution	prep_in	5	SENT_129	[p12l2018t2117r2149b2189, p12l8t2233r345b2305],
9	of	IN	O	of	_	0	SENT_129	[p12l369t2233r448b2305],
10	CYP2C19	NN	O	cyp2c19	nn	11	SENT_129	[p12l472t2237r855b2305],
11	genotypes	NNS	O	genotype	prep_of	8	SENT_129	[p12l880t2253r1256b2325],
12	among	IN	O	among	_	0	SENT_129	[p12l1282t2261r1541b2325],
13	the	DT	O	the	det	15	SENT_129	[p12l1563t2233r1678b2305],
14	3	CD	NUMBER	3	num	15	SENT_129	[p12l1705t2238r1744b2305],
15	groups	NNS	O	group	prep_among	11	SENT_129	[p12l1772t2260r2051b2325],
16	.	.	O	.	_	0	SENT_129	[p12l1772t2260r2051b2325],

1	In	IN	O	in	_	0	SENT_130	[p12l2075t2238r2151b2304],
2	group	NN	O	group	nn	3	SENT_130	[p12l9t2377r232b2441],
3	A	NN	O	a	prep_in	24	SENT_130	[p12l255t2352r340b2437],
4	,	,	O	,	_	0	SENT_130	[p12l255t2352r340b2437],
5	16	CD	PERCENT	16	number	6	SENT_130	[p12l370t2354r459b2421],
6	(	CD	PERCENT	(	nsubj	24	SENT_130	[p12l491t2353r826b2438],
7	34.0	CD	PERCENT	34.0	num	8	SENT_130	[p12l491t2353r826b2438],
8	%	NN	PERCENT	%	dep	6	SENT_130	[p12l491t2353r826b2438],
9	)	CD	NUMBER	)	dep	6	SENT_130	[p12l491t2353r826b2438],
10	,	,	O	,	_	0	SENT_130	[p12l491t2353r826b2438],
11	21	CD	PERCENT	21	conj_and	6	SENT_130	[p12l851t2354r940b2420],
12	(	CD	PERCENT	(	number	13	SENT_130	[p12l978t2353r1313b2438],
13	44.7	CD	PERCENT	44.7	num	14	SENT_130	[p12l978t2353r1313b2438],
14	%	NN	PERCENT	%	dep	11	SENT_130	[p12l978t2353r1313b2438],
15	)	CD	NUMBER	)	dep	11	SENT_130	[p12l978t2353r1313b2438],
16	,	,	O	,	_	0	SENT_130	[p12l978t2353r1313b2438],
17	and	CC	O	and	_	0	SENT_130	[p12l1339t2349r1479b2421],
18	10	CD	PERCENT	10	number	19	SENT_130	[p12l1510t2354r1599b2421],
19	(	CD	PERCENT	(	conj_and	6	SENT_130	[p12l1631t2353r1940b2438],
20	21.3	CD	PERCENT	21.3	num	21	SENT_130	[p12l1631t2353r1940b2438],
21	%	NN	PERCENT	%	dep	19	SENT_130	[p12l1631t2353r1940b2438],
22	)	CD	NUMBER	)	dep	19	SENT_130	[p12l1631t2353r1940b2438],
23	were	VBD	O	be	cop	24	SENT_130	[p12l1970t2377r2150b2421],
24	HomEM	NNP	O	HomEM	_	0	SENT_130	[p12l9t2471r382b2554],
25	,	,	O	,	_	0	SENT_130	[p12l9t2471r382b2554],
26	HetEM	NNP	O	HetEM	conj_and	24	SENT_130	[p12l423t2471r739b2554],
27	,	,	O	,	_	0	SENT_130	[p12l423t2471r739b2554],
28	and	CC	O	and	_	0	SENT_130	[p12l781t2465r924b2537],
29	PM	NNP	O	PM	conj_and	24	SENT_130	[p12l965t2471r1128b2554],
30	,	,	O	,	_	0	SENT_130	[p12l965t2471r1128b2554],
31	respectively	RB	O	respectively	advmod	24	SENT_130	[p12l1168t2465r1644b2557],
32	;	:	O	;	_	0	SENT_130	[p12l1168t2465r1644b2557],
33	in	IN	O	in	_	0	SENT_130	[p12l1689t2470r1761b2536],
34	group	NN	O	group	nn	35	SENT_130	[p12l1802t2493r2032b2557],
35	B	NN	O	b	prep_in	41	SENT_130	[p12l2075t2471r2150b2554],
36	,	,	O	,	_	0	SENT_130	[p12l2075t2471r2150b2554],
37	the	DT	O	the	det	39	SENT_130	[p12l8t2581r121b2653],
38	corresponding	JJ	O	corresponding	amod	39	SENT_130	[p12l142t2581r675b2673],
39	numbers	NNS	O	number	nsubj	41	SENT_130	[p12l695t2581r1016b2653],
40	were	VBD	O	be	cop	41	SENT_130	[p12l1036t2609r1214b2653],
41	15	CD	PERCENT	15	conj_and	24	SENT_130	[p12l1241t2586r1326b2653],
42	(	CD	PERCENT	(	number	43	SENT_130	[p12l1355t2585r1683b2669],
43	32.6	CD	PERCENT	32.6	num	44	SENT_130	[p12l1355t2585r1683b2669],
44	%	NN	PERCENT	%	dep	41	SENT_130	[p12l1355t2585r1683b2669],
45	)	CD	NUMBER	)	dep	41	SENT_130	[p12l1355t2585r1683b2669],
46	,	,	O	,	_	0	SENT_130	[p12l1355t2585r1683b2669],
47	19	CD	PERCENT	19	conj_and	24	SENT_130	[p12l1709t2586r1795b2653],
48	(	CD	PERCENT	(	number	49	SENT_130	[p12l1823t2585r2151b2669],
49	41.3	CD	PERCENT	41.3	num	50	SENT_130	[p12l1823t2585r2151b2669],
50	%	NN	PERCENT	%	dep	47	SENT_130	[p12l1823t2585r2151b2669],
51	)	CD	NUMBER	)	dep	47	SENT_130	[p12l1823t2585r2151b2669],
52	,	,	O	,	_	0	SENT_130	[p12l1823t2585r2151b2669],
53	and	CC	O	and	_	0	SENT_130	[p12l10t2697r154b2769],
54	12	CD	PERCENT	12	number	55	SENT_130	[p12l201t2702r291b2768],
55	(	CD	PERCENT	(	conj_and	41	SENT_130	[p12l340t2701r685b2786],
56	26.1	CD	PERCENT	26.1	num	57	SENT_130	[p12l340t2701r685b2786],
57	%	NN	PERCENT	%	dep	55	SENT_130	[p12l340t2701r685b2786],
58	)	CD	NUMBER	)	dep	55	SENT_130	[p12l340t2701r685b2786],
59	;	:	O	;	_	0	SENT_130	[p12l340t2701r685b2786],
60	and	CC	O	and	_	0	SENT_130	[p12l731t2697r873b2769],
61	in	IN	O	in	_	0	SENT_130	[p12l915t2702r987b2768],
62	group	NN	O	group	nn	63	SENT_130	[p12l1028t2725r1258b2789],
63	C	NN	O	c	prep_in	68	SENT_130	[p12l1304t2701r1387b2785],
64	,	,	O	,	_	0	SENT_130	[p12l1304t2701r1387b2785],
65	the	DT	O	the	det	66	SENT_130	[p12l1427t2697r1545b2769],
66	numbers	NNS	O	number	nsubj	68	SENT_130	[p12l1587t2697r1923b2769],
67	were	VBD	O	be	cop	68	SENT_130	[p12l1965t2725r2151b2769],
68	19	CD	PERCENT	19	conj_and	24	SENT_130	[p12l15t2820r103b2887],
69	(	CD	PERCENT	(	number	70	SENT_130	[p12l141t2819r489b2903],
70	35.2	CD	PERCENT	35.2	num	71	SENT_130	[p12l141t2819r489b2903],
71	%	NN	PERCENT	%	dep	68	SENT_130	[p12l141t2819r489b2903],
72	)	CD	NUMBER	)	dep	68	SENT_130	[p12l141t2819r489b2903],
73	,	,	O	,	_	0	SENT_130	[p12l141t2819r489b2903],
74	21	CD	PERCENT	21	conj_and	68	SENT_130	[p12l517t2820r609b2886],
75	(	CD	PERCENT	(	number	76	SENT_130	[p12l652t2819r1000b2903],
76	38.9	CD	PERCENT	38.9	num	77	SENT_130	[p12l652t2819r1000b2903],
77	%	NN	PERCENT	%	dep	74	SENT_130	[p12l652t2819r1000b2903],
78	)	CD	NUMBER	)	dep	74	SENT_130	[p12l652t2819r1000b2903],
79	,	,	O	,	_	0	SENT_130	[p12l652t2819r1000b2903],
80	and	CC	O	and	_	0	SENT_130	[p12l1030t2815r1173b2887],
81	14	CD	PERCENT	14	number	82	SENT_130	[p12l1210t2819r1300b2886],
82	(	CD	PERCENT	(	conj_and	68	SENT_130	[p12l1337t2819r1683b2903],
83	25.9	CD	PERCENT	25.9	num	84	SENT_130	[p12l1337t2819r1683b2903],
84	%	NN	PERCENT	%	dep	82	SENT_130	[p12l1337t2819r1683b2903],
85	)	CD	NUMBER	)	dep	82	SENT_130	[p12l1337t2819r1683b2903],
86	.	.	O	.	_	0	SENT_130	[p12l1337t2819r1683b2903],

1	In	IN	O	in	_	0	SENT_131	[p12l120t2935r198b3001],
2	the	DT	O	the	det	4	SENT_131	[p12l236t2930r354b3002],
3	PP	NN	O	pp	nn	4	SENT_131	[p12l394t2935r492b3001],
4	population	NN	O	population	prep_in	20	SENT_131	[p12l530t2930r987b3022],
5	,	,	O	,	_	0	SENT_131	[p12l530t2930r987b3022],
6	eradication	NN	O	eradication	nn	7	SENT_131	[p12l1025t2930r1467b3002],
7	rates	NNS	O	rate	nsubj	20	SENT_131	[p12l1506t2950r1690b3002],
8	in	IN	O	in	_	0	SENT_131	[p12l1731t2934r1803b3001],
9	patients	NNS	O	patient	prep_in	7	SENT_131	[p12l1841t2934r2150b3022],
10	with	IN	O	with	_	0	SENT_131	[p12l8t3047r186b3120],
11	HomEM	NNP	O	HomEM	prep_with	9	SENT_131	[p12l229t3053r604b3136],
12	,	,	O	,	_	0	SENT_131	[p12l229t3053r604b3136],
13	HetEM	NNP	O	HetEM	prep_with	9	SENT_131	[p12l646t3053r965b3136],
14	,	,	O	,	_	0	SENT_131	[p12l646t3053r965b3136],
15	and	CC	O	and	_	0	SENT_131	[p12l1009t3047r1153b3119],
16	PM	NN	O	pm	nn	17	SENT_131	[p12l1196t3053r1337b3119],
17	status	NN	O	status	prep_with	9	SENT_131	[p12l1381t3067r1607b3120],
18	were	VBD	O	be	cop	20	SENT_131	[p12l1650t3076r1838b3120],
19	82.0	CD	PERCENT	82.0	num	20	SENT_131	[p12l1887t3051r2144b3121],
20	%	NN	PERCENT	%	_	0	SENT_131	[p12l1887t3051r2144b3121],
21	(	CD	NUMBER	(	number	22	SENT_131	[p12l14t3167r310b3251],
22	41/50	CD	NUMBER	41/50	num	23	SENT_131	[p12l14t3167r310b3251],
23	)	NN	O	)	dep	20	SENT_131	[p12l14t3167r310b3251],
24	,	,	O	,	_	0	SENT_131	[p12l14t3167r310b3251],
25	82.0	CD	PERCENT	82.0	num	26	SENT_131	[p12l337t3167r586b3235],
26	%	NN	PERCENT	%	conj_and	20	SENT_131	[p12l337t3167r586b3235],
27	(	CD	NUMBER	(	number	28	SENT_131	[p12l621t3167r917b3251],
28	50/61	CD	NUMBER	50/61	num	29	SENT_131	[p12l621t3167r917b3251],
29	)	NN	O	)	dep	26	SENT_131	[p12l621t3167r917b3251],
30	,	,	O	,	_	0	SENT_131	[p12l621t3167r917b3251],
31	and	CC	O	and	_	0	SENT_131	[p12l940t3163r1079b3235],
32	88.9	CD	PERCENT	88.9	num	33	SENT_131	[p12l1107t3167r1356b3235],
33	%	NN	PERCENT	%	conj_and	20	SENT_131	[p12l1107t3167r1356b3235],
34	(	CD	NUMBER	(	number	35	SENT_131	[p12l1390t3167r1687b3251],
35	32/36	CD	NUMBER	32/36	num	36	SENT_131	[p12l1390t3167r1687b3251],
36	)	NN	O	)	dep	33	SENT_131	[p12l1390t3167r1687b3251],
37	,	,	O	,	_	0	SENT_131	[p12l1390t3167r1687b3251],
38	respectively	RB	O	respectively	advmod	40	SENT_131	[p12l1709t3163r2151b3254],
39	(	CD	NUMBER	(	num	40	SENT_131	[p12l14t3279r259b3367],
40	Table	NNP	O	Table	rcmod	33	SENT_131	[p12l14t3279r259b3367],
41	IV	CD	NUMBER	iv	num	40	SENT_131	[p12l290t3283r436b3367],
42	)	NN	O	)	dep	40	SENT_131	[p12l290t3283r436b3367],
43	.	.	O	.	_	0	SENT_131	[p12l290t3283r436b3367],

1	In	IN	O	in	_	0	SENT_132	[p12l470t3284r548b3350],
2	group	NN	O	group	nn	3	SENT_132	[p12l580t3307r811b3371],
3	A	NN	O	a	prep_in	17	SENT_132	[p12l841t3282r927b3367],
4	,	,	O	,	_	0	SENT_132	[p12l841t3282r927b3367],
5	eradication	NN	O	eradication	nn	6	SENT_132	[p12l959t3279r1401b3351],
6	rates	NNS	O	rate	nsubj	17	SENT_132	[p12l1434t3299r1618b3351],
7	by	IN	O	by	_	0	SENT_132	[p12l1654t3279r1747b3370],
8	HomEM	NNP	O	HomEM	prep_by	6	SENT_132	[p12l1779t3284r2152b3367],
9	,	,	O	,	_	0	SENT_132	[p12l1779t3284r2152b3367],
10	HetEM	NNP	O	HetEM	prep_by	6	SENT_132	[p12l9t3402r326b3485],
11	,	,	O	,	_	0	SENT_132	[p12l9t3402r326b3485],
12	and	CC	O	and	_	0	SENT_132	[p12l367t3396r510b3469],
13	PM	NN	O	pm	nn	14	SENT_132	[p12l550t3402r690b3468],
14	status	NN	O	status	prep_by	6	SENT_132	[p12l732t3416r955b3469],
15	were	VBD	O	be	cop	17	SENT_132	[p12l996t3425r1182b3469],
16	87.5	CD	PERCENT	87.5	num	17	SENT_132	[p12l1228t3400r1485b3470],
17	%	NN	PERCENT	%	_	0	SENT_132	[p12l1228t3400r1485b3470],
18	(	CD	NUMBER	(	number	19	SENT_132	[p12l1537t3400r1843b3485],
19	14/16	CD	NUMBER	14/16	num	20	SENT_132	[p12l1537t3400r1843b3485],
20	)	NN	O	)	dep	17	SENT_132	[p12l1537t3400r1843b3485],
21	,	,	O	,	_	0	SENT_132	[p12l1537t3400r1843b3485],
22	90.5	CD	PERCENT	90.5	num	23	SENT_132	[p12l1884t3400r2144b3470],
23	%	NN	PERCENT	%	conj_and	17	SENT_132	[p12l1884t3400r2144b3470],
24	(	CD	NUMBER	(	number	25	SENT_132	[p12l14t3517r321b3601],
25	19/21	CD	NUMBER	19/21	num	26	SENT_132	[p12l14t3517r321b3601],
26	)	NN	O	)	dep	23	SENT_132	[p12l14t3517r321b3601],
27	,	,	O	,	_	0	SENT_132	[p12l14t3517r321b3601],
28	and	CC	O	and	_	0	SENT_132	[p12l364t3512r508b3585],
29	90.0	CD	PERCENT	90.0	num	30	SENT_132	[p12l553t3517r812b3586],
30	%	NN	PERCENT	%	conj_and	17	SENT_132	[p12l553t3517r812b3586],
31	(	CD	NUMBER	(	number	32	SENT_132	[p12l867t3517r1123b3601],
32	9/10	CD	NUMBER	9/10	num	33	SENT_132	[p12l867t3517r1123b3601],
33	)	NN	O	)	dep	30	SENT_132	[p12l867t3517r1123b3601],
34	,	,	O	,	_	0	SENT_132	[p12l867t3517r1123b3601],
35	respectively	RB	O	respectively	advmod	17	SENT_132	[p12l1165t3513r1636b3604],
36	.	.	O	.	_	0	SENT_132	[p12l1165t3513r1636b3604],

1	In	IN	O	in	_	0	SENT_133	[p12l1680t3518r1757b3583],
2	group	NN	O	group	nn	3	SENT_133	[p12l1800t3540r2031b3604],
3	B	NN	O	b	prep_in	10	SENT_133	[p12l2076t3518r2151b3601],
4	,	,	O	,	_	0	SENT_133	[p12l2076t3518r2151b3601],
5	the	DT	O	the	det	7	SENT_133	[p12l8t3628r127b3700],
6	corresponding	JJ	O	corresponding	amod	7	SENT_133	[p12l171t3628r740b3720],
7	proportions	NNS	O	proportion	nsubj	10	SENT_133	[p12l782t3632r1252b3720],
8	were	VBD	O	be	cop	10	SENT_133	[p12l1296t3656r1482b3700],
9	73.3	CD	PERCENT	73.3	num	10	SENT_133	[p12l1529t3632r1788b3701],
10	%	NN	PERCENT	%	_	0	SENT_133	[p12l1529t3632r1788b3701],
11	(	CD	NUMBER	(	number	12	SENT_133	[p12l1843t3632r2152b3716],
12	11/15	CD	NUMBER	11/15	num	13	SENT_133	[p12l1843t3632r2152b3716],
13	)	NN	O	)	dep	10	SENT_133	[p12l1843t3632r2152b3716],
14	,	,	O	,	_	0	SENT_133	[p12l1843t3632r2152b3716],

1	94.7	CD	PERCENT	94.7	num	2	SENT_134	[p13l11t23r271b92],
2	%	NN	PERCENT	%	_	0	SENT_134	[p13l11t23r271b92],
3	(	CD	NUMBER	(	number	4	SENT_134	[p13l326t23r634b108],
4	18/19	CD	NUMBER	18/19	num	5	SENT_134	[p13l326t23r634b108],
5	)	NN	O	)	dep	2	SENT_134	[p13l326t23r634b108],
6	,	,	O	,	_	0	SENT_134	[p13l326t23r634b108],
7	and	CC	O	and	_	0	SENT_134	[p13l678t19r821b91],
8	100	CD	PERCENT	100	num	9	SENT_134	[p13l871t23r1101b92],
9	%	NN	PERCENT	%	conj_and	5	SENT_134	[p13l871t23r1101b92],
10	(	CD	NUMBER	(	number	11	SENT_134	[p13l1156t23r1462b108],
11	12/12	CD	NUMBER	12/12	num	12	SENT_134	[p13l1156t23r1462b108],
12	)	NN	O	)	dep	9	SENT_134	[p13l1156t23r1462b108],
13	.	.	O	.	_	0	SENT_134	[p13l1156t23r1462b108],

1	In	IN	O	in	_	0	SENT_135	[p13l1506t25r1585b90],
2	group	NN	O	group	nn	3	SENT_135	[p13l1627t47r1859b111],
3	C	NN	O	c	prep_in	9	SENT_135	[p13l1906t23r1990b108],
4	,	,	O	,	_	0	SENT_135	[p13l1906t23r1990b108],
5	the	DT	O	the	det	6	SENT_135	[p13l2031t19r2150b91],
6	proportions	NNS	O	proportion	nsubj	9	SENT_135	[p13l8t140r476b227],
7	were	VBD	O	be	cop	9	SENT_135	[p13l507t164r693b208],
8	84.2	CD	PERCENT	84.2	num	9	SENT_135	[p13l730t140r986b208],
9	%	NN	PERCENT	%	_	0	SENT_135	[p13l730t140r986b208],
10	(	CD	NUMBER	(	number	11	SENT_135	[p13l1029t140r1336b224],
11	16/19	CD	NUMBER	16/19	num	12	SENT_135	[p13l1029t140r1336b224],
12	)	NN	O	)	dep	9	SENT_135	[p13l1029t140r1336b224],
13	,	,	O	,	_	0	SENT_135	[p13l1029t140r1336b224],
14	61.9	CD	PERCENT	61.9	num	15	SENT_135	[p13l1369t140r1627b209],
15	%	NN	PERCENT	%	conj_and	9	SENT_135	[p13l1369t140r1627b209],
16	(	CD	NUMBER	(	number	17	SENT_135	[p13l1670t140r1977b224],
17	13/21	CD	NUMBER	13/21	num	18	SENT_135	[p13l1670t140r1977b224],
18	)	NN	O	)	dep	15	SENT_135	[p13l1670t140r1977b224],
19	,	,	O	,	_	0	SENT_135	[p13l1670t140r1977b224],
20	and	CC	O	and	_	0	SENT_135	[p13l2008t135r2151b208],
21	78.6	CD	PERCENT	78.6	num	22	SENT_135	[p13l12t255r270b324],
22	%	NN	PERCENT	%	conj_and	9	SENT_135	[p13l12t255r270b324],
23	(	CD	NUMBER	(	number	24	SENT_135	[p13l320t255r625b339],
24	11/14	CD	NUMBER	11/14	num	25	SENT_135	[p13l320t255r625b339],
25	)	NN	O	)	dep	22	SENT_135	[p13l320t255r625b339],
26	.	.	O	.	_	0	SENT_135	[p13l320t255r625b339],

1	There	EX	O	there	expl	2	SENT_136	[p13l659t251r886b323],
2	were	VBD	O	be	_	0	SENT_136	[p13l923t279r1110b323],
3	no	DT	O	no	det	5	SENT_136	[p13l1148t279r1245b323],
4	significant	JJ	O	significant	amod	5	SENT_136	[p13l1286t251r1692b343],
5	differences	NNS	O	difference	nsubj	2	SENT_136	[p13l1730t251r2150b323],
6	in	IN	O	in	_	0	SENT_136	[p13l9t372r84b438],
7	eradication	NN	O	eradication	nn	8	SENT_136	[p13l129t367r586b439],
8	rates	NNS	O	rate	prep_in	5	SENT_136	[p13l631t387r821b439],
9	by	IN	O	by	_	0	SENT_136	[p13l869t367r964b459],
10	CYP2C19	NN	O	cyp2c19	nn	11	SENT_136	[p13l1014t371r1418b439],
11	genotype	NN	O	genotype	prep_by	2	SENT_136	[p13l1465t387r1830b459],
12	among	IN	O	among	_	0	SENT_136	[p13l1877t395r2151b459],
13	treatment	NN	O	treatment	nn	14	SENT_136	[p13l8t504r411b556],
14	groups	NNS	O	group	prep_among	11	SENT_136	[p13l460t511r766b575],
15	.	.	O	.	_	0	SENT_136	[p13l460t511r766b575],

1	In	IN	O	in	_	0	SENT_137	[p13l817t489r898b554],
2	addition	NN	O	addition	prep_in	19	SENT_137	[p13l950t484r1322b572],
3	,	,	O	,	_	0	SENT_137	[p13l950t484r1322b572],
4	when	WRB	O	when	advmod	9	SENT_137	[p13l1369t484r1591b556],
5	HetEM	NN	O	hetem	nsubjpass	9	SENT_137	[p13l1642t489r1948b556],
6	and	CC	O	and	_	0	SENT_137	[p13l2000t484r2149b556],
7	HomEM	NNP	PERSON	HomEM	conj_and	5	SENT_137	[p13l9t604r354b671],
8	were	VBD	O	be	auxpass	9	SENT_137	[p13l376t627r559b671],
9	combined	VBN	O	combine	advcl	19	SENT_137	[p13l583t599r963b671],
10	into	IN	O	into	_	0	SENT_137	[p13l987t603r1137b671],
11	an	DT	O	a	det	13	SENT_137	[p13l1164t627r1254b671],
12	EM	NN	O	em	nn	13	SENT_137	[p13l1278t604r1421b670],
13	group	NN	O	group	prep_into	9	SENT_137	[p13l1444t626r1695b691],
14	,	,	O	,	_	0	SENT_137	[p13l1444t626r1695b691],
15	eradication	NN	O	eradication	nn	16	SENT_137	[p13l1718t599r2151b671],
16	rates	NNS	O	rate	nsubj	19	SENT_137	[p13l9t735r193b787],
17	did	VBD	O	do	aux	19	SENT_137	[p13l232t715r355b787],
18	not	RB	O	not	neg	19	SENT_137	[p13l390t735r520b787],
19	differ	VB	O	differ	_	0	SENT_137	[p13l556t715r767b787],
20	significantly	RB	O	significantly	advmod	19	SENT_137	[p13l803t715r1282b807],
21	between	IN	O	between	_	0	SENT_137	[p13l1318t715r1640b787],
22	the	DT	O	the	det	23	SENT_137	[p13l1676t715r1795b787],
23	PM	NN	O	pm	prep_between	19	SENT_137	[p13l1831t721r1971b787],
24	and	CC	O	and	_	0	SENT_137	[p13l2007t715r2151b787],
25	EM	NN	O	em	nn	26	SENT_137	[p13l9t837r154b903],
26	groups	NNS	O	group	nsubj	27	SENT_137	[p13l183t859r450b923],
27	(	VBP	O	(	conj_and	19	SENT_137	[p13l487t831r731b920],
28	Table	NNP	O	Table	nsubj	30	SENT_137	[p13l487t831r731b920],
29	IV	CD	NUMBER	iv	num	30	SENT_137	[p13l760t836r906b920],
30	)	NN	O	)	xcomp	27	SENT_137	[p13l760t836r906b920],
31	.	.	O	.	_	0	SENT_137	[p13l760t836r906b920],

1	Volume	NN	O	volume	_	0	SENT_138	[p13l1186t1090r1481b1156],
2	32	CD	NUMBER	32	dep	1	SENT_138	[p13l1514t1093r1606b1156],
3	Number	NNP	O	Number	dep	1	SENT_138	[p13l1645t1090r1966b1156],
4	12	CD	NUMBER	12	num	3	SENT_138	[p13l1999t1093r2083b1155],

1	X.	NNP	O	X.	nn	2	SENT_139	[p13l1848t1233r1883b1261],
2	Pan	NNP	O	Pan	_	0	SENT_139	[p13l1900t1233r1963b1261],
3	et	FW	O	et	nn	4	SENT_139	[p13l1979t1238r2013b1261],
4	al.	FW	O	al.	dep	2	SENT_139	[p13l2026t1231r2065b1261],
5	.	.	O	.	_	0	SENT_139	[p13l2026t1231r2065b1261],

1	Table	NNP	O	Table	nn	3	SENT_140	[p13l218t1388r312b1418],
2	I.	NNP	O	I.	nn	3	SENT_140	[p13l329t1390r346b1418],
3	Baseline	NNP	O	Baseline	_	0	SENT_140	[p13l373t1388r514b1418],
4	characteristics	NNS	O	characteristic	dep	3	SENT_140	[p13l529t1388r782b1418],
5	of	IN	O	of	_	0	SENT_140	[p13l796t1388r835b1418],
6	the	DT	O	the	det	8	SENT_140	[p13l843t1388r897b1418],
7	study	NN	O	study	nn	8	SENT_140	[p13l911t1388r1006b1428],
8	groups	NNS	O	group	prep_of	4	SENT_140	[p13l1017t1399r1147b1428],
9	.	.	O	.	_	0	SENT_140	[p13l1017t1399r1147b1428],

1	Group	NNP	O	Group	nn	6	SENT_141	[p13l975t1481r1085b1520],
2	A	NNP	O	A	nn	6	SENT_141	[p13l1098t1482r1123b1509],
3	Group	NNP	ORGANIZATION	Group	nn	6	SENT_141	[p13l1371t1481r1481b1520],
4	B	NNP	ORGANIZATION	B	nn	6	SENT_141	[p13l1498t1482r1517b1509],
5	Group	NNP	ORGANIZATION	Group	nn	6	SENT_141	[p13l1749t1481r1859b1520],
6	C	NNP	ORGANIZATION	C	_	0	SENT_141	[p13l1874t1482r1898b1509],
7	Characteristic	JJ	ORGANIZATION	characteristic	amod	9	SENT_141	[p13l221t1530r463b1559],
8	(	NN	O	(	nn	9	SENT_141	[p13l983t1530r1012b1569],
9	n	NN	O	n	dep	6	SENT_141	[p13l983t1530r1012b1569],
10	=	JJ	O	=	quantmod	12	SENT_141	[p13l1029t1542r1047b1549],
11	61	CD	NUMBER	61	number	12	SENT_141	[p13l1063t1530r1113b1569],
12	)	CD	NUMBER	)	num	22	SENT_141	[p13l1063t1530r1113b1569],
13	(	NN	O	(	nn	22	SENT_141	[p13l1378t1530r1407b1569],
14	n	NN	O	n	nn	22	SENT_141	[p13l1378t1530r1407b1569],
15	=	JJ	O	=	amod	22	SENT_141	[p13l1424t1542r1442b1549],
16	62	CD	NUMBER	62	number	17	SENT_141	[p13l1458t1530r1510b1569],
17	)	CD	NUMBER	)	num	22	SENT_141	[p13l1458t1530r1510b1569],
18	(	NN	O	(	nn	22	SENT_141	[p13l1758t1530r1787b1569],
19	n	NN	O	n	nn	22	SENT_141	[p13l1758t1530r1787b1569],
20	=	JJ	O	=	amod	22	SENT_141	[p13l1805t1542r1822b1549],
21	61	CD	NUMBER	61	num	22	SENT_141	[p13l1839t1530r1888b1569],
22	)	NN	O	)	dep	9	SENT_141	[p13l1839t1530r1888b1569],

1	Age	NNP	O	Age	dep	105	SENT_142	[p13l219t1615r293b1653],
2	,	,	O	,	_	0	SENT_142	[p13l219t1615r293b1653],
3	mean	VB	O	mean	dep	105	SENT_142	[p13l310t1624r400b1643],
4	(	JJ	O	(	dep	105	SENT_142	[p13l417t1613r500b1653],
5	SD	NN	O	sd	dep	105	SENT_142	[p13l417t1613r500b1653],
6	)	NN	O	)	dep	105	SENT_142	[p13l417t1613r500b1653],
7	,	,	O	,	_	0	SENT_142	[p13l417t1613r500b1653],
8	y	NN	O	y	dep	105	SENT_142	[p13l515t1624r532b1653],
9	43.9	CD	NUMBER	43.9	dep	105	SENT_142	[p13l952t1615r1026b1643],
10	(	NN	O	(	dep	105	SENT_142	[p13l1042t1613r1140b1653],
11	14.3	CD	NUMBER	14.3	dep	105	SENT_142	[p13l1042t1613r1140b1653],
12	)	CD	NUMBER	)	dep	105	SENT_142	[p13l1042t1613r1140b1653],
13	46.7	CD	NUMBER	46.7	dep	105	SENT_142	[p13l1351t1615r1427b1643],
14	(	NN	O	(	dep	105	SENT_142	[p13l1443t1613r1539b1653],
15	13.4	CD	NUMBER	13.4	dep	105	SENT_142	[p13l1443t1613r1539b1653],
16	)	CD	NUMBER	)	dep	105	SENT_142	[p13l1443t1613r1539b1653],
17	43.8	CD	NUMBER	43.8	dep	105	SENT_142	[p13l1735t1615r1809b1643],
18	(	NN	O	(	dep	105	SENT_142	[p13l1826t1614r1922b1653],
19	13.9	CD	NUMBER	13.9	dep	105	SENT_142	[p13l1826t1614r1922b1653],
20	)	CD	NUMBER	)	dep	105	SENT_142	[p13l1826t1614r1922b1653],
21	Sex	NN	O	sex	dep	105	SENT_142	[p13l220t1682r286b1716],
22	,	,	O	,	_	0	SENT_142	[p13l220t1682r286b1716],
23	no.	NN	O	no.	dep	105	SENT_142	[p13l303t1690r353b1709],
24	(	CD	PERCENT	(	dep	105	SENT_142	[p13l370t1680r422b1719],
25	%	NN	PERCENT	%	dep	105	SENT_142	[p13l370t1680r422b1719],
26	)	CD	NUMBER	)	dep	105	SENT_142	[p13l370t1680r422b1719],
27	Female	JJ	O	female	dep	105	SENT_142	[p13l264t1730r382b1759],
28	33	CD	NUMBER	33	dep	105	SENT_142	[p13l986t1732r1025b1759],
29	(	CD	NUMBER	(	dep	105	SENT_142	[p13l1042t1730r1138b1769],
30	54.1	CD	NUMBER	54.1	dep	105	SENT_142	[p13l1042t1730r1138b1769],
31	)	NN	O	)	dep	105	SENT_142	[p13l1042t1730r1138b1769],
32	32	CD	NUMBER	32	dep	105	SENT_142	[p13l1387t1732r1426b1759],
33	(	CD	NUMBER	(	dep	105	SENT_142	[p13l1442t1730r1539b1769],
34	51.6	CD	NUMBER	51.6	dep	105	SENT_142	[p13l1442t1730r1539b1769],
35	)	NN	O	)	dep	105	SENT_142	[p13l1442t1730r1539b1769],
36	34	CD	NUMBER	34	dep	105	SENT_142	[p13l1769t1732r1811b1759],
37	(	CD	NUMBER	(	dep	105	SENT_142	[p13l1826t1730r1925b1769],
38	55.7	CD	NUMBER	55.7	dep	105	SENT_142	[p13l1826t1730r1925b1769],
39	)	NN	O	)	dep	105	SENT_142	[p13l1826t1730r1925b1769],
40	Male	NN	O	male	dep	105	SENT_142	[p13l264t1780r347b1809],
41	28	CD	NUMBER	28	dep	105	SENT_142	[p13l987t1782r1026b1809],
42	(	CD	NUMBER	(	dep	105	SENT_142	[p13l1042t1780r1140b1819],
43	45.9	CD	NUMBER	45.9	dep	105	SENT_142	[p13l1042t1780r1140b1819],
44	)	CD	NUMBER	)	dep	105	SENT_142	[p13l1042t1780r1140b1819],
45	30	CD	NUMBER	30	dep	105	SENT_142	[p13l1386t1782r1426b1809],
46	(	NN	O	(	dep	105	SENT_142	[p13l1442t1780r1542b1819],
47	48.4	CD	NUMBER	48.4	dep	105	SENT_142	[p13l1442t1780r1542b1819],
48	)	CD	NUMBER	)	dep	105	SENT_142	[p13l1442t1780r1542b1819],
49	27	CD	NUMBER	27	dep	105	SENT_142	[p13l1771t1782r1810b1809],
50	(	NN	O	(	dep	105	SENT_142	[p13l1826t1780r1927b1819],
51	44.3	CD	NUMBER	44.3	dep	105	SENT_142	[p13l1826t1780r1927b1819],
52	)	CD	NUMBER	)	dep	105	SENT_142	[p13l1826t1780r1927b1819],
53	Endoscopic	JJ	O	endoscopic	dep	105	SENT_142	[p13l223t1846r420b1886],
54	diagnosis	NN	O	diagnosis	dep	105	SENT_142	[p13l435t1846r605b1887],
55	,	,	O	,	_	0	SENT_142	[p13l435t1846r605b1887],
56	no.	NN	O	no.	dep	105	SENT_142	[p13l623t1857r672b1876],
57	(	CD	PERCENT	(	dep	105	SENT_142	[p13l690t1847r741b1886],
58	%	NN	PERCENT	%	dep	105	SENT_142	[p13l690t1847r741b1886],
59	)	CD	NUMBER	)	dep	105	SENT_142	[p13l690t1847r741b1886],
60	Peptic	JJ	O	peptic	dep	105	SENT_142	[p13l265t1897r367b1936],
61	ulcer	NN	O	ulcer	dep	105	SENT_142	[p13l383t1896r465b1926],
62	disease	NN	O	disease	dep	105	SENT_142	[p13l478t1896r601b1926],
63	6	CD	NUMBER	6	dep	105	SENT_142	[p13l1009t1898r1026b1926],
64	(	NN	O	(	dep	105	SENT_142	[p13l1042t1897r1118b1936],
65	9.8	CD	NUMBER	9.8	dep	105	SENT_142	[p13l1042t1897r1118b1936],
66	)	CD	NUMBER	)	dep	105	SENT_142	[p13l1042t1897r1118b1936],
67	14	CD	NUMBER	14	dep	105	SENT_142	[p13l1390t1899r1427b1926],
68	(	NN	O	(	dep	105	SENT_142	[p13l1442t1897r1543b1936],
69	22.6	CD	NUMBER	22.6	dep	105	SENT_142	[p13l1442t1897r1543b1936],
70	)	CD	NUMBER	)	dep	105	SENT_142	[p13l1442t1897r1543b1936],
71	8	CD	NUMBER	8	dep	105	SENT_142	[p13l1792t1898r1809b1926],
72	(	NN	O	(	dep	105	SENT_142	[p13l1826t1897r1918b1936],
73	13.1	CD	NUMBER	13.1	dep	105	SENT_142	[p13l1826t1897r1918b1936],
74	)	CD	NUMBER	)	dep	105	SENT_142	[p13l1826t1897r1918b1936],
75	Gastritis	NNP	O	Gastritis	dep	105	SENT_142	[p13l263t1947r409b1976],
76	55	CD	NUMBER	55	dep	105	SENT_142	[p13l987t1949r1026b1976],
77	(	CD	NUMBER	(	dep	105	SENT_142	[p13l1042t1947r1143b1986],
78	90.2	CD	NUMBER	90.2	dep	105	SENT_142	[p13l1042t1947r1143b1986],
79	)	NN	O	)	dep	105	SENT_142	[p13l1042t1947r1143b1986],
80	48	CD	NUMBER	48	dep	105	SENT_142	[p13l1384t1948r1426b1976],
81	(	CD	NUMBER	(	dep	105	SENT_142	[p13l1443t1947r1540b1986],
82	77.4	CD	NUMBER	77.4	dep	105	SENT_142	[p13l1443t1947r1540b1986],
83	)	NN	O	)	dep	105	SENT_142	[p13l1443t1947r1540b1986],
84	53	CD	NUMBER	53	dep	105	SENT_142	[p13l1770t1948r1809b1976],
85	(	CD	NUMBER	(	dep	105	SENT_142	[p13l1826t1947r1926b1986],
86	86.9	CD	NUMBER	86.9	dep	105	SENT_142	[p13l1826t1947r1926b1986],
87	)	CD	NUMBER	)	dep	105	SENT_142	[p13l1826t1947r1926b1986],
88	Smokers	NNS	MISC	smoker	dep	105	SENT_142	[p13l220t2013r377b2050],
89	,	,	O	,	_	0	SENT_142	[p13l220t2013r377b2050],
90	no.	VBP	O	no.	dep	105	SENT_142	[p13l394t2024r444b2043],
91	(	CD	PERCENT	(	dep	105	SENT_142	[p13l461t2014r512b2053],
92	%	NN	PERCENT	%	dep	105	SENT_142	[p13l461t2014r512b2053],
93	)	CD	NUMBER	)	dep	105	SENT_142	[p13l461t2014r512b2053],
94	10	CD	NUMBER	10	dep	105	SENT_142	[p13l989t2015r1026b2043],
95	(	NN	O	(	dep	105	SENT_142	[p13l1042t2014r1140b2053],
96	16.4	CD	NUMBER	16.4	dep	105	SENT_142	[p13l1042t2014r1140b2053],
97	)	CD	NUMBER	)	dep	105	SENT_142	[p13l1042t2014r1140b2053],
98	20	CD	NUMBER	20	dep	105	SENT_142	[p13l1387t2015r1426b2043],
99	(	NN	O	(	dep	105	SENT_142	[p13l1443t2014r1542b2053],
100	32.3	CD	NUMBER	32.3	dep	105	SENT_142	[p13l1443t2014r1542b2053],
101	)	CD	NUMBER	)	dep	105	SENT_142	[p13l1443t2014r1542b2053],
102	12	CD	NUMBER	12	dep	105	SENT_142	[p13l1774t2015r1809b2042],
103	(	NN	O	(	dep	105	SENT_142	[p13l1826t2014r1923b2053],
104	19.7	CD	NUMBER	19.7	dep	105	SENT_142	[p13l1826t2014r1923b2053],
105	)	NN	O	)	_	0	SENT_142	[p13l1826t2014r1923b2053],

1	Group	NNP	O	Group	nn	4	SENT_143	[p13l221t2097r317b2131],
2	A	NN	O	a	nn	4	SENT_143	[p13l329t2097r351b2122],
3	=	JJ	O	=	amod	4	SENT_143	[p13l363t2106r379b2113],
4	Ievofloxacin	NN	O	ievofloxacin	_	0	SENT_143	[p13l393t2095r568b2122],
5	500	CD	NUMBER	500	num	6	SENT_143	[p13l583t2097r638b2122],
6	mg/d	NN	O	mg/d	dep	4	SENT_143	[p13l653t2095r739b2132],
7	,	,	O	,	_	0	SENT_143	[p13l653t2095r739b2132],
8	amoxicillin	NNP	O	amoxicillin	appos	6	SENT_143	[p13l752t2095r910b2122],
9	1000	CD	DATE	1000	num	11	SENT_143	[p13l926t2097r999b2122],
10	mg	NN	O	mg	nn	11	SENT_143	[p13l1013t2105r1058b2132],
11	BID	NNP	O	BID	dep	4	SENT_143	[p13l1071t2097r1133b2128],
12	,	,	O	,	_	0	SENT_143	[p13l1071t2097r1133b2128],
13	and	CC	O	and	_	0	SENT_143	[p13l1146t2095r1200b2122],
14	esomeprazole	NN	O	esomeprazole	conj_and	11	SENT_143	[p13l1215t2095r1423b2131],
15	20	CD	NUMBER	20	num	17	SENT_143	[p13l1436t2097r1471b2122],
16	mg	NN	O	mg	nn	17	SENT_143	[p13l1486t2105r1531b2132],
17	BID	NNP	O	BID	dep	4	SENT_143	[p13l1544t2097r1597b2122],
18	for1	NN	O	for1	nn	19	SENT_143	[p13l1609t2095r1675b2122],
19	week	NN	DURATION	week	tmod	17	SENT_143	[p13l1692t2095r1775b2128],
20	;	:	O	;	_	0	SENT_143	[p13l1692t2095r1775b2128],
21	group	NN	O	group	nn	22	SENT_143	[p13l1788t2105r1876b2132],
22	B	NN	O	b	dep	17	SENT_143	[p13l1891t2097r1908b2122],
23	=	JJ	O	=	amod	24	SENT_143	[p13l1921t2106r1937b2113],
24	Ievofloxacin	NN	O	ievofloxacin	dep	22	SENT_143	[p13l222t2141r397b2168],
25	500	CD	NUMBER	500	num	26	SENT_143	[p13l412t2143r468b2168],
26	mg/d	NN	O	mg/d	dep	4	SENT_143	[p13l482t2141r569b2177],
27	,	,	O	,	_	0	SENT_143	[p13l482t2141r569b2177],
28	amoxicillin	NNP	O	amoxicillin	appos	26	SENT_143	[p13l582t2141r740b2168],
29	1000	CD	DATE	1000	num	31	SENT_143	[p13l756t2143r829b2168],
30	mg	NN	O	mg	nn	31	SENT_143	[p13l843t2151r888b2177],
31	BID	NNP	O	BID	dep	4	SENT_143	[p13l902t2143r963b2174],
32	,	,	O	,	_	0	SENT_143	[p13l902t2143r963b2174],
33	and	CC	O	and	_	0	SENT_143	[p13l977t2141r1031b2168],
34	esomeprazole	NN	O	esomeprazole	dep	4	SENT_143	[p13l1045t2141r1254b2177],
35	40	CD	NUMBER	40	num	37	SENT_143	[p13l1266t2143r1303b2168],
36	mg	NN	O	mg	nn	37	SENT_143	[p13l1318t2151r1362b2177],
37	BID	NNP	O	BID	dep	4	SENT_143	[p13l1376t2143r1429b2167],
38	For1	NN	O	for1	nn	39	SENT_143	[p13l1442t2141r1507b2168],
39	week	NN	DURATION	week	tmod	37	SENT_143	[p13l1524t2141r1608b2174],
40	;	:	O	;	_	0	SENT_143	[p13l1524t2141r1608b2174],
41	group	NN	O	group	nn	42	SENT_143	[p13l1621t2151r1709b2177],
42	C	NN	O	c	dep	37	SENT_143	[p13l1728t2143r1749b2168],
43	=	JJ	O	=	amod	42	SENT_143	[p13l1762t2152r1777b2159],
44	|	CD	NUMBER	|	tmod	43	SENT_143	[p13l1792t2141r1938b2168, p13l220t2188r262b2214],
45	evoF	NN	O	evof	nn	47	SENT_143	[p13l1792t2141r1938b2168, p13l220t2188r262b2214],
46	|	NN	O	|	nn	47	SENT_143	[p13l1792t2141r1938b2168, p13l220t2188r262b2214],
47	oxacin	NN	O	oxacin	dep	4	SENT_143	[p13l1792t2141r1938b2168, p13l220t2188r262b2214],
48	500	CD	NUMBER	500	num	49	SENT_143	[p13l278t2189r335b2214],
49	mg/d	NN	O	mg/d	dep	47	SENT_143	[p13l350t2187r440b2223],
50	,	,	O	,	_	0	SENT_143	[p13l350t2187r440b2223],
51	amoxicillin	NNP	O	amoxicillin	appos	4	SENT_143	[p13l454t2187r619b2214],
52	1000	CD	DATE	1000	num	54	SENT_143	[p13l636t2189r712b2214],
53	mg	NN	O	mg	nn	54	SENT_143	[p13l727t2197r772b2223],
54	BID	NNP	O	BID	dep	51	SENT_143	[p13l786t2189r850b2220],
55	,	,	O	,	_	0	SENT_143	[p13l786t2189r850b2220],
56	and	CC	O	and	_	0	SENT_143	[p13l865t2187r920b2214],
57	rabeprazole	NN	O	rabeprazole	conj_and	51	SENT_143	[p13l936t2187r1122b2223],
58	10	CD	NUMBER	10	num	60	SENT_143	[p13l1137t2189r1170b2214],
59	mg	NN	O	mg	nn	60	SENT_143	[p13l1186t2197r1231b2223],
60	BID	NNP	O	BID	dep	4	SENT_143	[p13l1245t2189r1300b2213],
61	for1	NN	O	for1	nn	62	SENT_143	[p13l1314t2187r1382b2214],
62	week	NN	DURATION	week	tmod	60	SENT_143	[p13l1400t2187r1486b2214],
63	.	.	O	.	_	0	SENT_143	[p13l1400t2187r1486b2214],

1	DISCUSSION	NN	O	discussion	_	0	SENT_144	[p13l13t2433r588b2501],

1	In	IN	O	in	_	0	SENT_145	[p13l7t2551r83b2616],
2	this	DT	O	this	det	4	SENT_145	[p13l106t2545r241b2617],
3	small	JJ	O	small	amod	4	SENT_145	[p13l267t2545r466b2617],
4	population	NN	O	population	prep_in	38	SENT_145	[p13l489t2545r911b2637],
5	of	IN	O	of	_	0	SENT_145	[p13l936t2545r1015b2617],
6	Chinese	JJ	LOCATION	chinese	amod	7	SENT_145	[p13l1036t2545r1334b2617],
7	adults	NNS	O	adult	prep_of	4	SENT_145	[p13l1359t2545r1611b2634],
8	,	,	O	,	_	0	SENT_145	[p13l1359t2545r1611b2634],
9	triple	JJ	O	triple	amod	10	SENT_145	[p13l1633t2545r1833b2637],
10	therapy	NN	O	therapy	conj_and	4	SENT_145	[p13l1856t2545r2149b2637],
11	with	IN	O	with	_	0	SENT_145	[p13l6t2661r183b2733],
12	levofloxacin	NN	O	levofloxacin	nn	14	SENT_145	[p13l209t2661r692b2733],
13	500	CD	NUMBER	500	num	14	SENT_145	[p13l720t2666r865b2733],
14	mg/d	NN	O	mg/d	prep_with	10	SENT_145	[p13l893t2661r1113b2753],
15	,	,	O	,	_	0	SENT_145	[p13l893t2661r1113b2753],
16	amoxicillin	NNP	O	amoxicillin	conj_and	4	SENT_145	[p13l1138t2661r1580b2733],
17	1000	CD	DATE	1000	num	19	SENT_145	[p13l1612t2666r1804b2733],
18	mg	NN	O	mg	nn	19	SENT_145	[p13l1832t2690r1951b2753],
19	BID	NNP	O	BID	dep	16	SENT_145	[p13l1977t2667r2150b2750],
20	,	,	O	,	_	0	SENT_145	[p13l1977t2667r2150b2750],
21	and	CC	O	and	_	0	SENT_145	[p13l8t2777r148b2849],
22	a	DT	O	a	det	25	SENT_145	[p13l171t2805r210b2849],
23	PPI	NNP	O	PPI	nn	25	SENT_145	[p13l233t2782r359b2848],
24	(	NN	O	(	nn	25	SENT_145	[p13l386t2777r925b2869],
25	esomeprazole	NN	O	esomeprazole	prep_in	38	SENT_145	[p13l386t2777r925b2869],
26	20	CD	NUMBER	20	num	29	SENT_145	[p13l948t2782r1042b2849],
27	or	CC	O	or	_	0	SENT_145	[p13l1068t2805r1148b2849],
28	40	CD	NUMBER	40	conj_or	26	SENT_145	[p13l1170t2782r1264b2849],
29	mg	NN	O	mg	dep	25	SENT_145	[p13l1288t2805r1405b2869],
30	BID	NNP	O	BID	nsubjpass	38	SENT_145	[p13l1428t2782r1575b2848],
31	or	CC	O	or	_	0	SENT_145	[p13l1601t2805r1681b2849],
32	rabeprazole	JJ	O	rabeprazole	amod	34	SENT_145	[p13l1703t2777r2148b2869],
33	10	CD	NUMBER	10	tmod	32	SENT_145	[p13l13t2898r103b2965],
34	mg	NN	O	mg	nsubjpass	38	SENT_145	[p13l147t2921r267b2985],
35	BID	NNP	O	BID	dep	34	SENT_145	[p13l309t2898r489b2982],
36	)	CD	NUMBER	)	num	35	SENT_145	[p13l309t2898r489b2982],
37	was	VBD	O	be	auxpass	38	SENT_145	[p13l535t2921r684b2965],
38	associated	VBN	O	associate	_	0	SENT_145	[p13l730t2893r1130b2965],
39	with	IN	O	with	_	0	SENT_145	[p13l1170t2893r1347b2965],
40	acceptable	JJ	O	acceptable	amod	41	SENT_145	[p13l1391t2893r1800b2985],
41	rates	NNS	O	rate	prep_with	38	SENT_145	[p13l1843t2913r2028b2965],
42	of	IN	O	of	_	0	SENT_145	[p13l2073t2893r2154b2965],
43	H	NN	O	h	nn	45	SENT_145	[p13l6t3015r84b3080],
44	pylori	NN	O	pylorus	nn	45	SENT_145	[p13l100t3009r328b3101],
45	eradication	NN	O	eradication	prep_of	41	SENT_145	[p13l349t3009r780b3081],
46	and	CC	O	and	_	0	SENT_145	[p13l804t3009r944b3081],
47	was	VBD	O	be	auxpass	49	SENT_145	[p13l966t3038r1113b3081],
48	well	RB	O	well	advmod	49	SENT_145	[p13l1136t3009r1293b3081],
49	tolerated	VBN	O	tolerate	conj_and	38	SENT_145	[p13l1316t3009r1678b3081],
50	.	.	O	.	_	0	SENT_145	[p13l1316t3009r1678b3081],

1	Eradication	NN	O	eradication	nn	2	SENT_146	[p13l1702t3009r2148b3081],
2	rates	NNS	O	rate	nsubj	11	SENT_146	[p13l7t3145r181b3197],
3	in	IN	O	in	_	0	SENT_146	[p13l204t3129r274b3196],
4	the	DT	O	the	det	5	SENT_146	[p13l293t3125r407b3197],
5	ITT	NNP	ORGANIZATION	ITT	prep_in	2	SENT_146	[p13l429t3128r573b3196],
6	and	CC	O	and	_	0	SENT_146	[p13l594t3125r732b3197],
7	PP	NN	O	pp	nn	8	SENT_146	[p13l753t3130r848b3196],
8	analyses	NNS	O	analysis	prep_in	2	SENT_146	[p13l870t3125r1174b3216],
9	did	VBD	O	do	aux	11	SENT_146	[p13l1198t3125r1315b3197],
10	not	RB	O	not	neg	11	SENT_146	[p13l1336t3145r1460b3197],
11	differ	VB	O	differ	_	0	SENT_146	[p13l1482t3125r1680b3197],
12	significantly	RB	O	significantly	advmod	11	SENT_146	[p13l1702t3125r2151b3217],
13	among	IN	O	among	_	0	SENT_146	[p13l8t3269r269b3333],
14	the	DT	O	the	det	16	SENT_146	[p13l291t3241r407b3313],
15	3	CD	NUMBER	3	num	16	SENT_146	[p13l433t3246r472b3313],
16	regimens	NNS	O	regimen	prep_among	11	SENT_146	[p13l500t3246r860b3333],
17	.	.	O	.	_	0	SENT_146	[p13l500t3246r860b3333],

1	C	NN	O	c	nn	3	SENT_147	[p13l890t3245r949b3313],
2	YP2	NN	O	yp2	nn	3	SENT_147	[p13l956t3246r1107b3312],
3	C1	NN	O	c1	nsubj	9	SENT_147	[p13l1120t3245r1216b3313],
4	9	CD	NUMBER	9	num	6	SENT_147	[p13l1232t3246r1275b3312],
5	genetic	JJ	O	genetic	amod	6	SENT_147	[p13l1299t3246r1565b3333],
6	polymorphism	NN	O	polymorphism	dep	3	SENT_147	[p13l1587t3241r2148b3333],
7	did	VBD	O	do	aux	9	SENT_147	[p13l8t3357r129b3429],
8	not	RB	O	not	neg	9	SENT_147	[p13l158t3378r286b3429],
9	affect	VB	O	affect	_	0	SENT_147	[p13l315t3357r526b3429],
10	the	DT	O	the	det	12	SENT_147	[p13l553t3357r669b3429],
11	clinical	JJ	O	clinical	amod	12	SENT_147	[p13l698t3357r970b3429],
12	efficacy	NN	O	efficacy	dobj	9	SENT_147	[p13l999t3357r1292b3449],
13	of	IN	O	of	_	0	SENT_147	[p13l1320t3357r1400b3429],
14	levofloxacin-based	JJ	O	levofloxacin-based	amod	16	SENT_147	[p13l1424t3357r2149b3429],
15	triple	JJ	O	triple	amod	16	SENT_147	[p13l6t3473r208b3565],
16	therapy	NN	O	therapy	prep_of	12	SENT_147	[p13l237t3473r531b3565],
17	in	IN	O	in	_	0	SENT_147	[p13l559t3477r630b3544],
18	eradicating	VBG	O	eradicate	amod	21	SENT_147	[p13l660t3473r1087b3565],
19	H	NN	O	h	nn	21	SENT_147	[p13l1115t3478r1193b3544],
20	pylori	NN	O	pylorus	nn	21	SENT_147	[p13l1214t3473r1443b3564],
21	infection	NN	O	infection	prep_in	9	SENT_147	[p13l1470t3473r1828b3545],
22	.	.	O	.	_	0	SENT_147	[p13l1470t3473r1828b3545],

1	In	IN	O	in	_	0	SENT_148	[p13l118t3595r196b3660],
2	a	DT	O	a	det	4	SENT_148	[p13l231t3617r271b3661],
3	previous	JJ	O	previous	amod	4	SENT_148	[p13l305t3594r639b3681],
4	study	NN	O	study	prep_in	9	SENT_148	[p13l676t3589r901b3681],
5	,	,	O	,	_	0	SENT_148	[p13l676t3589r901b3681],
6	450	CD	NUMBER	450	num	7	SENT_148	[p13l934t3594r1082b3661],
7	patients	NNS	O	patient	nsubjpass	9	SENT_148	[p13l1117t3594r1426b3681],
8	were	VBD	O	be	auxpass	9	SENT_148	[p13l1460t3617r1646b3661],
9	randomized	VBN	O	randomize	_	0	SENT_148	[p13l1680t3589r2149b3661],
10	to	TO	O	to	aux	11	SENT_148	[p13l6t3726r82b3777],
11	receive	VB	O	receive	xcomp	9	SENT_148	[p13l104t3710r359b3777],
12	triple	JJ	O	triple	amod	13	SENT_148	[p13l380t3705r576b3797],
13	therapy	NN	O	therapy	dobj	11	SENT_148	[p13l598t3705r886b3797],
14	with	IN	O	with	prep	11	SENT_148	[p13l904t3705r1075b3777],
15	either	CC	O	either	prep	11	SENT_148	[p13l1097t3705r1308b3777],
16	clarithromyin	NN	O	clarithromyin	nn	19	SENT_148	[p13l1329t3705r1845b3797],
17	5	CD	NUMBER	5	num	19	SENT_148	[p13l1868t3712r1909b3777],
18	oo	NN	O	oo	nn	19	SENT_148	[p13l1918t3710r2010b3777],
19	mg	NN	O	mg	dep	15	SENT_148	[p13l2033t3734r2150b3797],

1	BID	NNP	O	BID	nsubjpass	45	SENT_149	[p14l8t24r177b107],
2	,	,	O	,	_	0	SENT_149	[p14l8t24r177b107],
3	amoxicillin	NNP	O	amoxicillin	dep	12	SENT_149	[p14l199t19r629b91],
4	1000	CD	DATE	1000	num	6	SENT_149	[p14l657t24r846b91],
5	mg	NN	O	mg	nn	6	SENT_149	[p14l871t47r989b111],
6	BID	NNP	O	BID	dep	3	SENT_149	[p14l1013t24r1181b107],
7	,	,	O	,	_	0	SENT_149	[p14l1013t24r1181b107],
8	and	CC	O	and	_	0	SENT_149	[p14l1204t19r1344b91],
9	esomeprazole	NN	O	esomeprazole	dep	3	SENT_149	[p14l1368t19r1888b111],
10	20	CD	NUMBER	20	num	11	SENT_149	[p14l1911t24r2006b91],
11	mg	NN	O	mg	dep	12	SENT_149	[p14l2031t47r2149b111],
12	BID	NNP	O	BID	dep	37	SENT_149	[p14l8t141r159b206],
13	for	IN	O	for	_	0	SENT_149	[p14l188t135r301b207],
14	7	CD	DURATION	7	num	15	SENT_149	[p14l330t142r375b207],
15	days	NNS	NUMBER	day	prep_for	12	SENT_149	[p14l400t135r598b227],
16	;	:	O	;	_	0	SENT_149	[p14l400t135r598b227],
17	the	DT	O	the	det	19	SENT_149	[p14l625t135r743b207],
18	same	JJ	O	same	amod	19	SENT_149	[p14l771t163r965b207],
19	antibiotics	NNS	O	antibiotic	conj_or	12	SENT_149	[p14l992t135r1401b207],
20	plus	CC	O	plus	_	0	SENT_149	[p14l1428t135r1587b227],
21	esomeprazole	NN	O	esomeprazole	conj_plus	19	SENT_149	[p14l1614t135r2148b227],
22	40	CD	NUMBER	40	num	24	SENT_149	[p14l7t257r103b324],
23	mg	NN	O	mg	nn	24	SENT_149	[p14l131t280r250b343],
24	BID	NNP	O	BID	dep	21	SENT_149	[p14l277t257r428b322],
25	for	IN	O	for	_	0	SENT_149	[p14l457t251r570b324],
26	7	CD	DURATION	7	num	27	SENT_149	[p14l599t258r644b324],
27	days	NNS	NUMBER	day	prep_for	24	SENT_149	[p14l670t252r868b343],
28	;	:	O	;	_	0	SENT_149	[p14l670t252r868b343],
29	or	CC	O	or	_	0	SENT_149	[p14l897t280r979b324],
30	the	DT	O	the	det	32	SENT_149	[p14l1004t252r1122b324],
31	same	JJ	O	same	amod	32	SENT_149	[p14l1150t280r1344b324],
32	antibiotics	NNS	O	antibiotic	dep	37	SENT_149	[p14l1372t251r1781b324],
33	plus	CC	O	plus	prep	12	SENT_149	[p14l1807t252r1967b343],
34	esomeprazole	NN	O	esomeprazole	dep	33	SENT_149	[p14l1994t280r2147b324, p14l7t367r413b459],
35	40	CD	NUMBER	40	num	37	SENT_149	[p14l442t372r539b439],
36	mg	NN	O	mg	nn	37	SENT_149	[p14l570t395r690b459],
37	BID	NNP	O	BID	dep	45	SENT_149	[p14l720t373r871b438],
38	for	IN	O	for	_	0	SENT_149	[p14l903t367r1016b439],
39	10	CD	DURATION	10	num	40	SENT_149	[p14l1052t372r1142b439],
40	days	NNS	NUMBER	day	prep_for	37	SENT_149	[p14l1175t364r1445b459],
41	.39	CD	NUMBER	.39	num	43	SENT_149	[p14l1175t364r1445b459],
42	Eradication	NN	O	eradication	nn	43	SENT_149	[p14l1476t367r1934b439],
43	rates	NNS	O	rate	nsubjpass	45	SENT_149	[p14l1963t387r2147b439],
44	were	VBD	O	be	auxpass	45	SENT_149	[p14l6t512r190b555],
45	evaluated	VBN	O	evaluate	_	0	SENT_149	[p14l216t483r587b555],
46	by	IN	O	by	_	0	SENT_149	[p14l613t483r704b575],
47	13C-urea	NN	O	13c-urea	nn	49	SENT_149	[p14l731t481r1063b555],
48	breath	NN	O	breath	nn	49	SENT_149	[p14l1090t483r1338b555],
49	testing	NN	O	testing	agent	45	SENT_149	[p14l1361t488r1617b575],
50	8	CD	DURATION	8	num	51	SENT_149	[p14l1646t489r1683b555],
51	weeks	NNS	NUMBER	week	tmod	49	SENT_149	[p14l1711t483r1945b555],
52	after	IN	O	after	_	0	SENT_149	[p14l1973t483r2150b555],
53	the	DT	O	the	det	54	SENT_149	[p14l6t600r127b672],
54	completion	NN	O	completion	prep_after	45	SENT_149	[p14l173t599r625b691],
55	of	IN	O	of	_	0	SENT_149	[p14l671t599r753b672],
56	treatment	NN	O	treatment	prep_of	54	SENT_149	[p14l792t620r1204b672],
57	.	.	O	.	_	0	SENT_149	[p14l792t620r1204b672],

1	In	IN	O	in	_	0	SENT_150	[p14l1249t605r1328b670],
2	the	DT	O	the	det	4	SENT_150	[p14l1371t599r1492b672],
3	PP	NN	O	pp	nn	4	SENT_150	[p14l1538t605r1637b670],
4	population	NN	O	population	prep_in	14	SENT_150	[p14l1681t600r2148b691],
5	,	,	O	,	_	0	SENT_150	[p14l1681t600r2148b691],
6	eradication	NN	O	eradication	nn	7	SENT_150	[p14l8t715r458b787],
7	rates	NNS	O	rate	nsubj	14	SENT_150	[p14l502t735r690b787],
8	with	IN	O	with	_	0	SENT_150	[p14l733t715r913b787],
9	the	DT	O	the	det	11	SENT_150	[p14l956t715r1077b787],
10	respective	JJ	O	respective	amod	11	SENT_150	[p14l1122t719r1514b807],
11	regimens	NNS	O	regimen	prep_with	7	SENT_150	[p14l1559t719r1914b807],
12	were	VBD	O	be	cop	14	SENT_150	[p14l1957t743r2147b787],
13	83.5	CD	PERCENT	83.5	num	14	SENT_150	[p14l12t835r294b920],
14	%	NN	PERCENT	%	_	0	SENT_150	[p14l12t835r294b920],
15	,	,	O	,	_	0	SENT_150	[p14l12t835r294b920],
16	84.8	CD	PERCENT	84.8	num	17	SENT_150	[p14l329t835r610b920],
17	%	NN	PERCENT	%	conj_and	14	SENT_150	[p14l329t835r610b920],
18	,	,	O	,	_	0	SENT_150	[p14l329t835r610b920],
19	and	CC	O	and	_	0	SENT_150	[p14l641t831r782b903],
20	88.2	CD	PERCENT	88.2	num	21	SENT_150	[p14l818t835r1100b920],
21	%	NN	PERCENT	%	conj_and	14	SENT_150	[p14l818t835r1100b920],
22	;	:	O	;	_	0	SENT_150	[p14l818t835r1100b920],
23	the	DT	O	the	det	25	SENT_150	[p14l1131t831r1248b903],
24	corresponding	JJ	O	corresponding	amod	25	SENT_150	[p14l1279t831r1835b923],
25	rates	NNS	O	rate	nsubj	32	SENT_150	[p14l1865t851r2045b903],
26	in	IN	O	in	_	0	SENT_150	[p14l2077t836r2149b902],
27	the	DT	O	the	det	29	SENT_150	[p14l6t947r124b1019],
28	ITT	NNP	O	ITT	nn	29	SENT_150	[p14l162t950r311b1018],
29	population	NN	O	population	prep_in	25	SENT_150	[p14l348t947r773b1039],
30	were	VBD	O	be	cop	32	SENT_150	[p14l811t976r994b1019],
31	74.0	CD	PERCENT	74.0	num	32	SENT_150	[p14l1036t952r1320b1036],
32	%	NN	PERCENT	%	parataxis	14	SENT_150	[p14l1036t952r1320b1036],
33	,	,	O	,	_	0	SENT_150	[p14l1036t952r1320b1036],
34	78.0	CD	PERCENT	78.0	num	35	SENT_150	[p14l1361t951r1644b1036],
35	%	NN	PERCENT	%	parataxis	14	SENT_150	[p14l1361t951r1644b1036],
36	,	,	O	,	_	0	SENT_150	[p14l1361t951r1644b1036],
37	and	CC	O	and	_	0	SENT_150	[p14l1683t947r1825b1019],
38	80.0	CD	PERCENT	80.0	num	39	SENT_150	[p14l1868t952r2148b1020],
39	%	NN	PERCENT	%	parataxis	14	SENT_150	[p14l1868t952r2148b1020],
40	.	.	O	.	_	0	SENT_150	[p14l1868t952r2148b1020],

1	The	DT	O	the	det	2	SENT_151	[p14l6t1063r154b1135],
2	differences	NNS	O	difference	nsubj	8	SENT_151	[p14l186t1063r596b1135],
3	between	IN	O	between	_	0	SENT_151	[p14l629t1063r946b1135],
4	regimens	NNS	O	regimen	prep_between	2	SENT_151	[p14l975t1067r1317b1155],
5	were	VBD	O	be	cop	8	SENT_151	[p14l1347t1091r1530b1135],
6	not	RB	O	not	neg	8	SENT_151	[p14l1561t1083r1689b1135],
7	statistically	RB	O	statistically	advmod	8	SENT_151	[p14l1719t1063r2150b1155],
8	significant	JJ	O	significant	_	0	SENT_151	[p14l8t1179r414b1271],
9	.	.	O	.	_	0	SENT_151	[p14l8t1179r414b1271],

1	Thus	RB	O	thus	advmod	15	SENT_152	[p14l432t1179r644b1268],
2	,	,	O	,	_	0	SENT_152	[p14l432t1179r644b1268],
3	a	DT	O	a	det	5	SENT_152	[p14l666t1207r705b1251],
4	higher	JJR	O	higher	amod	5	SENT_152	[p14l728t1179r965b1271],
5	dose	NN	O	dose	nsubjpass	15	SENT_152	[p14l988t1179r1155b1251],
6	of	IN	O	of	_	0	SENT_152	[p14l1179t1179r1257b1251],
7	esomeprazole	NN	O	esomeprazole	prep_of	5	SENT_152	[p14l1275t1179r1786b1271],
8	or	CC	O	or	_	0	SENT_152	[p14l1810t1207r1890b1251],
9	longer	JJR	O	longer	amod	10	SENT_152	[p14l1912t1179r2149b1271],
10	duration	NN	O	duration	conj_or	5	SENT_152	[p14l8t1296r341b1368],
11	of	IN	O	of	_	0	SENT_152	[p14l375t1295r455b1368],
12	therapy	NN	O	therapy	prep_of	10	SENT_152	[p14l482t1296r777b1387],
13	was	VBD	O	be	auxpass	15	SENT_152	[p14l807t1324r955b1368],
14	not	RB	O	not	neg	15	SENT_152	[p14l988t1316r1117b1368],
15	associated	VBN	O	associate	_	0	SENT_152	[p14l1150t1296r1542b1368],
16	with	IN	O	with	_	0	SENT_152	[p14l1573t1296r1747b1368],
17	improved	VBN	O	improve	amod	18	SENT_152	[p14l1780t1296r2149b1387],
18	rates	NNS	O	rate	prep_with	15	SENT_152	[p14l7t1431r189b1483],
19	of	IN	O	of	_	0	SENT_152	[p14l234t1411r314b1483],
20	H	NN	O	h	nn	22	SENT_152	[p14l351t1416r429b1482],
21	pylori	NN	O	pylorus	nn	22	SENT_152	[p14l463t1411r695b1503],
22	eradication	NN	O	eradication	prep_of	18	SENT_152	[p14l735t1411r1192b1483],
23	.	.	O	.	_	0	SENT_152	[p14l735t1411r1192b1483],

1	The	DT	O	the	det	3	SENT_153	[p14l1230t1411r1379b1483],
2	present	JJ	DATE	present	amod	3	SENT_153	[p14l1420t1431r1702b1503],
3	study	NN	O	study	nsubj	5	SENT_153	[p14l1744t1411r1953b1502],
4	also	RB	O	also	advmod	5	SENT_153	[p14l1995t1411r2146b1483],
5	found	VBD	O	find	_	0	SENT_153	[p14l7t1527r234b1599],
6	no	DT	O	no	det	8	SENT_153	[p14l257t1555r352b1599],
7	significant	JJ	O	significant	amod	8	SENT_153	[p14l378t1527r772b1619],
8	difference	NN	O	difference	dobj	5	SENT_153	[p14l795t1527r1168b1599],
9	in	IN	O	in	_	0	SENT_153	[p14l1192t1532r1263b1598],
10	rates	NNS	O	rate	prep_in	5	SENT_153	[p14l1285t1547r1465b1599],
11	of	IN	O	of	_	0	SENT_153	[p14l1490t1527r1570b1599],
12	H	NN	O	h	nn	14	SENT_153	[p14l1587t1533r1665b1598],
13	pylori	NN	O	pylorus	nn	14	SENT_153	[p14l1680t1527r1908b1619],
14	eradication	NN	O	eradication	prep_of	10	SENT_153	[p14l1929t1527r2147b1599, p14l7t1648r245b1716],
15	between	IN	O	between	_	0	SENT_153	[p14l275t1644r592b1716],
16	esomeprazole	NN	O	esomeprazole	prep_between	14	SENT_153	[p14l621t1644r1144b1735],
17	20	CD	NUMBER	20	num	16	SENT_153	[p14l1173t1649r1268b1716],
18	and	CC	O	and	_	0	SENT_153	[p14l1301t1644r1442b1716],
19	40	CD	NUMBER	40	num	21	SENT_153	[p14l1470t1649r1566b1716],
20	mg	NN	O	mg	nn	21	SENT_153	[p14l1596t1672r1715b1735],
21	BID	NNP	O	BID	prep_between	14	SENT_153	[p14l1743t1649r1911b1716],
22	.	.	O	.	_	0	SENT_153	[p14l1743t1649r1911b1716],

1	Unlike	IN	O	unlike	_	0	SENT_154	[p14l117t1759r369b1831],
2	omeprazole	NN	O	omeprazole	prep_unlike	22	SENT_154	[p14l395t1759r864b1851],
3	,	,	O	,	_	0	SENT_154	[p14l395t1759r864b1851],
4	which	WDT	O	which	nsubjpass	6	SENT_154	[p14l885t1759r1118b1831],
5	is	VBZ	O	be	auxpass	6	SENT_154	[p14l1142t1763r1196b1831],
6	composed	VBN	O	compose	rcmod	2	SENT_154	[p14l1221t1759r1609b1851],
7	in	IN	O	in	_	0	SENT_154	[p14l1633t1763r1704b1830],
8	equal	JJ	O	equal	amod	9	SENT_154	[p14l1728t1759r1934b1851],
9	parts	NNS	O	part	prep_in	6	SENT_154	[p14l1957t1779r2148b1851],
10	of	IN	O	of	_	0	SENT_154	[p14l8t1875r89b1947],
11	an	DT	O	a	det	12	SENT_154	[p14l111t1903r202b1947],
12	R-isomer	NN	O	r-isomer	prep_of	9	SENT_154	[p14l227t1880r585b1947],
13	and	CC	O	and	_	0	SENT_154	[p14l611t1875r753b1947],
14	an	DT	O	a	det	15	SENT_154	[p14l779t1903r871b1947],
15	S-isomer	NN	O	s-isomer	conj_and	12	SENT_154	[p14l895t1879r1246b1964],
16	,	,	O	,	_	0	SENT_154	[p14l895t1879r1246b1964],
17	esomeprazole	NN	O	esomeprazole	nsubj	22	SENT_154	[p14l1270t1875r1801b1967],
18	is	VBZ	O	be	cop	22	SENT_154	[p14l1826t1880r1882b1947],
19	a	DT	O	a	det	22	SENT_154	[p14l1909t1903r1948b1947],
20	pure	JJ	O	pure	amod	22	SENT_154	[p14l1973t1903r2148b1967],
21	optic	JJ	O	optic	amod	22	SENT_154	[p14l8t1996r206b2083],
22	S-isomer	NN	O	s-isomer	_	0	SENT_154	[p14l250t1996r608b2064],
23	.	.	O	.	_	0	SENT_154	[p14l250t1996r608b2064],

1	The	DT	O	the	det	2	SENT_155	[p14l649t1992r800b2064],
2	S-isomer	NN	O	s-isomer	nsubjpass	4	SENT_155	[p14l845t1996r1191b2064],
3	is	VBZ	O	be	auxpass	4	SENT_155	[p14l1235t1996r1292b2064],
4	associated	VBN	O	associate	_	0	SENT_155	[p14l1338t1991r1746b2064],
5	with	IN	O	with	_	0	SENT_155	[p14l1789t1991r1968b2064],
6	less	JJR	O	less	prep_with	4	SENT_155	[p14l2012t1992r2147b2064],

1	November	NNP	DATE	November	_	0	SENT_156	[p14l67t2250r475b2315],
2	2010	CD	DATE	2010	dep	1	SENT_156	[p14l504t2253r694b2315],

1	distribution	NN	O	distribution	_	0	SENT_157	[p14l9t2361r468b2433],
2	of	IN	O	of	_	0	SENT_157	[p14l494t2361r575b2433],
3	metabolites	NNS	O	metabolite	prep_of	1	SENT_157	[p14l594t2361r1043b2433],
4	into	IN	O	into	_	0	SENT_157	[p14l1069t2365r1222b2433],
5	the	DT	O	the	det	9	SENT_157	[p14l1247t2361r1365b2433],
6	CYPZCI9	NN	O	cypzci9	nn	9	SENT_157	[p14l1393t2365r1784b2433],
7	pathway	NN	O	pathway	nn	9	SENT_157	[p14l1811t2361r2150b2453],
8	(	CD	NUMBER	(	num	9	SENT_157	[p14l13t2483r552b2568],
9	~	NN	O	~	prep_into	3	SENT_157	[p14l13t2483r552b2568],
10	70	CD	PERCENT	70	number	11	SENT_157	[p14l13t2483r552b2568],
11	%	NN	PERCENT	%	amod	1	SENT_157	[p14l13t2483r552b2568],
12	.	.	O	.	_	0	SENT_157	[p14l13t2483r552b2568],

1	—	NN	O	—	_	0	SENT_158	[p14l13t2483r552b2568],
2	.	.	O	.	_	0	SENT_158	[p14l13t2483r552b2568],

1	76	CD	PERCENT	76	num	2	SENT_159	[p14l13t2483r552b2568],
2	%	NN	PERCENT	%	_	0	SENT_159	[p14l13t2483r552b2568],
3	)	CD	NUMBER	)	nsubj	19	SENT_159	[p14l13t2483r552b2568],
4	compared	VBN	O	compare	prep	3	SENT_159	[p14l601t2479r994b2571],
5	with	IN	O	with	pcomp	4	SENT_159	[p14l1037t2479r1215b2551],
6	the	DT	O	the	det	9	SENT_159	[p14l1257t2479r1377b2551],
7	R	NN	O	r	nn	9	SENT_159	[p14l1422t2484r1798b2568],
8	—	CD	NUMBER	—	num	9	SENT_159	[p14l1422t2484r1798b2568],
9	isomer	NN	O	isomer	pobj	5	SENT_159	[p14l1422t2484r1798b2568],
10	,	,	O	,	_	0	SENT_159	[p14l1422t2484r1798b2568],
11	and	CC	O	and	_	0	SENT_159	[p14l1842t2479r1986b2551],
12	the	DT	O	the	det	13	SENT_159	[p14l2029t2479r2148b2551],
13	AUC	NN	O	auc	pobj	5	SENT_159	[p14l7t2600r199b2669],
14	of	IN	O	of	_	0	SENT_159	[p14l237t2597r318b2669],
15	esomeprazole	NN	O	esomeprazole	prep_of	13	SENT_159	[p14l350t2597r883b2689],
16	is	VBZ	O	be	cop	19	SENT_159	[p14l920t2602r975b2669],
17	3.1	CD	NUMBER	3.1	num	18	SENT_159	[p14l1015t2602r1129b2669],
18	times	NNS	O	time	npadvmod	19	SENT_159	[p14l1171t2602r1376b2669],
19	greater	JJR	O	greater	rcmod	2	SENT_159	[p14l1413t2618r1687b2689],
20	in	IN	O	in	_	0	SENT_159	[p14l1722t2602r1795b2668],
21	those	DT	O	those	prep_in	19	SENT_159	[p14l1829t2597r2035b2669],
22	of	IN	O	of	_	0	SENT_159	[p14l2073t2597r2154b2669],
23	PM	NN	O	pm	nn	24	SENT_159	[p14l8t2720r147b2785],
24	status	NN	O	status	prep_of	21	SENT_159	[p14l173t2734r397b2786],
25	compared	VBN	O	compare	_	0	SENT_159	[p14l422t2714r813b2806],
26	with	IN	O	with	prepc_compared_with	19	SENT_159	[p14l836t2714r1013b2786],
27	EM	NN	O	em	nn	28	SENT_159	[p14l1038t2720r1182b2785],
28	status	NN	O	status	pobj	19	SENT_159	[p14l1208t2711r1529b2802],
29	,40	CD	NUMBER	,40	num	28	SENT_159	[p14l1208t2711r1529b2802],
30	resulting	VBG	O	result	partmod	2	SENT_159	[p14l1554t2714r1894b2806],
31	in	IN	O	in	_	0	SENT_159	[p14l1919t2719r1991b2785],
32	less	JJR	O	less	amod	34	SENT_159	[p14l2016t2714r2148b2786],
33	interindividual	JJ	O	interindividual	amod	34	SENT_159	[p14l8t2832r589b2904],
34	variation	NN	O	variation	prep_in	30	SENT_159	[p14l623t2837r980b2904],
35	in	IN	O	in	_	0	SENT_159	[p14l1015t2837r1087b2903],
36	drug	NN	O	drug	nn	37	SENT_159	[p14l1124t2832r1303b2924],
37	concentrations	NNS	O	concentration	prep_in	34	SENT_159	[p14l1338t2837r1918b2904],
38	comTable	JJ	O	comtable	amod	37	SENT_159	[p14l1954t2860r2148b2904, p15l119t205r328b270],

1	II	NNP	O	II	_	0	SENT_160	[p15l365t210r428b270],
2	.	.	O	.	_	0	SENT_160	[p15l365t210r428b270],

1	Helicobacter	NNP	PERSON	Helicobacter	nn	2	SENT_161	[p15l485t204r925b270],
2	pylori	NNP	PERSON	pylori	_	0	SENT_161	[p15l960t205r1158b293],
3	eradication	NN	O	eradication	nn	4	SENT_161	[p15l1201t204r1635b270],
4	rates	NNS	O	rate	dep	2	SENT_161	[p15l1689t221r1898b285],
5	,	,	O	,	_	0	SENT_161	[p15l1689t221r1898b285],
6	by	IN	O	by	_	0	SENT_161	[p15l1952t204r2038b293],
7	study	NN	O	study	nn	8	SENT_161	[p15l484t316r696b404],
8	regimen	NN	O	regimen	prep_by	2	SENT_161	[p15l726t316r1052b405],
9	.	.	O	.	_	0	SENT_161	[p15l726t316r1052b405],

1	Population	NNP	O	Population	_	0	SENT_162	[p15l130t519r580b608],
2	/	:	O	/	punct	4	SENT_162	[p15l130t519r580b608],
3	Eradication	NNP	O	Eradication	nn	4	SENT_162	[p15l844t519r1277b585],
4	Rate	NNP	O	Rate	dep	1	SENT_162	[p15l1319t524r1509b600],
5	,	,	O	,	_	0	SENT_162	[p15l1319t524r1509b600],
6	Treatment	NNP	ORGANIZATION	Treatment	nn	7	SENT_162	[p15l118t635r518b696],
7	Group	NNP	ORGANIZATION	Group	appos	4	SENT_162	[p15l549t634r792b719],
8	n/N	NN	O	n/n	dep	1	SENT_162	[p15l1007t635r1193b711],
9	*	CD	PERCENT	*	num	11	SENT_162	[p15l1007t635r1193b711],
10	(	CD	PERCENT	(	num	11	SENT_162	[p15l1231t631r1345b718],
11	%	NN	PERCENT	%	dep	1	SENT_162	[p15l1231t631r1345b718],
12	)	CD	PERCENT	)	num	15	SENT_162	[p15l1231t631r1345b718],
13	95	CD	PERCENT	95	number	14	SENT_162	[p15l1656t634r1809b696],
14	%	NN	PERCENT	%	amod	15	SENT_162	[p15l1656t634r1809b696],
15	CI	NN	O	ci	dep	11	SENT_162	[p15l1840t634r1912b696],

1	Intent	NN	O	intent	_	0	SENT_163	[p15l130t820r351b881],
2	to	TO	O	to	aux	3	SENT_163	[p15l379t832r456b881],
3	treat	VB	O	treat	dep	1	SENT_163	[p15l488t832r670b881],

1	Group	NNP	O	Group	nn	4	SENT_164	[p15l126t1815r346b1891],
2	A	NN	O	a	nn	4	SENT_164	[p15l370t1816r420b1870],
3	=	JJ	O	=	amod	4	SENT_164	[p15l446t1836r480b1850],
4	levofloxacin	NN	O	levofloxacin	_	0	SENT_164	[p15l512t1811r919b1871],
5	500	CD	NUMBER	500	num	6	SENT_164	[p15l950t1815r1077b1870],
6	mg/d	NN	O	mg/d	dep	4	SENT_164	[p15l1108t1811r1307b1892],
7	,	,	O	,	_	0	SENT_164	[p15l1108t1811r1307b1892],
8	amoxicil	NN	O	amoxicil	nn	9	SENT_164	[p15l1336t1811r1904b1871],
9	|	NN	O	|	appos	6	SENT_164	[p15l1336t1811r1904b1871],
10	in1000	CD	NUMBER	in1000	num	12	SENT_164	[p15l1336t1811r1904b1871],
11	mg	NN	O	mg	nn	12	SENT_164	[p15l1935t1833r2036b1892],
12	BID	NNP	O	BID	dep	4	SENT_164	[p15l129t1917r266b1986],
13	,	,	O	,	_	0	SENT_164	[p15l129t1917r266b1986],
14	and	CC	O	and	_	0	SENT_164	[p15l294t1913r414b1972],
15	esomeprazole	NN	O	esomeprazole	nn	17	SENT_164	[p15l444t1913r907b1993],
16	20	CD	NUMBER	20	num	17	SENT_164	[p15l934t1917r1012b1972],
17	mg	NN	O	mg	dep	4	SENT_164	[p15l1042t1934r1142b1993],
18	BID	NNP	O	BID	nn	19	SENT_164	[p15l1169t1917r1287b1971],
19	Forl	NNP	O	Forl	dep	4	SENT_164	[p15l1313t1913r1456b1972],
20	week	NN	DURATION	week	tmod	19	SENT_164	[p15l1492t1913r1678b1986],
21	;	:	O	;	_	0	SENT_164	[p15l1492t1913r1678b1986],
22	group	NN	O	group	nn	23	SENT_164	[p15l1703t1934r1900b1993],
23	B	NN	O	b	dep	19	SENT_164	[p15l1931t1917r1969b1971],
24	=	JJ	O	=	amod	25	SENT_164	[p15l1996t1937r2031b1952],
25	levofloxacin	NN	O	levofloxacin	dep	23	SENT_164	[p15l128t2015r526b2074],
26	500	CD	NUMBER	500	num	27	SENT_164	[p15l566t2019r693b2074],
27	mg/d	NN	O	mg/d	dep	4	SENT_164	[p15l733t2015r932b2095],
28	,	,	O	,	_	0	SENT_164	[p15l733t2015r932b2095],
29	amoxicillin	NNP	O	amoxicillin	appos	27	SENT_164	[p15l970t2015r1336b2074],
30	1000	CD	DATE	1000	num	32	SENT_164	[p15l1380t2019r1547b2074],
31	mg	NN	O	mg	nn	32	SENT_164	[p15l1588t2036r1689b2095],
32	BID	NNP	O	BID	dep	4	SENT_164	[p15l1726t2019r1868b2087],
33	,	,	O	,	_	0	SENT_164	[p15l1726t2019r1868b2087],
34	and	CC	O	and	_	0	SENT_164	[p15l1905t2015r2029b2074],
35	esomeprazole	NN	O	esomeprazole	conj_and	32	SENT_164	[p15l126t2116r607b2196],
36	40	CD	NUMBER	40	num	38	SENT_164	[p15l640t2120r724b2176],
37	mg	NN	O	mg	nn	38	SENT_164	[p15l762t2138r863b2197],
38	BID	NNP	O	BID	dep	4	SENT_164	[p15l899t2121r1021b2175],
39	For	IN	O	for	dep	41	SENT_164	[p15l1055t2116r1155b2176],
40	1	CD	DURATION	1	pobj	39	SENT_164	[p15l1190t2121r1210b2175],
41	week	NN	NUMBER	week	rcmod	38	SENT_164	[p15l1254t2116r1446b2189],
42	;	:	O	;	_	0	SENT_164	[p15l1254t2116r1446b2189],
43	group	NN	O	group	nn	44	SENT_164	[p15l1480t2138r1684b2197],
44	C	NN	O	c	dep	38	SENT_164	[p15l1719t2120r1767b2176],
45	=	JJ	O	=	amod	47	SENT_164	[p15l1801t2141r1836b2155],
46	|	CD	NUMBER	|	tmod	45	SENT_164	[p15l1875t2116r2033b2176, p15l124t2218r394b2277],
47	evoFloxacin	NN	O	evofloxacin	dep	44	SENT_164	[p15l1875t2116r2033b2176, p15l124t2218r394b2277],
48	500	CD	NUMBER	500	num	49	SENT_164	[p15l424t2222r551b2277],
49	mg/d	NN	O	mg/d	dep	4	SENT_164	[p15l581t2218r779b2298],
50	,	,	O	,	_	0	SENT_164	[p15l581t2218r779b2298],
51	amoxicil	NN	O	amoxicil	nn	52	SENT_164	[p15l806t2218r1374b2277],
52	|	NN	O	|	appos	49	SENT_164	[p15l806t2218r1374b2277],
53	in1000	CD	NUMBER	in1000	num	55	SENT_164	[p15l806t2218r1374b2277],
54	mg	NN	O	mg	nn	55	SENT_164	[p15l1403t2240r1505b2298],
55	BID	NNP	O	BID	dep	4	SENT_164	[p15l1531t2222r1673b2291],
56	,	,	O	,	_	0	SENT_164	[p15l1531t2222r1673b2291],
57	and	CC	O	and	_	0	SENT_164	[p15l1701t2218r1824b2277],
58	rabeprazo	NN	O	rabeprazo	nn	61	SENT_164	[p15l1855t2218r2032b2277, p15l128t2320r488b2399],
59	|	NN	O	|	nn	61	SENT_164	[p15l1855t2218r2032b2277, p15l128t2320r488b2399],
60	e10	NN	O	e10	nn	61	SENT_164	[p15l1855t2218r2032b2277, p15l128t2320r488b2399],
61	mg	NN	O	mg	conj_and	55	SENT_164	[p15l522t2341r623b2400],
62	BID	NNP	O	BID	dep	4	SENT_164	[p15l654t2324r776b2378],
63	For	IN	O	for	dep	65	SENT_164	[p15l806t2320r906b2379],
64	1	CD	DURATION	1	pobj	63	SENT_164	[p15l936t2325r956b2378],
65	week	NN	NUMBER	week	rcmod	62	SENT_164	[p15l996t2320r1187b2379],
66	.	.	O	.	_	0	SENT_164	[p15l996t2320r1187b2379],

1	*	NN	O	*	nn	2	SENT_165	[p15l128t2426r197b2480],
2	n	NN	O	n	nsubj	3	SENT_165	[p15l128t2426r197b2480],
3	represents	VBZ	O	represent	_	0	SENT_165	[p15l235t2438r583b2501],
4	the	DT	O	the	det	5	SENT_165	[p15l615t2422r721b2481],
5	number	NN	O	number	dobj	3	SENT_165	[p15l759t2422r1022b2481],
6	of	IN	O	of	_	0	SENT_165	[p15l1053t2421r1130b2481],
7	patients	NNS	O	patient	prep_of	5	SENT_165	[p15l1154t2423r1425b2501],
8	in	IN	O	in	_	0	SENT_165	[p15l1461t2423r1514b2480],
9	each	DT	O	each	det	10	SENT_165	[p15l1552t2422r1703b2481],
10	group	NN	O	group	prep_in	7	SENT_165	[p15l1739t2443r1939b2502],
11	in	IN	O	in	_	0	SENT_165	[p15l1977t2423r2030b2480],
12	whom	WP	O	whom	rel	17	SENT_165	[p15l164t2523r374b2583],
13	H	NNP	O	H	nn	15	SENT_165	[p15l411t2528r467b2582],
14	pylori	NN	O	pylorus	nn	15	SENT_165	[p15l490t2523r656b2604],
15	infection	NN	O	infection	nsubjpass	17	SENT_165	[p15l690t2523r982b2583],
16	was	VBD	O	be	auxpass	17	SENT_165	[p15l1017t2545r1148b2583],
17	eradicated	VBN	O	eradicate	rcmod	10	SENT_165	[p15l1182t2523r1539b2583],
18	at	IN	O	at	_	0	SENT_165	[p15l1577t2539r1642b2582],
19	the	DT	O	the	det	20	SENT_165	[p15l1672t2523r1778b2583],
20	end	NN	O	end	prep_at	17	SENT_165	[p15l1813t2523r1931b2583],
21	of	IN	O	of	_	0	SENT_165	[p15l1970t2523r2047b2583],
22	treatment	NN	O	treatment	prep_of	20	SENT_165	[p15l164t2641r523b2698],
23	;	:	O	;	_	0	SENT_165	[p15l164t2641r523b2698],
24	N	NN	O	n	nsubj	25	SENT_165	[p15l548t2630r604b2684],
25	represents	VBZ	O	represent	parataxis	3	SENT_165	[p15l625t2641r974b2705],
26	the	DT	O	the	det	28	SENT_165	[p15l995t2625r1101b2685],
27	number	NN	O	number	nn	28	SENT_165	[p15l1128t2625r1392b2685],
28	ofpatients	NNS	O	ofpatient	dobj	25	SENT_165	[p15l1411t2625r1773b2705],
29	in	IN	O	in	_	0	SENT_165	[p15l1800t2627r1851b2684],
30	each	DT	O	each	det	31	SENT_165	[p15l1880t2625r2030b2685],
31	group	NN	O	group	prep_in	25	SENT_165	[p15l165t2749r365b2807],
32	who	WP	O	who	nsubj	33	SENT_165	[p15l391t2727r536b2786],
33	completed	VBD	O	complete	rcmod	31	SENT_165	[p15l564t2727r921b2807],
34	triple	JJ	O	triple	amod	35	SENT_165	[p15l950t2727r1127b2807],
35	therapy	NN	O	therapy	dobj	33	SENT_165	[p15l1153t2727r1426b2807],
36	.	.	O	.	_	0	SENT_165	[p15l1153t2727r1426b2807],

1	Clinical	JJ	O	clinical	amod	2	SENT_166	[p15l95t3207r220b3237],
2	Therapeutics	NNS	O	therapeutics	_	0	SENT_166	[p15l234t3207r462b3247],

1	Table	NNP	O	Table	nn	2	SENT_167	[p16l220t96r314b125],
2	III	NNP	O	III	_	0	SENT_167	[p16l331t98r372b125],
3	.	.	O	.	_	0	SENT_167	[p16l331t98r372b125],

1	Adverse	JJ	O	adverse	amod	2	SENT_168	[p16l395t96r533b125],
2	events	NNS	O	event	_	0	SENT_168	[p16l548t103r666b125],
3	.	.	O	.	_	0	SENT_168	[p16l548t103r666b125],

1	Group	NNP	O	Group	nn	7	SENT_169	[p16l706t189r816b227],
2	A	NNP	O	A	nn	7	SENT_169	[p16l830t190r854b217],
3	Group	NNP	O	Group	nn	7	SENT_169	[p16l1061t189r1170b227],
4	B	NNP	O	B	nn	7	SENT_169	[p16l1188t190r1207b216],
5	Group	NNP	O	Group	nn	7	SENT_169	[p16l1409t189r1519b227],
6	C	NNP	O	C	nn	7	SENT_169	[p16l1534t189r1558b217],
7	Total	NNP	O	Total	_	0	SENT_169	[p16l1800t187r1887b217],
8	Adverse	JJ	O	adverse	amod	11	SENT_169	[p16l222t237r356b267],
9	Event	NN	O	event	nn	11	SENT_169	[p16l373t240r465b267],
10	(	NN	O	(	nn	11	SENT_169	[p16l715t238r744b277],
11	n	NN	O	n	dep	7	SENT_169	[p16l715t238r744b277],
12	=	JJ	O	=	quantmod	14	SENT_169	[p16l761t250r778b257],
13	61	CD	NUMBER	61	number	14	SENT_169	[p16l795t238r844b277],
14	)	CD	NUMBER	)	num	29	SENT_169	[p16l795t238r844b277],
15	(	NN	O	(	nn	29	SENT_169	[p16l1068t238r1097b277],
16	n	NN	O	n	nn	29	SENT_169	[p16l1068t238r1097b277],
17	=	JJ	O	=	amod	29	SENT_169	[p16l1114t250r1132b257],
18	62	CD	NUMBER	62	number	19	SENT_169	[p16l1148t238r1200b277],
19	)	CD	NUMBER	)	num	29	SENT_169	[p16l1148t238r1200b277],
20	(	NN	O	(	nn	29	SENT_169	[p16l1419t238r1448b277],
21	n	NN	O	n	nn	29	SENT_169	[p16l1419t238r1448b277],
22	=	JJ	O	=	amod	29	SENT_169	[p16l1465t250r1483b257],
23	61	CD	NUMBER	61	number	24	SENT_169	[p16l1499t238r1549b277],
24	)	CD	NUMBER	)	num	29	SENT_169	[p16l1499t238r1549b277],
25	(	NN	O	(	nn	29	SENT_169	[p16l1764t238r1802b277],
26	N	NN	O	n	nn	29	SENT_169	[p16l1764t238r1802b277],
27	=	JJ	O	=	amod	29	SENT_169	[p16l1820t250r1837b257],
28	184	CD	NUMBER	184	num	29	SENT_169	[p16l1856t238r1928b277],
29	)	NN	O	)	dep	11	SENT_169	[p16l1856t238r1928b277],

1	Abdominal	JJ	O	abdominal	amod	2	SENT_170	[p16l222t320r411b350],
2	pain	NN	O	pain	_	0	SENT_170	[p16l429t321r500b360],
3	2	CD	NUMBER	2	num	8	SENT_170	[p16l1848t322r1865b350],
4	Diarrhea	NNP	O	Diarrhea	nn	8	SENT_170	[p16l225t373r375b402],
5	Dizziness	NNP	O	Dizziness	nn	8	SENT_170	[p16l225t426r381b454],
6	Nausea	NN	O	nausea	nn	8	SENT_170	[p16l225t479r351b506],
7	Skin	NN	O	skin	nn	8	SENT_170	[p16l222t529r292b558],
8	rash	NN	O	rash	dep	2	SENT_170	[p16l309t529r379b559],
9	Total	JJ	O	total	amod	14	SENT_170	[p16l220t581r308b611],
10	5	CD	NUMBER	5	amod	14	SENT_170	[p16l771t583r788b611],
11	éOl	NN	O	éol	nn	14	SENT_170	[p16l770t322r788b558],
12	\	CD	NUMBER	\	num	14	SENT_170	[p16l770t322r788b558],
13	)	NN	O	)	nn	14	SENT_170	[p16l770t322r788b558],
14	l	NN	O	l	dep	8	SENT_170	[p16l770t322r788b558],
15	\	CD	NUMBER	\	num	17	SENT_170	[p16l770t322r788b558],
16	)	CD	NUMBER	)	num	17	SENT_170	[p16l770t322r788b558],
17	©	NN	O	©	dep	2	SENT_170	[p16l770t322r788b558],

1	O	NN	O	o	_	0	SENT_171	[p16l1124t323r1143b611],
2	\	SYM	O	\	dep	5	SENT_171	[p16l1124t323r1143b611],
3	©	CD	NUMBER	©	num	5	SENT_171	[p16l1124t323r1143b611],
4	C	NN	O	c	nn	5	SENT_171	[p16l1124t323r1143b611],
5	)	NN	O	)	rcmod	1	SENT_171	[p16l1124t323r1143b611],
6	l	NN	O	l	tmod	1	SENT_171	[p16l1124t323r1143b611],
7	\	CD	NUMBER	\	num	8	SENT_171	[p16l1124t323r1143b611],
8	JUJ	NN	O	juj	dep	1	SENT_171	[p16l1124t323r1143b611],
9	—	CD	NUMBER	—	num	10	SENT_171	[p16l1124t323r1143b611],
10	‘	NN	O	‘	dep	8	SENT_171	[p16l1124t323r1143b611],

1	Group	NNP	O	Group	nn	4	SENT_172	[p16l223t665r319b699],
2	A	NN	O	a	nn	4	SENT_172	[p16l330t665r353b689],
3	=	JJ	O	=	amod	4	SENT_172	[p16l364t674r380b681],
4	levofloxacin	NN	O	levofloxacin	dep	19	SENT_172	[p16l395t663r570b690],
5	500	CD	NUMBER	500	num	6	SENT_172	[p16l584t665r639b690],
6	mg/d	NN	O	mg/d	dep	4	SENT_172	[p16l654t663r740b699],
7	,	,	O	,	_	0	SENT_172	[p16l654t663r740b699],
8	amoxicillin	NNP	O	amoxicillin	conj_and	4	SENT_172	[p16l753t663r911b690],
9	1000	CD	DATE	1000	num	11	SENT_172	[p16l926t665r999b690],
10	mg	NN	O	mg	nn	11	SENT_172	[p16l1014t673r1058b699],
11	BID	NNP	O	BID	dep	8	SENT_172	[p16l1071t665r1133b696],
12	,	,	O	,	_	0	SENT_172	[p16l1071t665r1133b696],
13	and	CC	O	and	_	0	SENT_172	[p16l1146t663r1200b690],
14	esomeprazole	NN	O	esomeprazole	conj_and	4	SENT_172	[p16l1214t663r1423b699],
15	20	CD	NUMBER	20	num	16	SENT_172	[p16l1435t665r1471b690],
16	mg	NN	O	mg	dep	14	SENT_172	[p16l1485t673r1530b699],
17	BID	NNP	O	BID	nn	19	SENT_172	[p16l1542t665r1596b689],
18	for1	NN	O	for1	nn	19	SENT_172	[p16l1608t663r1673b690],
19	week	NN	DURATION	week	_	0	SENT_172	[p16l1690t663r1773b696],
20	;	:	O	;	_	0	SENT_172	[p16l1690t663r1773b696],
21	group	NN	O	group	nn	22	SENT_172	[p16l1786t673r1874b699],
22	B	NN	O	b	dep	24	SENT_172	[p16l1889t665r1906b689],
23	=	JJ	O	=	amod	24	SENT_172	[p16l1919t674r1935b681],
24	levofloxacin	NN	O	levofloxacin	parataxis	19	SENT_172	[p16l224t709r399b736],
25	500	CD	NUMBER	500	num	26	SENT_172	[p16l419t711r475b736],
26	mg/d	NN	O	mg/d	dep	24	SENT_172	[p16l489t709r575b745],
27	,	,	O	,	_	0	SENT_172	[p16l489t709r575b745],
28	amoxicillin	NNP	O	amoxicillin	parataxis	19	SENT_172	[p16l589t709r746b736],
29	1000	CD	DATE	1000	num	31	SENT_172	[p16l763t711r836b736],
30	mg	NN	O	mg	nn	31	SENT_172	[p16l850t719r895b745],
31	BID	NNP	O	BID	dep	28	SENT_172	[p16l908t711r970b742],
32	,	,	O	,	_	0	SENT_172	[p16l908t711r970b742],
33	and	CC	O	and	_	0	SENT_172	[p16l983t709r1038b736],
34	esomeprazole	NN	O	esomeprazole	nn	36	SENT_172	[p16l1052t709r1260b745],
35	40	CD	NUMBER	40	num	36	SENT_172	[p16l1272t711r1310b736],
36	mg	NN	O	mg	conj_and	24	SENT_172	[p16l1324t719r1369b745],
37	BID	NNP	O	BID	nn	39	SENT_172	[p16l1382t711r1436b735],
38	for1	NN	O	for1	nn	39	SENT_172	[p16l1448t709r1513b736],
39	week	NN	DURATION	week	dep	36	SENT_172	[p16l1531t709r1614b742],
40	;	:	O	;	_	0	SENT_172	[p16l1531t709r1614b742],
41	group	NN	O	group	nn	42	SENT_172	[p16l1627t719r1715b745],
42	C	NN	O	c	dep	44	SENT_172	[p16l1729t711r1750b736],
43	=	JJ	O	=	amod	44	SENT_172	[p16l1763t720r1778b726],
44	levofloxacin	NN	O	levofloxacin	parataxis	19	SENT_172	[p16l1793t709r1936b736, p16l222t755r264b781],
45	500	CD	NUMBER	500	num	46	SENT_172	[p16l279t756r335b781],
46	mg/d	NN	O	mg/d	dep	44	SENT_172	[p16l349t755r438b791],
47	,	,	O	,	_	0	SENT_172	[p16l349t755r438b791],
48	amoxicillin	NNP	O	amoxicillin	conj_and	44	SENT_172	[p16l451t755r613b781],
49	1000	CD	DATE	1000	num	51	SENT_172	[p16l630t756r706b781],
50	mg	NN	O	mg	nn	51	SENT_172	[p16l721t764r766b791],
51	BID	NNP	O	BID	dep	48	SENT_172	[p16l780t757r844b788],
52	,	,	O	,	_	0	SENT_172	[p16l780t757r844b788],
53	and	CC	O	and	_	0	SENT_172	[p16l858t755r914b781],
54	rabeprazo	NN	O	rabeprazo	nn	59	SENT_172	[p16l930t755r1164b791],
55	|	NN	O	|	nn	59	SENT_172	[p16l930t755r1164b791],
56	e1O	NN	O	e1o	nn	59	SENT_172	[p16l930t755r1164b791],
57	mg	NN	O	mg	nn	59	SENT_172	[p16l1179t764r1225b791],
58	BID	NNP	O	BID	nn	59	SENT_172	[p16l1238t757r1293b781],
59	For1	NN	O	for1	conj_and	44	SENT_172	[p16l1307t755r1374b781],
60	week	NN	DURATION	week	tmod	59	SENT_172	[p16l1392t755r1478b781],
61	.	.	O	.	_	0	SENT_172	[p16l1392t755r1478b781],

1	pared	VBN	O	pare	_	0	SENT_173	[p16l6t1006r235b1098],
2	with	IN	O	with	_	0	SENT_173	[p16l279t1006r461b1078],
3	omeprazole	NN	O	omeprazole	prep_with	1	SENT_173	[p16l508t1006r1001b1098],
4	.	.	O	.	_	0	SENT_173	[p16l508t1006r1001b1098],

1	In	IN	O	in	dep	100	SENT_174	[p16l1047t1012r1127b1077],
2	the	DT	O	the	dep	100	SENT_174	[p16l1171t1006r1294b1078],
3	previous	JJ	O	previous	dep	100	SENT_174	[p16l1339t1011r1684b1098],
4	study	NN	O	study	dep	100	SENT_174	[p16l1732t1006r1949b1098],
5	that	WDT	O	that	dep	100	SENT_174	[p16l1993t1006r2154b1078],
6	evaluated	VBD	O	evaluate	dep	100	SENT_174	[p16l8t1122r384b1194],
7	the	DT	O	the	dep	100	SENT_174	[p16l409t1122r528b1194],
8	association	NN	O	association	dep	100	SENT_174	[p16l555t1127r992b1194],
9	between	IN	O	between	dep	100	SENT_174	[p16l1020t1122r1343b1194],
10	CYPZC19	NN	O	cypzc19	dep	100	SENT_174	[p16l1374t1127r1769b1194],
11	genotype	NN	O	genotype	dep	100	SENT_174	[p16l1796t1143r2151b1214],
12	and	CC	O	and	dep	100	SENT_174	[p16l8t1238r152b1310],
13	the	DT	O	the	dep	100	SENT_174	[p16l192t1238r311b1310],
14	clinical	JJ	O	clinical	dep	100	SENT_174	[p16l351t1238r630b1310],
15	efficacy	NN	O	efficacy	dep	100	SENT_174	[p16l671t1238r970b1329],
16	of	IN	O	of	dep	100	SENT_174	[p16l1011t1238r1092b1310],
17	rescue	NN	O	rescue	dep	100	SENT_174	[p16l1127t1266r1369b1310],
18	levofloxacin-based	JJ	O	levofloxacin-based	dep	100	SENT_174	[p16l1411t1238r2152b1310],
19	triple	JJ	O	triple	dep	100	SENT_174	[p16l6t1354r209b1446],
20	therapy	NN	O	therapy	dep	100	SENT_174	[p16l235t1354r530b1446],
21	including	VBG	O	include	dep	100	SENT_174	[p16l556t1354r915b1446],
22	esomeprazole	NN	O	esomeprazole	dep	100	SENT_174	[p16l941t1354r1489b1446],
23	,	,	O	,	_	0	SENT_174	[p16l941t1354r1489b1446],
24	CYPZC19	NN	O	cypzc19	dep	100	SENT_174	[p16l1520t1358r1909b1426],
25	genotype	NN	O	genotype	dep	100	SENT_174	[p16l1937t1382r2151b1446, p16l6t1491r172b1563],
26	appeared	VBD	O	appear	dep	100	SENT_174	[p16l205t1471r565b1563],
27	to	TO	O	to	dep	100	SENT_174	[p16l596t1491r673b1543],
28	affect	VB	O	affect	dep	100	SENT_174	[p16l707t1470r923b1543],
29	the	DT	O	the	dep	100	SENT_174	[p16l953t1471r1072b1543],
30	outcome	NN	O	outcome	dep	100	SENT_174	[p16l1106t1491r1444b1543],
31	of	IN	O	of	dep	100	SENT_174	[p16l1478t1470r1559b1543],
32	therapy	NN	O	therapy	dep	100	SENT_174	[p16l1585t1468r1974b1563],
33	.36	CD	NUMBER	.36	dep	100	SENT_174	[p16l1585t1468r1974b1563],
34	The	DT	O	the	dep	100	SENT_174	[p16l2002t1470r2151b1543],
35	study	NN	O	study	dep	100	SENT_174	[p16l8t1587r220b1679],
36	enrolled	VBD	O	enrol	dep	100	SENT_174	[p16l248t1587r567b1659],
37	166	CD	NUMBER	166	dep	100	SENT_174	[p16l602t1592r744b1659],
38	patients	NNS	O	patient	dep	100	SENT_174	[p16l774t1591r1083b1679],
39	who	WP	O	who	dep	100	SENT_174	[p16l1111t1587r1282b1659],
40	had	VBD	O	have	dep	100	SENT_174	[p16l1312t1587r1457b1659],
41	failed	VBN	O	fail	dep	100	SENT_174	[p16l1486t1587r1702b1659],
42	to	TO	O	to	dep	100	SENT_174	[p16l1730t1607r1807b1659],
43	respond	VB	O	respond	dep	100	SENT_174	[p16l1837t1587r2152b1679],
44	to	TO	O	to	dep	100	SENT_174	[p16l6t1723r84b1775],
45	standard	JJ	O	standard	dep	100	SENT_174	[p16l113t1703r457b1775],
46	triple	JJ	O	triple	dep	100	SENT_174	[p16l483t1703r689b1795],
47	therapy	NN	O	therapy	dep	100	SENT_174	[p16l715t1703r1017b1795],
48	for	IN	O	for	dep	100	SENT_174	[p16l1042t1703r1156b1775],
49	H	NN	O	h	dep	100	SENT_174	[p16l1182t1709r1260b1774],
50	pylori	NN	O	pylorus	dep	100	SENT_174	[p16l1279t1703r1513b1795],
51	eradication	NN	O	eradication	dep	100	SENT_174	[p16l1538t1703r1981b1775],
52	and	CC	O	and	dep	100	SENT_174	[p16l2009t1703r2152b1775],
53	were	VBD	O	be	dep	100	SENT_174	[p16l6t1848r192b1891],
54	randomized	VBN	O	randomize	dep	100	SENT_174	[p16l226t1819r695b1891],
55	to	TO	O	to	dep	100	SENT_174	[p16l728t1840r805b1891],
56	receive	VB	O	receive	dep	100	SENT_174	[p16l839t1824r1107b1891],
57	a	DT	O	a	dep	100	SENT_174	[p16l1142t1848r1182b1891],
58	7-day	JJ	DURATION	7-day	dep	100	SENT_174	[p16l1219t1819r1439b1911],
59	regimen	NN	O	regimen	dep	100	SENT_174	[p16l1471t1824r1786b1911],
60	of	IN	O	of	dep	100	SENT_174	[p16l1820t1819r1902b1891],
61	either	CC	O	either	dep	100	SENT_174	[p16l1931t1819r2152b1891],
62	tetracycline	NN	O	tetracycline	dep	100	SENT_174	[p16l6t1935r460b2026],
63	5	CD	NUMBER	5	dep	100	SENT_174	[p16l491t1941r533b2007],
64	oo	NN	O	oo	dep	100	SENT_174	[p16l543t1940r637b2007],
65	mg	NN	O	mg	dep	100	SENT_174	[p16l668t1963r788b2027],
66	QID	NN	O	qid	dep	100	SENT_174	[p16l819t1939r1010b2026],
67	,	,	O	,	_	0	SENT_174	[p16l819t1939r1010b2026],
68	metronidazole	NN	O	metronidazole	dep	100	SENT_174	[p16l1037t1935r1604b2007],
69	250	CD	NUMBER	250	dep	100	SENT_174	[p16l1633t1940r1781b2007],
70	mg	NN	O	mg	dep	100	SENT_174	[p16l1811t1963r1931b2027],
71	QID	NN	O	qid	dep	100	SENT_174	[p16l1962t1939r2153b2026],
72	,	,	O	,	_	0	SENT_174	[p16l1962t1939r2153b2026],
73	bismuth	NN	O	bismuth	dep	100	SENT_174	[p16l9t2051r315b2123],
74	subcitrate	NN	O	subcitrate	dep	100	SENT_174	[p16l337t2051r704b2123],
75	120	CD	NUMBER	120	dep	100	SENT_174	[p16l732t2056r870b2123],
76	mg	NN	O	mg	dep	100	SENT_174	[p16l893t2079r1010b2143],
77	BID	NNP	O	BID	dep	100	SENT_174	[p16l1032t2057r1198b2139],
78	,	,	O	,	_	0	SENT_174	[p16l1032t2057r1198b2139],
79	and	CC	O	and	dep	100	SENT_174	[p16l1220t2051r1359b2123],
80	esomeprazole	NN	O	esomeprazole	dep	100	SENT_174	[p16l1381t2051r1893b2143],
81	40	CD	NUMBER	40	dep	100	SENT_174	[p16l1915t2056r2009b2123],
82	mg	NN	O	mg	dep	100	SENT_174	[p16l2033t2079r2152b2143],
83	BID	NNP	O	BID	dep	100	SENT_174	[p16l8t2173r181b2256],
84	,	,	O	,	_	0	SENT_174	[p16l8t2173r181b2256],
85	or	CC	O	or	dep	100	SENT_174	[p16l220t2196r302b2239],
86	levofloxacin	NN	O	levofloxacin	dep	100	SENT_174	[p16l341t2167r825b2239],
87	5	CD	NUMBER	5	dep	100	SENT_174	[p16l866t2174r907b2239],
88	oo	NN	O	oo	dep	100	SENT_174	[p16l918t2172r1012b2239],
89	mg/d	NN	O	mg/d	dep	100	SENT_174	[p16l1052t2167r1273b2259],
90	,	,	O	,	_	0	SENT_174	[p16l1052t2167r1273b2259],
91	amoxicillin	NNP	O	amoxicillin	dep	100	SENT_174	[p16l1312t2167r1754b2239],
92	1000	CD	DATE	1000	dep	100	SENT_174	[p16l1799t2172r1992b2239],
93	mg	NN	O	mg	dep	100	SENT_174	[p16l2033t2196r2153b2259],
94	BID	NNP	O	BID	dep	100	SENT_174	[p16l8t2288r170b2371],
95	,	,	O	,	_	0	SENT_174	[p16l8t2288r170b2371],
96	and	CC	O	and	dep	100	SENT_174	[p16l189t2283r325b2355],
97	esomeprazole	NN	O	esomeprazole	dep	100	SENT_174	[p16l345t2283r843b2375],
98	40	CD	NUMBER	40	dep	100	SENT_174	[p16l863t2288r955b2355],
99	mg	NN	O	mg	dep	100	SENT_174	[p16l976t2311r1091b2375],
100	BID	NNP	O	BID	_	0	SENT_174	[p16l1110t2288r1270b2355],
101	.	.	O	.	_	0	SENT_174	[p16l1110t2288r1270b2355],

1	Participants	NNS	O	participant	_	0	SENT_175	[p16l1290t2287r1744b2375],
2	’	CD	NUMBER	’	num	5	SENT_175	[p16l1290t2287r1744b2375],
3	C	NN	O	c	nn	5	SENT_175	[p16l1772t2287r1831b2355],
4	YP2	NN	O	yp2	nn	5	SENT_175	[p16l1837t2288r1986b2354],
5	C	NN	O	c	dep	1	SENT_175	[p16l1998t2287r2057b2355],
6	1	CD	NUMBER	1	number	7	SENT_175	[p16l2062t2288r2092b2354],
7	9	CD	NUMBER	9	dep	5	SENT_175	[p16l2108t2288r2151b2353],

1	genotypes	NNS	O	genotype	nsubjpass	3	SENT_176	[p16l7t2453r392b2525],
2	were	VBD	O	be	auxpass	3	SENT_176	[p16l416t2461r600b2505],
3	determined	VBN	O	determine	_	0	SENT_176	[p16l627t2433r1086b2522],
4	,	,	O	,	_	0	SENT_176	[p16l627t2433r1086b2522],
5	and	CC	O	and	_	0	SENT_176	[p16l1110t2433r1252b2505],
6	the	DT	O	the	det	8	SENT_176	[p16l1275t2433r1393b2505],
7	treatment	NN	O	treatment	nn	8	SENT_176	[p16l1417t2453r1795b2505],
8	response	NN	O	response	nsubjpass	10	SENT_176	[p16l1818t2461r2153b2525],
9	was	VBD	O	be	auxpass	10	SENT_176	[p16l6t2580r155b2623],
10	evaluated	VBN	O	evaluate	conj_and	3	SENT_176	[p16l186t2551r561b2623],
11	by	IN	O	by	_	0	SENT_176	[p16l591t2551r684b2643],
12	follow-up	JJ	O	follow-up	amod	13	SENT_176	[p16l711t2551r1096b2643],
13	endoscopy	NN	O	endoscopy	agent	10	SENT_176	[p16l1127t2551r1545b2643],
14	16	CD	DATE	16	num	15	SENT_176	[p16l1578t2557r1668b2623],
15	weeks	NNS	DATE	week	tmod	10	SENT_176	[p16l1697t2551r1934b2623],
16	later	RB	DATE	later	advmod	15	SENT_176	[p16l1964t2551r2151b2623],
17	.	.	O	.	_	0	SENT_176	[p16l1964t2551r2151b2623],

1	Cure	NN	O	cure	nn	2	SENT_177	[p16l10t2673r200b2741],
2	rates	NNS	O	rate	nsubj	5	SENT_177	[p16l245t2689r433b2741],
3	were	VBD	O	be	cop	5	SENT_177	[p16l477t2697r666b2741],
4	significantly	RB	O	significantly	advmod	5	SENT_177	[p16l713t2669r1200b2761],
5	lower	JJR	O	lower	dep	18	SENT_177	[p16l1244t2669r1469b2741],
6	in	IN	O	in	_	0	SENT_177	[p16l1514t2673r1587b2740],
7	the	DT	O	the	det	9	SENT_177	[p16l1631t2669r1752b2741],
8	HomEM	NNP	O	HomEM	nn	9	SENT_177	[p16l1797t2674r2152b2741],
9	group	NN	O	group	prep_in	5	SENT_177	[p16l7t2815r238b2879],
10	compared	VBN	O	compare	_	0	SENT_177	[p16l276t2787r668b2879],
11	with	IN	O	with	prepc_compared_with	5	SENT_177	[p16l704t2787r881b2859],
12	the	DT	O	the	det	14	SENT_177	[p16l918t2787r1037b2859],
13	combined	JJ	O	combined	amod	14	SENT_177	[p16l1075t2787r1462b2859],
14	HetEM	NN	O	hetem	pobj	5	SENT_177	[p16l1499t2793r1794b2859],
15	and	CC	O	and	_	0	SENT_177	[p16l1832t2787r1975b2859],
16	PM	NN	O	pm	nn	17	SENT_177	[p16l2012t2793r2153b2859],
17	groups	NNS	O	group	pobj	5	SENT_177	[p16l7t2933r277b2997],
18	(	VBP	O	(	_	0	SENT_177	[p16l327t2910r407b2994],
19	P	NN	O	p	nsubj	20	SENT_177	[p16l327t2910r407b2994],
20	=	JJ	O	=	xcomp	18	SENT_177	[p16l453t2943r495b2968],
21	0.03	CD	NUMBER	0.03	num	22	SENT_177	[p16l544t2910r772b2994],
22	)	NN	O	)	nsubj	18	SENT_177	[p16l544t2910r772b2994],
23	.	.	O	.	_	0	SENT_177	[p16l544t2910r772b2994],

1	In	IN	O	in	_	0	SENT_178	[p16l817t2911r897b2976],
2	the	DT	O	the	det	4	SENT_178	[p16l940t2905r1060b2977],
3	present	JJ	DATE	present	amod	4	SENT_178	[p16l1104t2926r1393b2997],
4	study	NN	O	study	prep_in	23	SENT_178	[p16l1438t2905r1652b2997],
5	of	IN	O	of	_	0	SENT_178	[p16l1696t2905r1778b2977],
6	first-line	JJ	O	first-line	amod	9	SENT_178	[p16l1818t2905r2151b2977],
7	levofloxacin-based	JJ	O	levofloxacin-based	amod	9	SENT_178	[p16l7t3023r749b3095],
8	triple	JJ	O	triple	amod	9	SENT_178	[p16l784t3023r991b3115],
9	therapy	NN	O	therapy	prep_of	4	SENT_178	[p16l1027t3023r1342b3115],
10	,	,	O	,	_	0	SENT_178	[p16l1027t3023r1342b3115],
11	eradication	NN	O	eradication	nn	12	SENT_178	[p16l1378t3023r1821b3095],
12	rates	NNS	O	rate	nsubjpass	23	SENT_178	[p16l1857t3043r2042b3095],
13	in	IN	O	in	_	0	SENT_178	[p16l2079t3027r2152b3094],
14	the	DT	O	the	det	16	SENT_178	[p16l6t3141r125b3213],
15	2	CD	NUMBER	2	num	16	SENT_178	[p16l166t3146r212b3212],
16	regimens	NNS	O	regimen	prep_in	12	SENT_178	[p16l255t3146r604b3233],
17	that	WDT	O	that	nsubj	18	SENT_178	[p16l646t3141r802b3213],
18	included	VBD	O	include	rcmod	16	SENT_178	[p16l843t3141r1178b3213],
19	esomeprazole	NN	O	esomeprazole	dobj	18	SENT_178	[p16l1219t3141r1754b3233],
20	were	VBD	O	be	auxpass	23	SENT_178	[p16l1794t3169r1981b3213],
21	not	RB	O	not	neg	23	SENT_178	[p16l2023t3161r2153b3213],
22	significantly	RB	O	significantly	advmod	23	SENT_178	[p16l8t3259r484b3351],
23	affected	VBN	O	affect	_	0	SENT_178	[p16l509t3259r814b3331],
24	by	IN	O	by	_	0	SENT_178	[p16l841t3259r933b3351],
25	CYPZC19	NN	O	cypzc19	nn	26	SENT_178	[p16l962t3264r1355b3331],
26	genotype	NN	O	genotype	agent	23	SENT_178	[p16l1381t3280r1756b3351],
27	.	.	O	.	_	0	SENT_178	[p16l1381t3280r1756b3351],

1	However	RB	O	however	advmod	18	SENT_179	[p16l1781t3265r2153b3348],
2	,	,	O	,	_	0	SENT_179	[p16l1781t3265r2153b3348],
3	because	IN	O	because	_	0	SENT_179	[p16l9t3377r311b3449],
4	of	IN	O	of	prepc_because_of	18	SENT_179	[p16l339t3377r420b3449],
5	the	DT	O	the	det	8	SENT_179	[p16l441t3377r560b3449],
6	small	JJ	O	small	amod	8	SENT_179	[p16l589t3377r793b3449],
7	sample	NN	O	sample	nn	8	SENT_179	[p16l822t3377r1093b3469],
8	sizes	NNS	O	size	pobj	18	SENT_179	[p16l1121t3381r1294b3449],
9	in	IN	O	in	_	0	SENT_179	[p16l1322t3381r1395b3448],
10	this	DT	O	this	prep_in	8	SENT_179	[p16l1421t3377r1560b3449],
11	and	CC	O	and	_	0	SENT_179	[p16l1589t3377r1733b3449],
12	the	DT	O	the	det	14	SENT_179	[p16l1758t3377r1877b3449],
13	earlier	JJR	O	earlier	amod	14	SENT_179	[p16l1905t3377r2152b3449],
14	study	NN	O	study	conj_and	10	SENT_179	[p16l8t3495r234b3587],
15	,	,	O	,	_	0	SENT_179	[p16l8t3495r234b3587],
16	the	DT	O	the	det	17	SENT_179	[p16l262t3495r381b3567],
17	findings	NNS	O	finding	nsubj	18	SENT_179	[p16l412t3495r725b3587],
18	require	VBP	O	require	_	0	SENT_179	[p16l756t3500r1035b3587],
19	further	JJ	O	further	amod	20	SENT_179	[p16l1066t3495r1339b3567],
20	investigation	NN	O	investigation	dobj	18	SENT_179	[p16l1370t3500r1896b3587],
21	.	.	O	.	_	0	SENT_179	[p16l1370t3500r1896b3587],

1	In	IN	O	in	dep	7	SENT_180	[p16l118t3619r199b3684],
2	the	DT	O	the	det	4	SENT_180	[p16l245t3613r369b3685],
3	present	JJ	DATE	present	amod	4	SENT_180	[p16l416t3634r715b3705],
4	study	NN	O	study	pobj	1	SENT_180	[p16l762t3613r999b3705],
5	,	,	O	,	_	0	SENT_180	[p16l762t3613r999b3705],
6	the	DT	O	the	det	7	SENT_180	[p16l1044t3613r1168b3685],
7	regimen	NN	O	regimen	_	0	SENT_180	[p16l1215t3618r1544b3705],
8	that	WDT	O	that	nsubj	9	SENT_180	[p16l1590t3613r1754b3685],
9	included	VBD	O	include	rcmod	7	SENT_180	[p16l1800t3613r2152b3685],
10	rabeprazole	NN	O	rabeprazole	nn	12	SENT_180	[p17l7t20r462b112],
11	10	CD	NUMBER	10	num	12	SENT_180	[p17l493t25r582b92],
12	mg	NN	O	mg	dobj	9	SENT_180	[p17l608t48r726b112],
13	BID	NNP	O	BID	nsubjpass	15	SENT_180	[p17l751t25r900b91],
14	was	VBD	O	be	auxpass	15	SENT_180	[p17l925t48r1073b92],
15	associated	VBN	O	associate	rcmod	12	SENT_180	[p17l1100t20r1494b92],
16	with	IN	O	with	_	0	SENT_180	[p17l1516t20r1691b92],
17	an	DT	O	a	det	19	SENT_180	[p17l1716t48r1807b92],
18	H	NN	O	h	nn	19	SENT_180	[p17l1830t25r1907b91],
19	pylori	NN	O	pylorus	prep_with	15	SENT_180	[p17l1924t20r2154b111],

1	Table	NNP	O	Table	_	0	SENT_181	[p17l120t239r214b269],
2	IV	CD	NUMBER	iv	dep	1	SENT_181	[p17l231t241r269b269],
3	.	.	O	.	_	0	SENT_181	[p17l231t241r269b269],

1	Effects	NNS	O	effect	_	0	SENT_182	[p17l297t239r414b269],
2	of	IN	O	of	_	0	SENT_182	[p17l430t239r469b269],
3	the	DT	O	the	det	7	SENT_182	[p17l477t239r532b269],
4	cytochrome	NN	O	cytochrome	nn	7	SENT_182	[p17l547t239r754b279],
5	P450	NN	O	p450	nn	7	SENT_182	[p17l772t241r856b269],
6	2C19	NN	O	2c19	nn	7	SENT_182	[p17l870t241r957b269],
7	genotype	NN	O	genotype	prep_of	1	SENT_182	[p17l971t247r1132b279],
8	on	IN	O	on	_	0	SENT_182	[p17l1147t250r1189b269],
9	rates	NNS	O	rate	prep_on	7	SENT_182	[p17l1207t246r1291b269],
10	of	IN	O	of	_	0	SENT_182	[p17l1306t239r1345b269],
11	Helicobacter	NNP	PERSON	Helicobacter	nn	13	SENT_182	[p17l1355t239r1553b269],
12	pylori	NNP	O	pylori	nn	13	SENT_182	[p17l1563t239r1652b279],
13	eradication	NN	O	eradication	prep_of	9	SENT_182	[p17l1665t239r1873b275],
14	,	,	O	,	_	0	SENT_182	[p17l1665t239r1873b275],
15	by	IN	O	by	_	0	SENT_182	[p17l1891t239r1930b279],
16	treatment	NN	O	treatment	prep_by	1	SENT_182	[p17l1943t246r2036b269, p17l296t296r383b319],

1	regimen	NN	O	regimen	_	0	SENT_183	[p17l397t289r545b329],
2	,	,	O	,	_	0	SENT_183	[p17l397t289r545b329],
3	in	IN	O	in	dep	1	SENT_183	[p17l561t289r588b318],
4	the	DT	O	the	det	6	SENT_183	[p17l603t289r658b319],
5	per-protocol	JJ	O	per-protocol	amod	6	SENT_183	[p17l673t289r888b329],
6	population	NN	O	population	pobj	3	SENT_183	[p17l905t289r1106b329],
7	.	.	O	.	_	0	SENT_183	[p17l905t289r1106b329],

1	Eradication	NN	O	eradication	nn	2	SENT_184	[p17l1016t381r1212b410],
2	Rate	NN	O	rate	_	0	SENT_184	[p17l1230t383r1316b417],
3	,	,	O	,	_	0	SENT_184	[p17l1230t383r1316b417],
4	n/N	NN	O	n/n	appos	2	SENT_184	[p17l1333t383r1417b417],
5	*	CD	PERCENT	*	number	6	SENT_184	[p17l1333t383r1417b417],
6	(	CD	PERCENT	(	num	7	SENT_184	[p17l1434t381r1486b420],
7	%	NN	PERCENT	%	dep	2	SENT_184	[p17l1434t381r1486b420],
8	)	CD	NUMBER	)	dep	7	SENT_184	[p17l1434t381r1486b420],

1	Group	NNP	O	Group	nn	6	SENT_185	[p17l123t474r233b512],
2	HomEM	NNP	O	HomEM	nn	6	SENT_185	[p17l497t475r637b502],
3	HetEM	NNP	O	HetEM	nn	6	SENT_185	[p17l955t475r1071b502],
4	Combined	NNP	O	Combined	nn	6	SENT_185	[p17l1346t472r1523b502],
5	EM	NNP	O	EM	nn	6	SENT_185	[p17l1542t475r1594b501],
6	PM	NNP	O	PM	_	0	SENT_185	[p17l1895t474r1947b501],

1	A	DT	O	a	dep	151	SENT_186	[p17l121t575r146b601],
2	14/16	CD	NUMBER	14/16	dep	151	SENT_186	[p17l464t574r558b609],
3	(	NN	O	(	dep	151	SENT_186	[p17l574t573r670b612],
4	87.5	CD	NUMBER	87.5	dep	151	SENT_186	[p17l574t573r670b612],
5	)	CD	NUMBER	)	dep	151	SENT_186	[p17l574t573r670b612],
6	19/21	CD	NUMBER	19/21	dep	151	SENT_186	[p17l910t574r997b609],
7	(	CD	NUMBER	(	dep	151	SENT_186	[p17l1019t573r1121b612],
8	90.5	CD	NUMBER	90.5	dep	151	SENT_186	[p17l1019t573r1121b612],
9	)	NN	O	)	dep	151	SENT_186	[p17l1019t573r1121b612],
10	33/37	CD	NUMBER	33/37	dep	151	SENT_186	[p17l1372t574r1471b609],
11	(	CD	NUMBER	(	dep	151	SENT_186	[p17l1486t573r1584b612],
12	89.2	CD	NUMBER	89.2	dep	151	SENT_186	[p17l1486t573r1584b612],
13	)	NN	O	)	dep	151	SENT_186	[p17l1486t573r1584b612],
14	9/10	CD	NUMBER	9/10	dep	151	SENT_186	[p17l1829t574r1903b609],
15	(	CD	NUMBER	(	dep	151	SENT_186	[p17l1919t573r2019b612],
16	90.0	CD	NUMBER	90.0	dep	151	SENT_186	[p17l1919t573r2019b612],
17	)	NN	O	)	dep	151	SENT_186	[p17l1919t573r2019b612],
18	B	NN	O	b	dep	151	SENT_186	[p17l125t641r144b668],
19	11/15	CD	NUMBER	11/15	dep	151	SENT_186	[p17l468t641r557b675],
20	(	CD	NUMBER	(	dep	151	SENT_186	[p17l573t639r674b678],
21	73.3	CD	NUMBER	73.3	dep	151	SENT_186	[p17l573t639r674b678],
22	)	NN	O	)	dep	151	SENT_186	[p17l573t639r674b678],
23	18/19	CD	NUMBER	18/19	dep	151	SENT_186	[p17l910t641r1003b675],
24	(	CD	NUMBER	(	dep	151	SENT_186	[p17l1019t639r1120b679],
25	94.7	CD	NUMBER	94.7	dep	151	SENT_186	[p17l1019t639r1120b679],
26	)	NN	O	)	dep	151	SENT_186	[p17l1019t639r1120b679],
27	29/34	CD	NUMBER	29/34	dep	151	SENT_186	[p17l1370t641r1471b675],
28	(	CD	NUMBER	(	dep	151	SENT_186	[p17l1486t639r1585b678],
29	85.3	CD	NUMBER	85.3	dep	151	SENT_186	[p17l1486t639r1585b678],
30	)	CD	NUMBER	)	dep	151	SENT_186	[p17l1486t639r1585b678],
31	12/12	CD	NUMBER	12/12	dep	151	SENT_186	[p17l1810t641r1902b675],
32	(	NN	O	(	dep	151	SENT_186	[p17l1919t639r2006b678],
33	100	CD	NUMBER	100	dep	151	SENT_186	[p17l1919t639r2006b678],
34	)	CD	NUMBER	)	dep	151	SENT_186	[p17l1919t639r2006b678],
35	C	NN	O	c	dep	151	SENT_186	[p17l123t707r147b735],
36	16/19	CD	NUMBER	16/19	dep	151	SENT_186	[p17l464t707r557b742],
37	(	CD	NUMBER	(	dep	151	SENT_186	[p17l574t706r675b745],
38	84.2	CD	NUMBER	84.2	dep	151	SENT_186	[p17l574t706r675b745],
39	)	NN	O	)	dep	151	SENT_186	[p17l574t706r675b745],
40	13/21	CD	NUMBER	13/21	dep	151	SENT_186	[p17l910t707r997b742],
41	(	CD	NUMBER	(	dep	151	SENT_186	[p17l1019t706r1115b745],
42	61.9	CD	NUMBER	61.9	dep	151	SENT_186	[p17l1019t706r1115b745],
43	)	NN	O	)	dep	151	SENT_186	[p17l1019t706r1115b745],
44	29/40	CD	NUMBER	29/40	dep	151	SENT_186	[p17l1372t707r1470b742],
45	(	CD	NUMBER	(	dep	151	SENT_186	[p17l1486t706r1588b745],
46	72.5	CD	NUMBER	72.5	dep	151	SENT_186	[p17l1486t706r1588b745],
47	)	NN	O	)	dep	151	SENT_186	[p17l1486t706r1588b745],
48	11/14	CD	NUMBER	11/14	dep	151	SENT_186	[p17l1814t708r1905b742],
49	(	CD	NUMBER	(	dep	151	SENT_186	[p17l1919t706r2021b745],
50	78.6	CD	NUMBER	78.6	dep	151	SENT_186	[p17l1919t706r2021b745],
51	)	CD	NUMBER	)	dep	151	SENT_186	[p17l1919t706r2021b745],
52	Total	JJ	O	total	dep	151	SENT_186	[p17l120t772r207b802],
53	41/50	CD	NUMBER	41/50	dep	151	SENT_186	[p17l461t774r557b809],
54	(	CD	NUMBER	(	dep	151	SENT_186	[p17l573t773r673b812],
55	82.0	CD	NUMBER	82.0	dep	151	SENT_186	[p17l573t773r673b812],
56	)	NN	O	)	dep	151	SENT_186	[p17l573t773r673b812],
57	50/61	CD	NUMBER	50/61	dep	151	SENT_186	[p17l907t774r997b809],
58	(	CD	NUMBER	(	dep	151	SENT_186	[p17l1019t773r1119b812],
59	82.0	CD	NUMBER	82.0	dep	151	SENT_186	[p17l1019t773r1119b812],
60	)	NN	O	)	dep	151	SENT_186	[p17l1019t773r1119b812],
61	91/111	CD	NUMBER	91/111	dep	151	SENT_186	[p17l1359t774r1464b809],
62	(	CD	NUMBER	(	dep	151	SENT_186	[p17l1486t773r1585b812],
63	82.0	CD	NUMBER	82.0	dep	151	SENT_186	[p17l1486t773r1585b812],
64	)	NN	O	)	dep	151	SENT_186	[p17l1486t773r1585b812],
65	32/36	CD	NUMBER	32/36	dep	151	SENT_186	[p17l1804t774r1903b809],
66	(	CD	NUMBER	(	dep	151	SENT_186	[p17l1919t773r2020b812],
67	88.9	CD	NUMBER	88.9	dep	151	SENT_186	[p17l1919t773r2020b812],
68	)	CD	NUMBER	)	dep	151	SENT_186	[p17l1919t773r2020b812],
69	HomEM	NN	O	homem	dep	151	SENT_186	[p17l125t856r252b881],
70	=	JJ	O	=	dep	151	SENT_186	[p17l271t865r287b872],
71	homozygous	JJ	O	homozygous	dep	151	SENT_186	[p17l306t854r503b890],
72	extensive	JJ	O	extensive	dep	151	SENT_186	[p17l519t855r659b881],
73	metabolizer	NN	O	metabolizer	dep	151	SENT_186	[p17l677t854r862b881],
74	status	NN	O	status	dep	151	SENT_186	[p17l877t861r980b887],
75	;	:	O	;	_	0	SENT_186	[p17l877t861r980b887],
76	HetEM	NN	O	hetem	dep	151	SENT_186	[p17l1000t856r1105b881],
77	=	JJ	O	=	dep	151	SENT_186	[p17l1124t865r1140b872],
78	heterozygous	JJ	O	heterozygous	dep	151	SENT_186	[p17l1159t854r1365b890],
79	extensive	JJ	O	extensive	dep	151	SENT_186	[p17l1382t855r1521b881],
80	metabolizer	NN	O	metabolizer	dep	151	SENT_186	[p17l1539t854r1724b881],
81	status	NN	O	status	dep	151	SENT_186	[p17l1739t861r1842b887],
82	;	:	O	;	_	0	SENT_186	[p17l1739t861r1842b887],
83	PM	NN	O	pm	dep	151	SENT_186	[p17l1862t856r1909b881],
84	=	JJ	O	=	dep	151	SENT_186	[p17l1928t865r1944b872],
85	poor	JJ	O	poor	dep	151	SENT_186	[p17l1963t864r2037b890],
86	metabolizer	NN	O	metabolizer	dep	151	SENT_186	[p17l124t900r309b927],
87	status	NN	O	status	dep	151	SENT_186	[p17l320t907r422b933],
88	;	:	O	;	_	0	SENT_186	[p17l320t907r422b933],
89	group	NN	O	group	dep	151	SENT_186	[p17l435t910r527b936],
90	A	NN	O	a	dep	151	SENT_186	[p17l539t902r561b926],
91	=	JJ	O	=	dep	151	SENT_186	[p17l573t911r589b918],
92	levofloxacin	NN	O	levofloxacin	dep	151	SENT_186	[p17l604t900r787b927],
93	500	CD	NUMBER	500	dep	151	SENT_186	[p17l802t902r859b927],
94	mg/d	NN	O	mg/d	dep	151	SENT_186	[p17l874t900r964b936],
95	,	,	O	,	_	0	SENT_186	[p17l874t900r964b936],
96	amoxicillin	NNP	O	amoxicillin	dep	151	SENT_186	[p17l977t900r1142b927],
97	1000	CD	DATE	1000	dep	151	SENT_186	[p17l1159t902r1234b927],
98	mg	NN	O	mg	dep	151	SENT_186	[p17l1249t910r1295b936],
99	BID	NNP	O	BID	dep	151	SENT_186	[p17l1308t902r1372b933],
100	,	,	O	,	_	0	SENT_186	[p17l1308t902r1372b933],
101	and	CC	O	and	dep	151	SENT_186	[p17l1386t900r1441b927],
102	esomeprazole	NN	O	esomeprazole	dep	151	SENT_186	[p17l1456t900r1673b936],
103	20	CD	NUMBER	20	dep	151	SENT_186	[p17l1686t902r1722b927],
104	mg	NN	O	mg	dep	151	SENT_186	[p17l1737t910r1783b936],
105	BID	NNP	O	BID	dep	151	SENT_186	[p17l1796t902r1851b926],
106	for	IN	O	for	dep	151	SENT_186	[p17l1864t900r1909b927],
107	1	CD	DURATION	1	dep	151	SENT_186	[p17l1922t902r1931b926],
108	week	NN	NUMBER	week	dep	151	SENT_186	[p17l1949t900r2035b933],
109	;	:	O	;	_	0	SENT_186	[p17l1949t900r2035b933],
110	group	NN	O	group	dep	151	SENT_186	[p17l122t956r214b982],
111	B	NN	O	b	dep	151	SENT_186	[p17l228t948r245b972],
112	=	JJ	O	=	dep	151	SENT_186	[p17l258t957r273b963],
113	levofloxacin	NN	O	levofloxacin	dep	151	SENT_186	[p17l287t946r471b973],
114	500	CD	NUMBER	500	dep	151	SENT_186	[p17l485t948r542b973],
115	mg/d	NN	O	mg/d	dep	151	SENT_186	[p17l556t946r645b982],
116	,	,	O	,	_	0	SENT_186	[p17l556t946r645b982],
117	amoxicillin1000	CD	NUMBER	amoxicillin1000	dep	151	SENT_186	[p17l658t946r914b973],
118	mg	NN	O	mg	dep	151	SENT_186	[p17l928t956r973b982],
119	BID	NNP	O	BID	dep	151	SENT_186	[p17l986t948r1050b979],
120	,	,	O	,	_	0	SENT_186	[p17l986t948r1050b979],
121	and	CC	O	and	dep	151	SENT_186	[p17l1062t946r1118b973],
122	esomeprazole	NN	O	esomeprazole	dep	151	SENT_186	[p17l1132t946r1349b982],
123	40	CD	NUMBER	40	dep	151	SENT_186	[p17l1360t948r1398b973],
124	mg	NN	O	mg	dep	151	SENT_186	[p17l1412t956r1457b982],
125	BID	NNP	O	BID	dep	151	SENT_186	[p17l1470t948r1525b972],
126	for	IN	O	for	dep	151	SENT_186	[p17l1537t946r1582b973],
127	1	CD	DURATION	1	dep	151	SENT_186	[p17l1594t948r1603b972],
128	week	NN	NUMBER	week	dep	151	SENT_186	[p17l1620t946r1706b979],
129	;	:	O	;	_	0	SENT_186	[p17l1620t946r1706b979],
130	group	NN	O	group	dep	151	SENT_186	[p17l1718t956r1810b982],
131	C	NN	O	c	dep	151	SENT_186	[p17l1822t948r1844b973],
132	=	JJ	O	=	dep	151	SENT_186	[p17l1856t957r1872b963],
133	levofloXa	NN	O	levofloxa	dep	151	SENT_186	[p17l1886t946r2035b973],
134	—	NN	O	—	dep	151	SENT_186	[p17l1886t946r2035b973],
135	cin	NN	O	cin	dep	151	SENT_186	[p17l122t992r164b1018],
136	500	CD	NUMBER	500	dep	151	SENT_186	[p17l180t993r237b1018],
137	mg/d	NN	O	mg/d	dep	151	SENT_186	[p17l252t992r342b1028],
138	,	,	O	,	_	0	SENT_186	[p17l252t992r342b1028],
139	amoxicillin	NNP	O	amoxicillin	dep	151	SENT_186	[p17l356t992r521b1018],
140	1000	CD	DATE	1000	dep	151	SENT_186	[p17l538t993r614b1018],
141	mg	NN	O	mg	dep	151	SENT_186	[p17l629t1001r674b1028],
142	BID	NNP	O	BID	dep	151	SENT_186	[p17l688t994r752b1025],
143	,	,	O	,	_	0	SENT_186	[p17l688t994r752b1025],
144	and	CC	O	and	dep	151	SENT_186	[p17l767t992r822b1018],
145	rabeprazole	NN	O	rabeprazole	dep	151	SENT_186	[p17l838t992r1024b1028],
146	10	CD	NUMBER	10	dep	151	SENT_186	[p17l1039t993r1072b1018],
147	mg	NN	O	mg	dep	151	SENT_186	[p17l1088t1001r1133b1028],
148	BID	NNP	O	BID	dep	151	SENT_186	[p17l1147t994r1202b1018],
149	for	IN	O	for	dep	151	SENT_186	[p17l1216t992r1261b1018],
150	1	CD	DURATION	1	dep	151	SENT_186	[p17l1275t994r1284b1018],
151	week	NN	NUMBER	week	_	0	SENT_186	[p17l1302t992r1388b1018],
152	.	.	O	.	_	0	SENT_186	[p17l1302t992r1388b1018],

1	*	NN	O	*	nn	2	SENT_187	[p17l124t1040r155b1064],
2	n	NN	O	n	nsubj	3	SENT_187	[p17l124t1040r155b1064],
3	represents	VBZ	O	represent	_	0	SENT_187	[p17l170t1045r326b1074],
4	the	DT	O	the	det	5	SENT_187	[p17l337t1037r384b1064],
5	number	NN	O	number	dobj	3	SENT_187	[p17l397t1037r514b1064],
6	of	IN	O	of	_	0	SENT_187	[p17l524t1037r559b1064],
7	patients	NNS	O	patient	prep_of	5	SENT_187	[p17l566t1038r686b1074],
8	in	IN	O	in	_	0	SENT_187	[p17l699t1038r722b1064],
9	each	DT	O	each	det	10	SENT_187	[p17l736t1037r803b1064],
10	group	NN	O	group	prep_in	7	SENT_187	[p17l816t1047r904b1074],
11	in	IN	O	in	_	0	SENT_187	[p17l918t1038r941b1064],
12	whom	WP	O	whom	nsubj	13	SENT_187	[p17l954t1037r1047b1064],
13	Hpy/ori	VBP	O	hpy/ori	prepc_in	10	SENT_187	[p17l1061t1037r1166b1074],
14	infection	NN	O	infection	nsubjpass	16	SENT_187	[p17l1179t1037r1307b1064],
15	was	VBD	O	be	auxpass	16	SENT_187	[p17l1320t1047r1378b1064],
16	eradicated	VBN	O	eradicate	ccomp	13	SENT_187	[p17l1391t1037r1548b1064],
17	at	IN	O	at	_	0	SENT_187	[p17l1562t1045r1591b1064],
18	the	DT	O	the	det	20	SENT_187	[p17l1601t1037r1648b1064],
19	end	NN	O	end	nn	20	SENT_187	[p17l1660t1037r1713b1064],
20	oftreatment	NN	O	oftreatment	prep_at	16	SENT_187	[p17l1727t1037r1925b1070],
21	;	:	O	;	_	0	SENT_187	[p17l1727t1037r1925b1070],
22	N	NN	O	n	nsubj	23	SENT_187	[p17l1939t1040r1964b1064],
23	represents	VBZ	O	represent	parataxis	3	SENT_187	[p17l1976t1047r2036b1074, p17l142t1090r251b1110],
24	the	DT	O	the	det	25	SENT_187	[p17l263t1083r311b1110],
25	number	NN	O	number	dobj	23	SENT_187	[p17l326t1083r446b1110],
26	of	IN	O	of	_	0	SENT_187	[p17l457t1083r492b1110],
27	patients	NNS	O	patient	prep_of	25	SENT_187	[p17l501t1084r625b1119],
28	in	IN	O	in	_	0	SENT_187	[p17l640t1084r663b1110],
29	each	DT	O	each	det	30	SENT_187	[p17l678t1083r747b1110],
30	group	NN	O	group	prep_in	27	SENT_187	[p17l761t1093r853b1120],
31	who	WP	O	who	nsubj	32	SENT_187	[p17l865t1083r931b1110],
32	completed	VBD	O	complete	rcmod	30	SENT_187	[p17l945t1083r1108b1119],
33	triple	JJ	O	triple	amod	34	SENT_187	[p17l1123t1083r1204b1119],
34	therapy	NN	O	therapy	dobj	32	SENT_187	[p17l1216t1083r1342b1119],
35	.	.	O	.	_	0	SENT_187	[p17l1216t1083r1342b1119],

1	2008	CD	DATE	2008	num	2	SENT_188	[p17l96t1239r185b1267],
2	Volume	NN	O	volume	_	0	SENT_188	[p17l1658t1237r1791b1267],
3	32	CD	NUMBER	32	dep	2	SENT_188	[p17l1806t1239r1847b1267],
4	Number	NNP	O	Number	dep	2	SENT_188	[p17l1865t1237r2010b1267],
5	12	CD	NUMBER	12	num	4	SENT_188	[p17l2024t1239r2063b1266],

1	eradication	NN	O	eradication	nn	2	SENT_189	[p17l8t1435r420b1507],
2	rate	NN	O	rate	_	0	SENT_189	[p17l441t1455r580b1507],
3	of	IN	O	of	_	0	SENT_189	[p17l603t1434r681b1507],
4	75.4	CD	PERCENT	75.4	num	5	SENT_189	[p17l699t1439r944b1507],
5	%	NN	PERCENT	%	prep_of	2	SENT_189	[p17l699t1439r944b1507],
6	in	IN	O	in	_	0	SENT_189	[p17l972t1439r1040b1505],
7	both	CC	O	both	preconj	9	SENT_189	[p17l1062t1435r1232b1507],
8	the	DT	O	the	det	9	SENT_189	[p17l1251t1435r1363b1507],
9	ITT	NNP	ORGANIZATION	ITT	prep_in	5	SENT_189	[p17l1384t1438r1528b1505],
10	and	CC	O	and	_	0	SENT_189	[p17l1548t1435r1685b1507],
11	PP	NN	O	pp	nn	12	SENT_189	[p17l1705t1440r1799b1505],
12	analyses	NNS	O	analysis	prep_in	5	SENT_189	[p17l1821t1435r2152b1526],
13	,	,	O	,	_	0	SENT_189	[p17l1821t1435r2152b1526],
14	numerically	RB	O	numerically	amod	27	SENT_189	[p17l7t1552r471b1643],
15	but	CC	O	but	_	0	SENT_189	[p17l507t1552r636b1624],
16	not	RB	O	not	conj_but	14	SENT_189	[p17l670t1572r800b1624],
17	significantly	RB	O	significantly	advmod	18	SENT_189	[p17l835t1552r1314b1644],
18	lower	JJR	O	lower	dep	14	SENT_189	[p17l1348t1552r1569b1624],
19	than	IN	O	than	_	0	SENT_189	[p17l1603t1552r1780b1624],
20	rates	NNS	O	rate	prep_than	18	SENT_189	[p17l1814t1572r1999b1624],
21	for	IN	O	for	_	0	SENT_189	[p17l2036t1552r2149b1624],
22	the	DT	O	the	det	25	SENT_189	[p17l6t1670r124b1742],
23	2	CD	NUMBER	2	num	25	SENT_189	[p17l148t1675r193b1741],
24	esomeprazole	NN	O	esomeprazole	nn	25	SENT_189	[p17l219t1670r998b1762],
25	—	NN	O	—	prep_for	20	SENT_189	[p17l219t1670r998b1762],
26	based	VBN	O	base	amod	27	SENT_189	[p17l219t1670r998b1762],
27	regimens	NNS	O	regimen	appos	2	SENT_189	[p17l1022t1675r1387b1762],
28	.	.	O	.	_	0	SENT_189	[p17l1022t1675r1387b1762],

1	A	DT	O	a	det	3	SENT_190	[p17l1408t1673r1471b1741],
2	rabeprazole	NN	O	rabeprazole	nn	3	SENT_190	[p17l1494t1670r1950b1762],
3	dose	NN	O	dose	nsubjpass	9	SENT_190	[p17l1975t1670r2146b1742],
4	of	IN	O	of	_	0	SENT_190	[p17l8t1788r90b1861],
5	20	CD	NUMBER	20	num	6	SENT_190	[p17l118t1794r214b1861],
6	mg/d	NN	O	mg/d	prep_of	3	SENT_190	[p17l249t1788r446b1880],
7	has	VBZ	O	have	aux	9	SENT_190	[p17l479t1788r606b1861],
8	been	VBN	O	be	auxpass	9	SENT_190	[p17l643t1789r821b1861],
9	reported	VBN	O	report	_	0	SENT_190	[p17l854t1789r1189b1880],
10	to	TO	O	to	aux	11	SENT_190	[p17l1221t1809r1298b1861],
11	produce	VB	O	produce	xcomp	9	SENT_190	[p17l1332t1789r1651b1880],
12	comparable	JJ	O	comparable	amod	14	SENT_190	[p17l1685t1789r2148b1880],
13	acid	NN	O	acid	nn	14	SENT_190	[p17l8t1906r167b1978],
14	inhibition	NN	O	inhibition	dobj	11	SENT_190	[p17l208t1906r594b1978],
15	to	TO	O	to	_	0	SENT_190	[p17l634t1926r711b1978],
16	a	DT	O	a	det	17	SENT_190	[p17l754t1934r794b1978],
17	dose	NN	O	dose	prep_to	11	SENT_190	[p17l836t1906r1010b1978],
18	of	IN	O	of	_	0	SENT_190	[p17l1053t1906r1134b1978],
19	40	CD	NUMBER	40	num	20	SENT_190	[p17l1169t1911r1266b1978],
20	mg/d	NN	O	mg/d	prep_of	17	SENT_190	[p17l1308t1906r1528b1998],
21	,	,	O	,	_	0	SENT_190	[p17l1308t1906r1528b1998],
22	with	IN	O	with	_	0	SENT_190	[p17l1566t1906r1743b1978],
23	a	DT	O	a	det	25	SENT_190	[p17l1785t1934r1824b1978],
24	smaller	JJR	O	smaller	amod	25	SENT_190	[p17l1867t1906r2149b1978],
25	increase	NN	O	increase	prep_with	11	SENT_190	[p17l7t2028r319b2095],
26	in	IN	O	in	_	0	SENT_190	[p17l345t2029r418b2094],
27	plasma	NN	O	plasma	nn	29	SENT_190	[p17l441t2023r719b2115],
28	gastrin	NN	O	gastrin	nn	29	SENT_190	[p17l744t2029r1012b2115],
29	concentrations	NNS	O	concentration	prep_in	25	SENT_190	[p17l1036t2020r1709b2095],
30	.	.	O	.	_	0	SENT_190	[p17l1036t2020r1709b2095],

1	“	NNP	O	“	nn	3	SENT_191	[p17l1036t2020r1709b2095],
2	One	CD	NUMBER	one	num	3	SENT_191	[p17l1741t2028r1902b2095],
3	metaanalysis	NN	O	metaanalysis	nsubj	41	SENT_191	[p17l1927t2043r2147b2095, p17l8t2142r314b2233],
4	of	IN	O	of	_	0	SENT_191	[p17l342t2141r423b2214],
5	clinical	JJ	O	clinical	amod	6	SENT_191	[p17l443t2141r720b2214],
6	studies	NNS	O	study	prep_of	3	SENT_191	[p17l746t2142r1011b2214],
7	comparing	VBG	O	compare	partmod	6	SENT_191	[p17l1037t2146r1458b2233],
8	H	NN	O	h	nn	11	SENT_191	[p17l1483t2147r1561b2212],
9	pylori	NN	O	pylorus	nn	11	SENT_191	[p17l1579t2142r1812b2233],
10	eradication	NN	O	eradication	nn	11	SENT_191	[p17l1836t2142r2147b2214, p17l6t2263r162b2331],
11	rates	NNS	O	rate	dobj	7	SENT_191	[p17l193t2279r378b2331],
12	with	IN	O	with	_	0	SENT_191	[p17l409t2259r586b2331],
13	triple	JJ	O	triple	amod	14	SENT_191	[p17l616t2259r823b2351],
14	therapies	NNS	O	therapy	prep_with	7	SENT_191	[p17l854t2259r1208b2351],
15	that	WDT	O	that	nsubj	16	SENT_191	[p17l1240t2259r1397b2331],
16	included	VBD	O	include	rcmod	14	SENT_191	[p17l1428t2259r1762b2331],
17	low-dose	JJ	O	low-dose	amod	19	SENT_191	[p17l1794t2259r2148b2331],
18	rabeprazole	NN	O	rabeprazole	nn	19	SENT_191	[p17l7t2377r470b2469],
19	(	NN	O	(	dobj	16	SENT_191	[p17l515t2382r638b2466],
20	10	CD	NUMBER	10	num	21	SENT_191	[p17l515t2382r638b2466],
21	mg	NN	O	mg	nsubj	30	SENT_191	[p17l680t2405r799b2469],
22	BID	NNP	O	BID	dep	21	SENT_191	[p17l840t2382r1020b2466],
23	)	CD	NUMBER	)	num	22	SENT_191	[p17l840t2382r1020b2466],
24	or	CC	O	or	_	0	SENT_191	[p17l1066t2405r1148b2449],
25	standard	JJ	O	standard	amod	26	SENT_191	[p17l1189t2377r1533b2449],
26	doses	NNS	O	dose	conj_or	21	SENT_191	[p17l1574t2377r1783b2449],
27	of	IN	O	of	_	0	SENT_191	[p17l1826t2377r1907b2449],
28	other	JJ	O	other	amod	29	SENT_191	[p17l1944t2377r2149b2449],
29	PPIs	NNS	O	ppi	prep_of	26	SENT_191	[p17l7t2501r165b2568],
30	(	VBP	O	(	rcmod	19	SENT_191	[p17l193t2495r657b2587],
31	omeprazole	NN	O	omeprazole	dobj	30	SENT_191	[p17l193t2495r657b2587],
32	20	CD	NUMBER	20	num	34	SENT_191	[p17l680t2501r774b2568],
33	mg	NN	O	mg	nn	34	SENT_191	[p17l797t2524r914b2587],
34	BID	NNP	O	BID	dep	31	SENT_191	[p17l937t2501r1084b2566],
35	or	CC	O	or	_	0	SENT_191	[p17l1110t2524r1189b2568],
36	lansoprazole	JJ	O	lansoprazole	amod	38	SENT_191	[p17l1211t2495r1689b2587],
37	30	CD	NUMBER	30	tmod	36	SENT_191	[p17l1714t2501r1805b2568],
38	mg	NN	O	mg	dobj	30	SENT_191	[p17l1829t2524r1946b2587],
39	BID	NNP	O	BID	dep	38	SENT_191	[p17l1968t2500r2145b2584],
40	)	CD	NUMBER	)	num	39	SENT_191	[p17l1968t2500r2145b2584],
41	found	VBD	O	find	_	0	SENT_191	[p17l8t2612r239b2684],
42	no	DT	O	no	det	44	SENT_191	[p17l281t2640r378b2684],
43	significant	JJ	O	significant	amod	44	SENT_191	[p17l423t2612r829b2704],
44	differences	NNS	O	difference	dobj	41	SENT_191	[p17l872t2612r1291b2684],
45	between	IN	O	between	_	0	SENT_191	[p17l1337t2612r1659b2684],
46	regimens	NNS	O	regimen	prep_between	44	SENT_191	[p17l1701t2609r2148b2704],
47	.	.	O	.	_	0	SENT_191	[p17l1701t2609r2148b2704],

1	“	NN	O	“	_	0	SENT_192	[p17l1701t2609r2148b2704],
2	Other	JJ	O	other	amod	3	SENT_192	[p17l10t2730r239b2802],
3	studies	NNS	O	study	nsubj	6	SENT_192	[p17l273t2730r539b2802],
4	also	RB	O	also	advmod	6	SENT_192	[p17l574t2730r726b2802],
5	have	VBP	O	have	aux	6	SENT_192	[p17l761t2730r940b2802],
6	reported	VBN	O	report	rcmod	1	SENT_192	[p17l973t2730r1308b2822],
7	no	DT	O	no	det	9	SENT_192	[p17l1341t2758r1438b2802],
8	significant	JJ	O	significant	amod	9	SENT_192	[p17l1474t2730r1880b2822],
9	differences	NNS	O	difference	dobj	6	SENT_192	[p17l1913t2730r2147b2802, p17l8t2877r212b2921],
10	in	IN	O	in	_	0	SENT_192	[p17l242t2853r315b2919],
11	eradication	NN	O	eradication	nn	12	SENT_192	[p17l343t2849r785b2921],
12	rates	NNS	O	rate	prep_in	9	SENT_192	[p17l813t2869r997b2921],
13	between	IN	O	between	_	0	SENT_192	[p17l1029t2849r1352b2921],
14	regimens	NNS	O	regimen	prep_between	1	SENT_192	[p17l1379t2853r1728b2940],
15	consisting	VBG	O	consist	partmod	14	SENT_192	[p17l1758t2853r2150b2940],
16	of	IN	O	of	_	0	SENT_192	[p17l9t2966r88b3038],
17	amoxicillin	NNP	O	amoxicillin	prep_of	15	SENT_192	[p17l108t2966r531b3038],
18	and	CC	O	and	_	0	SENT_192	[p17l556t2966r695b3038],
19	clarithromycin	NN	O	clarithromycin	conj_and	17	SENT_192	[p17l719t2966r1276b3057],
20	plus	CC	O	plus	prep	19	SENT_192	[p17l1299t2966r1453b3058],
21	rabeprazole	NN	O	rabeprazole	dep	20	SENT_192	[p17l1478t2966r1922b3058],
22	10	CD	NUMBER	10	num	21	SENT_192	[p17l1952t2971r2040b3038],
23	or	CC	O	or	_	0	SENT_192	[p17l2067t2994r2150b3038],
24	20	CD	NUMBER	20	num	25	SENT_192	[p17l7t3091r103b3157],
25	mg	NN	O	mg	dep	20	SENT_192	[p17l136t3114r255b3177],
26	BID	NNP	O	BID	dobj	15	SENT_192	[p17l286t3082r619b3157],
27	.34	CD	NUMBER	.34	num	26	SENT_192	[p17l286t3082r619b3157],
28	=	JJ	O	=	amod	26	SENT_192	[p17l286t3082r619b3157],
29	43	CD	NUMBER	43	tmod	28	SENT_192	[p17l286t3082r619b3157],

1	The	DT	O	the	det	3	SENT_193	[p17l117t3204r269b3276],
2	PPI	NNP	O	PPI	nn	3	SENT_193	[p17l314t3209r445b3274],
3	rabeprazole	NN	O	rabeprazole	nsubjpass	5	SENT_193	[p17l489t3204r959b3295],
4	is	VBZ	O	be	auxpass	5	SENT_193	[p17l1005t3208r1061b3276],
5	metabolized	VBN	O	metabolize	_	0	SENT_193	[p17l1106t3203r1593b3276],
6	to	TO	O	to	aux	7	SENT_193	[p17l1637t3224r1715b3276],
7	thioetherrabeprazole	VB	O	thioetherrabeprazole	xcomp	5	SENT_193	[p17l1760t3204r2147b3276, p17l7t3321r460b3413],
8	mainly	RB	O	mainly	advmod	7	SENT_193	[p17l496t3321r761b3412],
9	Via	NNP	O	Via	dobj	7	SENT_193	[p17l794t3325r905b3393],
10	a	DT	O	a	det	12	SENT_193	[p17l943t3349r982b3393],
11	nonenzymatic	JJ	O	nonenzymatic	amod	12	SENT_193	[p17l1018t3325r1558b3412],
12	pathway	NN	O	pathway	dep	9	SENT_193	[p17l1593t3321r1942b3413],
13	,	,	O	,	_	0	SENT_193	[p17l1593t3321r1942b3413],
14	with	IN	O	with	_	0	SENT_193	[p17l1975t3321r2149b3393],
15	minor	JJ	O	minor	amod	16	SENT_193	[p17l7t3444r241b3510],
16	involvement	NN	O	involvement	prep_with	9	SENT_193	[p17l278t3438r752b3510],
17	of	IN	O	of	_	0	SENT_193	[p17l789t3438r870b3510],
18	CYP2C19	NN	O	cyp2c19	prep_of	16	SENT_193	[p17l904t3436r1388b3510],
19	.25	CD	NUMBER	.25	num	18	SENT_193	[p17l904t3436r1388b3510],
20	In	IN	O	in	_	0	SENT_193	[p17l1426t3444r1503b3509],
21	studies	NNS	O	study	prep_in	39	SENT_193	[p17l1541t3438r1800b3510],
22	of	IN	O	of	_	0	SENT_193	[p17l1840t3438r1920b3510],
23	rabeprazole	NN	O	rabeprazole	nn	24	SENT_193	[p17l1951t3438r2147b3510, p17l7t3556r289b3648],
24	use	NN	O	use	prep_of	21	SENT_193	[p17l317t3585r438b3628],
25	in	IN	O	in	_	0	SENT_193	[p17l466t3561r537b3627],
26	triple	JJ	O	triple	amod	27	SENT_193	[p17l563t3556r764b3648],
27	therapies	NNS	O	therapy	prep_in	24	SENT_193	[p17l792t3556r1162b3648],
28	,	,	O	,	_	0	SENT_193	[p17l792t3556r1162b3648],
29	no	DT	O	no	det	31	SENT_193	[p17l1188t3585r1284b3628],
30	significant	JJ	O	significant	amod	31	SENT_193	[p17l1313t3556r1710b3648],
31	differences	NNS	O	difference	nsubjpass	39	SENT_193	[p17l1737t3556r2147b3628],
32	in	IN	O	in	_	0	SENT_193	[p17l8t3678r78b3745],
33	rates	NNS	O	rate	prep_in	31	SENT_193	[p17l101t3694r280b3746],
34	of	IN	O	of	_	0	SENT_193	[p17l305t3674r385b3746],
35	H	NN	O	h	nn	37	SENT_193	[p17l402t3679r480b3745],
36	pylori	NN	O	pylorus	nn	37	SENT_193	[p17l495t3674r723b3766],
37	eradication	NN	O	eradication	prep_of	33	SENT_193	[p17l744t3674r1172b3746],
38	were	VBD	O	be	auxpass	39	SENT_193	[p17l1194t3702r1376b3746],
39	reported	VBN	O	report	rcmod	18	SENT_193	[p17l1399t3674r1724b3766],
40	among	IN	O	among	_	0	SENT_193	[p17l1748t3702r2009b3766],
41	the	DT	O	the	prep_among	39	SENT_193	[p17l2031t3674r2146b3746],

1	3	CD	NUMBER	3	num	4	SENT_194	[p18l9t27r48b93],
2	C	NN	O	c	nn	4	SENT_194	[p18l81t26r140b93],
3	YP2	NN	O	yp2	nn	4	SENT_194	[p18l147t27r297b92],
4	C1	NN	O	c1	nsubjpass	40	SENT_194	[p18l310t26r405b93],
5	9	CD	NUMBER	9	num	6	SENT_194	[p18l420t27r464b92],
6	genotypes	NNS	O	genotype	dep	4	SENT_194	[p18l487t18r1214b113],
7	.30	CD	NUMBER	.30	dep	4	SENT_194	[p18l487t18r1214b113],
8	=	JJ	O	=	amod	7	SENT_194	[p18l487t18r1214b113],
9	31	CD	NUMBER	31	tmod	8	SENT_194	[p18l487t18r1214b113],
10	=	JJ	O	=	amod	7	SENT_194	[p18l487t18r1214b113],
11	34	CD	NUMBER	34	tmod	10	SENT_194	[p18l487t18r1214b113],
12	=	JJ	O	=	amod	7	SENT_194	[p18l487t18r1214b113],
13	35	CD	NUMBER	35	tmod	12	SENT_194	[p18l487t18r1214b113],
14	Like	IN	O	like	_	0	SENT_194	[p18l1239t21r1402b93],
15	the	DT	O	the	det	17	SENT_194	[p18l1424t21r1539b93],
16	clarithromycin	NN	O	clarithromycin	nn	17	SENT_194	[p18l1561t21r2147b113],
17	—	NN	O	—	prep_like	40	SENT_194	[p18l1561t21r2147b113],
18	and	CC	O	and	_	0	SENT_194	[p18l8t139r150b210],
19	rabeprazole-based	JJ	O	rabeprazole-based	amod	21	SENT_194	[p18l174t138r880b230],
20	regimen	NN	O	regimen	nn	21	SENT_194	[p18l903t136r1394b230],
21	,34	NN	O	,34	prep_like	40	SENT_194	[p18l903t136r1394b230],
22	=	JJ	O	=	amod	17	SENT_194	[p18l903t136r1394b230],
23	35	CD	NUMBER	35	tmod	22	SENT_194	[p18l903t136r1394b230],
24	the	DT	O	the	det	26	SENT_194	[p18l1419t139r1536b210],
25	clinical	JJ	O	clinical	amod	26	SENT_194	[p18l1561t138r1832b210],
26	efficacy	NN	O	efficacy	nsubjpass	40	SENT_194	[p18l1857t138r2150b230],
27	of	IN	O	of	_	0	SENT_194	[p18l8t256r89b328],
28	the	DT	O	the	det	29	SENT_194	[p18l119t256r236b328],
29	levofloXacin	NN	O	levofloxacin	prep_of	26	SENT_194	[p18l273t256r775b328],
30	-	:	O	-	_	0	SENT_194	[p18l273t256r775b328],
31	and	CC	O	and	_	0	SENT_194	[p18l814t256r955b328],
32	rabeprazole-based	JJ	O	rabeprazole-based	amod	33	SENT_194	[p18l991t256r1697b348],
33	regimen	NN	O	regimen	prep_of	26	SENT_194	[p18l1732t260r2041b348],
34	in	IN	O	in	_	0	SENT_194	[p18l2077t260r2149b327],
35	the	DT	O	the	det	37	SENT_194	[p18l6t374r124b446],
36	present	JJ	DATE	present	amod	37	SENT_194	[p18l149t394r429b466],
37	study	NN	O	study	prep_in	33	SENT_194	[p18l455t374r662b466],
38	was	VBD	O	be	auxpass	40	SENT_194	[p18l685t402r833b446],
39	not	RB	O	not	neg	40	SENT_194	[p18l861t394r989b446],
40	affected	VBN	O	affect	_	0	SENT_194	[p18l1015t374r1316b446],
41	by	IN	O	by	_	0	SENT_194	[p18l1344t374r1435b466],
42	C	NN	O	c	nn	44	SENT_194	[p18l1466t378r1525b446],
43	YP2	NN	O	yp2	nn	44	SENT_194	[p18l1532t379r1684b445],
44	C1	NN	O	c1	agent	40	SENT_194	[p18l1698t378r1794b446],
45	9	CD	NUMBER	9	num	47	SENT_194	[p18l1811t379r1854b445],
46	genetic	JJ	O	genetic	amod	47	SENT_194	[p18l1881t379r2149b466],
47	polymorphism	NN	O	polymorphism	dep	44	SENT_194	[p18l6t492r594b584],
48	.	.	O	.	_	0	SENT_194	[p18l6t492r594b584],

1	In	FW	O	in	nn	2	SENT_195	[p18l118t615r196b681],
2	vitro	FW	O	vitro	nsubjpass	7	SENT_195	[p18l235t614r445b698],
3	,	,	O	,	_	0	SENT_195	[p18l235t614r445b698],
4	levofloxacin	NN	O	levofloxacin	appos	2	SENT_195	[p18l483t610r967b682],
5	has	VBZ	O	have	aux	7	SENT_195	[p18l1006t610r1134b682],
6	been	VBN	O	be	auxpass	7	SENT_195	[p18l1177t610r1356b682],
7	reported	VBN	O	report	ccomp	30	SENT_195	[p18l1395t610r1730b702],
8	to	TO	O	to	aux	9	SENT_195	[p18l1769t630r1846b682],
9	have	VB	O	have	xcomp	7	SENT_195	[p18l1887t610r2067b682],
10	a	DT	O	a	det	12	SENT_195	[p18l2108t638r2148b682],
11	synergistic	JJ	O	synergistic	amod	12	SENT_195	[p18l8t733r419b820],
12	effect	NN	O	effect	dobj	9	SENT_195	[p18l463t728r674b800],
13	against	IN	O	against	_	0	SENT_195	[p18l718t733r995b820],
14	H	NN	O	h	nn	15	SENT_195	[p18l1037t734r1115b799],
15	pylori	NN	O	pylorus	prep_against	12	SENT_195	[p18l1151t728r1385b820],
16	with	IN	O	with	_	0	SENT_195	[p18l1424t728r1601b800],
17	PPIs	NNS	O	ppi	prep_with	9	SENT_195	[p18l1644t734r1808b800],
18	such	JJ	O	such	_	0	SENT_195	[p18l1854t728r2028b800],
19	as	IN	O	as	_	0	SENT_195	[p18l2073t756r2147b800],
20	pantoprazole	NN	O	pantoprazole	prep_such_as	17	SENT_195	[p18l6t845r530b937],
21	and	CC	O	and	_	0	SENT_195	[p18l576t845r720b917],
22	omeprazole	NN	O	omeprazole	prep_such_as	17	SENT_195	[p18l765t843r1323b937],
23	.15	CD	NUMBER	.15	num	22	SENT_195	[p18l765t843r1323b937],
24	In	IN	O	in	_	0	SENT_195	[p18l1368t852r1447b916],
25	clinical	JJ	O	clinical	amod	26	SENT_195	[p18l1490t845r1770b917],
26	practice	NN	O	practice	prep_in	9	SENT_195	[p18l1813t851r2149b937],
27	,	,	O	,	_	0	SENT_195	[p18l1813t851r2149b937],
28	levofloxacin	NN	O	levofloxacin	nsubj	30	SENT_195	[p18l8t963r491b1035],
29	is	VBZ	O	be	cop	30	SENT_195	[p18l523t967r579b1035],
30	likely	JJ	O	likely	_	0	SENT_195	[p18l613t963r824b1054],
31	to	TO	O	to	aux	32	SENT_195	[p18l854t983r932b1035],
32	have	VB	O	have	xcomp	30	SENT_195	[p18l965t963r1145b1035],
33	a	DT	O	a	det	35	SENT_195	[p18l1179t991r1218b1035],
34	synergistic	JJ	O	synergistic	amod	35	SENT_195	[p18l1252t967r1663b1055],
35	effect	NN	O	effect	dobj	32	SENT_195	[p18l1695t963r1907b1035],
36	when	WRB	O	when	advmod	37	SENT_195	[p18l1936t963r2149b1035],
37	used	VBN	O	use	advcl	32	SENT_195	[p18l8t1081r179b1153],
38	in	IN	O	in	_	0	SENT_195	[p18l203t1086r274b1152],
39	combination	NN	O	combination	prep_in	37	SENT_195	[p18l297t1081r785b1153],
40	with	IN	O	with	_	0	SENT_195	[p18l807t1081r980b1153],
41	a	DT	O	a	det	42	SENT_195	[p18l1005t1109r1044b1153],
42	PPI	NNP	O	PPI	prep_with	37	SENT_195	[p18l1068t1087r1195b1152],
43	for	IN	O	for	_	0	SENT_195	[p18l1219t1081r1330b1153],
44	H	NN	O	h	nn	46	SENT_195	[p18l1352t1087r1430b1152],
45	pylori	NN	O	pylorus	nn	46	SENT_195	[p18l1446t1081r1674b1173],
46	eradication	NN	O	eradication	prep_for	42	SENT_195	[p18l1696t1081r2150b1170],
47	,	,	O	,	_	0	SENT_195	[p18l1696t1081r2150b1170],
48	although	IN	O	although	mark	50	SENT_195	[p18l8t1199r358b1291],
49	this	DT	O	this	nsubj	50	SENT_195	[p18l399t1199r538b1271],
50	requires	VBZ	O	require	advcl	37	SENT_195	[p18l581t1204r894b1291],
51	further	RB	O	further	advmod	50	SENT_195	[p18l938t1199r1212b1271],
52	investigation	NN	O	investigation	dobj	50	SENT_195	[p18l1254t1204r1779b1291],
53	.	.	O	.	_	0	SENT_195	[p18l1254t1204r1779b1291],

1	PPIs	NNS	O	ppi	nsubjpass	3	SENT_196	[p18l1822t1205r1986b1271],
2	are	VBP	O	be	auxpass	3	SENT_196	[p18l2031t1228r2148b1271],
3	known	VBN	O	know	ccomp	56	SENT_196	[p18l7t1317r269b1389],
4	to	TO	O	to	aux	6	SENT_196	[p18l289t1337r362b1389],
5	be	VB	O	be	auxpass	6	SENT_196	[p18l386t1317r468b1389],
6	metabolized	VBN	O	metabolize	xcomp	3	SENT_196	[p18l490t1317r943b1389],
7	in	IN	O	in	_	0	SENT_196	[p18l964t1321r1034b1388],
8	the	DT	O	the	det	9	SENT_196	[p18l1053t1317r1166b1389],
9	liver	NN	O	liver	prep_in	6	SENT_196	[p18l1188t1317r1360b1405],
10	,	,	O	,	_	0	SENT_196	[p18l1188t1317r1360b1405],
11	mainly	RB	O	mainly	advmod	3	SENT_196	[p18l1379t1317r1635b1409],
12	by	IN	O	by	_	0	SENT_196	[p18l1657t1317r1746b1409],
13	CYPZC19	NN	O	cypzc19	agent	3	SENT_196	[p18l1768t1321r2144b1389],
14	and	CC	O	and	_	0	SENT_196	[p18l8t1434r152b1506],
15	CYP3A4	NN	O	cyp3a4	agent	3	SENT_196	[p18l181t1431r622b1506],
16	.24	CD	NUMBER	.24	num	15	SENT_196	[p18l181t1431r622b1506],
17	A	DT	O	a	det	19	SENT_196	[p18l645t1438r709b1505],
18	previous	JJ	O	previous	amod	19	SENT_196	[p18l734t1440r1068b1526],
19	study	NN	O	study	nsubj	20	SENT_196	[p18l1097t1434r1308b1526],
20	reported	VBD	O	report	rcmod	15	SENT_196	[p18l1333t1434r1668b1526],
21	that	IN	O	that	complm	24	SENT_196	[p18l1694t1434r1850b1506],
22	fluoroquinolone	JJ	O	fluoroquinolone	amod	23	SENT_196	[p18l1876t1434r2147b1506, p18l9t1553r403b1644],
23	antibiotics	NNS	O	antibiotic	nsubj	24	SENT_196	[p18l436t1552r845b1625],
24	decreased	VBD	O	decrease	ccomp	20	SENT_196	[p18l879t1553r1258b1625],
25	CYP3A	NN	O	cyp3a	dobj	24	SENT_196	[p18l1292t1556r1615b1625],
26	-	:	O	-	_	0	SENT_196	[p18l1292t1556r1615b1625],
27	and	CC	O	and	_	0	SENT_196	[p18l1648t1553r1791b1625],
28	CYP1Amediated	JJ	TIME	cyp1amediated	amod	29	SENT_196	[p18l1825t1556r2148b1625, p18l7t1670r367b1742],
29	biotransformation	NN	O	biotransformation	dobj	24	SENT_196	[p18l393t1670r1115b1742],
30	by	IN	O	by	_	0	SENT_196	[p18l1142t1670r1234b1761],
31	competitive	JJ	O	competitive	amod	32	SENT_196	[p18l1258t1674r1714b1762],
32	inhibition	NN	O	inhibition	prep_by	24	SENT_196	[p18l1740t1670r2148b1758],
33	,	,	O	,	_	0	SENT_196	[p18l1740t1670r2148b1758],
34	indicating	VBG	O	indicate	partmod	24	SENT_196	[p18l8t1788r399b1880],
35	a	DT	O	a	det	36	SENT_196	[p18l438t1816r478b1860],
36	potential	JJ	O	potential	dobj	34	SENT_196	[p18l516t1788r867b1880],
37	to	TO	O	to	aux	38	SENT_196	[p18l904t1808r982b1860],
38	interact	VB	O	interact	xcomp	34	SENT_196	[p18l1022t1793r1321b1860],
39	with	IN	O	with	_	0	SENT_196	[p18l1357t1788r1534b1860],
40	agents	NNS	O	agent	prep_with	38	SENT_196	[p18l1573t1808r1818b1880],
41	such	JJ	O	such	_	0	SENT_196	[p18l1859t1788r2033b1860],
42	as	IN	O	as	_	0	SENT_196	[p18l2073t1816r2147b1860],
43	PPIs	NNS	O	ppi	prep_such_as	40	SENT_196	[p18l7t1912r169b1977],
44	that	WDT	O	that	nsubjpass	46	SENT_196	[p18l204t1905r358b1977],
45	are	VBP	O	be	auxpass	46	SENT_196	[p18l392t1934r507b1977],
46	metabolized	VBN	O	metabolize	rcmod	43	SENT_196	[p18l542t1905r1012b1977],
47	by	IN	O	by	_	0	SENT_196	[p18l1047t1906r1139b1997],
48	these	DT	O	these	det	49	SENT_196	[p18l1172t1905r1364b1977],
49	enzymes	NNS	O	enzyme	agent	46	SENT_196	[p18l1399t1903r1817b1997],
50	.44	CD	NUMBER	.44	npadvmod	51	SENT_196	[p18l1399t1903r1817b1997],
51	Thus	RB	O	thus	advmod	49	SENT_196	[p18l1848t1905r2064b1994],
52	,	,	O	,	_	0	SENT_196	[p18l1848t1905r2064b1994],
53	it	PRP	O	it	nsubjpass	56	SENT_196	[p18l2098t1911r2150b1978],
54	can	MD	O	can	aux	56	SENT_196	[p18l7t2051r135b2095],
55	be	VB	O	be	auxpass	56	SENT_196	[p18l157t2023r239b2095],
56	postulated	VBN	O	postulate	_	0	SENT_196	[p18l260t2023r647b2115],
57	that	IN	O	that	complm	60	SENT_196	[p18l666t2023r814b2095],
58	levoﬂoxacin	NN	O	levoﬂoxacin	nsubj	60	SENT_196	[p18l834t2023r1286b2095],
59	may	MD	O	may	aux	60	SENT_196	[p18l1307t2051r1466b2114],
60	inhibit	VB	O	inhibit	ccomp	56	SENT_196	[p18l1486t2023r1727b2095],
61	the	DT	O	the	det	62	SENT_196	[p18l1746t2023r1859b2095],
62	activity	NN	O	activity	dobj	60	SENT_196	[p18l1881t2027r2150b2114],
63	of	IN	O	of	_	0	SENT_196	[p18l8t2141r87b2213],
64	CYP3A4	NN	O	cyp3a4	nn	66	SENT_196	[p18l107t2144r438b2213],
65	and/or	NN	O	and/or	nn	66	SENT_196	[p18l463t2141r710b2213],
66	CYPZC19	NN	O	cypzc19	prep_of	62	SENT_196	[p18l734t2145r1138b2230],
67	,	,	O	,	_	0	SENT_196	[p18l734t2145r1138b2230],
68	decreasing	VBG	O	decrease	dep	60	SENT_196	[p18l1160t2141r1553b2233],
69	the	DT	O	the	det	70	SENT_196	[p18l1573t2141r1688b2213],
70	metabolism	NN	O	metabolism	dobj	68	SENT_196	[p18l1710t2141r2150b2213],
71	of	IN	O	of	_	0	SENT_196	[p18l8t2259r89b2332],
72	PPIs	NNS	O	ppi	prep_of	70	SENT_196	[p18l127t2265r313b2348],
73	,	,	O	,	_	0	SENT_196	[p18l127t2265r313b2348],
74	particularly	RB	O	particularly	advmod	75	SENT_196	[p18l353t2260r808b2351],
75	in	IN	O	in	conj_and	68	SENT_196	[p18l849t2264r921b2330],
76	those	DT	O	those	pobj	75	SENT_196	[p18l962t2259r1166b2332],
77	of	IN	O	of	_	0	SENT_196	[p18l1210t2259r1291b2332],
78	HomEM	NNP	O	HomEM	nn	79	SENT_196	[p18l1328t2265r1677b2332],
79	status	NN	O	status	prep_of	76	SENT_196	[p18l1720t2280r1966b2348],
80	,	,	O	,	_	0	SENT_196	[p18l1720t2280r1966b2348],
81	and	CC	O	and	_	0	SENT_196	[p18l2008t2259r2150b2332],
82	resulting	VBG	O	result	conj_and	68	SENT_196	[p18l7t2377r340b2469],
83	in	IN	O	in	_	0	SENT_196	[p18l374t2381r446b2448],
84	higher	JJR	O	higher	amod	85	SENT_196	[p18l480t2377r722b2469],
85	concentrations	NNS	O	concentration	prep_in	82	SENT_196	[p18l756t2381r1324b2449],
86	of	IN	O	of	_	0	SENT_196	[p18l1361t2377r1441b2449],
87	PPIs	NNS	O	ppi	prep_of	85	SENT_196	[p18l1470t2382r1653b2449],
88	.	.	O	.	_	0	SENT_196	[p18l1470t2382r1653b2449],

1	The	DT	O	the	det	2	SENT_197	[p18l1684t2377r1832b2449],
2	less	JJR	O	less	dep	4	SENT_197	[p18l1867t2377r1997b2449],
3	the	DT	O	the	det	4	SENT_197	[p18l2031t2377r2148b2449],
4	Variation	NN	O	variation	dep	24	SENT_197	[p18l6t2500r348b2567],
5	in	IN	O	in	_	0	SENT_197	[p18l370t2500r440b2566],
6	PPI	NNP	O	PPI	nn	7	SENT_197	[p18l462t2501r587b2566],
7	concentrations	NNS	O	concentration	prep_in	4	SENT_197	[p18l609t2500r1165b2567],
8	among	IN	O	among	_	0	SENT_197	[p18l1189t2523r1448b2587],
9	those	DT	O	those	prep_among	7	SENT_197	[p18l1469t2495r1668b2567],
10	of	IN	O	of	_	0	SENT_197	[p18l1692t2495r1770b2567],
11	HomEM	NNP	O	HomEM	prep_of	9	SENT_197	[p18l1788t2501r2151b2584],
12	,	,	O	,	_	0	SENT_197	[p18l1788t2501r2151b2584],
13	HetEM	NNP	O	HetEM	prep_of	9	SENT_197	[p18l7t2619r310b2702],
14	,	,	O	,	_	0	SENT_197	[p18l7t2619r310b2702],
15	and	CC	O	and	_	0	SENT_197	[p18l332t2614r469b2686],
16	PM	NN	O	pm	nn	17	SENT_197	[p18l490t2619r627b2685],
17	status	NN	O	status	prep_of	9	SENT_197	[p18l649t2634r883b2702],
18	,	,	O	,	_	0	SENT_197	[p18l649t2634r883b2702],
19	the	DT	O	the	det	20	SENT_197	[p18l902t2614r1015b2686],
20	less	JJR	O	less	dep	24	SENT_197	[p18l1037t2614r1163b2686],
21	effect	NN	O	effect	nn	24	SENT_197	[p18l1186t2613r1385b2686],
22	C	NN	O	c	nn	24	SENT_197	[p18l1411t2618r1469b2686],
23	YP2	NN	O	yp2	nn	24	SENT_197	[p18l1476t2619r1624b2684],
24	C1	NN	O	c1	_	0	SENT_197	[p18l1637t2618r1730b2686],
25	9	CD	NUMBER	9	num	26	SENT_197	[p18l1746t2619r1789b2684],
26	genotype	NN	O	genotype	nsubj	28	SENT_197	[p18l1811t2634r2148b2705],
27	may	MD	O	may	aux	28	SENT_197	[p18l7t2759r171b2822],
28	have	VB	O	have	rcmod	24	SENT_197	[p18l202t2731r379b2803],
29	on	IN	O	on	_	0	SENT_197	[p18l412t2759r509b2803],
30	the	DT	O	the	det	32	SENT_197	[p18l539t2731r656b2803],
31	clinical	JJ	O	clinical	amod	32	SENT_197	[p18l688t2731r960b2803],
32	efficacy	NN	O	efficacy	prep_on	28	SENT_197	[p18l993t2731r1285b2822],
33	of	IN	O	of	_	0	SENT_197	[p18l1317t2731r1397b2803],
34	levofloxacin-based	JJ	O	levofloxacin-based	amod	36	SENT_197	[p18l1424t2731r2149b2803],
35	triple	JJ	O	triple	amod	36	SENT_197	[p18l6t2849r206b2941],
36	therapy	NN	O	therapy	prep_of	24	SENT_197	[p18l228t2849r520b2941],
37	containing	VBG	O	contain	partmod	36	SENT_197	[p18l542t2854r946b2941],
38	a	DT	O	a	det	39	SENT_197	[p18l970t2877r1009b2921],
39	PPI	NNP	O	PPI	dobj	37	SENT_197	[p18l1033t2855r1179b2921],
40	.	.	O	.	_	0	SENT_197	[p18l1033t2855r1179b2921],

1	However	RB	O	however	advmod	5	SENT_198	[p18l1202t2855r1566b2938],
2	,	,	O	,	_	0	SENT_198	[p18l1202t2855r1566b2938],
3	this	DT	O	this	det	4	SENT_198	[p18l1587t2849r1721b2921],
4	hypothesis	NN	O	hypothesis	nsubj	5	SENT_198	[p18l1745t2849r2148b2941],
5	required	VBN	O	require	_	0	SENT_198	[p18l7t2968r330b3059],
6	further	RB	O	further	advmod	5	SENT_198	[p18l359t2967r627b3040],
7	investigation	NN	O	investigation	dobj	5	SENT_198	[p18l655t2972r1168b3059],
8	.	.	O	.	_	0	SENT_198	[p18l655t2972r1168b3059],

1	Among	IN	O	among	_	0	SENT_199	[p18l117t3088r407b3177],
2	the	DT	O	the	det	3	SENT_199	[p18l435t3085r554b3157],
3	limitations	NNS	O	limitation	prep_among	8	SENT_199	[p18l585t3085r1005b3157],
4	of	IN	O	of	_	0	SENT_199	[p18l1037t3085r1118b3157],
5	the	DT	O	the	det	7	SENT_199	[p18l1143t3085r1262b3157],
6	present	JJ	DATE	present	amod	7	SENT_199	[p18l1291t3105r1576b3177],
7	study	NN	O	study	prep_of	3	SENT_199	[p18l1606t3085r1817b3177],
8	were	VBD	O	be	_	0	SENT_199	[p18l1844t3113r2030b3157],
9	its	PRP$	O	its	poss	11	SENT_199	[p18l2061t3089r2147b3157],
10	open-label	JJ	O	open-label	amod	11	SENT_199	[p18l8t3203r434b3295],
11	design	NN	O	design	dep	8	SENT_199	[p18l481t3203r735b3295],
12	and	CC	O	and	_	0	SENT_199	[p18l782t3203r929b3275],
13	relatively	RB	O	relatively	advmod	14	SENT_199	[p18l974t3203r1350b3295],
14	small	JJ	O	small	amod	16	SENT_199	[p18l1396t3203r1607b3275],
15	sample	NN	O	sample	nn	16	SENT_199	[p18l1654t3203r1933b3295],
16	size	NN	O	size	conj_and	11	SENT_199	[p18l1981t3208r2146b3275],
17	.	.	O	.	_	0	SENT_199	[p18l1981t3208r2146b3275],

1	However	RB	O	however	advmod	3	SENT_200	[p18l7t3327r381b3410],
2	,	,	O	,	_	0	SENT_200	[p18l7t3327r381b3410],
3	based	VBN	O	base	_	0	SENT_200	[p18l416t3322r636b3394],
4	on	IN	O	on	_	0	SENT_200	[p18l672t3350r769b3394],
5	an	DT	O	a	det	7	SENT_200	[p18l805t3350r897b3394],
6	ITT	NN	O	itt	nn	7	SENT_200	[p18l931t3325r1082b3392],
7	analysis	NN	O	analysis	prep_on	3	SENT_200	[p18l1117t3322r1448b3413],
8	,	,	O	,	_	0	SENT_200	[p18l1117t3322r1448b3413],
9	determination	NN	O	determination	appos	7	SENT_200	[p18l1482t3322r2037b3394],
10	of	IN	O	of	prep	9	SENT_200	[p18l2073t3321r2154b3394],

1	November	NNP	DATE	November	_	0	SENT_201	[p18l67t3580r475b3645],
2	2010	CD	DATE	2010	dep	1	SENT_201	[p18l504t3583r694b3645],

1	X.	NNP	O	X.	nn	2	SENT_202	[p18l1609t3695r1687b3756],
2	Pan	NNP	O	Pan	_	0	SENT_202	[p18l1726t3695r1866b3756],
3	et	FW	O	et	nn	4	SENT_202	[p18l1901t3705r1976b3757],
4	al.	FW	O	al.	dep	2	SENT_202	[p18l2004t3690r2091b3756],
5	.	.	O	.	_	0	SENT_202	[p18l2004t3690r2091b3756],

1	a	DT	O	a	det	4	SENT_203	[p19l9t164r49b208],
2	statistically	RB	O	statistically	advmod	3	SENT_203	[p19l85t135r527b227],
3	significant	JJ	O	significant	amod	4	SENT_203	[p19l560t135r966b227],
4	difference	NN	O	difference	nsubj	19	SENT_203	[p19l1000t135r1384b208],
5	in	IN	O	in	_	0	SENT_203	[p19l1418t140r1491b206],
6	eradication	NN	O	eradication	nn	7	SENT_203	[p19l1525t135r1967b208],
7	rate	NN	O	rate	prep_in	4	SENT_203	[p19l2000t156r2149b208],
8	(	CD	PERCENT	(	number	9	SENT_203	[p19l13t257r333b342],
9	14.6	CD	PERCENT	14.6	num	10	SENT_203	[p19l13t257r333b342],
10	%	NN	PERCENT	%	dep	7	SENT_203	[p19l13t257r333b342],
11	)	CD	NUMBER	)	dep	7	SENT_203	[p19l13t257r333b342],
12	between	IN	O	between	_	0	SENT_203	[p19l365t253r688b325],
13	groups	NNS	O	group	nn	14	SENT_203	[p19l712t281r980b345],
14	B	NN	O	b	prep_between	11	SENT_203	[p19l1007t259r1057b324],
15	and	CC	O	and	_	0	SENT_203	[p19l1085t253r1228b325],
16	C	NN	O	c	prep_in	4	SENT_203	[p19l1257t257r1315b325],
17	would	MD	O	would	aux	19	SENT_203	[p19l1340t253r1589b325],
18	have	VB	O	have	aux	19	SENT_203	[p19l1614t253r1794b325],
19	required	VBN	O	require	_	0	SENT_203	[p19l1820t253r2150b345],
20	enrollment	NN	O	enrollment	dobj	19	SENT_203	[p19l9t371r417b443],
21	of	IN	O	of	_	0	SENT_203	[p19l440t371r519b443],
22	1216	CD	DATE	1216	num	23	SENT_203	[p19l542t376r728b443],
23	patients	NNS	O	patient	prep_of	20	SENT_203	[p19l751t375r1045b463],
24	(	IN	O	(	_	0	SENT_203	[p19l1074t375r1238b459],
25	608	CD	NUMBER	608	prep_(	19	SENT_203	[p19l1074t375r1238b459],
26	in	IN	O	in	_	0	SENT_203	[p19l1265t375r1335b442],
27	each	DT	O	each	det	29	SENT_203	[p19l1358t371r1526b443],
28	group	NN	O	group	nn	29	SENT_203	[p19l1548t375r1820b463],
29	)	NN	O	)	prep_in	19	SENT_203	[p19l1548t375r1820b463],
30	.	.	O	.	_	0	SENT_203	[p19l1548t375r1820b463],

1	Another	DT	O	another	det	2	SENT_204	[p19l1839t371r2151b443],
2	limitation	NN	O	limitation	nsubj	5	SENT_204	[p19l8t489r394b561],
3	is	VBZ	O	be	cop	5	SENT_204	[p19l420t494r476b561],
4	the	DT	O	the	det	5	SENT_204	[p19l502t489r620b561],
5	lack	NN	O	lack	_	0	SENT_204	[p19l647t489r807b561],
6	of	IN	O	of	_	0	SENT_204	[p19l834t489r915b561],
7	baseline	NN	O	baseline	nn	8	SENT_204	[p19l938t489r1249b561],
8	data	NNS	O	datum	prep_of	5	SENT_204	[p19l1277t489r1445b561],
9	on	IN	O	on	_	0	SENT_204	[p19l1473t518r1570b561],
10	H	NN	O	h	nn	12	SENT_204	[p19l1595t495r1673b560],
11	pylori	NN	O	pylorus	nn	12	SENT_204	[p19l1691t489r1925b581],
12	resistance	NN	O	resistance	prep_on	8	SENT_204	[p19l1948t494r2148b561, p19l7t627r214b679],
13	to	TO	O	to	_	0	SENT_204	[p19l243t627r320b679],
14	levofloxacin	NN	O	levofloxacin	prep_to	12	SENT_204	[p19l353t607r858b679],
15	.	.	O	.	_	0	SENT_204	[p19l353t607r858b679],

1	CONCLUSIONS	NNS	O	conclusion	_	0	SENT_205	[p19l9t846r705b914],
2	One	CD	DURATION	one	num	3	SENT_205	[p19l11t963r172b1031],
3	week	NN	NUMBER	week	tmod	1	SENT_205	[p19l201t958r404b1031],
4	of	IN	O	of	_	0	SENT_205	[p19l434t958r515b1031],
5	first-line	JJ	O	first-line	amod	7	SENT_205	[p19l540t958r868b1031],
6	triple	JJ	O	triple	amod	7	SENT_205	[p19l897t959r1103b1050],
7	therapy	NN	O	therapy	prep_of	1	SENT_205	[p19l1133t958r1433b1050],
8	with	IN	O	with	_	0	SENT_205	[p19l1460t959r1637b1031],
9	levofloxacin	NN	O	levofloxacin	prep_with	7	SENT_205	[p19l1666t958r2150b1031],
10	and	CC	O	and	_	0	SENT_205	[p19l9t1074r153b1146],
11	amoxicillin	NNP	O	amoxicillin	conj_and	7	SENT_205	[p19l179t1074r620b1146],
12	plus	CC	O	plus	prep	11	SENT_205	[p19l644t1074r803b1166],
13	esomeprazole	JJ	O	esomeprazole	amod	22	SENT_205	[p19l831t1074r1364b1166],
14	20	CD	NUMBER	20	tmod	13	SENT_205	[p19l1389t1079r1486b1146],
15	or	CC	O	or	_	0	SENT_205	[p19l1515t1102r1596b1146],
16	40	CD	NUMBER	40	conj_or	14	SENT_205	[p19l1621t1079r1717b1146],
17	mg	NN	O	mg	nn	22	SENT_205	[p19l1744t1102r1863b1166],
18	BID	NNP	O	BID	nn	22	SENT_205	[p19l1889t1080r2040b1145],
19	or	CC	O	or	_	0	SENT_205	[p19l2069t1102r2151b1146],
20	rabeprazole	JJ	O	rabeprazole	nn	22	SENT_205	[p19l8t1190r475b1282],
21	10	CD	NUMBER	10	tmod	20	SENT_205	[p19l526t1195r616b1262],
22	mg	NN	O	mg	dep	12	SENT_205	[p19l662t1218r782b1282],
23	BID	NNP	O	BID	nsubjpass	33	SENT_205	[p19l826t1195r979b1261],
24	was	VBD	O	be	cop	25	SENT_205	[p19l1024t1218r1175b1262],
25	effective	JJ	O	effective	dep	1	SENT_205	[p19l1220t1190r1546b1262],
26	in	IN	O	in	_	0	SENT_205	[p19l1591t1194r1664b1261],
27	eradicating	VBG	O	eradicate	prepc_in	25	SENT_205	[p19l1709t1190r2150b1282],
28	H	NN	O	h	nn	29	SENT_205	[p19l7t1312r85b1377],
29	pylori	NN	O	pylorus	dobj	27	SENT_205	[p19l102t1306r334b1398],
30	and	CC	O	and	_	0	SENT_205	[p19l357t1306r499b1378],
31	was	VBD	O	be	auxpass	33	SENT_205	[p19l522t1335r671b1378],
32	well	RB	O	well	advmod	33	SENT_205	[p19l695t1306r854b1378],
33	tolerated	VBN	O	tolerate	dep	1	SENT_205	[p19l878t1306r1225b1378],
34	in	IN	O	in	_	0	SENT_205	[p19l1250t1311r1322b1377],
35	these	DT	O	these	det	37	SENT_205	[p19l1346t1306r1539b1378],
36	Chinese	JJ	LOCATION	chinese	amod	37	SENT_205	[p19l1567t1306r1869b1378],
37	adults	NNS	O	adult	prep_in	33	SENT_205	[p19l1896t1306r2152b1395],
38	,	,	O	,	_	0	SENT_205	[p19l1896t1306r2152b1395],
39	with	IN	O	with	_	0	SENT_205	[p19l7t1422r177b1494],
40	no	DT	O	no	det	42	SENT_205	[p19l199t1450r293b1494],
41	significant	JJ	O	significant	amod	42	SENT_205	[p19l318t1422r705b1514],
42	differences	NNS	O	difference	prep_with	1	SENT_205	[p19l728t1422r1127b1494],
43	between	IN	O	between	_	0	SENT_205	[p19l1153t1422r1463b1494],
44	treatment	NN	O	treatment	nn	45	SENT_205	[p19l1484t1442r1850b1494],
45	groups	NNS	O	group	prep_between	42	SENT_205	[p19l1871t1450r2148b1514],
46	.	.	O	.	_	0	SENT_205	[p19l1871t1450r2148b1514],

1	CYP2	NN	O	cyp2	nn	3	SENT_206	[p19l14t1543r236b1611],
2	C19	NN	O	c19	nn	3	SENT_206	[p19l250t1543r408b1611],
3	genotype	NN	O	genotype	nsubj	4	SENT_206	[p19l443t1559r798b1630],
4	had	VBD	O	have	_	0	SENT_206	[p19l833t1539r978b1611],
5	no	DT	O	no	det	7	SENT_206	[p19l1013t1567r1109b1611],
6	significant	JJ	O	significant	amod	7	SENT_206	[p19l1146t1538r1553b1630],
7	effect	NN	O	effect	dobj	4	SENT_206	[p19l1587t1538r1798b1611],
8	on	IN	O	on	_	0	SENT_206	[p19l1833t1567r1930b1611],
9	rates	NNS	O	rate	prep_on	7	SENT_206	[p19l1964t1559r2148b1611],
10	of	IN	O	of	_	0	SENT_206	[p19l9t1654r90b1726],
11	H	NN	O	h	nn	13	SENT_206	[p19l116t1660r194b1725],
12	pylori	NN	O	pylorus	nn	13	SENT_206	[p19l217t1654r451b1746],
13	eradication	NN	O	eradication	prep_of	9	SENT_206	[p19l480t1654r944b1726],
14	.	.	O	.	_	0	SENT_206	[p19l480t1654r944b1726],

1	Larger	JJR	O	larger	amod	2	SENT_207	[p19l976t1660r1233b1746],
2	studies	NNS	O	study	nsubjpass	4	SENT_207	[p19l1265t1654r1530b1726],
3	are	VBP	O	be	auxpass	4	SENT_207	[p19l1564t1682r1681b1726],
4	required	VBN	O	require	_	0	SENT_207	[p19l1712t1654r2042b1746],
5	to	TO	O	to	aux	6	SENT_207	[p19l2072t1674r2149b1726],
6	investigate	VB	O	investigate	xcomp	4	SENT_207	[p19l8t1774r424b1862],
7	these	DT	O	these	det	8	SENT_207	[p19l454t1770r650b1842],
8	observations	NNS	O	observation	dobj	6	SENT_207	[p19l683t1770r1202b1842],
9	.	.	O	.	_	0	SENT_207	[p19l683t1770r1202b1842],

1	ACKNOWLEDGMENTS	NNS	O	acknowledgment	nsubjpass	5	SENT_208	[p19l6t2015r1055b2083],
2	This	DT	O	this	det	3	SENT_208	[p19l7t2123r177b2195],
3	work	NN	O	work	dep	1	SENT_208	[p19l208t2123r416b2195],
4	was	VBD	O	be	auxpass	5	SENT_208	[p19l446t2151r596b2195],
5	supported	VBN	O	support	_	0	SENT_208	[p19l629t2123r1024b2214],
6	by	IN	O	by	_	0	SENT_208	[p19l1057t2123r1150b2214],
7	research	NN	O	research	nn	8	SENT_208	[p19l1180t2123r1505b2195],
8	grants	NNS	O	grant	agent	5	SENT_208	[p19l1536t2143r1777b2214],
9	from	IN	O	from	_	0	SENT_208	[p19l1810t2122r2000b2195],
10	the	DT	O	the	det	13	SENT_208	[p19l2031t2123r2149b2195],
11	Natural	JJ	O	natural	amod	13	SENT_208	[p19l7t2233r317b2306],
12	Science	NN	O	science	nn	13	SENT_208	[p19l352t2237r632b2306],
13	Funds	NNS	O	fund	prep_from	5	SENT_208	[p19l667t2233r903b2306],
14	of	IN	O	of	_	0	SENT_208	[p19l939t2233r1020b2305],
15	China	NNP	LOCATION	China	prep_of	13	SENT_208	[p19l1051t2233r1285b2306],
16	(	CD	NUMBER	(	num	15	SENT_208	[p19l1324t2238r1531b2322],
17	Nos.	NNP	O	Nos.	dep	13	SENT_208	[p19l1324t2238r1531b2322],
18	81072032	CD	NUMBER	81072032	num	17	SENT_208	[p19l1570t2238r1970b2306],
19	and	CC	O	and	_	0	SENT_208	[p19l2007t2233r2150b2306],
20	30770992	CD	NUMBER	30770992	num	21	SENT_208	[p19l10t2349r441b2433],
21	)	NN	O	)	dep	13	SENT_208	[p19l10t2349r441b2433],
22	and	CC	O	and	_	0	SENT_208	[p19l489t2345r632b2417],
23	grants	NNS	O	grant	conj_and	13	SENT_208	[p19l673t2365r915b2436],
24	from	IN	O	from	_	0	SENT_208	[p19l958t2344r1149b2417],
25	the	DT	O	the	det	28	SENT_208	[p19l1190t2344r1308b2417],
26	Social	NNP	O	Social	nn	28	SENT_208	[p19l1353t2345r1583b2417],
27	Development	NNP	O	Development	nn	28	SENT_208	[p19l1625t2345r2150b2436],
28	Funds	NNPS	O	Funds	prep_from	23	SENT_208	[p19l8t2455r244b2527],
29	of	IN	O	of	_	0	SENT_208	[p19l290t2455r371b2527],
30	Jiangsu	NNP	LOCATION	Jiangsu	nn	31	SENT_208	[p19l404t2460r698b2547],
31	Province	NNP	LOCATION	Province	prep_of	28	SENT_208	[p19l741t2460r1105b2544],
32	,	,	O	,	_	0	SENT_208	[p19l741t2460r1105b2544],
33	China	NNP	LOCATION	China	appos	31	SENT_208	[p19l1150t2455r1383b2527],
34	(	CD	NUMBER	(	num	33	SENT_208	[p19l1432t2460r1640b2544],
35	Nos.	NNP	O	Nos.	dep	33	SENT_208	[p19l1432t2460r1640b2544],
36	.	.	O	.	_	0	SENT_208	[p19l1432t2460r1640b2544],

1	B52007070	NN	O	b52007070	_	0	SENT_209	[p19l1684t2460r2145b2527],
2	and	CC	O	and	_	0	SENT_209	[p19l9t2566r153b2638],
3	H200702	NN	O	h200702	conj_and	1	SENT_209	[p19l195t2571r628b2654],
4	)	NN	O	)	dep	1	SENT_209	[p19l195t2571r628b2654],
5	.	.	O	.	_	0	SENT_209	[p19l195t2571r628b2654],

1	Medjaden	NNP	ORGANIZATION	Medjaden	nn	3	SENT_210	[p19l671t2566r1068b2657],
2	Bioscience	NNP	ORGANIZATION	Bioscience	nn	3	SENT_210	[p19l1111t2571r1516b2638],
3	Limited	NNP	ORGANIZATION	Limited	nsubj	8	SENT_210	[p19l1560t2566r1887b2654],
4	,	,	O	,	_	0	SENT_210	[p19l1560t2566r1887b2654],
5	Hong	NNP	LOCATION	Hong	nn	6	SENT_210	[p19l1928t2572r2150b2658],
6	Kong	NNP	LOCATION	Kong	appos	3	SENT_210	[p19l8t2683r243b2769],
7	,	,	O	,	_	0	SENT_210	[p19l8t2683r243b2769],
8	assisted	VBN	O	assist	_	0	SENT_210	[p19l273t2678r571b2750],
9	in	IN	O	in	_	0	SENT_210	[p19l601t2682r673b2748],
10	the	DT	O	the	det	11	SENT_210	[p19l703t2678r822b2750],
11	preparation	NN	O	preparation	prep_in	8	SENT_210	[p19l852t2682r1316b2769],
12	of	IN	O	of	_	0	SENT_210	[p19l1348t2677r1429b2750],
13	the	DT	O	the	det	14	SENT_210	[p19l1454t2678r1572b2750],
14	manuscript	NN	O	manuscript	prep_of	11	SENT_210	[p19l1603t2682r2067b2769],
15	.	.	O	.	_	0	SENT_210	[p19l1603t2682r2067b2769],

1	Xiaolin	NNP	PERSON	Xiaolin	nn	2	SENT_211	[p19l119t2788r401b2860],
2	Pan	NNP	PERSON	Pan	nsubj	10	SENT_211	[p19l433t2794r596b2877],
3	,	,	O	,	_	0	SENT_211	[p19l433t2794r596b2877],
4	Yuqing	NNP	PERSON	Yuqing	nn	5	SENT_211	[p19l623t2793r897b2880],
5	Li	NNP	PERSON	Li	nsubj	10	SENT_211	[p19l930t2793r1026b2877],
6	,	,	O	,	_	0	SENT_211	[p19l930t2793r1026b2877],
7	and	CC	O	and	_	0	SENT_211	[p19l1059t2788r1198b2860],
8	Yuping	NNP	PERSON	Yuping	nn	9	SENT_211	[p19l1227t2793r1500b2880],
9	Qiu	NNP	PERSON	Qiu	conj_and	2	SENT_211	[p19l1535t2792r1678b2879],
10	contributed	VBD	O	contribute	_	0	SENT_211	[p19l1710t2788r2150b2860],
11	equally	RB	O	equally	advmod	10	SENT_211	[p19l9t2899r282b2991],
12	to	TO	O	to	_	0	SENT_211	[p19l320t2919r395b2971],
13	this	DT	O	this	det	14	SENT_211	[p19l435t2899r569b2971],
14	paper	NN	O	paper	prep_to	10	SENT_211	[p19l610t2926r834b2991],
15	.	.	O	.	_	0	SENT_211	[p19l610t2926r834b2991],

1	Yuqing	VBG	PERSON	yuqe	csubj	3	SENT_212	[p19l871t2903r1146b2991],
2	Li	NNP	PERSON	Li	dobj	1	SENT_212	[p19l1186t2903r1261b2970],
3	conducted	VBD	O	conduct	_	0	SENT_212	[p19l1300t2899r1694b2971],
4	the	DT	O	the	det	6	SENT_212	[p19l1733t2899r1848b2971],
5	genetic	JJ	O	genetic	amod	6	SENT_212	[p19l1888t2903r2151b2991],
6	analysis	NN	O	analysis	dobj	3	SENT_212	[p19l9t3010r294b3102],
7	and	CC	O	and	_	0	SENT_212	[p19l317t3010r453b3082],
8	wrote	VBD	O	write	conj_and	3	SENT_212	[p19l471t3031r686b3082],
9	the	DT	O	the	det	11	SENT_212	[p19l705t3010r818b3082],
10	first	JJ	ORDINAL	first	amod	11	SENT_212	[p19l838t3010r982b3082],
11	draft	NN	O	draft	dobj	8	SENT_212	[p19l1002t3010r1180b3082],
12	of	IN	O	of	_	0	SENT_212	[p19l1200t3010r1277b3082],
13	the	DT	O	the	det	14	SENT_212	[p19l1292t3010r1404b3082],
14	manuscript	NN	O	manuscript	prep_of	11	SENT_212	[p19l1424t3015r1858b3102],
15	.	.	O	.	_	0	SENT_212	[p19l1424t3015r1858b3102],

1	Ruihua	NNP	PERSON	Ruihua	nn	2	SENT_213	[p19l1879t3010r2150b3082],
2	Shi	NNP	PERSON	Shi	nsubj	14	SENT_213	[p19l10t3121r123b3193],
3	and	CC	O	and	_	0	SENT_213	[p19l157t3121r296b3193],
4	Guoxin	NNP	PERSON	Guoxin	nn	5	SENT_213	[p19l331t3125r618b3193],
5	Zhang	NNP	PERSON	Zhang	conj_and	2	SENT_213	[p19l649t3121r900b3213],
6	contributed	VBD	O	contribute	_	0	SENT_213	[p19l931t3121r1371b3193],
7	to	TO	O	to	_	0	SENT_213	[p19l1402t3141r1477b3193],
8	the	DT	O	the	det	9	SENT_213	[p19l1509t3121r1625b3193],
9	design	NN	O	design	prep_to	6	SENT_213	[p19l1659t3121r1896b3213],
10	of	IN	O	of	_	0	SENT_213	[p19l1929t3121r2008b3193],
11	the	DT	O	the	det	12	SENT_213	[p19l2034t3121r2149b3193],
12	study	NN	O	study	prep_of	9	SENT_213	[p19l9t3232r213b3324],
13	and	CC	O	and	_	0	SENT_213	[p19l241t3232r380b3304],
14	performed	VBD	O	perform	conj_and	6	SENT_213	[p19l407t3232r805b3324],
15	the	DT	O	the	det	17	SENT_213	[p19l832t3232r947b3304],
16	statistical	JJ	O	statistical	amod	17	SENT_213	[p19l976t3232r1326b3304],
17	analysis	NN	O	analysis	dobj	14	SENT_213	[p19l1356t3232r1670b3323],
18	.	.	O	.	_	0	SENT_213	[p19l1356t3232r1670b3323],

1	Qiyun	NNP	PERSON	Qiyun	nn	2	SENT_214	[p19l1701t3236r1939b3323],
2	Tang	NNP	PERSON	Tang	nsubj	6	SENT_214	[p19l1961t3235r2150b3324],
3	and	CC	O	and	_	0	SENT_214	[p19l9t3343r149b3415],
4	Linhua	NNP	PERSON	Linhua	nn	5	SENT_214	[p19l173t3343r440b3415],
5	Yao	NNP	PERSON	Yao	conj_and	2	SENT_214	[p19l461t3349r608b3415],
6	performed	VBD	O	perform	_	0	SENT_214	[p19l631t3343r1029b3435],
7	the	DT	O	the	det	9	SENT_214	[p19l1052t3343r1166b3415],
8	data	NNS	O	datum	nn	9	SENT_214	[p19l1192t3343r1355b3415],
9	collection	NN	O	collection	dobj	6	SENT_214	[p19l1379t3343r1765b3432],
10	,	,	O	,	_	0	SENT_214	[p19l1379t3343r1765b3432],
11	and	CC	O	and	_	0	SENT_214	[p19l1788t3343r1928b3415],
12	Bingbing	NNP	PERSON	Bingbing	nn	13	SENT_214	[p19l1952t3348r2149b3435, p19l10t3454r171b3546],
13	Qian	NNP	PERSON	Qian	nsubj	14	SENT_214	[p19l194t3458r379b3545],
14	conducted	VBD	O	conduct	conj_and	6	SENT_214	[p19l400t3454r786b3526],
15	the	DT	O	the	det	17	SENT_214	[p19l806t3454r920b3526],
16	telephone	NN	O	telephone	nn	17	SENT_214	[p19l940t3454r1301b3546],
17	interviews	NNS	O	interview	dobj	14	SENT_214	[p19l1323t3459r1720b3526],
18	.	.	O	.	_	0	SENT_214	[p19l1323t3459r1720b3526],

1	All	DT	O	all	det	2	SENT_215	[p19l1738t3454r1847b3525],
2	authors	NNS	O	author	nsubj	3	SENT_215	[p19l1869t3454r2150b3526],
3	read	VBP	O	read	_	0	SENT_215	[p19l8t3566r171b3638],
4	and	CC	O	and	_	0	SENT_215	[p19l193t3566r331b3638],
5	approved	VBD	O	approve	conj_and	3	SENT_215	[p19l353t3565r706b3657],
6	the	DT	O	the	det	8	SENT_215	[p19l726t3566r840b3638],
7	final	JJ	O	final	amod	8	SENT_215	[p19l862t3565r1027b3638],
8	manuscript	NN	O	manuscript	dobj	5	SENT_215	[p19l1048t3570r1489b3657],
9	.	.	O	.	_	0	SENT_215	[p19l1048t3570r1489b3657],

1	The	DT	O	the	det	2	SENT_216	[p19l1507t3566r1651b3638],
2	authors	NNS	O	author	nsubj	4	SENT_216	[p19l1674t3566r1956b3638],
3	have	VBP	O	have	aux	4	SENT_216	[p19l1978t3566r2151b3638],
4	indicated	VBN	O	indicate	_	0	SENT_216	[p19l8t3676r354b3748],
5	that	IN	O	that	complm	7	SENT_216	[p19l380t3676r530b3748],
6	they	PRP	O	they	nsubj	7	SENT_216	[p19l556t3676r717b3768],
7	have	VBP	O	have	ccomp	4	SENT_216	[p19l743t3676r917b3748],
8	no	DT	O	no	det	10	SENT_216	[p19l944t3704r1040b3748],
9	potential	JJ	O	potential	amod	10	SENT_216	[p19l1067t3676r1403b3768],
10	conflicts	NNS	O	conflict	dobj	7	SENT_216	[p19l1430t3676r1743b3748],
11	of	IN	O	of	_	0	SENT_216	[p19l1773t3676r1852b3748],
12	interest	NN	O	interest	prep_of	10	SENT_216	[p19l1875t3681r2151b3748],
13	with	IN	O	with	_	0	SENT_216	[p20l7t16r178b88],
14	regard	NN	O	regard	prep_with	12	SENT_216	[p20l204t16r448b108],
15	to	TO	O	to	_	0	SENT_216	[p20l473t36r549b88],
16	the	DT	O	the	det	17	SENT_216	[p20l576t16r691b88],
17	content	NN	O	content	prep_to	7	SENT_216	[p20l718t36r1002b88],
18	of	IN	O	of	_	0	SENT_216	[p20l1028t16r1108b88],
19	this	DT	O	this	det	20	SENT_216	[p20l1129t16r1262b88],
20	manuscript	NN	O	manuscript	prep_of	17	SENT_216	[p20l1290t20r1736b108],
21	.	.	O	.	_	0	SENT_216	[p20l1290t20r1736b108],

1	REFERENCES	NNS	O	reference	_	0	SENT_217	[p20l14t262r619b330],

1	Cover	NNP	O	Cover	nn	2	SENT_218	[p20l177t385r372b441],
2	TL	NNP	O	TL	_	0	SENT_218	[p20l398t386r504b454],
3	,	,	O	,	_	0	SENT_218	[p20l398t386r504b454],
4	Blaser	NNP	PERSON	Blaser	nn	5	SENT_218	[p20l547t382r749b441],
5	MJ	NNP	O	MJ	appos	2	SENT_218	[p20l784t386r890b455],
6	.	.	O	.	_	0	SENT_218	[p20l784t386r890b455],

1	Helicobacter	NNP	PERSON	Helicobacter	nn	2	SENT_219	[p20l930t382r1308b441],
2	pylori	NNP	PERSON	pylori	_	0	SENT_219	[p20l1329t382r1497b462],
3	in	IN	O	in	_	0	SENT_219	[p20l1532t383r1584b440],
4	health	NN	O	health	prep_in	2	SENT_219	[p20l1627t382r1829b441],
5	and	CC	O	and	_	0	SENT_219	[p20l1869t382r1991b441],
6	disease	NN	O	disease	prep_in	2	SENT_219	[p20l2031t382r2149b441, p20l176t514r336b552],
7	.	.	O	.	_	0	SENT_219	[p20l2031t382r2149b441, p20l176t514r336b552],

1	Gastroenterology	NN	O	gastroenterology	_	0	SENT_220	[p20l371t493r894b573],
2	.	.	O	.	_	0	SENT_220	[p20l371t493r894b573],

1	2009	CD	DATE	2009	_	0	SENT_221	[p20l929t496r1694b566],
2	;	:	O	;	_	0	SENT_221	[p20l929t496r1694b566],
3	136:1863	CD	DURATION	136:1863	number	4	SENT_221	[p20l929t496r1694b566],
4	-1873	CD	DURATION	-1873	dep	1	SENT_221	[p20l929t496r1694b566],
5	.	.	O	.	_	0	SENT_221	[p20l929t496r1694b566],

1	Malfertheiner	NN	O	malfertheiner	nn	2	SENT_222	[p20l179t604r641b663],
2	P	NN	O	p	_	0	SENT_222	[p20l678t608r728b677],
3	,	,	O	,	_	0	SENT_222	[p20l678t608r728b677],
4	Megraud	NN	O	megraud	nn	5	SENT_222	[p20l771t604r1070b684],
5	F	NN	O	f	appos	2	SENT_222	[p20l1113t609r1162b677],
6	,	,	O	,	_	0	SENT_222	[p20l1113t609r1162b677],
7	O’Morain	NN	O	o’morain	nn	8	SENT_222	[p20l1202t606r1533b664],
8	C	NN	O	c	appos	2	SENT_222	[p20l1574t608r1641b677],
9	,	,	O	,	_	0	SENT_222	[p20l1574t608r1641b677],
10	et	FW	O	et	nn	11	SENT_222	[p20l1681t620r1741b663],
11	al.	FW	O	al.	appos	2	SENT_222	[p20l1776t604r1850b663],
12	.	.	O	.	_	0	SENT_222	[p20l1776t604r1850b663],

1	Current	JJ	DATE	current	amod	2	SENT_223	[p20l1892t608r2151b663],
2	concepts	NNS	O	concept	_	0	SENT_223	[p20l176t730r478b794],
3	in	IN	O	in	_	0	SENT_223	[p20l522t716r574b773],
4	the	DT	O	the	det	5	SENT_223	[p20l617t714r722b774],
5	management	NN	O	management	prep_in	2	SENT_223	[p20l766t730r1209b795],
6	of	IN	O	of	_	0	SENT_223	[p20l1249t714r1326b774],
7	Helicobacter	NNP	PERSON	Helicobacter	nn	9	SENT_223	[p20l1354t714r1733b774],
8	pylori	NN	O	pylorus	nn	9	SENT_223	[p20l1759t714r1928b794],
9	infection	NN	O	infection	prep_of	5	SENT_223	[p20l1968t714r2149b774, p20l174t827r327b885],
10	:	:	O	:	_	0	SENT_223	[p20l1968t714r2149b774, p20l174t827r327b885],
11	The	DT	O	the	det	13	SENT_223	[p20l354t826r482b885],
12	Maastricht	NNP	MISC	Maastricht	nn	13	SENT_223	[p20l515t826r881b885],
13	|	NNP	O	|	nsubj	14	SENT_223	[p20l913t830r967b884],
14	|	VBD	O	|	dep	2	SENT_223	[p20l913t830r967b884],
15	|	CD	NUMBER	|	dobj	14	SENT_223	[p20l913t830r967b884],
16	Consensus	NNP	O	Consensus	nn	17	SENT_223	[p20l1002t829r1364b885],
17	Report	NNP	O	Report	dep	15	SENT_223	[p20l1397t830r1643b905],
18	.	.	O	.	_	0	SENT_223	[p20l1397t830r1643b905],

1	Cut	NNP	O	Cut	_	0	SENT_224	[p20l1678t829r1808b885],
2	.	.	O	.	_	0	SENT_224	[p20l1678t829r1808b885],

1	2007,56	CD	NUMBER	2007,56	_	0	SENT_225	[p20l1843t829r2145b899],
2	:	:	O	:	_	0	SENT_225	[p20l1843t829r2145b899],
3	772-781	CD	NUMBER	772-781	dep	1	SENT_225	[p20l178t941r491b997],
4	.	.	O	.	_	0	SENT_225	[p20l178t941r491b997],

1	Fukase	NNP	PERSON	Fukase	nn	2	SENT_226	[p20l178t1048r404b1107],
2	K	NNP	PERSON	K	_	0	SENT_226	[p20l449t1053r508b1121],
3	,	,	O	,	_	0	SENT_226	[p20l449t1053r508b1121],
4	Kato	NNP	PERSON	Kato	nn	5	SENT_226	[p20l555t1053r709b1107],
5	M	NNP	PERSON	M	appos	2	SENT_226	[p20l754t1053r839b1121],
6	,	,	O	,	_	0	SENT_226	[p20l754t1053r839b1121],
7	Kikuchi	NNP	PERSON	Kikuchi	nn	8	SENT_226	[p20l886t1048r1127b1107],
8	S	NNP	PERSON	S	appos	2	SENT_226	[p20l1169t1052r1227b1121],
9	,	,	O	,	_	0	SENT_226	[p20l1169t1052r1227b1121],
10	et	FW	O	et	nn	11	SENT_226	[p20l1270t1064r1330b1107],
11	al	FW	O	al	appos	2	SENT_226	[p20l1368t1048r1445b1121],
12	,	,	O	,	_	0	SENT_226	[p20l1368t1048r1445b1121],
13	for	IN	O	for	_	0	SENT_226	[p20l1486t1048r1584b1108],
14	the	DT	O	the	det	18	SENT_226	[p20l1618t1048r1723b1107],
15	japan	NN	O	japan	nn	18	SENT_226	[p20l1751t1053r1951b1128],
16	Gast	NNP	ORGANIZATION	Gast	nn	18	SENT_226	[p20l1996t1052r2151b1107],
17	Study	NNP	ORGANIZATION	Study	nn	18	SENT_226	[p20l175t1160r368b1239],
18	Group	NNP	ORGANIZATION	Group	prep_for	2	SENT_226	[p20l393t1163r626b1239],
19	.	.	O	.	_	0	SENT_226	[p20l393t1163r626b1239],

1	Effect	NN	O	effect	_	0	SENT_227	[p20l663t1159r852b1219],
2	of	IN	O	of	_	0	SENT_227	[p20l880t1159r957b1219],
3	eradication	NN	O	eradication	prep_of	1	SENT_227	[p20l973t1159r1353b1219],
4	of	IN	O	of	_	0	SENT_227	[p20l1386t1159r1464b1219],
5	Helicobacter	NNP	PERSON	Helicobacter	nn	6	SENT_227	[p20l1478t1159r1857b1219],
6	pylori	NN	PERSON	pylorus	prep_of	3	SENT_227	[p20l1871t1160r2040b1239],
7	on	IN	O	on	_	0	SENT_227	[p20l2065t1181r2145b1219],
8	incidence	NN	O	incidence	prep_on	1	SENT_227	[p20l178t1271r493b1330],
9	of	IN	O	of	_	0	SENT_227	[p20l522t1271r600b1330],
10	metachronous	JJ	O	metachronous	amod	12	SENT_227	[p20l618t1271r1108b1330],
11	gastric	JJ	O	gastric	amod	12	SENT_227	[p20l1135t1272r1357b1351],
12	carcinoma	NN	O	carcinoma	prep_of	8	SENT_227	[p20l1385t1272r1744b1330],
13	after	IN	O	after	_	0	SENT_227	[p20l1772t1271r1931b1330],
14	endoscopic	JJ	O	endoscopic	amod	15	SENT_227	[p20l1955t1271r2149b1330, p20l176t1384r389b1462],
15	resection	NN	O	resection	prep_after	12	SENT_227	[p20l434t1384r732b1441],
16	of	IN	O	of	_	0	SENT_227	[p20l780t1382r858b1441],
17	early	JJ	O	early	amod	19	SENT_227	[p20l887t1382r1045b1462],
18	gastric	JJ	O	gastric	amod	19	SENT_227	[p20l1083t1384r1305b1462],
19	cancer	NN	O	cancer	prep_of	15	SENT_227	[p20l1348t1404r1587b1441],
20	:	:	O	:	_	0	SENT_227	[p20l1348t1404r1587b1441],
21	An	DT	O	a	det	26	SENT_227	[p20l1631t1387r1720b1440],
22	open-label	JJ	O	open-label	amod	26	SENT_227	[p20l1768t1382r2147b1462],
23	,	,	O	,	_	0	SENT_227	[p20l1768t1382r2147b1462],
24	randomised	JJ	O	randomised	amod	26	SENT_227	[p20l178t1492r577b1551],
25	controlled	JJ	O	controlled	amod	26	SENT_227	[p20l610t1492r953b1551],
26	trial	NN	O	trial	dep	1	SENT_227	[p20l984t1492r1136b1551],
27	.	.	O	.	_	0	SENT_227	[p20l984t1492r1136b1551],

1	Lancet	NNP	O	Lancet	_	0	SENT_228	[p20l1169t1497r1381b1551],
2	.	.	O	.	_	0	SENT_228	[p20l1169t1497r1381b1551],

1	2008	CD	DATE	2008	_	0	SENT_229	[p20l1416t1496r2086b1565],
2	;	:	O	;	_	0	SENT_229	[p20l1416t1496r2086b1565],
3	372:392	CD	NUMBER	372:392	num	4	SENT_229	[p20l1416t1496r2086b1565],
4	—	NN	O	—	dep	1	SENT_229	[p20l1416t1496r2086b1565],
5	397	CD	NUMBER	397	dep	4	SENT_229	[p20l1416t1496r2086b1565],
6	.	.	O	.	_	0	SENT_229	[p20l1416t1496r2086b1565],

1	Ford	NNP	ORGANIZATION	Ford	nn	2	SENT_230	[p20l178t1604r326b1663],
2	AC	NN	ORGANIZATION	ac	_	0	SENT_230	[p20l351t1607r473b1677],
3	,	,	O	,	_	0	SENT_230	[p20l351t1607r473b1677],
4	Delaney	NNP	PERSON	Delaney	nn	5	SENT_230	[p20l505t1604r773b1683],
5	BC	NNP	O	BC	appos	2	SENT_230	[p20l798t1607r911b1677],
6	,	,	O	,	_	0	SENT_230	[p20l798t1607r911b1677],
7	Forman	NNP	PERSON	Forman	nn	8	SENT_230	[p20l941t1608r1196b1663],
8	D	NNP	O	D	appos	2	SENT_230	[p20l1229t1608r1295b1677],
9	,	,	O	,	_	0	SENT_230	[p20l1229t1608r1295b1677],
10	Moayyedi	NNP	LOCATION	Moayyedi	nn	13	SENT_230	[p20l1326t1604r1646b1683],
11	P.	NNP	O	P.	nn	13	SENT_230	[p20l1679t1608r1728b1663],
12	Eradication	NN	O	eradication	nn	13	SENT_230	[p20l1761t1604r2146b1663],
13	therapy	NN	O	therapy	appos	2	SENT_230	[p20l174t1715r444b1795],
14	for	IN	O	for	_	0	SENT_230	[p20l491t1715r592b1774],
15	peptic	JJ	O	peptic	amod	17	SENT_230	[p20l643t1716r857b1795],
16	ulcer	NN	O	ulcer	nn	17	SENT_230	[p20l912t1715r1080b1774],
17	disease	NN	O	disease	prep_for	13	SENT_230	[p20l1128t1715r1378b1774],
18	in	IN	O	in	_	0	SENT_230	[p20l1433t1716r1487b1773],
19	Helicobacter	NNP	O	Helicobacter	nn	22	SENT_230	[p20l1543t1715r1940b1774],
20	pylori	NNP	O	pylori	nn	22	SENT_230	[p20l1976t1715r2152b1795],
21	positive	JJ	O	positive	amod	22	SENT_230	[p20l179t1827r439b1906],
22	patients	NNS	O	patient	prep_in	17	SENT_230	[p20l494t1827r781b1906],
23	.	.	O	.	_	0	SENT_230	[p20l494t1827r781b1906],

1	Cochrane	NNP	ORGANIZATION	Cochrane	nn	4	SENT_231	[p20l838t1826r1115b1885],
2	Database	NNP	ORGANIZATION	Database	nn	4	SENT_231	[p20l1160t1826r1445b1885],
3	Syst	NNP	ORGANIZATION	Syst	nn	4	SENT_231	[p20l1487t1830r1605b1905],
4	Rev.	NNP	O	Rev.	_	0	SENT_231	[p20l1647t1830r1769b1885],
5	2006	CD	DATE	2006	num	4	SENT_231	[p20l1825t1827r2145b1905],
6	;	:	O	;	_	0	SENT_231	[p20l1825t1827r2145b1905],
7	(	CD	NUMBER	(	number	8	SENT_231	[p20l1825t1827r2145b1905],
8	2	CD	NUMBER	2	dep	4	SENT_231	[p20l1825t1827r2145b1905],
9	)	NN	O	)	dep	8	SENT_231	[p20l1825t1827r2145b1905],
10	:	:	O	:	_	0	SENT_231	[p20l1825t1827r2145b1905],
11	CD003840	NN	O	cd003840	dep	8	SENT_231	[p20l177t1941r571b1997],
12	.	.	O	.	_	0	SENT_231	[p20l177t1941r571b1997],

1	Clinical	JJ	O	clinical	amod	2	SENT_232	[p20l43t2348r245b2396],
2	Therapeutics	NNS	O	therapeutics	_	0	SENT_232	[p20l267t2348r637b2413],

1	Chey	NNP	O	Chey	nn	2	SENT_233	[p20l125t2536r247b2594],
2	WD	NNP	O	WD	_	0	SENT_233	[p20l268t2539r378b2589],
3	,	,	O	,	_	0	SENT_233	[p20l268t2539r378b2589],
4	Wong	NNP	PERSON	Wong	nn	5	SENT_233	[p20l404t2540r555b2595],
5	BC	NNP	O	BC	appos	2	SENT_233	[p20l583t2539r665b2589],
6	,	,	O	,	_	0	SENT_233	[p20l583t2539r665b2589],
7	for	IN	O	for	_	0	SENT_233	[p20l693t2536r765b2579],
8	the	DT	O	the	det	11	SENT_233	[p20l787t2536r863b2579],
9	Practice	NNP	ORGANIZATION	Practice	nn	11	SENT_233	[p20l893t2540r1015b2579, p20l123t2601r209b2643],
10	Parameters	NNPS	ORGANIZATION	Parameters	nn	11	SENT_233	[p20l244t2603r520b2643],
11	Committee	NNP	ORGANIZATION	Committee	prep_for	2	SENT_233	[p20l552t2601r829b2643],
12	of	IN	ORGANIZATION	of	_	0	SENT_233	[p20l861t2599r918b2643],
13	the	DT	ORGANIZATION	the	det	15	SENT_233	[p20l939t2599r1016b2643],
14	American	NNP	ORGANIZATION	American	nn	15	SENT_233	[p20l123t2665r347b2707],
15	College	NNP	ORGANIZATION	College	prep_of	11	SENT_233	[p20l372t2664r546b2723],
16	of	IN	O	of	_	0	SENT_233	[p20l568t2664r624b2707],
17	Gastroenterolo	NNP	O	Gastroenterolo	nn	19	SENT_233	[p20l636t2664r1015b2707],
18	—	CD	NUMBER	—	num	19	SENT_233	[p20l636t2664r1015b2707],
19	gy	NN	O	gy	prep_of	15	SENT_233	[p20l123t2760r185b2803],
20	.	.	O	.	_	0	SENT_233	[p20l123t2760r185b2803],

1	American	NNP	O	American	nn	2	SENT_234	[p20l203t2746r432b2788],
2	College	NNP	O	College	_	0	SENT_234	[p20l452t2744r629b2803],
3	of	IN	O	of	_	0	SENT_234	[p20l647t2744r703b2788],
4	Gastroenter	NNP	O	Gastroenter	prep_of	2	SENT_234	[p20l710t2747r1015b2788],
5	—	CD	NUMBER	—	num	4	SENT_234	[p20l710t2747r1015b2788],
6	ology	NN	O	ology	nn	7	SENT_234	[p20l125t2824r257b2883],
7	guideline	NN	O	guideline	dep	2	SENT_234	[p20l275t2824r493b2883],
8	on	IN	O	on	_	0	SENT_234	[p20l516t2840r575b2868],
9	the	DT	O	the	det	10	SENT_234	[p20l599t2824r674b2868],
10	management	NN	O	management	prep_on	7	SENT_234	[p20l700t2836r1017b2883],
11	of	IN	O	of	_	0	SENT_234	[p20l125t2891r181b2935],
12	Helicobacter	NNP	O	Helicobacter	nn	14	SENT_234	[p20l203t2892r473b2935],
13	pylori	NN	O	pylorus	nn	14	SENT_234	[p20l492t2892r612b2950],
14	infection	NN	O	infection	prep_of	10	SENT_234	[p20l643t2891r866b2935],
15	.	.	O	.	_	0	SENT_234	[p20l643t2891r866b2935],

1	Am	VBP	O	be	dep	2	SENT_235	[p20l896t2895r975b2934],
2	j	NN	O	j	_	0	SENT_235	[p20l990t2895r1018b2946],
3	Gastroentero	NNP	O	Gastroentero	dep	2	SENT_235	[p20l126t2972r429b3015],
4	/	:	O	/	punct	3	SENT_235	[p20l126t2972r429b3015],
5	.	.	O	.	_	0	SENT_235	[p20l126t2972r429b3015],

1	2007	CD	DATE	2007	_	0	SENT_236	[p20l454t2975r1001b3025],
2	;	:	O	;	_	0	SENT_236	[p20l454t2975r1001b3025],
3	102:1808	CD	DURATION	102:1808	number	4	SENT_236	[p20l454t2975r1001b3025],
4	-1825	CD	DURATION	-1825	dep	1	SENT_236	[p20l454t2975r1001b3025],
5	.	.	O	.	_	0	SENT_236	[p20l454t2975r1001b3025],

1	Mégraud	NNP	O	Mégraud	nn	3	SENT_237	[p20l127t3053r345b3111],
2	F.	NNP	O	F.	nn	3	SENT_237	[p20l373t3056r407b3096],
3	Hp_y	NNP	O	Hp_y	_	0	SENT_237	[p20l433t3053r611b3111],
4	/	:	O	/	punct	3	SENT_237	[p20l433t3053r611b3111],
5	ori	NN	O	orus	dep	3	SENT_237	[p20l433t3053r611b3111],
6	antibiotic	JJ	O	antibiotic	amod	7	SENT_237	[p20l631t3053r869b3096],
7	resistance	NN	O	resistance	dep	5	SENT_237	[p20l893t3054r1015b3096, p20l123t3144r272b3176],
8	:	:	O	:	_	0	SENT_237	[p20l893t3054r1015b3096, p20l123t3144r272b3176],
9	Prevalence	NN	O	prevalence	dep	5	SENT_237	[p20l301t3133r572b3186],
10	,	,	O	,	_	0	SENT_237	[p20l301t3133r572b3186],
11	importance	NN	O	importance	conj_and	9	SENT_237	[p20l598t3134r899b3191],
12	,	,	O	,	_	0	SENT_237	[p20l598t3134r899b3191],
13	and	CC	O	and	_	0	SENT_237	[p20l924t3133r1013b3176],
14	advances	NNS	O	advance	conj_and	9	SENT_237	[p20l125t3212r350b3256],
15	in	IN	O	in	_	0	SENT_237	[p20l381t3214r419b3255],
16	testing	NN	O	testing	prep_in	9	SENT_237	[p20l451t3214r629b3271],
17	.	.	O	.	_	0	SENT_237	[p20l451t3214r629b3271],

1	Gut	NN	O	gut	_	0	SENT_238	[p20l663t3215r758b3256],
2	.	.	O	.	_	0	SENT_238	[p20l663t3215r758b3256],

1	2004	CD	DATE	2004	_	0	SENT_239	[p20l792t3215r1013b3266],
2	;	:	O	;	_	0	SENT_239	[p20l792t3215r1013b3266],
3	53	CD	NUMBER	53	num	5	SENT_239	[p20l792t3215r1013b3266],
4	:	:	O	:	_	0	SENT_239	[p20l792t3215r1013b3266],
5	1374-1384	CD	DATE	1374-1384	dep	1	SENT_239	[p20l128t3296r422b3337],
6	.	.	O	.	_	0	SENT_239	[p20l128t3296r422b3337],

1	Fischbach	NNP	ORGANIZATION	Fischbach	nn	2	SENT_240	[p20l126t3374r359b3417],
2	L	NNP	ORGANIZATION	L	_	0	SENT_240	[p20l381t3377r416b3427],
3	,	,	O	,	_	0	SENT_240	[p20l381t3377r416b3427],
4	Evans	NNP	PERSON	Evans	nn	5	SENT_240	[p20l437t3377r569b3417],
5	EL	NNP	O	EL	appos	2	SENT_240	[p20l588t3377r653b3417],
6	.	.	O	.	_	0	SENT_240	[p20l588t3377r653b3417],

1	Meta	NN	O	meta	nn	3	SENT_241	[p20l675t3374r1012b3432],
2	—	NN	O	—	nn	3	SENT_241	[p20l675t3374r1012b3432],
3	analysis	NN	O	analysis	_	0	SENT_241	[p20l675t3374r1012b3432],
4	:	:	O	:	_	0	SENT_241	[p20l675t3374r1012b3432],
5	The	DT	O	the	det	6	SENT_241	[p20l120t3454r213b3497],
6	effect	NN	O	effect	dep	3	SENT_241	[p20l249t3454r385b3497],
7	of	IN	O	of	_	0	SENT_241	[p20l418t3454r475b3497],
8	antibiotic	JJ	O	antibiotic	amod	10	SENT_241	[p20l500t3454r738b3497],
9	resistance	NN	O	resistance	nn	10	SENT_241	[p20l774t3455r1015b3497],
10	status	NN	O	status	prep_of	6	SENT_241	[p20l125t3547r271b3579],
11	on	IN	O	on	_	0	SENT_241	[p20l298t3551r356b3579],
12	the	DT	O	the	det	13	SENT_241	[p20l384t3535r460b3579],
13	efﬁcacy	NN	O	efﬁcacy	prep_on	10	SENT_241	[p20l487t3535r676b3594],
14	of	IN	O	of	_	0	SENT_241	[p20l699t3535r756b3579],
15	triple	JJ	O	triple	prep_of	13	SENT_241	[p20l770t3535r897b3594],
16	and	CC	O	and	_	0	SENT_241	[p20l924t3535r1013b3579],
17	j	NN	O	j	nn	19	SENT_241	[p20l1242t2539r1270b2590],
18	Antimicrob	NNP	PERSON	Antimicrob	nn	19	SENT_241	[p20l1302t2535r1559b2578],
19	Chemother	NNP	PERSON	Chemother	prep_of	13	SENT_241	[p20l1600t2535r1866b2578],
20	.	.	O	.	_	0	SENT_241	[p20l1600t2535r1866b2578],

1	1997	CD	DATE	1997	_	0	SENT_242	[p20l1918t2538r2145b2589],
2	;	:	O	;	_	0	SENT_242	[p20l1918t2538r2145b2589],
3	40	CD	NUMBER	40	num	5	SENT_242	[p20l1918t2538r2145b2589],
4	:	:	O	:	_	0	SENT_242	[p20l1918t2538r2145b2589],
5	235-240	CD	NUMBER	235-240	dep	1	SENT_242	[p20l1258t2601r1497b2642],
6	.	.	O	.	_	0	SENT_242	[p20l1258t2601r1497b2642],

1	Tanaka	NNP	PERSON	Tanaka	nn	2	SENT_243	[p20l1252t2661r1435b2704],
2	M	NNP	O	M	_	0	SENT_243	[p20l1460t2665r1522b2715],
3	,	,	O	,	_	0	SENT_243	[p20l1460t2665r1522b2715],
4	Isogai	NNP	PERSON	Isogai	nn	5	SENT_243	[p20l1549t2662r1687b2720],
5	E	NNP	PERSON	E	appos	2	SENT_243	[p20l1715t2665r1755b2715],
6	,	,	O	,	_	0	SENT_243	[p20l1715t2665r1755b2715],
7	Isogai	NNP	PERSON	Isogai	nn	8	SENT_243	[p20l1783t2662r1921b2720],
8	H	NNP	O	H	appos	2	SENT_243	[p20l1949t2665r2001b2715],
9	,	,	O	,	_	0	SENT_243	[p20l1949t2665r2001b2715],
10	et	FW	O	et	nn	11	SENT_243	[p20l2025t2673r2069b2705],
11	al.	FW	O	al.	appos	2	SENT_243	[p20l2090t2661r2144b2704],
12	.	.	O	.	_	0	SENT_243	[p20l2090t2661r2144b2704],

1	Synergic	JJ	MISC	synergic	amod	3	SENT_244	[p20l1255t2741r1454b2798],
2	effect	NN	O	effect	nn	3	SENT_244	[p20l1472t2739r1605b2783],
3	ofquinolone	NN	O	ofquinolone	_	0	SENT_244	[p20l1621t2739r1931b2798],
4	antibacterial	JJ	O	antibacterial	amod	5	SENT_244	[p20l1948t2740r2147b2783, p20l1255t2817r1374b2861],
5	agents	NNS	O	agent	dep	3	SENT_244	[p20l1407t2829r1563b2876],
6	and	CC	O	and	_	0	SENT_244	[p20l1593t2817r1681b2860],
7	proton	NN	O	proton	nn	9	SENT_244	[p20l1717t2829r1879b2876],
8	pump	NN	O	pump	nn	9	SENT_244	[p20l1915t2833r2055b2876],
9	inhibitors	NNS	O	inhibitor	dep	3	SENT_244	[p20l2089t2818r2147b2860, p20l1259t2883r1438b2926],
10	on	IN	O	on	_	0	SENT_244	[p20l1458t2899r1516b2926],
11	Helicobacter	NNP	PERSON	Helicobacter	nn	12	SENT_244	[p20l1538t2883r1801b2926],
12	pylori	NNP	PERSON	pylori	prep_on	5	SENT_244	[p20l1811t2883r1938b2941],
13	.	.	O	.	_	0	SENT_244	[p20l1811t2883r1938b2941],

1	j	NN	O	j	_	0	SENT_245	[p20l1946t2886r1974b2937],
2	Antimicrob	NNP	PERSON	Antimicrob	nn	3	SENT_245	[p20l1985t2885r2147b2926, p20l1255t2961r1343b3004],
3	Chemother	NNP	PERSON	Chemother	dep	1	SENT_245	[p20l1361t2961r1604b3004],
4	.	.	O	.	_	0	SENT_245	[p20l1361t2961r1604b3004],

1	2002	CD	DATE	2002	_	0	SENT_246	[p20l1627t2964r2132b3015],
2	;	:	O	;	_	0	SENT_246	[p20l1627t2964r2132b3015],
3	49:1039	CD	NUMBER	49:1039	number	4	SENT_246	[p20l1627t2964r2132b3015],
4	—	CD	NUMBER	—	dep	1	SENT_246	[p20l1627t2964r2132b3015],
5	1040	CD	DATE	1040	dep	4	SENT_246	[p20l1627t2964r2132b3015],
6	.	.	O	.	_	0	SENT_246	[p20l1627t2964r2132b3015],

1	GisbertJP	NNP	O	GisbertJP	_	0	SENT_247	[p20l1257t3041r1508b3094],
2	,	,	O	,	_	0	SENT_247	[p20l1257t3041r1508b3094],
3	Morena	NNP	PERSON	Morena	nn	6	SENT_247	[p20l1537t3044r1723b3084],
4	F.	NNP	O	F.	nn	6	SENT_247	[p20l1748t3044r1782b3084],
5	Systematic	NNP	O	Systematic	nn	6	SENT_247	[p20l1809t3042r2063b3098],
6	review	NN	O	review	appos	1	SENT_247	[p20l2089t3057r2147b3084, p20l1254t3121r1359b3163],
7	and	CC	O	and	_	0	SENT_247	[p20l1373t3119r1460b3162],
8	meta	NN	O	meta	appos	1	SENT_247	[p20l1482t3119r1815b3177],
9	—	CD	NUMBER	—	num	12	SENT_247	[p20l1482t3119r1815b3177],
10	ana	NN	O	ana	nn	12	SENT_247	[p20l1482t3119r1815b3177],
11	|	NN	O	|	nn	12	SENT_247	[p20l1482t3119r1815b3177],
12	ysis	NN	O	ysis	dep	6	SENT_247	[p20l1482t3119r1815b3177],
13	:	:	O	:	_	0	SENT_247	[p20l1482t3119r1815b3177],
14	Levofloxacin	NN	O	levofloxacin	nn	15	SENT_247	[p20l1838t3119r2147b3163],
15	—	NN	O	—	dep	1	SENT_247	[p20l1838t3119r2147b3163],
16	based	VBN	O	base	partmod	15	SENT_247	[p20l1259t3198r1393b3241],
17	rescue	NN	O	rescue	nn	18	SENT_247	[p20l1432t3214r1578b3241],
18	regimens	NNS	O	regimen	dobj	16	SENT_247	[p20l1615t3199r1825b3257],
19	after	IN	O	after	_	0	SENT_247	[p20l1860t3198r1971b3241],
20	He/icobacter	NNP	O	He/icobacter	prep_after	16	SENT_247	[p20l2003t3198r2148b3241, p20l1256t3277r1387b3320],
21	pylori	NN	O	pylorus	nn	23	SENT_247	[p20l1400t3277r1517b3336],
22	treatment	NN	O	treatment	nn	23	SENT_247	[p20l1537t3289r1774b3321],
23	failure	NN	O	failure	dep	20	SENT_247	[p20l1796t3277r1956b3321],
24	.	.	O	.	_	0	SENT_247	[p20l1796t3277r1956b3321],

1	Aliment	NNP	O	Aliment	nn	2	SENT_248	[p20l1979t3277r2151b3320],
2	Pharmaco	NNP	O	Pharmaco	_	0	SENT_248	[p20l1256t3357r1483b3400],
3	/	:	O	/	punct	2	SENT_248	[p20l1256t3357r1483b3400],
4	Ther	NNP	O	Ther	dep	2	SENT_248	[p20l1498t3357r1606b3400],
5	.	.	O	.	_	0	SENT_248	[p20l1498t3357r1606b3400],

1	2006	CD	DATE	2006	_	0	SENT_249	[p20l1629t3360r2008b3410],
2	;	:	O	;	_	0	SENT_249	[p20l1629t3360r2008b3410],
3	23:35	CD	TIME	23:35	number	4	SENT_249	[p20l1629t3360r2008b3410],
4	-44	CD	NUMBER	-44	dep	1	SENT_249	[p20l1629t3360r2008b3410],
5	.	.	O	.	_	0	SENT_249	[p20l1629t3360r2008b3410],

1	Wong	NNP	ORGANIZATION	Wong	nn	2	SENT_250	[p20l1254t3439r1404b3494],
2	WM	NNP	ORGANIZATION	WM	_	0	SENT_250	[p20l1430t3439r1553b3489],
3	,	,	O	,	_	0	SENT_250	[p20l1430t3439r1553b3489],
4	Gu	NNP	O	Gu	nn	5	SENT_250	[p20l1585t3438r1653b3479],
5	Q	NNP	O	Q	appos	2	SENT_250	[p20l1686t3438r1743b3489],
6	,	,	O	,	_	0	SENT_250	[p20l1686t3438r1743b3489],
7	Lam	NNP	LOCATION	Lam	nn	8	SENT_250	[p20l1778t3439r1877b3478],
8	SK	NNP	LOCATION	SK	appos	2	SENT_250	[p20l1908t3438r1986b3489],
9	,	,	O	,	_	0	SENT_250	[p20l1908t3438r1986b3489],
10	et	FW	O	et	nn	11	SENT_250	[p20l2018t3447r2062b3479],
11	al.	FW	O	al.	appos	2	SENT_250	[p20l2090t3435r2144b3478],
12	.	.	O	.	_	0	SENT_250	[p20l2090t3435r2144b3478],

1	Randomized	VBN	O	randomize	_	0	SENT_251	[p20l1260t3516r1565b3559],
2	controlled	JJ	O	controlled	amod	3	SENT_251	[p20l1588t3516r1839b3559],
3	study	NN	O	study	dobj	1	SENT_251	[p20l1863t3516r1996b3574],
4	of	IN	O	of	_	0	SENT_251	[p20l2014t3516r2071b3559],
5	raquadruple	NN	O	raquadruple	prep_of	3	SENT_251	[p20l2083t3532r2147b3559, p21l125t29r382b88],

1	first	RB	ORDINAL	first	advmod	3	SENT_252	[p21l424t29r632b72],
2	—	CD	NUMBER	—	num	3	SENT_252	[p21l424t29r632b72],
3	line	NN	O	line	_	0	SENT_252	[p21l424t29r632b72],
4	therapies	NNS	O	therapy	dep	3	SENT_252	[p21l674t29r904b88],
5	for	IN	O	for	_	0	SENT_252	[p21l947t29r1019b72],
6	Helicobacter	NNP	PERSON	Helicobacter	nn	7	SENT_252	[p21l125t110r401b154],
7	pylori	NNP	PERSON	pylori	prep_for	4	SENT_252	[p21l418t110r553b169],
8	.	.	O	.	_	0	SENT_252	[p21l418t110r553b169],

1	Aliment	NNP	O	Aliment	nn	3	SENT_253	[p21l580t110r760b154],
2	Pnarmacol	NNP	O	Pnarmacol	nn	3	SENT_253	[p21l783t110r1019b154],
3	Ther	NNP	O	Ther	_	0	SENT_253	[p21l125t192r232b235],
4	.	.	O	.	_	0	SENT_253	[p21l125t192r232b235],

1	2007	CD	DATE	2007	_	0	SENT_254	[p21l259t194r715b245],
2	;	:	O	;	_	0	SENT_254	[p21l259t194r715b245],
3	26:343	CD	NUMBER	26:343	number	4	SENT_254	[p21l259t194r715b245],
4	-357	CD	NUMBER	-357	dep	1	SENT_254	[p21l259t194r715b245],
5	.	.	O	.	_	0	SENT_254	[p21l259t194r715b245],

1	Huang	NNP	PERSON	Huang	nn	2	SENT_255	[p21l128t396r292b451],
2	AH	NNP	O	AH	_	0	SENT_255	[p21l306t396r401b445],
3	,	,	O	,	_	0	SENT_255	[p21l306t396r401b445],
4	Sheu	NNP	PERSON	Sheu	nn	5	SENT_255	[p21l420t392r536b435],
5	BS	NNP	O	BS	appos	2	SENT_255	[p21l560t395r634b446],
6	,	,	O	,	_	0	SENT_255	[p21l560t395r634b446],
7	Yang	NNP	ORGANIZATION	Yang	nn	8	SENT_255	[p21l649t396r770b451],
8	HB	NNP	ORGANIZATION	HB	appos	2	SENT_255	[p21l789t396r878b445],
9	,	,	O	,	_	0	SENT_255	[p21l789t396r878b445],
10	et	FW	O	et	nn	11	SENT_255	[p21l898t404r941b435],
11	al.	FW	O	al.	appos	2	SENT_255	[p21l958t392r1013b435],
12	.	.	O	.	_	0	SENT_255	[p21l958t392r1013b435],

1	Impact	NN	O	impact	_	0	SENT_256	[p21l128t477r301b532],
2	of	IN	O	of	_	0	SENT_256	[p21l324t473r382b517],
3	Helicobacter	NNP	PERSON	Helicobacter	nn	6	SENT_256	[p21l396t473r676b516],
4	pylori	NNP	PERSON	pylori	nn	6	SENT_256	[p21l690t473r815b532],
5	antimicrobial	JJ	O	antimicrobial	amod	6	SENT_256	[p21l837t475r1015b516, p21l124t555r292b598],
6	resistance	NN	O	resistance	prep_of	1	SENT_256	[p21l327t556r568b598],
7	on	IN	O	on	_	0	SENT_256	[p21l599t570r658b598],
8	the	DT	O	the	det	9	SENT_256	[p21l689t555r766b598],
9	outcome	NN	O	outcome	prep_on	1	SENT_256	[p21l797t566r1016b598],
10	of	IN	O	of	_	0	SENT_256	[p21l125t748r182b792],
11	1	CD	DURATION	1	prep_of	9	SENT_256	[p21l197t752r211b791],
12	-	:	DURATION	-	_	0	SENT_256	[p21l226t749r367b792],
13	week	NN	DURATION	week	dep	1	SENT_256	[p21l226t749r367b792],
14	lansoprazole-based	JJ	O	lansoprazole-based	amod	16	SENT_256	[p21l388t749r865b807],
15	triple	JJ	O	triple	amod	16	SENT_256	[p21l888t749r1016b807],
16	therapy	NN	O	therapy	dep	13	SENT_256	[p21l123t830r322b888],
17	.	.	O	.	_	0	SENT_256	[p21l123t830r322b888],

1	j	NN	O	j	_	0	SENT_257	[p21l342t833r370b884],
2	Formos	NNP	ORGANIZATION	Formos	nn	4	SENT_257	[p21l396t833r555b873],
3	Med	NNP	ORGANIZATION	Med	nn	4	SENT_257	[p21l581t830r683b873],
4	Assoc	NNP	ORGANIZATION	Assoc	dep	1	SENT_257	[p21l703t833r838b873],
5	.	.	O	.	_	0	SENT_257	[p21l703t833r838b873],

1	2000	CD	DATE	2000	_	0	SENT_258	[p21l874t832r1014b883],
2	;	:	O	;	_	0	SENT_258	[p21l874t832r1014b883],
3	99:704	CD	NUMBER	99:704	number	4	SENT_258	[p21l126t913r439b954],
4	-709	CD	NUMBER	-709	dep	1	SENT_258	[p21l126t913r439b954],
5	.	.	O	.	_	0	SENT_258	[p21l126t913r439b954],

1	Kato	NNP	PERSON	Kato	nn	2	SENT_259	[p21l128t995r236b1035],
2	S	NNP	PERSON	S	_	0	SENT_259	[p21l263t995r303b1045],
3	,	,	O	,	_	0	SENT_259	[p21l263t995r303b1045],
4	Fujimura	NNP	PERSON	Fujimura	nn	5	SENT_259	[p21l333t993r544b1051],
5	S.	NNP	O	S.	appos	2	SENT_259	[p21l568t995r608b1035],
6	Primary	JJ	O	primary	amod	8	SENT_259	[p21l641t993r823b1050],
7	antimicrobial	JJ	O	antimicrobial	amod	8	SENT_259	[p21l846t993r1015b1035, p21l124t1073r285b1116],
8	resistance	NN	O	resistance	dep	5	SENT_259	[p21l310t1074r540b1116],
9	of	IN	O	of	_	0	SENT_259	[p21l562t1073r617b1116],
10	Helicobacter	NNP	PERSON	Helicobacter	nn	11	SENT_259	[p21l628t1073r891b1116],
11	pylori	NNP	PERSON	pylori	prep_of	8	SENT_259	[p21l901t1073r1018b1131],
12	in	IN	O	in	_	0	SENT_259	[p21l127t1155r163b1197],
13	children	NNS	O	child	prep_in	11	SENT_259	[p21l195t1154r382b1197],
14	during	IN	O	during	_	0	SENT_259	[p21l414t1154r568b1213],
15	the	DT	DURATION	the	det	18	SENT_259	[p21l594t1154r668b1197],
16	past	JJ	DURATION	past	amod	18	SENT_259	[p21l699t1165r798b1212],
17	9	CD	DURATION	9	num	18	SENT_259	[p21l827t1157r852b1197],
18	years	NNS	NUMBER	year	prep_during	13	SENT_259	[p21l881t1170r1013b1212],
19	.	.	O	.	_	0	SENT_259	[p21l881t1170r1013b1212],

1	Pediatr/nt	NN	O	pediatr/nt	_	0	SENT_260	[p21l124t1235r359b1278],
2	.	.	O	.	_	0	SENT_260	[p21l124t1235r359b1278],

1	2010	CD	DATE	2010	_	0	SENT_261	[p21l382t1238r824b1288],
2	;	:	O	;	_	0	SENT_261	[p21l382t1238r824b1288],
3	52:187	CD	NUMBER	52:187	number	4	SENT_261	[p21l382t1238r824b1288],
4	-190	CD	NUMBER	-190	dep	1	SENT_261	[p21l382t1238r824b1288],
5	.	.	O	.	_	0	SENT_261	[p21l382t1238r824b1288],

1	Hori	NNP	PERSON	Hori	nn	2	SENT_262	[p21l128t1316r274b1359],
2	|	NN	O	|	_	0	SENT_262	[p21l128t1316r274b1359],
3	<	JJR	O	<	dep	2	SENT_262	[p21l128t1316r274b1359],
4	i	FW	O	i	dep	3	SENT_262	[p21l128t1316r274b1359],
5	N	NN	O	n	dep	2	SENT_262	[p21l306t1320r358b1369],
6	,	,	O	,	_	0	SENT_262	[p21l306t1320r358b1369],
7	Omata	NNP	PERSON	Omata	nn	8	SENT_262	[p21l387t1319r561b1360],
8	F	NN	O	f	appos	5	SENT_262	[p21l590t1320r626b1369],
9	,	,	O	,	_	0	SENT_262	[p21l590t1320r626b1369],
10	Uemura	NNP	O	Uemura	nn	11	SENT_262	[p21l657t1320r853b1359],
11	M	NNP	O	M	appos	2	SENT_262	[p21l882t1320r944b1369],
12	,	,	O	,	_	0	SENT_262	[p21l882t1320r944b1369],
13	et	FW	O	et	nn	14	SENT_262	[p21l973t1328r1017b1359],
14	al.	FW	O	al.	appos	2	SENT_262	[p21l125t1397r179b1440],
15	.	.	O	.	_	0	SENT_262	[p21l125t1397r179b1440],

1	Annual	JJ	SET	annual	amod	2	SENT_263	[p21l204t1397r379b1440],
2	change	NN	O	change	_	0	SENT_263	[p21l406t1397r580b1456],
3	of	IN	O	of	_	0	SENT_263	[p21l605t1397r662b1440],
4	primary	JJ	O	primary	amod	5	SENT_263	[p21l678t1398r870b1455],
5	resistance	NN	O	resistance	prep_of	2	SENT_263	[p21l893t1398r1015b1440, p21l123t1490r258b1521],
6	to	TO	O	to	_	0	SENT_263	[p21l275t1490r325b1521],
7	clarithromycin	NN	O	clarithromycin	prep_to	5	SENT_263	[p21l344t1478r699b1536],
8	among	IN	O	among	_	0	SENT_263	[p21l721t1494r893b1537],
9	Helicobacter	NNP	PERSON	Helicobacter	nn	11	SENT_263	[p21l910t1478r1016b1521, p21l123t1559r308b1602],
10	pylori	NNP	PERSON	pylori	nn	11	SENT_263	[p21l338t1559r462b1618],
11	isolates	NNS	O	isolate	prep_among	2	SENT_263	[p21l504t1559r687b1602],
12	from	IN	O	from	_	0	SENT_263	[p21l729t1559r844b1602],
13	1996	CD	DATE	1996	prep_from	11	SENT_263	[p21l894t1562r1015b1602],
14	through	IN	DATE	through	_	0	SENT_263	[p21l123t1640r319b1699],
15	2008	CD	DATE	2008	num	16	SENT_263	[p21l343t1643r466b1684],
16	injapan	NN	O	injapan	prep_through	2	SENT_263	[p21l490t1642r704b1699],
17	.	.	O	.	_	0	SENT_263	[p21l490t1642r704b1699],

1	He/icobacter	NN	O	he/icobacter	_	0	SENT_264	[p21l727t1640r1013b1684],
2	.	.	O	.	_	0	SENT_264	[p21l727t1640r1013b1684],

1	2009	CD	DATE	2009	_	0	SENT_265	[p21l126t1724r521b1774],
2	;	:	O	;	_	0	SENT_265	[p21l126t1724r521b1774],
3	14:86	CD	NUMBER	14:86	number	4	SENT_265	[p21l126t1724r521b1774],
4	—	CD	NUMBER	—	dep	1	SENT_265	[p21l126t1724r521b1774],
5	90	CD	NUMBER	90	dep	4	SENT_265	[p21l126t1724r521b1774],
6	.	.	O	.	_	0	SENT_265	[p21l126t1724r521b1774],

1	Gerrits	JJ	O	gerrits	amod	2	SENT_266	[p21l125t1804r289b1846],
2	MM	NN	O	mm	_	0	SENT_266	[p21l319t1807r435b1856],
3	,	,	O	,	_	0	SENT_266	[p21l319t1807r435b1856],
4	van	NN	PERSON	van	nn	6	SENT_266	[p21l462t1819r545b1846],
5	Vliet	NNP	PERSON	Vliet	nn	6	SENT_266	[p21l573t1803r683b1846],
6	AH	NNP	O	AH	appos	2	SENT_266	[p21l707t1807r802b1856],
7	,	,	O	,	_	0	SENT_266	[p21l707t1807r802b1856],
8	Kuipers	NNP	PERSON	Kuipers	nn	9	SENT_266	[p21l835t1804r1016b1861],
9	EJ	NNP	O	EJ	appos	2	SENT_266	[p21l128t1888r185b1939],
10	,	,	O	,	_	0	SENT_266	[p21l128t1888r185b1939],
11	KustersJG	NNP	O	KustersJG	appos	2	SENT_266	[p21l210t1888r475b1939],
12	.	.	O	.	_	0	SENT_266	[p21l210t1888r475b1939],

1	Helicobacter	NNP	PERSON	Helicobacter	nn	2	SENT_267	[p21l498t1885r775b1928],
2	pylori	NNP	PERSON	pylori	_	0	SENT_267	[p21l785t1885r907b1943],
3	and	CC	O	and	_	0	SENT_267	[p21l924t1885r1013b1928],
4	antimicrobial	JJ	O	antimicrobial	amod	5	SENT_267	[p21l125t1967r454b2010],
5	resistance	NN	O	resistance	conj_and	2	SENT_267	[p21l483t1968r738b2010],
6	:	:	O	:	_	0	SENT_267	[p21l483t1968r738b2010],
7	Molecular	JJ	O	molecular	amod	8	SENT_267	[p21l769t1967r1019b2010],
8	mechanisms	NNS	O	mechanism	dep	2	SENT_267	[p21l127t2048r436b2091],
9	and	CC	O	and	_	0	SENT_267	[p21l472t2048r562b2091],
10	clinical	JJ	O	clinical	amod	11	SENT_267	[p21l601t2048r773b2091],
11	implications	NNS	O	implication	conj_and	8	SENT_267	[p21l814t2048r1015b2106, p21l123t2131r259b2173],
12	.	.	O	.	_	0	SENT_267	[p21l814t2048r1015b2106, p21l123t2131r259b2173],

1	Lancet	NNP	O	Lancet	nn	3	SENT_268	[p21l287t2134r431b2173],
2	Inﬁect	NNP	O	Inﬁect	nn	3	SENT_268	[p21l450t2130r571b2185],
3	Dis	NNP	O	Dis	_	0	SENT_268	[p21l590t2132r670b2173],
4	.	.	O	.	_	0	SENT_268	[p21l590t2132r670b2173],

1	2006	CD	DATE	2006	_	0	SENT_269	[p21l700t2133r1016b2183],
2	;	:	O	;	_	0	SENT_269	[p21l700t2133r1016b2183],
3	6:699	CD	NUMBER	6:699	num	4	SENT_269	[p21l700t2133r1016b2183],
4	—	NN	O	—	dep	1	SENT_269	[p21l700t2133r1016b2183],
5	709	CD	NUMBER	709	dep	4	SENT_269	[p21l126t2215r232b2255],
6	.	.	O	.	_	0	SENT_269	[p21l126t2215r232b2255],

1	Croom	NNP	PERSON	Croom	nn	2	SENT_270	[p21l125t2296r294b2337],
2	KF	NNP	O	KF	_	0	SENT_270	[p21l322t2297r392b2347],
3	,	,	O	,	_	0	SENT_270	[p21l322t2297r392b2347],
4	Goa	NNP	LOCATION	Goa	nn	5	SENT_270	[p21l416t2296r518b2337],
5	KL	NNP	LOCATION	KL	appos	2	SENT_270	[p21l542t2297r613b2337],
6	.	.	O	.	_	0	SENT_270	[p21l542t2297r613b2337],

1	Levofloxacin	NNP	O	Levofloxacin	_	0	SENT_271	[p21l641t2293r959b2337],
2	:	:	O	:	_	0	SENT_271	[p21l641t2293r959b2337],
3	A	NNP	O	A	nn	4	SENT_271	[p21l981t2297r1017b2336],
4	review	NN	O	review	nsubj	5	SENT_271	[p21l126t2377r279b2418],
5	ofits	VBZ	O	ofit	dep	1	SENT_271	[p21l298t2375r420b2418],
6	use	NN	O	use	dobj	5	SENT_271	[p21l444t2391r521b2418],
7	in	IN	O	in	_	0	SENT_271	[p21l544t2377r582b2418],
8	the	DT	O	the	det	9	SENT_271	[p21l605t2375r682b2418],
9	treatment	NN	O	treatment	prep_in	5	SENT_271	[p21l702t2387r948b2418],
10	of	IN	O	of	_	0	SENT_271	[p21l969t2375r1026b2418],
11	bacterial	JJ	O	bacterial	amod	12	SENT_271	[p21l127t2457r336b2500],
12	infections	NNS	O	infection	prep_of	9	SENT_271	[p21l379t2457r617b2500],
13	in	IN	O	in	_	0	SENT_271	[p21l657t2458r696b2499],
14	the	DT	O	the	det	16	SENT_271	[p21l735t2457r812b2500],
15	United	NNP	LOCATION	United	nn	16	SENT_271	[p21l852t2457r1013b2500],
16	States	NNPS	LOCATION	States	prep_in	12	SENT_271	[p21l124t2541r287b2582],
17	.	.	O	.	_	0	SENT_271	[p21l124t2541r287b2582],

1	Drugs	NNS	O	drug	_	0	SENT_272	[p21l311t2542r449b2597],
2	.	.	O	.	_	0	SENT_272	[p21l311t2542r449b2597],

1	2003	CD	DATE	2003	_	0	SENT_273	[p21l475t2541r1000b2591],
2	;	:	O	;	_	0	SENT_273	[p21l475t2541r1000b2591],
3	63:2769	CD	NUMBER	63:2769	number	4	SENT_273	[p21l475t2541r1000b2591],
4	—	CD	NUMBER	—	dep	1	SENT_273	[p21l475t2541r1000b2591],
5	2802	CD	DATE	2802	dep	4	SENT_273	[p21l475t2541r1000b2591],
6	.	.	O	.	_	0	SENT_273	[p21l475t2541r1000b2591],

1	Fujimura	NNP	PERSON	Fujimura	nn	2	SENT_274	[p21l126t2617r350b2674],
2	S	NNP	O	S	nsubj	25	SENT_274	[p21l396t2619r438b2669],
3	,	,	O	,	_	0	SENT_274	[p21l396t2619r438b2669],
4	Kato	NNP	PERSON	Kato	nn	5	SENT_274	[p21l491t2619r605b2659],
5	S	NNP	PERSON	S	conj_and	2	SENT_274	[p21l652t2619r695b2669],
6	,	,	O	,	_	0	SENT_274	[p21l652t2619r695b2669],
7	linuma	NN	O	linuma	nn	8	SENT_274	[p21l747t2617r920b2659],
8	K	NN	O	k	conj_and	2	SENT_274	[p21l970t2619r1014b2669],
9	,	,	O	,	_	0	SENT_274	[p21l970t2619r1014b2669],
10	Watanabe	NNP	PERSON	Watanabe	nn	11	SENT_274	[p21l122t2696r380b2739],
11	A.	NN	O	a.	conj_and	2	SENT_274	[p21l400t2700r449b2739],
12	In	FW	O	in	nn	15	SENT_274	[p21l477t2700r516b2739],
13	vitro	FW	O	vitro	nn	15	SENT_274	[p21l538t2698r649b2739],
14	activity	NN	O	activity	nn	15	SENT_274	[p21l671t2698r846b2754],
15	offluoroquinolone	NN	O	offluoroquinolone	dep	11	SENT_274	[p21l865t2696r1015b2739, p21l125t2776r463b2834],
16	and	CC	O	and	_	0	SENT_274	[p21l505t2776r594b2819],
17	the	DT	O	the	det	20	SENT_274	[p21l638t2776r714b2819],
18	gyrA	NN	O	gyra	nn	20	SENT_274	[p21l755t2780r864b2835],
19	gene	NN	O	gene	nn	20	SENT_274	[p21l903t2792r1016b2835],
20	mutation	NN	O	mutation	nsubj	25	SENT_274	[p21l127t2858r352b2900],
21	in	IN	O	in	_	0	SENT_274	[p21l374t2858r412b2899],
22	Helicobacter	NNP	PERSON	Helicobacter	nn	24	SENT_274	[p21l432t2857r709b2900],
23	pylori	NN	PERSON	pylorus	nn	24	SENT_274	[p21l716t2857r839b2915],
24	strains	NNS	O	strain	prep_in	2	SENT_274	[p21l854t2858r1016b2900],
25	isolated	VBN	O	isolate	_	0	SENT_274	[p21l126t2937r316b2980],
26	from	IN	O	from	_	0	SENT_274	[p21l341t2937r457b2980],
27	children	NNS	O	child	prep_from	25	SENT_274	[p21l483t2937r736b2991],
28	.	.	O	.	_	0	SENT_274	[p21l483t2937r736b2991],

1	_	NN	O	_	_	0	SENT_275	[p21l483t2937r736b2991],
2	/	:	O	/	punct	4	SENT_275	[p21l483t2937r736b2991],
3	Med	NNP	LOCATION	Med	nn	4	SENT_275	[p21l754t2937r856b2980],
4	Microbio	NNP	LOCATION	Microbio	dep	1	SENT_275	[p21l872t2939r1016b2980, p21l124t3018r215b3061],
5	/	:	O	/	punct	4	SENT_275	[p21l872t2939r1016b2980, p21l124t3018r215b3061],
6	.	.	O	.	_	0	SENT_275	[p21l872t2939r1016b2980, p21l124t3018r215b3061],

1	2004	CD	DATE	2004	_	0	SENT_276	[p21l240t3021r766b3072],
2	;	:	O	;	_	0	SENT_276	[p21l240t3021r766b3072],
3	53:1019	CD	DURATION	53:1019	number	4	SENT_276	[p21l240t3021r766b3072],
4	-1022	CD	DURATION	-1022	dep	1	SENT_276	[p21l240t3021r766b3072],
5	.	.	O	.	_	0	SENT_276	[p21l240t3021r766b3072],

1	Irie	NNP	O	Irie	nn	2	SENT_277	[p21l128t3084r199b3126],
2	Y	NN	O	y	_	0	SENT_277	[p21l212t3087r253b3136],
3	,	,	O	,	_	0	SENT_277	[p21l212t3087r253b3136],
4	Tateda	NNP	PERSON	Tateda	nn	5	SENT_277	[p21l268t3083r442b3126],
5	K	NNP	PERSON	K	appos	2	SENT_277	[p21l462t3087r506b3136],
6	,	,	O	,	_	0	SENT_277	[p21l462t3087r506b3136],
7	Matsumoto	NNP	ORGANIZATION	Matsumoto	nn	8	SENT_277	[p21l528t3087r818b3126],
8	T	NN	ORGANIZATION	t	appos	2	SENT_277	[p21l832t3087r878b3136],
9	,	,	O	,	_	0	SENT_277	[p21l832t3087r878b3136],
10	et	FW	O	et	nn	11	SENT_277	[p21l898t3094r942b3126],
11	al.	FW	O	al.	appos	2	SENT_277	[p21l959t3083r1012b3126],
12	.	.	O	.	_	0	SENT_277	[p21l959t3083r1012b3126],

1	Antibiotic	JJ	O	antibiotic	amod	2	SENT_278	[p21l122t3147r369b3190],
2	M	NN	O	m	_	0	SENT_278	[p21l414t3150r541b3190],
3	|	CD	NUMBER	|	num	4	SENT_278	[p21l414t3150r541b3190],
4	Cs	NNS	O	c	dep	2	SENT_278	[p21l414t3150r541b3190],
5	and	CC	O	and	_	0	SENT_278	[p21l584t3147r673b3190],
6	short	JJ	O	short	amod	7	SENT_278	[p21l719t3147r848b3190],
7	timekilling	NN	O	timekilling	conj_and	2	SENT_278	[p21l888t3148r1015b3190, p21l127t3212r272b3271],
8	against	IN	O	against	_	0	SENT_278	[p21l325t3213r505b3271],
9	He/icobacter	NN	O	he/icobacter	nn	10	SENT_278	[p21l558t3212r837b3255],
10	py/ori	NNS	O	py/ori	prep_against	7	SENT_278	[p21l877t3212r1013b3270],
11	:	:	O	:	_	0	SENT_278	[p21l877t3212r1013b3270],
12	Therapeutic	JJ	O	therapeutic	amod	13	SENT_278	[p21l120t3275r414b3333],
13	potential	NN	O	potential	dep	2	SENT_278	[p21l436t3275r649b3333],
14	of	IN	O	of	_	0	SENT_278	[p21l671t3275r727b3318],
15	kanamycin	NN	O	kanamycin	prep_of	13	SENT_278	[p21l739t3275r1012b3333],
16	.	.	O	.	_	0	SENT_278	[p21l739t3275r1012b3333],

1	beprazole	NN	O	beprazole	_	0	SENT_279	[p21l1259t8r1507b67],
2	,	,	O	,	_	0	SENT_279	[p21l1259t8r1507b67],
3	levofloxacin	NN	O	levofloxacin	conj_and	1	SENT_279	[p21l1528t8r1810b51],
4	and	CC	O	and	_	0	SENT_279	[p21l1830t8r1918b51],
5	rifabutin	NN	O	rifabutin	conj_and	1	SENT_279	[p21l1940t8r2145b51],
6	triple	JJ	O	triple	amod	7	SENT_279	[p21l1255t88r1379b146],
7	therapy	NN	O	therapy	dep	1	SENT_279	[p21l1402t88r1588b146],
8	vs.	CC	O	vs.	prep	7	SENT_279	[p21l1607t104r1666b131],
9	quadruple	NN	O	quadruple	nn	10	SENT_279	[p21l1693t88r1942b146],
10	therapy	NN	O	therapy	dep	8	SENT_279	[p21l1965t88r2151b146],
11	as	IN	O	as	_	0	SENT_279	[p21l1257t184r1306b211],
12	second	JJ	ORDINAL	second	amod	15	SENT_279	[p21l1334t168r1609b211],
13	—	NN	O	—	nn	15	SENT_279	[p21l1334t168r1609b211],
14	line	NN	O	line	nn	15	SENT_279	[p21l1334t168r1609b211],
15	treatment	NN	O	treatment	prep_as	10	SENT_279	[p21l1636t180r1877b211],
16	for	IN	O	for	_	0	SENT_279	[p21l1904t168r1974b211],
17	He/icobacter	NN	O	he/icobacter	prep_for	15	SENT_279	[p21l1999t168r2147b211, p21l1256t368r1390b411],

1	pylori	NN	O	pylorus	_	0	SENT_280	[p21l1397t368r1517b426],
2	infection	NN	O	infection	dep	1	SENT_280	[p21l1534t367r1757b411],
3	.	.	O	.	_	0	SENT_280	[p21l1534t367r1757b411],

1	Aliment	NNP	O	Aliment	nn	2	SENT_281	[p21l1773t368r1949b411],
2	Pharmaco	NNP	O	Pharmaco	_	0	SENT_281	[p21l1961t368r2148b410, p21l1255t447r1314b491],
3	/	:	O	/	punct	2	SENT_281	[p21l1961t368r2148b410, p21l1255t447r1314b491],
4	Ther	NNP	O	Ther	dep	2	SENT_281	[p21l1330t447r1440b490],
5	.	.	O	.	_	0	SENT_281	[p21l1330t447r1440b490],

1	2003	CD	DATE	2003	_	0	SENT_282	[p21l1464t450r1913b501],
2	;	:	O	;	_	0	SENT_282	[p21l1464t450r1913b501],
3	17:553	CD	NUMBER	17:553	number	4	SENT_282	[p21l1464t450r1913b501],
4	-560	CD	NUMBER	-560	dep	1	SENT_282	[p21l1464t450r1913b501],
5	.	.	O	.	_	0	SENT_282	[p21l1464t450r1913b501],

1	Nista	NNP	ORGANIZATION	Nista	nn	2	SENT_283	[p21l1259t528r1386b570],
2	EC	NNP	ORGANIZATION	EC	_	0	SENT_283	[p21l1410t530r1490b580],
3	,	,	O	,	_	0	SENT_283	[p21l1410t530r1490b580],
4	Candelli	NNP	O	Candelli	nn	5	SENT_283	[p21l1514t527r1713b570],
5	M	NNP	O	M	dep	2	SENT_283	[p21l1740t531r1802b580],
6	,	,	O	,	_	0	SENT_283	[p21l1740t531r1802b580],
7	Cremonini	NNP	ORGANIZATION	Cremonini	nn	8	SENT_283	[p21l1826t528r2083b571],
8	F	NN	O	f	appos	5	SENT_283	[p21l2110t531r2146b580],
9	,	,	O	,	_	0	SENT_283	[p21l2110t531r2146b580],

1	et	FW	O	et	_	0	SENT_284	[p21l1257t731r1302b763],
2	al.	FW	O	al.	dep	1	SENT_284	[p21l1356t720r1412b763],
3	.	.	O	.	_	0	SENT_284	[p21l1356t720r1412b763],

1	Levofloxacin	NN	O	levofloxacin	nn	2	SENT_285	[p21l1474t720r1958b763],
2	—	NN	O	—	nsubj	3	SENT_285	[p21l1474t720r1958b763],
3	based	VBN	O	base	_	0	SENT_285	[p21l1474t720r1958b763],
4	triple	JJ	O	triple	amod	5	SENT_285	[p21l2015t720r2147b778],
5	therapy	NN	O	therapy	tmod	3	SENT_285	[p21l1255t800r1445b858],
6	vs.	CC	O	vs.	prep	5	SENT_285	[p21l1480t816r1540b843],
7	quadruple	NN	O	quadruple	nn	8	SENT_285	[p21l1585t800r1838b858],
8	therapy	NN	O	therapy	dep	6	SENT_285	[p21l1878t800r2067b858],
9	in	IN	O	in	_	0	SENT_285	[p21l2107t801r2145b842],
10	second	JJ	ORDINAL	second	amod	15	SENT_285	[p21l1257t879r1538b923],
11	—	NN	O	—	nn	15	SENT_285	[p21l1257t879r1538b923],
12	line	NN	O	line	nn	15	SENT_285	[p21l1257t879r1538b923],
13	Helicobacter	NN	PERSON	helicobacter	nn	15	SENT_285	[p21l1568t879r1844b923],
14	pylori	NN	PERSON	pylorus	nn	15	SENT_285	[p21l1863t879r1986b938],
15	treatment	NN	O	treatment	prep_in	8	SENT_285	[p21l2013t891r2147b923, p21l1259t971r1395b1003],
16	:	:	O	:	_	0	SENT_285	[p21l2013t891r2147b923, p21l1259t971r1395b1003],
17	A	DT	O	a	det	19	SENT_285	[p21l1430t963r1467b1002],
18	randomized	JJ	O	randomized	amod	19	SENT_285	[p21l1501t959r1792b1003],
19	trial	NN	O	trial	dep	5	SENT_285	[p21l1828t959r1938b1002],
20	.	.	O	.	_	0	SENT_285	[p21l1828t959r1938b1002],

1	Aliment	NNP	O	Aliment	nn	3	SENT_286	[p21l1971t959r2151b1002],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_286	[p21l1256t1039r1493b1082],
3	Tner	NNP	O	Tner	_	0	SENT_286	[p21l1510t1039r1623b1082],
4	.	.	O	.	_	0	SENT_286	[p21l1510t1039r1623b1082],

1	2003	CD	DATE	2003	_	0	SENT_287	[p21l1648t1042r2109b1092],
2	;	:	O	;	_	0	SENT_287	[p21l1648t1042r2109b1092],
3	18:627	CD	NUMBER	18:627	number	4	SENT_287	[p21l1648t1042r2109b1092],
4	-633	CD	NUMBER	-633	dep	1	SENT_287	[p21l1648t1042r2109b1092],
5	.	.	O	.	_	0	SENT_287	[p21l1648t1042r2109b1092],

1	Schrauwen	NNP	O	Schrauwen	nn	2	SENT_288	[p21l1255t1119r1524b1162],
2	RW	NNP	O	RW	_	0	SENT_288	[p21l1547t1122r1843b1173],
3	,	,	O	,	_	0	SENT_288	[p21l1547t1122r1843b1173],
4	Janssen	NNP	PERSON	Janssen	nn	6	SENT_288	[p21l1547t1122r1843b1173],
5	M	NNP	O	M	nn	6	SENT_288	[p21l1865t1122r1944b1173],
6	]	NN	O	]	appos	2	SENT_288	[p21l1865t1122r1944b1173],
7	,	,	O	,	_	0	SENT_288	[p21l1865t1122r1944b1173],
8	de	FW	O	de	nn	9	SENT_288	[p21l1963t1119r2018b1162],
9	Boer	FW	O	boer	appos	2	SENT_288	[p21l2038t1122r2151b1162],
10	WA	NNP	O	WA	dep	9	SENT_288	[p21l1254t1202r1359b1242],
11	.	.	O	.	_	0	SENT_288	[p21l1254t1202r1359b1242],

1	Seven-day	JJ	DURATION	seven-day	amod	3	SENT_289	[p21l1403t1199r1653b1257],
2	PPI-triple	NN	O	ppi-triple	nn	3	SENT_289	[p21l1695t1199r1919b1257],
3	therapy	NN	O	therapy	nsubj	8	SENT_289	[p21l1961t1199r2151b1257],
4	with	IN	O	with	_	0	SENT_289	[p21l1254t1279r1358b1322],
5	levofloxacin	NN	O	levofloxacin	prep_with	3	SENT_289	[p21l1383t1278r1671b1322],
6	is	VBZ	O	be	cop	8	SENT_289	[p21l1694t1280r1727b1322],
7	very	RB	O	very	advmod	8	SENT_289	[p21l1743t1294r1843b1337],
8	effective	JJ	O	effective	_	0	SENT_289	[p21l1859t1278r2060b1322],
9	for	IN	O	for	_	0	SENT_289	[p21l2079t1278r2151b1322],
10	Helicobacter	NNP	PERSON	Helicobacter	nn	12	SENT_289	[p21l1256t1358r1533b1401],
11	pylori	NNP	PERSON	pylori	nn	12	SENT_289	[p21l1557t1358r1680b1417],
12	eradication	NN	O	eradication	prep_for	8	SENT_289	[p21l1711t1358r2006b1402],
13	.	.	O	.	_	0	SENT_289	[p21l1711t1358r2006b1402],

1	Neth	NN	O	neth	_	0	SENT_290	[p21l2041t1358r2147b1401],
2	jMea	NN	O	jmea	nn	3	SENT_290	[p21l1242t1438r1398b1493],
3	’	NN	O	’	dep	1	SENT_290	[p21l1242t1438r1398b1493],
4	.	.	O	.	_	0	SENT_290	[p21l1242t1438r1398b1493],

1	2009	CD	DATE	2009	_	0	SENT_291	[p21l1423t1441r1847b1491],
2	;	:	O	;	_	0	SENT_291	[p21l1423t1441r1847b1491],
3	67:96	CD	NUMBER	67:96	num	4	SENT_291	[p21l1423t1441r1847b1491],
4	—	NN	O	—	dep	1	SENT_291	[p21l1423t1441r1847b1491],
5	101	CD	NUMBER	101	dep	4	SENT_291	[p21l1423t1441r1847b1491],
6	.	.	O	.	_	0	SENT_291	[p21l1423t1441r1847b1491],

1	Rispo	NNP	MISC	Rispo	nn	2	SENT_292	[p21l1260t1519r1389b1576],
2	A	NNP	MISC	A	_	0	SENT_292	[p21l1404t1521r1454b1571],
3	,	,	O	,	_	0	SENT_292	[p21l1404t1521r1454b1571],
4	Di	NNP	PERSON	Di	nn	6	SENT_292	[p21l1476t1519r1523b1560],
5	Girolamo	NNP	PERSON	Girolamo	nn	6	SENT_292	[p21l1543t1518r1768b1561],
6	E	NNP	PERSON	E	appos	2	SENT_292	[p21l1789t1521r1828b1571],
7	,	,	O	,	_	0	SENT_292	[p21l1789t1521r1828b1571],
8	Cozzolino	NNP	PERSON	Cozzolino	nn	9	SENT_292	[p21l1847t1518r2081b1561],
9	A	NNP	O	A	appos	2	SENT_292	[p21l2096t1521r2146b1571],
10	,	,	O	,	_	0	SENT_292	[p21l2096t1521r2146b1571],
11	et	FW	O	et	nn	12	SENT_292	[p21l1257t1609r1299b1641],
12	al.	FW	O	al.	appos	2	SENT_292	[p21l1326t1598r1377b1641],
13	.	.	O	.	_	0	SENT_292	[p21l1326t1598r1377b1641],

1	Levofloxacin	NNP	O	Levofloxacin	_	0	SENT_293	[p21l1412t1597r1700b1641],
2	in	IN	O	in	_	0	SENT_293	[p21l1732t1599r1769b1640],
3	ﬁrst-line	JJ	O	ﬁrst-line	amod	4	SENT_293	[p21l1799t1597r1992b1641],
4	treatment	NN	O	treatment	prep_in	1	SENT_293	[p21l2019t1609r2147b1641, p21l1259t1689r1379b1721],
5	of	IN	O	of	_	0	SENT_293	[p21l1412t1677r1468b1721],
6	Helicobacter	NNP	O	Helicobacter	nn	8	SENT_293	[p21l1492t1677r1755b1721],
7	pylori	NN	O	pylorus	nn	8	SENT_293	[p21l1777t1678r1894b1736],
8	infection	NN	O	infection	prep_of	1	SENT_293	[p21l1927t1677r2144b1721],
9	.	.	O	.	_	0	SENT_293	[p21l1927t1677r2144b1721],

1	He/icobacter	NN	O	he/icobacter	_	0	SENT_294	[p21l1256t1757r1528b1800],
2	.	.	O	.	_	0	SENT_294	[p21l1256t1757r1528b1800],

1	2007	CD	DATE	2007	_	0	SENT_295	[p21l1551t1760r1993b1810],
2	;	:	O	;	_	0	SENT_295	[p21l1551t1760r1993b1810],
3	12:364	CD	NUMBER	12:364	number	4	SENT_295	[p21l1551t1760r1993b1810],
4	-365	CD	NUMBER	-365	dep	1	SENT_295	[p21l1551t1760r1993b1810],
5	.	.	O	.	_	0	SENT_295	[p21l1551t1760r1993b1810],

1	Marzio	NNP	PERSON	Marzio	nn	2	SENT_296	[p21l1259t1838r1423b1880],
2	L	NNP	PERSON	L	_	0	SENT_296	[p21l1445t1840r1481b1890],
3	,	,	O	,	_	0	SENT_296	[p21l1445t1840r1481b1890],
4	Coraggio	NNP	ORGANIZATION	Coraggio	nn	5	SENT_296	[p21l1501t1838r1718b1896],
5	D	NNP	ORGANIZATION	D	appos	2	SENT_296	[p21l1740t1840r1787b1890],
6	,	,	O	,	_	0	SENT_296	[p21l1740t1840r1787b1890],
7	Capodicasa	NNP	O	Capodicasa	nn	8	SENT_296	[p21l1807t1837r2088b1895],
8	S	NNP	O	S	appos	2	SENT_296	[p21l2105t1840r2146b1890],
9	,	,	O	,	_	0	SENT_296	[p21l2105t1840r2146b1890],
10	et	FW	O	et	nn	11	SENT_296	[p21l1257t1928r1300b1960],
11	al.	FW	O	al.	appos	2	SENT_296	[p21l1318t1917r1370b1960],
12	.	.	O	.	_	0	SENT_296	[p21l1318t1917r1370b1960],

1	Role	NN	O	role	nn	2	SENT_297	[p21l1396t1917r1498b1960],
2	ofthe	NN	O	ofthe	conj_and	2	SENT_297	[p21l1518t1917r1657b1960],
3	preliminary	JJ	O	preliminary	amod	5	SENT_297	[p21l1678t1917r1953b1975],
4	susceptibility	NN	O	susceptibility	nn	5	SENT_297	[p21l1969t1933r2147b1975, p21l1255t1997r1412b2055],
5	testing	NN	O	testing	npadvmod	2	SENT_297	[p21l1450t1998r1617b2055],
6	for	IN	O	for	_	0	SENT_297	[p21l1657t1996r1729b2040],
7	initial	JJ	O	initial	prep_for	2	SENT_297	[p21l1770t1997r1903b2040],
8	and	CC	O	and	_	0	SENT_297	[p21l1949t1997r2038b2040],
9	after	IN	O	after	_	0	SENT_297	[p21l2084t1997r2146b2040, p21l1255t2088r1324b2120],
10	failed	VBN	O	fail	amod	11	SENT_297	[p21l1364t2076r1499b2120],
11	therapy	NN	O	therapy	prep_after	2	SENT_297	[p21l1544t2076r1738b2135],
12	of	IN	O	of	_	0	SENT_297	[p21l1779t2076r1836b2120],
13	Helicobacter	NNP	PERSON	Helicobacter	nn	15	SENT_297	[p21l1870t2076r2152b2120],
14	pylori	NN	PERSON	pylorus	nn	15	SENT_297	[p21l1252t2156r1377b2215],
15	infection	NN	O	infection	prep_of	11	SENT_297	[p21l1420t2156r1636b2199],
16	with	IN	O	with	_	0	SENT_297	[p21l1680t2156r1785b2199],
17	levofloxacin	NN	O	levofloxacin	prep_with	15	SENT_297	[p21l1834t2156r2146b2209],
18	,	,	O	,	_	0	SENT_297	[p21l1834t2156r2146b2209],
19	amoxicillin	NNP	O	amoxicillin	conj_and	17	SENT_297	[p21l1257t2236r1537b2289],
20	,	,	O	,	_	0	SENT_297	[p21l1257t2236r1537b2289],
21	and	CC	O	and	_	0	SENT_297	[p21l1557t2236r1646b2279],
22	esomeprazole	NN	O	esomeprazole	conj_and	17	SENT_297	[p21l1667t2236r2021b2294],
23	.	.	O	.	_	0	SENT_297	[p21l1667t2236r2021b2294],

1	He/icobacter	NN	O	he/icobacter	_	0	SENT_298	[p21l2042t2236r2147b2279, p21l1255t2316r1449b2359],
2	.	.	O	.	_	0	SENT_298	[p21l2042t2236r2147b2279, p21l1255t2316r1449b2359],

1	2006	CD	DATE	2006	_	0	SENT_299	[p21l1474t2318r1935b2369],
2	;	:	O	;	_	0	SENT_299	[p21l1474t2318r1935b2369],
3	11:237	CD	NUMBER	11:237	number	4	SENT_299	[p21l1474t2318r1935b2369],
4	-242	CD	NUMBER	-242	dep	1	SENT_299	[p21l1474t2318r1935b2369],
5	.	.	O	.	_	0	SENT_299	[p21l1474t2318r1935b2369],

1	Antos	NNP	PERSON	Antos	nn	2	SENT_300	[p21l1254t2399r1402b2439],
2	D	NNP	O	D	_	0	SENT_300	[p21l1451t2399r1500b2449],
3	,	,	O	,	_	0	SENT_300	[p21l1451t2399r1500b2449],
4	Schneider-Brachert	NNP	O	Schneider-Brachert	nn	5	SENT_300	[p21l1547t2395r2036b2439],
5	W	NNP	O	W	conj_and	2	SENT_300	[p21l2078t2399r2146b2449],
6	,	,	O	,	_	0	SENT_300	[p21l2078t2399r2146b2449],
7	Bastlein	NNP	PERSON	Bastlein	nn	8	SENT_300	[p21l1260t2475r1448b2518],
8	E	NNP	O	E	conj_and	2	SENT_300	[p21l1476t2479r1516b2528],
9	,	,	O	,	_	0	SENT_300	[p21l1476t2479r1516b2528],
10	et	FW	O	et	nn	11	SENT_300	[p21l1541t2487r1584b2518],
11	al.	FW	O	al.	appos	8	SENT_300	[p21l1606t2475r1660b2518],
12	7-Day	JJ	DURATION	7-day	amod	14	SENT_300	[p21l1686t2478r1834b2533],
13	triple	JJ	O	triple	amod	14	SENT_300	[p21l1852t2475r1979b2533],
14	therapy	NN	O	therapy	dep	2	SENT_300	[p21l2000t2475r2147b2518, p21l1259t2571r1314b2613],
15	of	IN	O	of	_	0	SENT_300	[p21l1355t2555r1412b2598],
16	Helicobacter	NNP	PERSON	Helicobacter	prep_of	14	SENT_300	[p21l1446t2555r1729b2598],
17	pylori	NN	PERSON	pylorus	nn	18	SENT_300	[p21l1759t2555r1885b2613],
18	infection	NN	O	infection	dep	2	SENT_300	[p21l1928t2555r2145b2598],
19	with	IN	O	with	_	0	SENT_300	[p21l1254t2630r1358b2673],
20	levofloxacin	NN	O	levofloxacin	prep_with	18	SENT_300	[p21l1397t2630r1703b2683],
21	,	,	O	,	_	0	SENT_300	[p21l1397t2630r1703b2683],
22	amoxicillin	NNP	O	amoxicillin	conj_and	2	SENT_300	[p21l1739t2630r2019b2683],
23	,	,	O	,	_	0	SENT_300	[p21l1739t2630r2019b2683],
24	and	CC	O	and	_	0	SENT_300	[p21l2055t2630r2144b2673],
25	high	JJ	O	high	amod	28	SENT_300	[p21l1259t2709r1498b2767],
26	—	NN	O	—	nn	28	SENT_300	[p21l1259t2709r1498b2767],
27	dose	NN	O	dose	nn	28	SENT_300	[p21l1259t2709r1498b2767],
28	esomeprazole	NN	O	esomeprazole	conj_and	2	SENT_300	[p21l1521t2709r1861b2767],
29	in	IN	O	in	_	0	SENT_300	[p21l1886t2710r1924b2751],
30	patients	NNS	O	patient	prep_in	28	SENT_300	[p21l1952t2710r2147b2767],
31	with	IN	O	with	_	0	SENT_300	[p21l1254t2787r1358b2830],
32	known	JJ	O	known	amod	34	SENT_300	[p21l1390t2787r1549b2830],
33	antimicrobial	JJ	O	antimicrobial	amod	34	SENT_300	[p21l1578t2787r1908b2830],
34	sensitivity	NN	O	sensitivity	prep_with	30	SENT_300	[p21l1937t2788r2147b2830, p21l1255t2877r1309b2923],
35	.	.	O	.	_	0	SENT_300	[p21l1937t2788r2147b2830, p21l1255t2877r1309b2923],

1	He/icobacter	NN	O	he/icobacter	_	0	SENT_301	[p21l1334t2866r1619b2909],
2	.	.	O	.	_	0	SENT_301	[p21l1334t2866r1619b2909],

1	2006	CD	DATE	2006	_	0	SENT_302	[p21l1645t2868r1768b2909],
2	;	:	O	;	_	0	SENT_302	[p21l1776t2869r1809b2919],
3	1	CD	NUMBER	1	number	4	SENT_302	[p21l1776t2869r1809b2919],
4	1	CD	NUMBER	1	dep	1	SENT_302	[p21l1827t2869r1842b2908],
5	:39	CD	NUMBER	:39	num	6	SENT_302	[p21l1859t2868r2040b2909],
6	—	NN	O	—	dep	4	SENT_302	[p21l1859t2868r2040b2909],
7	45	CD	NUMBER	45	dep	4	SENT_302	[p21l1859t2868r2040b2909],
8	.	.	O	.	_	0	SENT_302	[p21l1859t2868r2040b2909],

1	Cammarota	NNP	PERSON	Cammarota	nn	2	SENT_303	[p21l1257t2946r1557b2986],
2	G	NNP	PERSON	G	_	0	SENT_303	[p21l1593t2946r1646b2996],
3	,	,	O	,	_	0	SENT_303	[p21l1593t2946r1646b2996],
4	Cianci	NNP	PERSON	Cianci	nn	5	SENT_303	[p21l1684t2944r1835b2986],
5	R	NNP	PERSON	R	appos	2	SENT_303	[p21l1877t2946r1922b2996],
6	,	,	O	,	_	0	SENT_303	[p21l1877t2946r1922b2996],
7	Canniz	NNP	O	Canniz	appos	2	SENT_303	[p21l1960t2944r2147b2986],
8	—	CD	NUMBER	—	num	10	SENT_303	[p21l1960t2944r2147b2986],
9	zaro	NN	O	zaro	nn	10	SENT_303	[p21l1254t3037r1359b3065],
10	O	NN	O	o	dep	7	SENT_303	[p21l1388t3024r1445b3075],
11	,	,	O	,	_	0	SENT_303	[p21l1388t3024r1445b3075],
12	et	FW	O	et	nn	13	SENT_303	[p21l1475t3033r1518b3065],
13	al.	FW	O	al.	appos	2	SENT_303	[p21l1544t3021r1598b3065],
14	.	.	O	.	_	0	SENT_303	[p21l1544t3021r1598b3065],

1	Efficacy	NN	O	efficacy	_	0	SENT_304	[p21l1632t3021r1823b3080],
2	of	IN	O	of	_	0	SENT_304	[p21l1848t3021r1904b3065],
3	two	CD	NUMBER	two	num	6	SENT_304	[p21l1920t3033r2012b3065],
4	oneweek	JJ	O	oneweek	amod	6	SENT_304	[p21l2040t3037r2147b3065, p21l1254t3084r1376b3127],
5	rabeprazole/levofloxacin	NN	O	rabeprazole/levofloxacin	nn	6	SENT_304	[p21l1385t3084r2144b3142],
6	—	NN	O	—	prep_of	1	SENT_304	[p21l1385t3084r2144b3142],
7	based	VBN	O	base	partmod	6	SENT_304	[p21l1385t3084r2144b3142],
8	triple	JJ	O	triple	amod	9	SENT_304	[p21l1255t3146r1382b3204],
9	therapies	NNS	O	therapy	dobj	7	SENT_304	[p21l1402t3146r1630b3204],
10	for	IN	O	for	_	0	SENT_304	[p21l1650t3146r1722b3189],
11	Helicobacter	NNP	PERSON	Helicobacter	nn	13	SENT_304	[p21l1740t3146r2016b3189],
12	pylori	NN	O	pylorus	nn	13	SENT_304	[p21l2027t3146r2150b3204],
13	infection	NN	O	infection	prep_for	9	SENT_304	[p21l1258t3211r1470b3254],
14	.	.	O	.	_	0	SENT_304	[p21l1258t3211r1470b3254],

1	Aliment	NNP	O	Aliment	nn	3	SENT_305	[p21l1482t3211r1651b3254],
2	Pnarmacol	NNP	O	Pnarmacol	nn	3	SENT_305	[p21l1659t3211r1881b3254],
3	Ther	NNP	O	Ther	_	0	SENT_305	[p21l1890t3211r1996b3254],
4	.	.	O	.	_	0	SENT_305	[p21l1890t3211r1996b3254],

1	2000	CD	DATE	2000	_	0	SENT_306	[p21l2013t3214r2146b3264],
2	;	:	O	;	_	0	SENT_306	[p21l2013t3214r2146b3264],
3	14:1339	CD	NUMBER	14:1339	number	4	SENT_306	[p21l1260t3277r1636b3317],
4	—	CD	NUMBER	—	dep	1	SENT_306	[p21l1260t3277r1636b3317],
5	1343	CD	DATE	1343	dep	4	SENT_306	[p21l1260t3277r1636b3317],
6	.	.	O	.	_	0	SENT_306	[p21l1260t3277r1636b3317],

1	24	CD	NUMBER	24	_	0	SENT_307	[p22l8t139r163b225],
2	.	.	O	.	_	0	SENT_307	[p22l8t139r163b225],

1	Ishizaki	NNP	PERSON	Ishizaki	nn	2	SENT_308	[p22l268t134r634b225],
2	T	NN	O	t	_	0	SENT_308	[p22l694t141r791b245],
3	,	,	O	,	_	0	SENT_308	[p22l694t141r791b245],
4	Horai	NNP	ORGANIZATION	Horai	nn	7	SENT_308	[p22l865t136r1148b225],
5	Y.	NNP	ORGANIZATION	Y.	nn	7	SENT_308	[p22l1209t141r1293b225],
6	Review	NNP	ORGANIZATION	Review	nn	7	SENT_308	[p22l1369t136r1720b225],
7	article	NN	O	article	appos	2	SENT_308	[p22l1779t134r2126b225],
8	:	:	O	:	_	0	SENT_308	[p22l1779t134r2126b225],
9	Cytochrome	NN	O	cytochrome	nn	10	SENT_308	[p22l261t287r900b410],
10	P450	NN	O	p450	dep	2	SENT_308	[p22l950t294r1206b378],
11	and	CC	O	and	_	0	SENT_308	[p22l1252t287r1439b378],
12	the	DT	O	the	det	13	SENT_308	[p22l1487t287r1648b378],
13	metaboIism	NN	O	metaboiism	conj_and	10	SENT_308	[p22l1698t287r2132b379, p22l266t442r461b534],
14	of	IN	O	of	_	0	SENT_308	[p22l545t442r665b534],
15	proton	NN	O	proton	nn	17	SENT_308	[p22l727t467r1075b565],
16	pump	NN	O	pump	nn	17	SENT_308	[p22l1163t476r1461b565],
17	inhibitorsemphasis	NN	O	inhibitorsemphasis	prep_of	13	SENT_308	[p22l1546t442r2132b534, p22l261t599r745b720],
18	on	IN	O	on	_	0	SENT_308	[p22l830t631r952b689],
19	rabeprazole	NN	O	rabeprazole	prep_on	17	SENT_308	[p22l1044t599r1683b720],
20	.	.	O	.	_	0	SENT_308	[p22l1044t599r1683b720],

1	Aliment	NNP	O	Aliment	nn	3	SENT_309	[p22l1762t599r2141b689],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_309	[p22l261t754r758b845],
3	Ther	NNP	O	Ther	_	0	SENT_309	[p22l818t754r1055b845],
4	.	.	O	.	_	0	SENT_309	[p22l818t754r1055b845],

1	1999	CD	DATE	1999	_	0	SENT_310	[p22l1141t754r1914b877],
2	;	:	O	;	_	0	SENT_310	[p22l1141t754r1914b877],
3	13	CD	NUMBER	13	number	4	SENT_310	[p22l1141t754r1914b877],
4	(	CD	NUMBER	(	num	8	SENT_310	[p22l1141t754r1914b877],
5	Supp	NNP	O	Supp	nn	8	SENT_310	[p22l1141t754r1914b877],
6	|	CD	NUMBER	|	num	8	SENT_310	[p22l1141t754r1914b877],
7	3	CD	NUMBER	3	amod	8	SENT_310	[p22l1991t756r2127b876],
8	)	NN	O	)	dep	1	SENT_310	[p22l1991t756r2127b876],
9	:	:	O	:	_	0	SENT_310	[p22l1991t756r2127b876],
10	27-36	CD	DATE	27-36	dep	1	SENT_310	[p22l263t914r612b999],
11	.	.	O	.	_	0	SENT_310	[p22l263t914r612b999],

1	25	CD	NUMBER	25	_	0	SENT_311	[p22l8t1069r161b1155],
2	.	.	O	.	_	0	SENT_311	[p22l8t1069r161b1155],

1	Adachi	NNP	PERSON	Adachi	nn	2	SENT_312	[p22l256t1064r615b1155],
2	K	NNP	PERSON	K	_	0	SENT_312	[p22l673t1071r764b1175],
3	,	,	O	,	_	0	SENT_312	[p22l673t1071r764b1175],
4	|	CD	NUMBER	|	appos	2	SENT_312	[p22l821t1064r1233b1155],
5	<	JJR	O	<	amod	7	SENT_312	[p22l821t1064r1233b1155],
6	atsube	NN	O	atsube	nn	7	SENT_312	[p22l821t1064r1233b1155],
7	T	NN	O	t	dep	4	SENT_312	[p22l1271t1071r1368b1175],
8	,	,	O	,	_	0	SENT_312	[p22l1271t1071r1368b1175],
9	Kawamura	NNP	PERSON	Kawamura	nn	10	SENT_312	[p22l1425t1071r1982b1155],
10	A	NNP	O	A	appos	2	SENT_312	[p22l2023t1071r2129b1175],
11	,	,	O	,	_	0	SENT_312	[p22l2023t1071r2129b1175],
12	et	FW	O	et	nn	13	SENT_312	[p22l261t1243r352b1310],
13	al.	FW	O	al.	appos	2	SENT_312	[p22l396t1219r507b1310],
14	.	.	O	.	_	0	SENT_312	[p22l396t1219r507b1310],

1	CYP2C19	NN	O	cyp2c19	nn	3	SENT_313	[p22l561t1224r1037b1310],
2	genotype	NN	O	genotype	nn	3	SENT_313	[p22l1083t1243r1547b1342],
3	status	NN	O	status	_	0	SENT_313	[p22l1594t1243r1895b1310],
4	and	CC	O	and	_	0	SENT_313	[p22l1941t1219r2127b1310],
5	intragastric	JJ	O	intragastric	amod	6	SENT_313	[p22l265t1393r835b1513],
6	pH	NN	O	ph	conj_and	3	SENT_313	[p22l905t1397r1048b1513],
7	during	IN	O	during	_	0	SENT_313	[p22l1122t1390r1453b1513],
8	dosing	NN	O	dosing	prep_during	3	SENT_313	[p22l1516t1390r1855b1513],
9	with	IN	O	with	_	0	SENT_313	[p22l1914t1390r2127b1481],
10	Iansoprazole	NN	O	iansoprazole	prep_with	3	SENT_313	[p22l266t1543r893b1666],
11	or	CC	O	or	_	0	SENT_313	[p22l952t1577r1058b1635],
12	rabeprazole	NN	O	rabeprazole	conj_or	10	SENT_313	[p22l1112t1543r1723b1666],
13	.	.	O	.	_	0	SENT_313	[p22l1112t1543r1723b1666],

1	Aliment	NNP	O	Aliment	nn	3	SENT_314	[p22l1778t1543r2141b1635],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_314	[p22l261t1700r738b1791],
3	Ther	NNP	O	Ther	_	0	SENT_314	[p22l768t1700r995b1791],
4	.	.	O	.	_	0	SENT_314	[p22l768t1700r995b1791],

1	2000	CD	DATE	2000	_	0	SENT_315	[p22l1044t1705r2105b1811],
2	;	:	O	;	_	0	SENT_315	[p22l1044t1705r2105b1811],
3	14:1259	CD	NUMBER	14:1259	number	4	SENT_315	[p22l1044t1705r2105b1811],
4	—	CD	NUMBER	—	dep	1	SENT_315	[p22l1044t1705r2105b1811],
5	1266	CD	DATE	1266	dep	4	SENT_315	[p22l1044t1705r2105b1811],
6	.	.	O	.	_	0	SENT_315	[p22l1044t1705r2105b1811],

1	26	CD	NUMBER	26	_	0	SENT_316	[p22l8t1860r156b1946],
2	.	.	O	.	_	0	SENT_316	[p22l8t1860r156b1946],

1	Furuta	NNP	PERSON	Furuta	nn	2	SENT_317	[p22l265t1862r588b1946],
2	T	NN	O	t	_	0	SENT_317	[p22l610t1862r705b1966],
3	,	,	O	,	_	0	SENT_317	[p22l610t1862r705b1966],
4	Shirai	NNP	PERSON	Shirai	nn	5	SENT_317	[p22l740t1855r1017b1946],
5	N	NNP	O	N	appos	2	SENT_317	[p22l1060t1862r1167b1966],
6	,	,	O	,	_	0	SENT_317	[p22l1060t1862r1167b1966],
7	Sugimoto	NNP	PERSON	Sugimoto	nn	8	SENT_317	[p22l1201t1857r1688b1978],
8	M	NNP	O	M	appos	2	SENT_317	[p22l1727t1862r1855b1966],
9	,	,	O	,	_	0	SENT_317	[p22l1727t1862r1855b1966],
10	et	FW	O	et	nn	11	SENT_317	[p22l1893t1879r1982b1946],
11	al.	FW	O	al.	appos	2	SENT_317	[p22l2013t1855r2127b1946],
12	.	.	O	.	_	0	SENT_317	[p22l2013t1855r2127b1946],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_318	[p22l268t2026r1269b2150],
2	of	IN	O	of	_	0	SENT_318	[p22l1306t2026r1424b2116],
3	proton	NN	O	proton	nn	4	SENT_318	[p22l1446t2050r1786b2148],
4	pump	NN	O	pump	prep_of	1	SENT_318	[p22l1834t2060r2130b2148],
5	in	IN	O	in	_	0	SENT_318	[p22l265t2184r345b2271],
6	hibito	NN	O	hibito	nn	7	SENT_318	[p22l365t2181r663b2273],
7	rs	NNS	O	r	prep_in	1	SENT_318	[p22l678t2215r789b2273],
8	.	.	O	.	_	0	SENT_318	[p22l678t2215r789b2273],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_319	[p22l860t2181r1761b2305],
2	.	.	O	.	_	0	SENT_319	[p22l860t2181r1761b2305],

1	2004	CD	DATE	2004	_	0	SENT_320	[p22l1836t2188r2129b2293],
2	;	:	O	;	_	0	SENT_320	[p22l1836t2188r2129b2293],
3	5:1	CD	NUMBER	5:1	number	4	SENT_320	[p22l263t2344r403b2427],
4	81	CD	NUMBER	81	dep	1	SENT_320	[p22l435t2342r540b2427],
5	-202	CD	NUMBER	-202	dep	4	SENT_320	[p22l569t2342r852b2427],
6	.	.	O	.	_	0	SENT_320	[p22l569t2342r852b2427],

1	27	CD	NUMBER	27	_	0	SENT_321	[p22l8t2497r154b2584],
2	.	.	O	.	_	0	SENT_321	[p22l8t2497r154b2584],

1	Sakai	NNP	ORGANIZATION	Sakai	nn	2	SENT_322	[p22l259t2492r529b2583],
2	T	NN	ORGANIZATION	t	_	0	SENT_322	[p22l590t2499r687b2605],
3	,	,	O	,	_	0	SENT_322	[p22l590t2499r687b2605],
4	Aoyama	NNP	ORGANIZATION	Aoyama	nn	5	SENT_322	[p22l752t2499r1180b2615],
5	N	NNP	ORGANIZATION	N	appos	2	SENT_322	[p22l1250t2499r1359b2603],
6	,	,	O	,	_	0	SENT_322	[p22l1250t2499r1359b2603],
7	Kita	NNP	PERSON	Kita	nn	8	SENT_322	[p22l1436t2495r1635b2583],
8	T	NN	O	t	appos	2	SENT_322	[p22l1691t2499r1787b2605],
9	,	,	O	,	_	0	SENT_322	[p22l1691t2499r1787b2605],
10	et	FW	O	et	nn	11	SENT_322	[p22l1858t2516r1950b2583],
11	al.	FW	O	al.	appos	2	SENT_322	[p22l2013t2492r2127b2583],
12	.	.	O	.	_	0	SENT_322	[p22l2013t2492r2127b2583],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_323	[p22l261t2653r746b2736],
2	genotype	NN	O	genotype	_	0	SENT_323	[p22l796t2670r1269b2770],
3	and	CC	O	and	_	0	SENT_323	[p22l1318t2646r1506b2736],
4	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	2	SENT_323	[p22l1567t2646r2132b2768, p22l266t2818r646b2908],
5	of	IN	O	of	_	0	SENT_323	[p22l714t2818r833b2908],
6	three	CD	NUMBER	three	num	9	SENT_323	[p22l877t2818r1138b2908],
7	proton	NN	O	proton	nn	9	SENT_323	[p22l1211t2842r1558b2939],
8	pump	NN	O	pump	nn	9	SENT_323	[p22l1635t2850r1933b2939],
9	inhibitors	NNS	O	inhibitor	prep_of	2	SENT_323	[p22l2007t2820r2132b2907, p22l266t2973r660b3063],
10	in	IN	O	in	_	0	SENT_323	[p22l726t2975r806b3062],
11	healthy	JJ	O	healthy	amod	12	SENT_323	[p22l881t2973r1255b3094],
12	subjects	NNS	O	subject	prep_in	2	SENT_323	[p22l1311t2973r1756b3097],
13	.	.	O	.	_	0	SENT_323	[p22l1311t2973r1756b3097],

1	Pharm	NNP	O	Pharm	nn	2	SENT_324	[p22l1825t2973r2132b3063],
2	Res	NNP	O	Res	_	0	SENT_324	[p22l261t3135r444b3218],
3	.	.	O	.	_	0	SENT_324	[p22l261t3135r444b3218],

1	2001	CD	DATE	2001	_	0	SENT_325	[p22l498t3133r1456b3240],
2	;	:	O	;	_	0	SENT_325	[p22l498t3133r1456b3240],
3	18:721	CD	NUMBER	18:721	number	4	SENT_325	[p22l498t3133r1456b3240],
4	-727	CD	NUMBER	-727	dep	1	SENT_325	[p22l498t3133r1456b3240],
5	.	.	O	.	_	0	SENT_325	[p22l498t3133r1456b3240],

1	28	CD	NUMBER	28	_	0	SENT_326	[p22l8t3289r161b3374],
2	.	.	O	.	_	0	SENT_326	[p22l8t3289r161b3374],

1	Sagar	FW	O	sagar	nsubj	4	SENT_327	[p22l259t3289r554b3406],
2	M	NN	O	m	dep	1	SENT_327	[p22l593t3290r724b3394],
3	,	,	O	,	_	0	SENT_327	[p22l593t3290r724b3394],
4	Tybring	VBG	O	tybr	_	0	SENT_327	[p22l760t3282r1155b3406],
5	G	NN	O	g	dobj	4	SENT_327	[p22l1194t3289r1305b3394],
6	,	,	O	,	_	0	SENT_327	[p22l1194t3289r1305b3394],
7	Dahl	NNP	PERSON	Dahl	nn	8	SENT_327	[p22l1357t3282r1591b3372],
8	ML	NNP	O	ML	appos	5	SENT_327	[p22l1643t3290r1836b3394],
9	,	,	O	,	_	0	SENT_327	[p22l1643t3290r1836b3394],
10	et	FW	O	et	nn	11	SENT_327	[p22l1882t3307r1974b3374],
11	al.	FW	O	al.	appos	8	SENT_327	[p22l2013t3282r2127b3374],
12	.	.	O	.	_	0	SENT_327	[p22l2013t3282r2127b3374],

1	Effects	NNS	O	effect	nsubj	13	SENT_328	[p22l268t3437r605b3529],
2	of	IN	O	of	_	0	SENT_328	[p22l665t3438r784b3529],
3	omeprazole	NN	O	omeprazole	prep_of	1	SENT_328	[p22l823t3438r1431b3560],
4	on	IN	O	on	_	0	SENT_328	[p22l1490t3471r1613b3529],
5	intragas	JJ	O	intragas	amod	8	SENT_328	[p22l1681t3440r2132b3561],
6	—	NN	O	—	nn	8	SENT_328	[p22l1681t3440r2132b3561],
7	tric	JJ	O	tric	amod	8	SENT_328	[p22l258t3612r425b3700],
8	pH	NN	O	ph	prep_on	3	SENT_328	[p22l482t3616r626b3732],
9	and	CC	O	and	_	0	SENT_328	[p22l688t3609r876b3700],
10	plasma	NN	O	plasma	nn	11	SENT_328	[p22l940t3609r1310b3732],
11	gastrin	NN	O	gastrin	conj_and	8	SENT_328	[p22l1359t3612r1706b3732],
12	are	VBP	O	be	cop	13	SENT_328	[p22l1766t3643r1921b3700],
13	dependent	JJ	O	dependent	_	0	SENT_328	[p22l1975t3609r2132b3700, p23l266t22r689b145],

1	on	IN	O	on	_	0	SENT_329	[p23l736t56r860b114],
2	the	DT	O	the	det	4	SENT_329	[p23l912t22r1073b113],
3	CYPZC19	NN	O	cypzc19	nn	4	SENT_329	[p23l1124t29r1609b113],
4	polymorphism	NN	O	polymorphism	pobj	1	SENT_329	[p23l1667t22r2132b145, p23l266t178r604b301],
5	.	.	O	.	_	0	SENT_329	[p23l1667t22r2132b145, p23l266t178r604b301],

1	Gastroentero/ogy	NN	O	gastroentero/ogy	_	0	SENT_330	[p23l698t178r1500b302],
2	.	.	O	.	_	0	SENT_330	[p23l698t178r1500b302],

1	2000	CD	DATE	2000	_	0	SENT_331	[p23l1594t185r2127b290],
2	;	:	O	;	_	0	SENT_331	[p23l1594t185r2127b290],
3	119	CD	NUMBER	119	num	5	SENT_331	[p23l1594t185r2127b290],
4	:	:	O	:	_	0	SENT_331	[p23l1594t185r2127b290],
5	670-676	CD	NUMBER	670-676	dep	1	SENT_331	[p23l263t339r748b424],
6	.	.	O	.	_	0	SENT_331	[p23l263t339r748b424],

1	Furuta	NNP	PERSON	Furuta	nn	2	SENT_332	[p23l265t496r600b580],
2	T	NN	O	t	_	0	SENT_332	[p23l631t496r728b602],
3	,	,	O	,	_	0	SENT_332	[p23l631t496r728b602],
4	Ohashi	NNP	PERSON	Ohashi	nn	5	SENT_332	[p23l773t489r1138b581],
5	K	NNP	PERSON	K	appos	2	SENT_332	[p23l1191t496r1281b602],
6	,	,	O	,	_	0	SENT_332	[p23l1191t496r1281b602],
7	Kosuge	NNP	PERSON	Kosuge	nn	8	SENT_332	[p23l1333t496r1699b612],
8	K	NNP	PERSON	K	appos	2	SENT_332	[p23l1747t496r1838b602],
9	,	,	O	,	_	0	SENT_332	[p23l1747t496r1838b602],
10	et	FW	O	et	nn	11	SENT_332	[p23l1883t513r1975b580],
11	al.	FW	O	al.	appos	2	SENT_332	[p23l2013t489r2127b580],
12	.	.	O	.	_	0	SENT_332	[p23l2013t489r2127b580],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_333	[p23l261t650r747b733],
2	genotype	NN	O	genotype	_	0	SENT_333	[p23l818t667r1291b767],
3	status	NN	O	status	dep	2	SENT_333	[p23l1363t667r1671b733],
4	and	CC	O	and	_	0	SENT_333	[p23l1742t643r1930b733],
5	effect	NN	O	effect	dep	2	SENT_333	[p23l2009t643r2132b733, p23l259t813r449b905],
6	of	IN	O	of	_	0	SENT_333	[p23l513t813r631b905],
7	omeprazole	NN	O	omeprazole	prep_of	3	SENT_333	[p23l677t814r1284b936],
8	on	IN	O	on	_	0	SENT_333	[p23l1351t847r1475b905],
9	intragastric	JJ	O	intragastric	amod	10	SENT_333	[p23l1550t816r2134b937],
10	pH	NN	O	ph	prep_on	7	SENT_333	[p23l266t976r408b1092],
11	in	IN	O	in	_	0	SENT_333	[p23l474t971r554b1058],
12	humans	NNS	O	human	prep_in	10	SENT_333	[p23l619t969r1056b1060],
13	.	.	O	.	_	0	SENT_333	[p23l619t969r1056b1060],

1	Clin	NNP	O	Clin	nn	3	SENT_334	[p23l1119t969r1298b1060],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_334	[p23l1349t969r1846b1060],
3	Ther	NNP	O	Ther	_	0	SENT_334	[p23l1890t969r2127b1060],
4	.	.	O	.	_	0	SENT_334	[p23l1890t969r2127b1060],

1	1999	CD	DATE	1999	_	0	SENT_335	[p23l270t1130r1227b1236],
2	;	:	O	;	_	0	SENT_335	[p23l270t1130r1227b1236],
3	65:552	CD	NUMBER	65:552	number	4	SENT_335	[p23l270t1130r1227b1236],
4	-561	CD	NUMBER	-561	dep	1	SENT_335	[p23l270t1130r1227b1236],
5	.	.	O	.	_	0	SENT_335	[p23l270t1130r1227b1236],

1	Zhao	NNP	PERSON	Zhao	nn	2	SENT_336	[p23l256t1279r524b1371],
2	F	NN	PERSON	f	_	0	SENT_336	[p23l571t1287r646b1391],
3	,	,	O	,	_	0	SENT_336	[p23l571t1287r646b1391],
4	Wang	NNP	PERSON	Wang	nn	5	SENT_336	[p23l687t1287r1092b1403],
5	]	NNP	O	]	appos	2	SENT_336	[p23l687t1287r1092b1403],
6	,	,	O	,	_	0	SENT_336	[p23l687t1287r1092b1403],
7	Yang	NNP	PERSON	Yang	nn	8	SENT_336	[p23l1129t1287r1383b1403],
8	Y	NN	PERSON	y	appos	2	SENT_336	[p23l1412t1287r1497b1391],
9	,	,	O	,	_	0	SENT_336	[p23l1412t1287r1497b1391],
10	et	FW	O	et	nn	11	SENT_336	[p23l1545t1304r1637b1371],
11	al.	FW	O	al.	appos	2	SENT_336	[p23l1676t1279r1790b1370],
12	.	.	O	.	_	0	SENT_336	[p23l1676t1279r1790b1370],

1	Effect	NN	O	effect	nn	4	SENT_337	[p23l1846t1279r2136b1371],
2	ofCYP2C19	NN	O	ofcyp2c19	nn	4	SENT_337	[p23l261t1434r883b1526],
3	genetic	JJ	O	genetic	amod	4	SENT_337	[p23l922t1437r1288b1558],
4	polymorphisms	NNS	O	polymorphism	nsubj	13	SENT_337	[p23l1330t1435r2134b1557],
5	on	IN	O	on	_	0	SENT_337	[p23l261t1624r385b1681],
6	the	DT	O	the	det	7	SENT_337	[p23l474t1590r634b1681],
7	efficacy	NN	O	efficacy	prep_on	4	SENT_337	[p23l722t1590r1119b1713],
8	of	IN	O	of	_	0	SENT_337	[p23l1199t1590r1318b1681],
9	proton	NN	O	proton	nn	12	SENT_337	[p23l1388t1614r1735b1713],
10	pump	NN	O	pump	nn	12	SENT_337	[p23l1832t1624r2130b1713],
11	inhibitor	NN	O	inhibitor	nn	12	SENT_337	[p23l265t1745r1056b1836],
12	—	NN	O	—	prep_of	7	SENT_337	[p23l265t1745r1056b1836],
13	based	VBN	O	base	_	0	SENT_337	[p23l265t1745r1056b1836],
14	triple	JJ	O	triple	amod	15	SENT_337	[p23l1150t1745r1419b1868],
15	therapy	NN	O	therapy	tmod	13	SENT_337	[p23l1505t1745r1906b1868],
16	for	IN	O	for	_	0	SENT_337	[p23l1989t1745r2139b1836],
17	Helicobacter	NNP	PERSON	Helicobacter	nn	19	SENT_337	[p23l261t1898r842b1990],
18	pylori	NNP	PERSON	pylori	nn	19	SENT_337	[p23l863t1898r1121b2021],
19	eradication	NN	O	eradication	prep_for	15	SENT_337	[p23l1161t1898r1780b1990],
20	:	:	O	:	_	0	SENT_337	[p23l1161t1898r1780b1990],
21	A	DT	O	a	det	24	SENT_337	[p23l1825t1906r1902b1989],
22	metaana	NN	O	metaana	nn	24	SENT_337	[p23l1946t1932r2132b1990, p23l258t2055r2132b2176, p23l263t2216r483b2299],
23	|	NN	O	|	nn	24	SENT_337	[p23l1946t1932r2132b1990, p23l258t2055r2132b2176, p23l263t2216r483b2299],
24	ysis	NN	O	ysis	dep	15	SENT_337	[p23l1946t1932r2132b1990, p23l258t2055r2132b2176, p23l263t2216r483b2299],
25	.	.	O	.	_	0	SENT_337	[p23l1946t1932r2132b1990, p23l258t2055r2132b2176, p23l263t2216r483b2299],

1	He/icobacter	NN	O	he/icobacter	_	0	SENT_338	[p23l1946t1932r2132b1990, p23l258t2055r2132b2176, p23l263t2216r483b2299],
2	.2008	CD	NUMBER	.2008	num	1	SENT_338	[p23l1946t1932r2132b1990, p23l258t2055r2132b2176, p23l263t2216r483b2299],
3	;	:	O	;	_	0	SENT_338	[p23l1946t1932r2132b1990, p23l258t2055r2132b2176, p23l263t2216r483b2299],
4	13:532541	CD	NUMBER	13:532541	dep	1	SENT_338	[p23l1946t1932r2132b1990, p23l258t2055r2132b2176, p23l263t2216r483b2299],
5	.	.	O	.	_	0	SENT_338	[p23l1946t1932r2132b1990, p23l258t2055r2132b2176, p23l263t2216r483b2299],

1	Kawabata	NNP	PERSON	Kawabata	nn	2	SENT_339	[p23l268t2362r787b2452],
2	H	NNP	PERSON	H	_	0	SENT_339	[p23l848t2370r958b2474],
3	,	,	O	,	_	0	SENT_339	[p23l848t2370r958b2474],
4	Habu	NNP	PERSON	Habu	nn	5	SENT_339	[p23l1025t2362r1301b2454],
5	Y	NN	PERSON	y	appos	2	SENT_339	[p23l1354t2370r1441b2474],
6	,	,	O	,	_	0	SENT_339	[p23l1354t2370r1441b2474],
7	Tomioka	NN	PERSON	tomioka	nn	8	SENT_339	[p23l1490t2362r1957b2454],
8	H	NN	PERSON	h	appos	2	SENT_339	[p23l2019t2370r2129b2474],
9	,	,	O	,	_	0	SENT_339	[p23l2019t2370r2129b2474],
10	et	FW	O	et	nn	11	SENT_339	[p23l261t2541r354b2608],
11	al.	FW	O	al.	appos	2	SENT_339	[p23l442t2517r558b2608],
12	.	.	O	.	_	0	SENT_339	[p23l442t2517r558b2608],

1	Effect	NN	O	effect	_	0	SENT_340	[p23l663t2516r956b2608],
2	of	IN	O	of	_	0	SENT_340	[p23l1046t2516r1165b2608],
3	different	JJ	O	different	amod	6	SENT_340	[p23l1236t2516r1684b2608],
4	proton	NN	O	proton	nn	6	SENT_340	[p23l1778t2541r2128b2639],
5	pump	NN	O	pump	nn	6	SENT_340	[p23l266t2706r569b2796],
6	inhibitors	NNS	O	inhibitor	prep_of	1	SENT_340	[p23l688t2673r1232b2784],
7	,	,	O	,	_	0	SENT_340	[p23l688t2673r1232b2784],
8	differences	NNS	O	difference	prep_of	1	SENT_340	[p23l1349t2673r1928b2764],
9	in	IN	O	in	_	0	SENT_340	[p23l2043t2675r2125b2762],
10	CYP2C19	NN	O	cyp2c19	nn	11	SENT_340	[p23l261t2834r747b2917],
11	genotype	NN	O	genotype	prep_in	8	SENT_340	[p23l821t2851r1293b2951],
12	and	CC	O	and	_	0	SENT_340	[p23l1367t2827r1555b2917],
13	antibiotic	JJ	O	antibiotic	amod	14	SENT_340	[p23l1635t2827r2134b2917],
14	resistance	NN	O	resistance	conj_and	6	SENT_340	[p23l264t2984r771b3073],
15	on	IN	O	on	dep	1	SENT_340	[p23l809t3015r932b3073],
16	the	DT	O	the	det	18	SENT_340	[p23l973t2981r1133b3073],
17	eradication	NN	O	eradication	nn	18	SENT_340	[p23l1172t2981r1756b3073],
18	rate	NN	O	rate	pobj	15	SENT_340	[p23l1801t3006r1996b3073],
19	of	IN	O	of	dep	1	SENT_340	[p23l2035t2981r2154b3073],

1	Helicobacter	NNP	PERSON	Helicobacter	nn	3	SENT_341	[p23l261t3138r857b3229],
2	pylori	NN	PERSON	pylorus	nn	3	SENT_341	[p23l930t3138r1196b3261],
3	infection	NN	O	infection	_	0	SENT_341	[p23l1297t3137r1754b3229],
4	by	IN	O	by	_	0	SENT_341	[p23l1866t3138r1984b3260],
5	a	DT	O	a	det	7	SENT_341	[p23l2079t3171r2134b3229],
6	1-week	JJ	DURATION	1-week	amod	7	SENT_341	[p23l270t3309r626b3400],
7	regimen	NN	O	regimen	prep_by	3	SENT_341	[p23l707t3312r1111b3432],
8	of	IN	O	of	_	0	SENT_341	[p23l1202t3309r1322b3400],
9	proton	NN	O	proton	nn	11	SENT_341	[p23l1390t3333r1737b3432],
10	pump	NN	O	pump	nn	11	SENT_341	[p23l1832t3343r2130b3432],
11	inhibitor	NN	O	inhibitor	prep_of	3	SENT_341	[p23l265t3462r735b3574],
12	,	,	O	,	_	0	SENT_341	[p23l265t3462r735b3574],
13	amoxicillin	NNP	O	amoxicillin	conj_and	11	SENT_341	[p23l794t3462r1346b3552],
14	and	CC	O	and	_	0	SENT_341	[p23l1405t3462r1592b3552],
15	c	NN	O	c	nn	17	SENT_341	[p23l1652t3462r2132b3552, p23l266t3620r592b3739],
16	|	NN	O	|	nn	17	SENT_341	[p23l1652t3462r2132b3552, p23l266t3620r592b3739],
17	arithromycin	NN	O	arithromycin	conj_and	11	SENT_341	[p23l1652t3462r2132b3552, p23l266t3620r592b3739],
18	.	.	O	.	_	0	SENT_341	[p23l1652t3462r2132b3552, p23l266t3620r592b3739],

1	Aliment	NNP	O	Aliment	nn	3	SENT_342	[p23l625t3618r1003b3708],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_342	[p23l1029t3618r1526b3708],
3	Ther	NNP	O	Ther	_	0	SENT_342	[p23l1553t3618r1790b3708],
4	.	.	O	.	_	0	SENT_342	[p23l1553t3618r1790b3708],

1	2003	CD	DATE	2003	_	0	SENT_343	[p23l1836t3623r2129b3729],
2	;	:	O	;	_	0	SENT_343	[p23l1836t3623r2129b3729],

1	32	CD	NUMBER	32	_	0	SENT_344	[p24l6t180r161b265],
2	.	.	O	.	_	0	SENT_344	[p24l6t180r161b265],

1	Schwab	NNP	PERSON	Schwab	nn	2	SENT_345	[p24l259t175r661b265],
2	M	NNP	O	M	dep	30	SENT_345	[p24l728t182r857b287],
3	,	,	O	,	_	0	SENT_345	[p24l728t182r857b287],
4	Schaeffeler	NNP	O	Schaeffeler	nn	5	SENT_345	[p24l920t175r1494b265],
5	E	NNP	O	E	appos	2	SENT_345	[p24l1555t182r1638b287],
6	,	,	O	,	_	0	SENT_345	[p24l1555t182r1638b287],
7	Klotz	NNP	PERSON	Klotz	nn	8	SENT_345	[p24l1708t175r1965b265],
8	U	NNP	PERSON	U	appos	2	SENT_345	[p24l2026t182r2129b287],
9	,	,	O	,	_	0	SENT_345	[p24l2026t182r2129b287],
10	Treiber	NNP	PERSON	Treiber	nn	12	SENT_345	[p24l251t328r624b420],
11	G.	NNP	PERSON	G.	nn	12	SENT_345	[p24l670t335r777b420],
12	CYP2C19	NNP	PERSON	CYP2C19	appos	2	SENT_345	[p24l836t335r1320b420],
13	polymorphism	NN	O	polymorphism	dep	12	SENT_345	[p24l1379t328r2127b451],
14	is	VBZ	O	be	auxpass	30	SENT_345	[p24l265t502r331b591],
15	a	DT	O	a	det	17	SENT_345	[p24l404t533r459b591],
16	major	JJ	O	major	amod	17	SENT_345	[p24l534t502r838b623],
17	predictor	NN	O	predictor	attr	30	SENT_345	[p24l908t500r1385b622],
18	of	IN	O	of	_	0	SENT_345	[p24l1451t499r1570b591],
19	treatment	NN	O	treatment	nn	20	SENT_345	[p24l1618t524r2135b591],
20	failure	NN	O	failure	prep_of	17	SENT_345	[p24l259t655r584b746],
21	in	IN	O	in	_	0	SENT_345	[p24l653t657r733b744],
22	white	JJ	O	white	amod	23	SENT_345	[p24l799t655r1080b746],
23	patients	NNS	O	patient	prep_in	20	SENT_345	[p24l1150t657r1562b778],
24	by	IN	O	by	_	0	SENT_345	[p24l1630t655r1746b778],
25	use	NN	O	use	prep_by	23	SENT_345	[p24l1808t688r1969b746],
26	of	IN	O	of	_	0	SENT_345	[p24l2035t655r2154b746],
27	|	NN	O	|	nn	29	SENT_345	[p24l266t808r1225b931],
28	ansoprazole	NN	O	ansoprazole	nn	29	SENT_345	[p24l266t808r1225b931],
29	—	NN	O	—	prep_of	25	SENT_345	[p24l266t808r1225b931],
30	based	VBN	O	base	_	0	SENT_345	[p24l266t808r1225b931],
31	quadruple	JJ	O	quadruple	amod	32	SENT_345	[p24l1272t808r1785b931],
32	theraVolume	NN	O	theravolume	nsubjpass	30	SENT_345	[p24l1824t808r2132b899, p24l654t1186r1107b1286],

1	32	CD	NUMBER	32	num	2	SENT_346	[p24l1158t1191r1298b1286],
2	Number	NN	O	number	_	0	SENT_346	[p24l1357t1186r1851b1286],
3	12	CD	NUMBER	12	dep	2	SENT_346	[p24l1900t1191r2030b1284],

1	py	NN	O	py	_	0	SENT_347	[p24l227t1531r324b1606],
2	for	IN	O	for	_	0	SENT_347	[p24l392t1502r520b1580],
3	eradication	NN	O	eradication	prep_for	1	SENT_347	[p24l590t1502r1085b1580],
4	of	IN	O	of	_	0	SENT_347	[p24l1165t1502r1266b1580],
5	Helicobacter	NNP	PERSON	Helicobacter	nn	6	SENT_347	[p24l1324t1502r1817b1579],
6	pylori	NNP	PERSON	pylori	prep_of	1	SENT_347	[p24l215t1646r454b1750],
7	.	.	O	.	_	0	SENT_347	[p24l215t1646r454b1750],

1	Clin	NNP	O	Clin	nn	3	SENT_348	[p24l506t1646r657b1723],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_348	[p24l699t1646r1121b1723],
3	Ther	NNP	O	Ther	_	0	SENT_348	[p24l1156t1646r1357b1723],
4	.	.	O	.	_	0	SENT_348	[p24l1156t1646r1357b1723],

1	2004	CD	DATE	2004	_	0	SENT_349	[p24l1410t1652r1803b1741],
2	;	:	O	;	_	0	SENT_349	[p24l1410t1652r1803b1741],
3	76	CD	NUMBER	76	num	5	SENT_349	[p24l1410t1652r1803b1741],
4	:	:	O	:	_	0	SENT_349	[p24l1410t1652r1803b1741],
5	201-209	CD	NUMBER	201-209	dep	1	SENT_349	[p24l225t1782r636b1853],
6	.	.	O	.	_	0	SENT_349	[p24l225t1782r636b1853],

1	41	CD	NUMBER	41	_	0	SENT_350	[p24l2019t1783r2150b1854],
2	.	.	O	.	_	0	SENT_350	[p24l2019t1783r2150b1854],

1	33	CD	NUMBER	33	_	0	SENT_351	[p24l6t1912r139b1983],
2	.	.	O	.	_	0	SENT_351	[p24l6t1912r139b1983],

1	Furuta	NNP	PERSON	Furuta	nn	2	SENT_352	[p24l225t1913r511b1983],
2	T	NN	O	t	_	0	SENT_352	[p24l536t1913r618b2001],
3	,	,	O	,	_	0	SENT_352	[p24l536t1913r618b2001],
4	Shirai	NNP	PERSON	Shirai	nn	5	SENT_352	[p24l653t1906r899b1983],
5	N	NNP	O	N	appos	2	SENT_352	[p24l942t1913r1034b2001],
6	,	,	O	,	_	0	SENT_352	[p24l942t1913r1034b2001],
7	Takashima	NNP	PERSON	Takashima	nn	8	SENT_352	[p24l1064t1906r1546b1983],
8	M	NNP	O	M	appos	2	SENT_352	[p24l1585t1913r1695b2001],
9	,	,	O	,	_	0	SENT_352	[p24l1585t1913r1695b2001],
10	et	FW	O	et	nn	11	SENT_352	[p24l1733t1926r1810b1983],
11	al.	FW	O	al.	appos	2	SENT_352	[p24l223t2036r319b2112],
12	.	.	O	.	_	0	SENT_352	[p24l223t2036r319b2112],

1	Effect	NN	O	effect	_	0	SENT_353	[p24l365t2036r612b2113],
2	ofgenotypic	JJ	O	ofgenotypic	amod	3	SENT_353	[p24l645t2036r1188b2141],
3	differences	NNS	O	difference	dep	1	SENT_353	[p24l1223t2036r1698b2113],
4	in	IN	O	in	_	0	SENT_353	[p24l1736t2039r1804b2112],
5	CYP2C19	NN	O	cyp2c19	prep_in	3	SENT_353	[p24l224t2172r634b2243],
6	on	IN	O	on	_	0	SENT_353	[p24l693t2195r798b2244],
7	cure	NN	O	cure	nn	8	SENT_353	[p24l858t2195r1041b2243],
8	rates	NNS	O	rate	prep_on	5	SENT_353	[p24l1099t2186r1307b2243],
9	for	IN	O	for	_	0	SENT_353	[p24l1361t2166r1488b2244],
10	Helicobacter	NNP	PERSON	Helicobacter	prep_for	8	SENT_353	[p24l1538t2166r1808b2243, p24l222t2297r466b2374],

1	pylori	NN	O	pylorus	nn	2	SENT_354	[p24l484t2297r703b2401],
2	infection	NN	O	infection	_	0	SENT_354	[p24l738t2297r1115b2374],
3	by	IN	O	by	_	0	SENT_354	[p24l1161t2297r1258b2401],
4	triple	JJ	O	triple	amod	5	SENT_354	[p24l1286t2297r1513b2401],
5	therapy	NN	O	therapy	prep_by	2	SENT_354	[p24l1546t2297r1807b2374, p24l227t2456r324b2531],
6	with	IN	O	with	_	0	SENT_354	[p24l374t2427r558b2504],
7	a	DT	O	a	det	10	SENT_354	[p24l622t2456r668b2504],
8	proton	NN	O	proton	nn	10	SENT_354	[p24l730t2447r1024b2531],
9	pump	NN	O	pump	nn	10	SENT_354	[p24l1090t2456r1343b2531],
10	inhibitor	NN	O	inhibitor	prep_with	2	SENT_354	[p24l1406t2427r1805b2522],
11	,	,	O	,	_	0	SENT_354	[p24l1406t2427r1805b2522],
12	amoxicillin	NNP	O	amoxicillin	prep_with	2	SENT_354	[p24l223t2557r722b2652],
13	,	,	O	,	_	0	SENT_354	[p24l223t2557r722b2652],
14	and	CC	O	and	_	0	SENT_354	[p24l758t2557r917b2634],
15	clarithromycin	NN	O	clarithromycin	prep_with	2	SENT_354	[p24l954t2557r1617b2661],
16	.	.	O	.	_	0	SENT_354	[p24l954t2557r1617b2661],

1	Clin	NNP	O	Clin	nn	3	SENT_355	[p24l1657t2557r1807b2634],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_355	[p24l222t2688r643b2764],
3	Ther	NNP	O	Ther	_	0	SENT_355	[p24l673t2688r874b2764],
4	.	.	O	.	_	0	SENT_355	[p24l673t2688r874b2764],

1	2001	CD	DATE	2001	_	0	SENT_356	[p24l920t2693r1739b2783],
2	;	:	O	;	_	0	SENT_356	[p24l920t2693r1739b2783],
3	69:158	CD	NUMBER	69:158	number	4	SENT_356	[p24l920t2693r1739b2783],
4	-168	CD	NUMBER	-168	dep	1	SENT_356	[p24l920t2693r1739b2783],
5	.	.	O	.	_	0	SENT_356	[p24l920t2693r1739b2783],

1	42	CD	NUMBER	42	_	0	SENT_357	[p24l2019t2694r2153b2765],
2	.	.	O	.	_	0	SENT_357	[p24l2019t2694r2153b2765],

1	34	CD	NUMBER	34	_	0	SENT_358	[p24l6t2822r139b2894],
2	.	.	O	.	_	0	SENT_358	[p24l6t2822r139b2894],

1	Kuwayama	NNP	ORGANIZATION	Kuwayama	nn	2	SENT_359	[p24l228t2823r706b2921],
2	H	NNP	ORGANIZATION	H	_	0	SENT_359	[p24l761t2823r854b2911],
3	,	,	O	,	_	0	SENT_359	[p24l761t2823r854b2911],
4	Asaka	NNP	ORGANIZATION	Asaka	nn	5	SENT_359	[p24l904t2817r1168b2894],
5	M	NNP	ORGANIZATION	M	appos	2	SENT_359	[p24l1222t2823r1332b2912],
6	,	,	O	,	_	0	SENT_359	[p24l1222t2823r1332b2912],
7	Sugiyama	NNP	PERSON	Sugiyama	nn	8	SENT_359	[p24l1384t2820r1809b2921],
8	T	NN	O	t	appos	2	SENT_359	[p24l215t2953r296b3041],
9	,	,	O	,	_	0	SENT_359	[p24l215t2953r296b3041],
10	et	FW	O	et	nn	11	SENT_359	[p24l347t2967r424b3024],
11	al	FW	O	al	appos	2	SENT_359	[p24l469t2947r567b3042],
12	,	,	O	,	_	0	SENT_359	[p24l469t2947r567b3042],
13	for	IN	O	for	_	0	SENT_359	[p24l616t2947r743b3024],
14	the	DT	O	the	det	18	SENT_359	[p24l782t2947r919b3024],
15	Japan	NNP	LOCATION	Japan	nn	18	SENT_359	[p24l950t2953r1209b3051],
16	Rabeprazole	NNP	O	Rabeprazole	nn	18	SENT_359	[p24l1266t2947r1808b3051],
17	Study	NNP	O	Study	nn	18	SENT_359	[p24l221t3077r476b3181],
18	Group	NNP	O	Group	prep_for	2	SENT_359	[p24l551t3082r859b3181],
19	.	.	O	.	_	0	SENT_359	[p24l551t3082r859b3181],

1	Rabeprazole-based	JJ	O	rabeprazole-based	amod	3	SENT_360	[p24l949t3077r1802b3181],
2	eradication	NN	O	eradication	nn	3	SENT_360	[p24l223t3207r717b3284],
3	therapy	NN	O	therapy	_	0	SENT_360	[p24l770t3207r1108b3311],
4	for	IN	O	for	_	0	SENT_360	[p24l1152t3207r1279b3284],
5	Helicobacter	NNP	PERSON	Helicobacter	nn	6	SENT_360	[p24l1324t3207r1817b3284],
6	pylori	NNP	O	pylori	prep_for	3	SENT_360	[p24l215t3337r453b3441],
7	:	:	O	:	_	0	SENT_360	[p24l215t3337r453b3441],
8	A	DT	O	a	det	13	SENT_360	[p24l510t3343r576b3412],
9	|	NN	O	|	nn	13	SENT_360	[p24l630t3337r1088b3441],
10	arge	NN	O	arge	nn	13	SENT_360	[p24l630t3337r1088b3441],
11	—	CD	NUMBER	—	num	13	SENT_360	[p24l630t3337r1088b3441],
12	sca	NN	O	sca	nn	13	SENT_360	[p24l630t3337r1088b3441],
13	|	NN	O	|	dep	3	SENT_360	[p24l630t3337r1088b3441],
14	e	SYM	O	e	dep	15	SENT_360	[p24l630t3337r1088b3441],
15	study	NN	O	study	nsubj	21	SENT_360	[p24l1143t3337r1380b3440],
16	in	IN	O	in	_	0	SENT_360	[p24l1433t3339r1501b3412],
17	japan	NN	LOCATION	japan	prep_in	15	SENT_360	[p24l1545t3343r1804b3441],
18	[	CD	NUMBER	[	num	17	SENT_360	[p24l228t3467r678b3571],
19	published	VBN	O	publish	partmod	17	SENT_360	[p24l228t3467r678b3571],
20	correction	NN	O	correction	dobj	19	SENT_360	[p24l718t3469r1152b3544],
21	appears	VBZ	O	appear	rcmod	13	SENT_360	[p24l1193t3495r1532b3571],
22	in	IN	O	in	_	0	SENT_360	[p24l1569t3469r1637b3542],
23	Aliment	NNP	O	Aliment	nn	25	SENT_360	[p24l1667t3467r1808b3542, p24l221t3613r417b3674],
24	Pharmacol	NNP	O	Pharmacol	nn	25	SENT_360	[p24l446t3598r858b3674],
25	Ther	NNP	O	Ther	prep_in	21	SENT_360	[p24l890t3598r1075b3674],
26	.	.	O	.	_	0	SENT_360	[p24l890t3598r1075b3674],

1	2007	CD	DATE	2007	_	0	SENT_361	[p24l1122t3599r1803b3700],
2	;	:	O	;	_	0	SENT_361	[p24l1122t3599r1803b3700],
3	25:1479	CD	NUMBER	25:1479	num	4	SENT_361	[p24l1122t3599r1803b3700],
4	]	NN	O	]	dep	1	SENT_361	[p24l1122t3599r1803b3700],
5	.	.	O	.	_	0	SENT_361	[p24l1122t3599r1803b3700],

1	Aliment	NNP	O	Aliment	nn	3	SENT_362	[p25l215t21r541b98],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_362	[p25l609t21r1039b98],
3	Ther	NNP	O	Ther	_	0	SENT_362	[p25l1108t21r1313b98],
4	.	.	O	.	_	0	SENT_362	[p25l1108t21r1313b98],

1	2007	CD	DATE	2007	_	0	SENT_363	[p25l1403t25r1804b115],
2	;	:	O	;	_	0	SENT_363	[p25l1403t25r1804b115],
3	25	CD	NUMBER	25	num	5	SENT_363	[p25l1403t25r1804b115],
4	:	:	O	:	_	0	SENT_363	[p25l1403t25r1804b115],
5	1105-1113	CD	DATE	1105-1113	dep	1	SENT_363	[p25l229t156r752b228],
6	.	.	O	.	_	0	SENT_363	[p25l229t156r752b228],

1	Ho	NNP	O	Ho	nn	2	SENT_364	[p25l228t281r517b358],
2	|	NN	O	|	dep	5	SENT_364	[p25l228t281r517b358],
3	<	JJR	O	<	dep	2	SENT_364	[p25l228t281r517b358],
4	ari	CD	PERSON	ari	num	5	SENT_364	[p25l228t281r517b358],
5	K	NN	PERSON	k	_	0	SENT_364	[p25l577t287r654b375],
6	,	,	O	,	_	0	SENT_364	[p25l577t287r654b375],
7	Sugiyama	NN	ORGANIZATION	sugiyama	nn	8	SENT_364	[p25l705t283r1131b385],
8	T	NN	ORGANIZATION	t	appos	5	SENT_364	[p25l1172t287r1254b375],
9	,	,	O	,	_	0	SENT_364	[p25l1172t287r1254b375],
10	Kato	NNP	PERSON	Kato	nn	11	SENT_364	[p25l1314t287r1513b358],
11	M	NNP	PERSON	M	appos	5	SENT_364	[p25l1569t287r1679b375],
12	,	,	O	,	_	0	SENT_364	[p25l1569t287r1679b375],
13	et	FW	O	et	nn	14	SENT_364	[p25l1733t301r1810b358],
14	al.	FW	O	al.	appos	5	SENT_364	[p25l223t411r319b488],
15	.	.	O	.	_	0	SENT_364	[p25l223t411r319b488],

1	Efficacy	NN	O	efficacy	_	0	SENT_365	[p25l394t411r736b514],
2	of	IN	O	of	_	0	SENT_365	[p25l795t411r896b488],
3	triple	JJ	O	triple	amod	4	SENT_365	[p25l939t411r1165b515],
4	therapy	NN	O	therapy	prep_of	1	SENT_365	[p25l1227t411r1565b515],
5	with	IN	O	with	_	0	SENT_365	[p25l1619t411r1804b488],
6	rabeprazole	NN	O	rabeprazole	prep_with	1	SENT_365	[p25l225t541r742b645],
7	for	IN	O	for	_	0	SENT_365	[p25l777t541r905b618],
8	Helicobacter	NNP	PERSON	Helicobacter	nn	10	SENT_365	[p25l936t541r1428b618],
9	pylori	NN	PERSON	pylorus	nn	10	SENT_365	[p25l1447t541r1666b645],
10	infection	NN	O	infection	prep_for	1	SENT_365	[p25l1702t543r1808b616, p25l221t671r519b748],
11	and	CC	O	and	_	0	SENT_365	[p25l569t671r727b747],
12	CYPZC19	NN	O	cypzc19	nn	14	SENT_365	[p25l779t675r1190b748],
13	genetic	JJ	O	genetic	amod	14	SENT_365	[p25l1236t672r1546b775],
14	polymorphism	NN	O	polymorphism	prep_for	1	SENT_365	[p25l1595t671r1808b774, p25l227t802r699b904],
15	.	.	O	.	_	0	SENT_365	[p25l1595t671r1808b774, p25l227t802r699b904],

1	Aliment	NNP	O	Aliment	nn	3	SENT_366	[p25l759t802r1079b878],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_366	[p25l1129t802r1550b878],
3	Ther	NNP	O	Ther	_	0	SENT_366	[p25l1602t802r1803b878],
4	.	.	O	.	_	0	SENT_366	[p25l1602t802r1803b878],

1	2001	CD	DATE	2001	_	0	SENT_367	[p25l225t936r1160b1025],
2	;	:	O	;	_	0	SENT_367	[p25l225t936r1160b1025],
3	15:1479	CD	NUMBER	15:1479	number	4	SENT_367	[p25l225t936r1160b1025],
4	—	CD	NUMBER	—	dep	1	SENT_367	[p25l225t936r1160b1025],
5	1484	CD	DATE	1484	dep	4	SENT_367	[p25l225t936r1160b1025],
6	.	.	O	.	_	0	SENT_367	[p25l225t936r1160b1025],

1	Kuo	NNP	PERSON	Kuo	nn	2	SENT_368	[p25l228t1067r395b1138],
2	CH	NN	O	ch	_	0	SENT_368	[p25l434t1066r603b1155],
3	,	,	O	,	_	0	SENT_368	[p25l434t1066r603b1155],
4	Hu	NNP	O	Hu	nn	5	SENT_368	[p25l649t1067r769b1138],
5	HM	NNS	O	hm	appos	2	SENT_368	[p25l817t1067r1006b1155],
6	,	,	O	,	_	0	SENT_368	[p25l817t1067r1006b1155],
7	Kuo	NNP	ORGANIZATION	Kuo	nn	8	SENT_368	[p25l1053t1067r1219b1138],
8	FC	NNP	ORGANIZATION	FC	appos	2	SENT_368	[p25l1262t1066r1399b1155],
9	,	,	O	,	_	0	SENT_368	[p25l1262t1066r1399b1155],
10	et	FW	O	et	nn	11	SENT_368	[p25l1440t1081r1518b1138],
11	al.	FW	O	al.	appos	2	SENT_368	[p25l1553t1060r1650b1137],
12	.	.	O	.	_	0	SENT_368	[p25l1553t1060r1650b1137],

1	Efficacy	NN	O	efficacy	_	0	SENT_369	[p25l1699t1060r1807b1136, p25l221t1190r477b1294],
2	of	IN	O	of	_	0	SENT_369	[p25l525t1190r626b1268],
3	levofloxacin-based	JJ	O	levofloxacin-based	amod	5	SENT_369	[p25l666t1190r1477b1268],
4	rescue	NN	O	rescue	nn	5	SENT_369	[p25l1537t1219r1808b1267],
5	therapy	NN	O	therapy	prep_of	1	SENT_369	[p25l220t1321r558b1425],
6	for	IN	O	for	_	0	SENT_369	[p25l603t1321r730b1398],
7	Helicobacter	NNP	PERSON	Helicobacter	nn	9	SENT_369	[p25l777t1321r1269b1398],
8	pylori	NN	PERSON	pylorus	nn	9	SENT_369	[p25l1302t1321r1521b1425],
9	infection	NN	O	infection	prep_for	1	SENT_369	[p25l1573t1321r1808b1398, p25l220t1453r390b1528],
10	after	IN	O	after	_	0	SENT_369	[p25l453t1451r660b1528],
11	standard	JJ	O	standard	amod	13	SENT_369	[p25l714t1451r1102b1528],
12	triple	JJ	O	triple	amod	13	SENT_369	[p25l1162t1451r1389b1555],
13	therapy	NN	O	therapy	prep_after	1	SENT_369	[p25l1445t1451r1803b1555],
14	:	:	O	:	_	0	SENT_369	[p25l1445t1451r1803b1555],
15	A	DT	O	a	dep	1	SENT_369	[p25l218t1588r283b1657],
16	randomized	VBN	O	randomize	dep	15	SENT_369	[p25l317t1582r826b1659],
17	controlled	JJ	O	controlled	amod	19	SENT_369	[p25l865t1582r1301b1659],
18	tria	NN	O	trium	nn	19	SENT_369	[p25l1338t1582r1808b1679, p25l221t1711r489b1789],
19	|	NN	O	|	dobj	16	SENT_369	[p25l1338t1582r1808b1679, p25l221t1711r489b1789],
20	.	.	O	.	_	0	SENT_369	[p25l1338t1582r1808b1679, p25l221t1711r489b1789],

1	jAntimicrob	NN	O	jantimicrob	_	0	SENT_370	[p25l1338t1582r1808b1679, p25l221t1711r489b1789],
2	Chemother	NN	O	chemother	dep	1	SENT_370	[p25l565t1711r1026b1789],
3	.	.	O	.	_	0	SENT_370	[p25l565t1711r1026b1789],

1	2009	CD	DATE	2009	_	0	SENT_371	[p25l1116t1717r1808b1806],
2	;	:	O	;	_	0	SENT_371	[p25l1116t1717r1808b1806],
3	63:1017	CD	NUMBER	63:1017	number	4	SENT_371	[p25l1116t1717r1808b1806],
4	—	CD	NUMBER	—	dep	1	SENT_371	[p25l1116t1717r1808b1806],
5	1024	CD	DATE	1024	dep	4	SENT_371	[p25l229t1847r471b1918],
6	.	.	O	.	_	0	SENT_371	[p25l229t1847r471b1918],

1	de	IN	O	de	amod	3	SENT_372	[p25l223t1974r322b2051],
2	Morais	NNP	O	Morais	nn	3	SENT_372	[p25l360t1977r664b2051],
3	SM	NNP	O	SM	_	0	SENT_372	[p25l694t1979r865b2069],
4	,	,	O	,	_	0	SENT_372	[p25l694t1979r865b2069],
5	Wilkinson	NNP	PERSON	Wilkinson	nn	6	SENT_372	[p25l897t1974r1335b2051],
6	GR	NN	O	gr	appos	3	SENT_372	[p25l1374t1979r1533b2069],
7	,	,	O	,	_	0	SENT_372	[p25l1374t1979r1533b2069],
8	Blais	NNP	PERSON	Blais	appos	6	SENT_372	[p25l1576t1974r1807b2050],
9	—	CD	NUMBER	—	num	11	SENT_372	[p25l1576t1974r1807b2050],
10	dell	NN	O	dell	nn	11	SENT_372	[p25l223t2104r370b2180],
11	J	NN	O	j	dep	8	SENT_372	[p25l408t2110r473b2199],
12	,	,	O	,	_	0	SENT_372	[p25l408t2110r473b2199],
13	et	FW	O	et	nn	14	SENT_372	[p25l526t2124r605b2180],
14	al.	FW	O	al.	appos	6	SENT_372	[p25l652t2104r748b2180],
15	.	.	O	.	_	0	SENT_372	[p25l652t2104r748b2180],

1	The	DT	O	the	det	4	SENT_373	[p25l795t2104r961b2180],
2	major	JJ	O	major	amod	4	SENT_373	[p25l1015t2106r1272b2209],
3	genetic	JJ	O	genetic	amod	4	SENT_373	[p25l1314t2106r1625b2208],
4	defect	NN	O	defect	nsubj	13	SENT_373	[p25l1675t2104r1808b2180, p25l221t2234r382b2310],
5	responsible	JJ	O	responsible	amod	4	SENT_373	[p25l451t2234r948b2336],
6	for	IN	O	for	_	0	SENT_373	[p25l1016t2234r1143b2310],
7	the	DT	O	the	det	10	SENT_373	[p25l1204t2234r1340b2310],
8	polymorphism	NN	O	polymorphism	nn	10	SENT_373	[p25l1413t2234r1808b2336, p25l226t2362r475b2466],
9	ofS-mephenytoin	NN	O	ofs-mephenytoin	nn	10	SENT_373	[p25l516t2362r1266b2466],
10	metabolism	NN	O	metabolism	prep_for	5	SENT_373	[p25l1311t2362r1804b2440],
11	in	IN	O	in	_	0	SENT_373	[p25l226t2496r293b2570],
12	humans	NNS	O	human	prep_in	10	SENT_373	[p25l354t2493r806b2590],
13	]	VBP	O	]	_	0	SENT_373	[p25l354t2493r806b2590],
14	Biol	NNP	ORGANIZATION	Biol	nn	15	SENT_373	[p25l849t2493r1003b2570],
15	Chem	NNP	ORGANIZATION	Chem	dobj	13	SENT_373	[p25l1046t2493r1293b2570],
16	.	.	O	.	_	0	SENT_373	[p25l1046t2493r1293b2570],

1	1994	CD	DATE	1994	_	0	SENT_374	[p25l1357t2499r1803b2589],
2	;	:	O	;	_	0	SENT_374	[p25l1357t2499r1803b2589],
3	269	CD	NUMBER	269	num	5	SENT_374	[p25l1357t2499r1803b2589],
4	:	:	O	:	_	0	SENT_374	[p25l1357t2499r1803b2589],
5	15419-15422	CD	NUMBER	15419-15422	dep	1	SENT_374	[p25l229t2629r867b2701],
6	.	.	O	.	_	0	SENT_374	[p25l229t2629r867b2701],

1	DeCosterj	NNP	O	DeCosterj	nn	5	SENT_375	[p25l228t2759r712b2850],
2	,	,	O	,	_	0	SENT_375	[p25l228t2759r712b2850],
3	Claypool	NNP	PERSON	Claypool	appos	5	SENT_375	[p25l746t2754r1132b2858],
4	H.	NNP	PERSON	H.	nn	5	SENT_375	[p25l1174t2760r1264b2831],
5	Data	NNP	PERSON	Data	_	0	SENT_375	[p25l1305t2760r1516b2831],
6	analysis	NN	O	analysis	dep	5	SENT_375	[p25l1545t2754r1808b2857, p25l222t2886r325b2961],
7	in	IN	O	in	_	0	SENT_375	[p25l392t2886r460b2960],
8	SPSS	NNP	ORGANIZATION	SPSS	prep_in	6	SENT_375	[p25l528t2889r767b2961],
9	.	.	O	.	_	0	SENT_375	[p25l528t2889r767b2961],

1	http://vwvw.stat-help	NN	O	http://vwvw.stat-help	_	0	SENT_376	[p25l841t2885r1803b2987],
2	.	.	O	.	_	0	SENT_376	[p25l841t2885r1803b2987],

1	com/notes	NNS	O	com/notes	_	0	SENT_377	[p25l222t3013r962b3108],
2	.	.	O	.	_	0	SENT_377	[p25l222t3013r962b3108],

1	html	NN	O	html	_	0	SENT_378	[p25l222t3013r962b3108],
2	.	.	O	.	_	0	SENT_378	[p25l222t3013r962b3108],

1	Accessed	VBN	O	access	_	0	SENT_379	[p25l1005t3013r1398b3091],
2	October	NNP	DATE	October	tmod	1	SENT_379	[p25l1445t3013r1814b3091],
3	15,2008	CD	DATE	15,2008	num	2	SENT_379	[p25l229t3149r647b3238],
4	.	.	O	.	_	0	SENT_379	[p25l229t3149r647b3238],

1	Cuisbert	NNP	O	Cuisbert	nn	2	SENT_380	[p25l224t3273r512b3350],
2	JP	NNP	O	JP	_	0	SENT_380	[p25l542t3279r648b3369],
3	,	,	O	,	_	0	SENT_380	[p25l542t3279r648b3369],
4	Dominguez	NNP	PERSON	Dominguez	appos	2	SENT_380	[p25l705t3276r1478b3378],
5	.	.	O	.	_	0	SENT_380	[p25l705t3276r1478b3378],

1	—	NN	O	—	_	0	SENT_381	[p25l705t3276r1478b3378],
2	.	.	O	.	_	0	SENT_381	[p25l705t3276r1478b3378],

1	Mur	JJ	MISC	mur	_	0	SENT_382	[p25l705t3276r1478b3378],
2	"	``	O	"	punct	1	SENT_382	[p25l705t3276r1478b3378],
3	1oz	NN	O	1oz	nn	4	SENT_382	[p25l705t3276r1478b3378],
4	A	NN	O	a	dep	1	SENT_382	[p25l1519t3280r1604b3368],
5	,	,	O	,	_	0	SENT_382	[p25l1519t3280r1604b3368],
6	Dominguez-Martin	NNP	O	Dominguez-Martin	nn	7	SENT_382	[p25l1661t3279r1807b3350, p25l227t3406r855b3508],
7	A	NNP	O	A	appos	1	SENT_382	[p25l885t3410r971b3498],
8	,	,	O	,	_	0	SENT_382	[p25l885t3410r971b3498],
9	et	FW	O	et	nn	10	SENT_382	[p25l1004t3423r1076b3480],
10	al.	FW	O	al.	appos	7	SENT_382	[p25l1103t3403r1188b3479],
11	.	.	O	.	_	0	SENT_382	[p25l1103t3403r1188b3479],

1	Esomeprazole	JJ	O	esomeprazole	amod	2	SENT_383	[p25l1229t3403r1807b3507],
2	—	NN	O	—	nsubj	3	SENT_383	[p25l1229t3403r1807b3507],
3	based	VBN	O	base	_	0	SENT_383	[p25l227t3533r473b3610],
4	therapy	NN	O	therapy	dobj	3	SENT_383	[p25l536t3533r874b3637],
5	in	IN	O	in	_	0	SENT_383	[p25l931t3536r998b3609],
6	Helicobacter	NNP	LOCATION	Helicobacter	nn	8	SENT_383	[p25l1063t3533r1555b3610],
7	pylori	NNP	O	pylori	nn	8	SENT_383	[p25l1593t3533r1813b3637],
8	eradication	NN	O	eradication	prep_in	4	SENT_383	[p25l223t3663r747b3741],
9	:	:	O	:	_	0	SENT_383	[p25l223t3663r747b3741],
10	Any	DT	O	any	det	11	SENT_383	[p25l803t3670r973b3767],
11	effect	NN	O	effect	dep	4	SENT_383	[p25l1024t3663r1265b3740],
12	by	IN	O	by	_	0	SENT_383	[p25l1322t3663r1419b3767],
13	increasing	VBG	O	increase	prep_by	11	SENT_383	[p25l1472t3666r1807b3740, p26l226t30r354b132],

1	the	DT	O	the	det	2	SENT_384	[p26l417t27r553b104],
2	dose	NN	O	dose	_	0	SENT_384	[p26l623t27r824b104],
3	of	IN	O	of	_	0	SENT_384	[p26l894t27r995b104],
4	esomeprazole	NN	O	esomeprazole	prep_of	2	SENT_384	[p26l1047t27r1651b131],
5	or	CC	O	or	_	0	SENT_384	[p26l1721t56r1814b104],
6	prolonging	VBG	O	prolong	prep_of	2	SENT_384	[p26l227t193r707b297],
7	the	DT	O	the	det	8	SENT_384	[p26l734t193r870b270],
8	treatment	NN	O	treatment	dobj	6	SENT_384	[p26l901t198r1382b270],
9	?	.	O	?	_	0	SENT_384	[p26l901t198r1382b270],

1	Amj	NNP	PERSON	Amj	nn	2	SENT_385	[p26l1410t199r1606b290],
2	Gastroenterol	NNP	PERSON	Gastroenterol	_	0	SENT_385	[p26l1634t198r1808b270, p26l223t337r625b414],
3	.	.	O	.	_	0	SENT_385	[p26l1634t198r1808b270, p26l223t337r625b414],

1	2005	CD	DATE	2005	_	0	SENT_386	[p26l669t342r1663b431],
2	;	:	O	;	_	0	SENT_386	[p26l669t342r1663b431],
3	100:1935	CD	DURATION	100:1935	number	4	SENT_386	[p26l669t342r1663b431],
4	-1940	CD	DURATION	-1940	dep	1	SENT_386	[p26l669t342r1663b431],
5	.	.	O	.	_	0	SENT_386	[p26l669t342r1663b431],

1	jects	NNS	O	ject	_	0	SENT_387	[p26l6t740r136b801],
2	.	.	O	.	_	0	SENT_387	[p26l6t740r136b801],

1	Clin	NNP	O	Clin	nn	3	SENT_388	[p26l178t739r264b785],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_388	[p26l299t739r539b785],
3	Ther	NNP	O	Ther	_	0	SENT_388	[p26l571t739r685b785],
4	.	.	O	.	_	0	SENT_388	[p26l571t739r685b785],

1	1997	CD	DATE	1997	_	0	SENT_389	[p26l731t742r952b795],
2	;	:	O	;	_	0	SENT_389	[p26l731t742r952b795],
3	62	CD	NUMBER	62	num	5	SENT_389	[p26l731t742r952b795],
4	:	:	O	:	_	0	SENT_389	[p26l731t742r952b795],
5	129-137	CD	NUMBER	129-137	dep	1	SENT_389	[p26l17t819r251b862],
6	.	.	O	.	_	0	SENT_389	[p26l17t819r251b862],

1	Ohning	VBG	O	ohn	_	0	SENT_390	[p26l14t894r212b957],
2	GV	NN	O	gv	dep	1	SENT_390	[p26l256t897r346b951],
3	,	,	O	,	_	0	SENT_390	[p26l256t897r346b951],
4	Barbuti	NNP	O	Barbuti	nn	5	SENT_390	[p26l397t894r586b940],
5	RC	NNP	O	RC	appos	2	SENT_390	[p26l637t897r726b951],
6	,	,	O	,	_	0	SENT_390	[p26l637t897r726b951],
7	Kovacs	NNP	PERSON	Kovacs	appos	2	SENT_390	[p26l776t898r955b941],
8	TO	TO	O	to	infmod	7	SENT_390	[p26l8t975r109b1029],
9	,	,	O	,	_	0	SENT_390	[p26l8t975r109b1029],
10	et	FW	O	et	nn	11	SENT_390	[p26l155t985r201b1018],
11	al.	FW	O	al.	appos	2	SENT_390	[p26l243t972r300b1018],
12	.	.	O	.	_	0	SENT_390	[p26l243t972r300b1018],

1	Rabeprazole	NN	O	rabeprazole	nsubj	2	SENT_391	[p26l350t972r672b1034],
2	produces	VBZ	O	produce	_	0	SENT_391	[p26l717t972r956b1034],
3	rapid	JJ	O	rapid	acomp	2	SENT_391	[p26l15t1050r166b1112],
4	,	,	O	,	_	0	SENT_391	[p26l15t1050r166b1112],
5	potent	JJ	O	potent	dep	3	SENT_391	[p26l192t1063r379b1112],
6	,	,	O	,	_	0	SENT_391	[p26l192t1063r379b1112],
7	and	CC	O	and	_	0	SENT_391	[p26l403t1050r497b1096],
8	|	NN	O	|	conj_and	2	SENT_391	[p26l525t1050r820b1113],
9	ong	FW	O	ong	nn	8	SENT_391	[p26l525t1050r820b1113],
10	—	FW	O	—	dep	8	SENT_391	[p26l525t1050r820b1113],
11	acting	VBG	O	act	xcomp	8	SENT_391	[p26l525t1050r820b1113],
12	inhibition	NN	O	inhibition	nn	13	SENT_391	[p26l842t1050r955b1096, p26l15t1128r164b1175],
13	oF	NN	O	of	nsubj	16	SENT_391	[p26l203t1128r263b1175],
14	gastric	JJ	O	gastric	amod	16	SENT_391	[p26l288t1130r460b1191],
15	acid	NN	O	acid	nn	16	SENT_391	[p26l496t1128r600b1174],
16	secretion	NN	O	secretion	xcomp	11	SENT_391	[p26l639t1130r871b1174],
17	in	IN	O	in	_	0	SENT_391	[p26l912t1130r953b1174],
18	subjects	NNS	O	subject	prep_in	16	SENT_391	[p26l13t1206r223b1269],
19	with	IN	O	with	_	0	SENT_391	[p26l258t1206r368b1252],
20	Helicobacter	NNP	PERSON	Helicobacter	nn	22	SENT_391	[p26l408t1206r700b1252],
21	pylori	NNP	PERSON	pylori	nn	22	SENT_391	[p26l725t1206r855b1269],
22	inFection	NNP	O	inFection	prep_with	18	SENT_391	[p26l892t1208r955b1252, p26l12t1283r214b1329],
23	.	.	O	.	_	0	SENT_391	[p26l892t1208r955b1252, p26l12t1283r214b1329],

1	Aliment	NNP	O	Aliment	nn	3	SENT_392	[p26l273t1283r468b1329],
2	Pliarmacol	NNP	O	Pliarmacol	nn	3	SENT_392	[p26l519t1283r777b1329],
3	Ther	NNP	O	Ther	_	0	SENT_392	[p26l829t1283r952b1329],
4	.	.	O	.	_	0	SENT_392	[p26l829t1283r952b1329],

1	2000	CD	DATE	2000	_	0	SENT_393	[p26l14t1362r501b1416],
2	;	:	O	;	_	0	SENT_393	[p26l14t1362r501b1416],
3	14:701	CD	NUMBER	14:701	number	4	SENT_393	[p26l14t1362r501b1416],
4	-708	CD	NUMBER	-708	dep	1	SENT_393	[p26l14t1362r501b1416],
5	.	.	O	.	_	0	SENT_393	[p26l14t1362r501b1416],

1	Gisbert	NNP	PERSON	Gisbert	nn	2	SENT_394	[p26l14t1437r204b1483],
2	JP	NNP	PERSON	JP	_	0	SENT_394	[p26l232t1441r301b1495],
3	,	,	O	,	_	0	SENT_394	[p26l232t1441r301b1495],
4	Khorrami	NNP	PERSON	Khorrami	nn	5	SENT_394	[p26l345t1437r586b1483],
5	S	NNP	O	S	appos	2	SENT_394	[p26l625t1440r670b1494],
6	,	,	O	,	_	0	SENT_394	[p26l625t1440r670b1494],
7	Calvet	NNP	PERSON	Calvet	nn	8	SENT_394	[p26l710t1437r871b1483],
8	X	NNP	O	X	appos	2	SENT_394	[p26l904t1441r954b1494],
9	,	,	O	,	_	0	SENT_394	[p26l904t1441r954b1494],
10	Pajares	NNP	PERSON	Pajares	nn	11	SENT_394	[p26l17t1516r205b1577],
11	JM	NN	O	jm	appos	2	SENT_394	[p26l258t1518r354b1572],
12	.	.	O	.	_	0	SENT_394	[p26l258t1518r354b1572],

1	Systematic	JJ	MISC	systematic	amod	2	SENT_395	[p26l419t1516r709b1576],
2	review	NN	O	review	_	0	SENT_395	[p26l772t1516r953b1560],
3	:	:	O	:	_	0	SENT_395	[p26l772t1516r953b1560],
4	Rabeprazole-based	JJ	O	rabeprazole-based	amod	5	SENT_395	[p26l17t1592r531b1654],
5	therapies	NNS	O	therapy	dep	2	SENT_395	[p26l596t1592r845b1654],
6	in	IN	O	in	_	0	SENT_395	[p26l911t1594r952b1637],
7	Helicobacter	NNP	O	Helicobacter	nn	9	SENT_395	[p26l13t1670r298b1716],
8	pylori	NNP	O	pylori	nn	9	SENT_395	[p26l306t1670r433b1732],
9	eradication	NN	O	eradication	prep_in	5	SENT_395	[p26l450t1670r754b1716],
10	.	.	O	.	_	0	SENT_395	[p26l450t1670r754b1716],

1	Aliment	NNP	O	Aliment	nn	2	SENT_396	[p26l771t1670r960b1716],
2	Pl1armacolTlier	NNP	O	Pl1armacolTlier	_	0	SENT_396	[p26l13t1747r401b1793],
3	.	.	O	.	_	0	SENT_396	[p26l13t1747r401b1793],

1	2003	CD	DATE	2003	_	0	SENT_397	[p26l427t1750r912b1803],
2	;	:	O	;	_	0	SENT_397	[p26l427t1750r912b1803],
3	17:751	CD	NUMBER	17:751	number	4	SENT_397	[p26l427t1750r912b1803],
4	-764	CD	NUMBER	-764	dep	1	SENT_397	[p26l427t1750r912b1803],
5	.	.	O	.	_	0	SENT_397	[p26l427t1750r912b1803],

1	40	CD	NUMBER	40	_	0	SENT_398	[p26l67t1880r114b1905],
2	.	.	O	.	_	0	SENT_398	[p26l67t1880r114b1905],

1	Tybring	VBG	O	tybr	_	0	SENT_399	[p26l140t1878r256b1914],
2	G	NN	O	g	nsubj	7	SENT_399	[p26l269t1880r301b1911],
3	,	,	O	,	_	0	SENT_399	[p26l269t1880r301b1911],
4	Bottiger	NNP	O	Bottiger	nn	5	SENT_399	[p26l318t1879r440b1914],
5	Y	NN	O	y	appos	2	SENT_399	[p26l449t1880r474b1911],
6	,	,	O	,	_	0	SENT_399	[p26l449t1880r474b1911],
7	Widen	VB	O	widen	ccomp	1	SENT_399	[p26l487t1878r586b1905],
8	J	NN	O	j	dobj	7	SENT_399	[p26l596t1880r618b1911],
9	,	,	O	,	_	0	SENT_399	[p26l596t1880r618b1911],
10	Bertilsson	NNP	O	Bertilsson	nn	14	SENT_399	[p26l635t1880r692b1905, p26l142t1928r239b1955],
11	L.	NNP	O	L.	nn	14	SENT_399	[p26l260t1930r281b1955],
12	Enantioselective	NNP	O	Enantioselective	nn	14	SENT_399	[p26l302t1928r546b1955],
13	hydroxy	NN	O	hydroxy	nn	14	SENT_399	[p26l565t1928r692b1964],
14	—	NN	O	—	appos	8	SENT_399	[p26l565t1928r692b1964],

1	X.	NNP	O	X.	nn	2	SENT_400	[p26l1736t563r1796b609],
2	Pan	NNP	O	Pan	_	0	SENT_400	[p26l1826t563r1934b609],
3	et	FW	O	et	nn	4	SENT_400	[p26l1961t571r2019b610],
4	al.	FW	O	al.	dep	2	SENT_400	[p26l2041t559r2108b609],
5	.	.	O	.	_	0	SENT_400	[p26l2041t559r2108b609],

1	Miwa	NN	PERSON	miwa	nn	2	SENT_401	[p26l1213t741r1355b785],
2	H	NN	PERSON	h	_	0	SENT_401	[p26l1388t743r1443b796],
3	,	,	O	,	_	0	SENT_401	[p26l1388t743r1443b796],
4	Yamada	NNP	PERSON	Yamada	nn	5	SENT_401	[p26l1470t739r1683b785],
5	T	NN	O	t	appos	2	SENT_401	[p26l1708t743r1757b796],
6	,	,	O	,	_	0	SENT_401	[p26l1708t743r1757b796],
7	Sato	NNP	PERSON	Sato	nn	8	SENT_401	[p26l1788t742r1905b785],
8	K	NNP	O	K	appos	2	SENT_401	[p26l1939t743r1985b796],
9	,	,	O	,	_	0	SENT_401	[p26l1939t743r1985b796],
10	et	FW	O	et	nn	11	SENT_401	[p26l2017t751r2063b785],
11	al.	FW	O	al.	appos	2	SENT_401	[p26l2092t739r2149b785],
12	.	.	O	.	_	0	SENT_401	[p26l2092t739r2149b785],

1	Efﬁcacy	NN	O	efﬁcacy	_	0	SENT_402	[p26l1214t816r1417b878],
2	of	IN	O	of	_	0	SENT_402	[p26l1436t816r1497b862],
3	reduced	VBN	O	reduce	amod	4	SENT_402	[p26l1510t816r1714b862],
4	dosage	NN	O	dosage	prep_of	1	SENT_402	[p26l1741t816r1923b879],
5	of	IN	O	of	_	0	SENT_402	[p26l1946t816r2007b862],
6	rabe	NN	O	rabe	nn	8	SENT_402	[p26l2020t816r2152b862],
7	—	NN	O	—	nn	8	SENT_402	[p26l2020t816r2152b862],
8	prazole	NN	O	prazole	prep_of	4	SENT_402	[p26l1213t895r1400b957],
9	in	IN	O	in	_	0	SENT_402	[p26l1430t896r1470b940],
10	PPI/AC	NN	O	ppi/ac	nn	11	SENT_402	[p26l1505t898r1690b952],
11	therapy	NN	O	therapy	prep_in	8	SENT_402	[p26l1716t895r1917b957],
12	For	IN	O	for	_	0	SENT_402	[p26l1941t895r2016b941],
13	Helicobacter	NNP	PERSON	Helicobacter	nn	15	SENT_402	[p26l2041t895r2153b941, p26l1209t973r1404b1019],
14	pylori	NN	PERSON	pylorus	nn	15	SENT_402	[p26l1413t973r1539b1035],
15	infection	NN	O	infection	prep_for	11	SENT_402	[p26l1563t973r1805b1019],
16	:	:	O	:	_	0	SENT_402	[p26l1563t973r1805b1019],
17	Comparison	NN	O	comparison	dep	1	SENT_402	[p26l1828t974r2150b1035],
18	of	IN	O	of	_	0	SENT_402	[p26l1211t1051r1271b1097],
19	20	CD	NUMBER	20	prep_of	17	SENT_402	[p26l1290t1054r1351b1097],
20	and	CC	O	and	_	0	SENT_402	[p26l1381t1051r1475b1097],
21	40	CD	NUMBER	40	num	23	SENT_402	[p26l1505t1054r1569b1097],
22	mg	NN	O	mg	nn	23	SENT_402	[p26l1601t1068r1679b1113],
23	rabeprazole	NN	O	rabeprazole	dep	1	SENT_402	[p26l1707t1051r2014b1113],
24	with	IN	O	with	_	0	SENT_402	[p26l2040t1051r2150b1097],
25	60	CD	NUMBER	60	num	27	SENT_402	[p26l1212t1132r1273b1175],
26	mg	NN	O	mg	nn	27	SENT_402	[p26l1322t1146r1400b1191],
27	Iansoprazole	NN	O	iansoprazole	prep_with	23	SENT_402	[p26l1446t1129r1793b1191],
28	.	.	O	.	_	0	SENT_402	[p26l1446t1129r1793b1191],

1	Dig	VB	O	dig	_	0	SENT_403	[p26l1841t1131r1924b1191],
2	Dis	NNP	O	Dis	nn	3	SENT_403	[p26l1960t1131r2035b1175],
3	Sci	NNP	O	Sci	dobj	1	SENT_403	[p26l2073t1131r2150b1175],
4	.	.	O	.	_	0	SENT_403	[p26l2073t1131r2150b1175],

1	2000	CD	DATE	2000	num	3	SENT_404	[p26l1212t1210r1629b1264],
2	;	:	O	;	_	0	SENT_404	[p26l1212t1210r1629b1264],
3	45:77	CD	NUMBER	45:77	_	0	SENT_404	[p26l1212t1210r1629b1264],
4	—	CD	NUMBER	—	number	5	SENT_404	[p26l1212t1210r1629b1264],
5	82	CD	NUMBER	82	num	3	SENT_404	[p26l1212t1210r1629b1264],
6	.	.	O	.	_	0	SENT_404	[p26l1212t1210r1629b1264],

1	McLe	NNP	O	McLe	nsubj	2	SENT_405	[p26l1213t1284r1445b1329],
2	|	VBD	O	|	_	0	SENT_405	[p26l1213t1284r1445b1329],
3	|	CD	NUMBER	|	dobj	2	SENT_405	[p26l1213t1284r1445b1329],
4	an	DT	O	a	det	5	SENT_405	[p26l1213t1284r1445b1329],
5	RA	NN	MISC	ra	tmod	2	SENT_405	[p26l1488t1287r1575b1340],
6	,	,	O	,	_	0	SENT_405	[p26l1488t1287r1575b1340],
7	Drobitch	NNP	O	Drobitch	nn	8	SENT_405	[p26l1616t1284r1845b1329],
8	RK	NNP	O	RK	appos	5	SENT_405	[p26l1887t1287r1972b1340],
9	,	,	O	,	_	0	SENT_405	[p26l1887t1287r1972b1340],
10	Monshouwer	NNP	O	Monshouwer	nn	11	SENT_405	[p26l2012t1288r2152b1329, p26l1210t1360r1433b1406],
11	M	NNP	O	M	appos	8	SENT_405	[p26l1452t1364r1517b1416],
12	,	,	O	,	_	0	SENT_405	[p26l1452t1364r1517b1416],
13	Renton	NNP	LOCATION	Renton	nn	16	SENT_405	[p26l1543t1363r1726b1406],
14	K	NNP	O	K	nn	16	SENT_405	[p26l1752t1364r1854b1406],
15	\	NNP	O	\	nn	16	SENT_405	[p26l1752t1364r1854b1406],
16	N.	NNP	O	N.	appos	8	SENT_405	[p26l1752t1364r1854b1406],
17	F	NN	O	f	nn	20	SENT_405	[p26l1879t1360r2152b1422, p26l1213t1438r1394b1484],
18	|	NN	O	|	nn	20	SENT_405	[p26l1879t1360r2152b1422, p26l1213t1438r1394b1484],
19	uoroquinolone	NN	O	uoroquinolone	nn	20	SENT_405	[p26l1879t1360r2152b1422, p26l1213t1438r1394b1484],
20	antibiotics	NNS	O	antibiotic	nsubj	21	SENT_405	[p26l1451t1438r1736b1484],
21	inhibit	VBP	O	inhibit	rcmod	16	SENT_405	[p26l1794t1438r1967b1484],
22	cytochrome	NN	O	cytochrome	nn	26	SENT_405	[p26l2021t1450r2152b1500, p26l1210t1515r1407b1561],
23	P450-mediated	JJ	O	p450-mediated	amod	26	SENT_405	[p26l1426t1515r1824b1561],
24	microsomal	JJ	O	microsomal	amod	26	SENT_405	[p26l1845t1515r2150b1561],
25	drug	NN	O	drug	nn	26	SENT_405	[p26l1211t1593r1330b1655],
26	metabolism	NN	O	metabolism	dobj	21	SENT_405	[p26l1350t1593r1655b1639],
27	in	IN	O	in	_	0	SENT_405	[p26l1680t1594r1720b1638],
28	rat	NN	O	rat	prep_in	26	SENT_405	[p26l1745t1605r1816b1639],
29	and	CC	O	and	_	0	SENT_405	[p26l1834t1593r1929b1639],
30	human	JJ	O	human	conj_and	28	SENT_405	[p26l1954t1593r2149b1639],
31	.	.	O	.	_	0	SENT_405	[p26l1954t1593r2149b1639],

1	Drug	NN	O	drug	_	0	SENT_406	[p26l1210t1674r1331b1733],
2	Metab	NNP	O	Metab	nn	3	SENT_406	[p26l1357t1671r1509b1717],
3	Dispos	NNP	O	Dispos	dep	1	SENT_406	[p26l1543t1673r1708b1733],
4	.	.	O	.	_	0	SENT_406	[p26l1543t1673r1708b1733],

1	1996	CD	DATE	1996	_	0	SENT_407	[p26l1752t1674r2153b1727],
2	;	:	O	;	_	0	SENT_407	[p26l1752t1674r2153b1727],
3	24:1134	CD	NUMBER	24:1134	number	4	SENT_407	[p26l1752t1674r2153b1727],
4	—	CD	NUMBER	—	dep	1	SENT_407	[p26l1752t1674r2153b1727],
5	1138	CD	DATE	1138	dep	4	SENT_407	[p26l1215t1751r1358b1794],
6	.	.	O	.	_	0	SENT_407	[p26l1215t1751r1358b1794],

1	Address	NN	O	address	nn	2	SENT_408	[p26l765t1915r911b1948],
2	correspondence	NN	O	correspondence	_	0	SENT_408	[p26l944t1915r1233b1957],
3	to	TO	O	to	dep	2	SENT_408	[p26l1264t1923r1310b1948],
4	:	:	O	:	_	0	SENT_408	[p26l1264t1923r1310b1948],
5	Guoxin	NNP	PERSON	Guoxin	nn	6	SENT_408	[p26l1345t1917r1482b1948],
6	Zhang	NNP	PERSON	Zhang	pobj	3	SENT_408	[p26l1515t1915r1646b1957],
7	,	,	O	,	_	0	SENT_408	[p26l1515t1915r1646b1957],
8	PhD	NNP	O	PhD	appos	6	SENT_408	[p26l1679t1915r1769b1955],
9	,	,	O	,	_	0	SENT_408	[p26l1679t1915r1769b1955],
10	Department	NNP	O	Department	appos	6	SENT_408	[p26l1802t1917r2023b1957],
11	of	IN	O	of	_	0	SENT_408	[p26l2056t1915r2092b1948],
12	Iation	NNP	O	Iation	prep_of	10	SENT_408	[p26l144t1976r228b2003],
13	of	IN	O	of	_	0	SENT_408	[p26l250t1975r285b2003],
14	omeprazole	NN	O	omeprazole	prep_of	12	SENT_408	[p26l300t1975r478b2012],
15	catalyzed	VBN	O	catalyze	partmod	14	SENT_408	[p26l498t1975r637b2012],
16	by	IN	O	by	_	0	SENT_408	[p26l661t1975r694b2012],
17	Gastroenterology	NNP	O	Gastroenterology	agent	15	SENT_408	[p26l767t1967r1088b2009],
18	,	,	O	,	_	0	SENT_408	[p26l767t1967r1088b2009],
19	First	NNP	ORGANIZATION	First	nn	21	SENT_408	[p26l1100t1969r1181b2000],
20	Affiliated	NNP	ORGANIZATION	Affiliated	nn	21	SENT_408	[p26l1191t1967r1363b2000],
21	Hospital	NNP	ORGANIZATION	Hospital	appos	6	SENT_408	[p26l1374t1967r1529b2009],
22	of	IN	ORGANIZATION	of	_	0	SENT_408	[p26l1541t1967r1577b2000],
23	Nanjing	NNP	ORGANIZATION	Nanjing	nn	25	SENT_408	[p26l1585t1969r1731b2009],
24	Medical	NNP	ORGANIZATION	Medical	nn	25	SENT_408	[p26l1741t1967r1888b2000],
25	University	NNP	ORGANIZATION	University	prep_of	21	SENT_408	[p26l1898t1969r2090b2009],
26	,	,	O	,	_	0	SENT_408	[p26l1898t1969r2090b2009],
27	CYPZC19	NN	O	cypzc19	appos	6	SENT_408	[p26l143t2025r288b2051],
28	in	IN	O	in	_	0	SENT_408	[p26l315t2024r339b2050],
29	Swedish	JJ	MISC	swedish	amod	31	SENT_408	[p26l366t2023r491b2051],
30	white	JJ	O	white	amod	31	SENT_408	[p26l517t2023r601b2051],
31	subNovember	NN	O	subnovember	prep_in	27	SENT_408	[p26l627t2023r692b2051, p26l94t2075r278b2105],
32	2010	CD	DATE	2010	dep	27	SENT_408	[p26l291t2077r377b2105],

1	Nanjing	VBG	O	nanj	_	0	SENT_409	[p26l765t2021r910b2061],
2	210029	CD	NUMBER	210029	dobj	1	SENT_409	[p26l925t2022r1070b2060],
3	,	,	O	,	_	0	SENT_409	[p26l925t2022r1070b2060],
4	China	NNP	LOCATION	China	appos	2	SENT_409	[p26l1087t2019r1205b2052],
5	.	.	O	.	_	0	SENT_409	[p26l1087t2019r1205b2052],

1	E	NN	O	e	nn	3	SENT_410	[p26l1221t2019r1351b2052],
2	—	CD	NUMBER	—	num	3	SENT_410	[p26l1221t2019r1351b2052],
3	mail	NN	O	mail	_	0	SENT_410	[p26l1221t2019r1351b2052],
4	:	:	O	:	_	0	SENT_410	[p26l1221t2019r1351b2052],
5	guoxinz@njmu.edu.cn	NN	O	guoxinz@njmu.edu.cn	dep	3	SENT_410	[p26l1368t2019r1769b2061],

